displayName,description,datatype,patientAttribute,priority,clinicalAttributeId,studyId
"Adjuvant Chemotherapy","Adjuvant Chemotherapy","STRING",true,"1","ADJUVANT_CHEMO","acbc_mskcc_2015"
"Adjuvant Treatment","Adjuvant treatment.","STRING",true,"1","ADJUVANT_TX","acbc_mskcc_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","acbc_mskcc_2015"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","acbc_mskcc_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","acbc_mskcc_2015"
"ER Status By IHC","breast carcinoma progesterone receptor status","STRING",false,"1","ER_STATUS_BY_IHC","acbc_mskcc_2015"
"Followup (years)","Followup in years","NUMBER",true,"1","FOLLOWUP_YEARS","acbc_mskcc_2015"
"Fusion Status","Fusion Status","STRING",false,"1","FUSION_STATUS","acbc_mskcc_2015"
"Genomic Alterations","Number of genomic alterations","NUMBER",false,"1","GENOMIC_ALTERATIONS","acbc_mskcc_2015"
"IHC-HER2","IHC-HER2","STRING",false,"1","IHC_HER2","acbc_mskcc_2015"
"Local Regional Recurrence","Local Regional Recurrence","STRING",true,"1","LOCAL_REGIONAL_RECURRENCE","acbc_mskcc_2015"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","acbc_mskcc_2015"
"Metastatic tumor indicator","Distant metastasis present ind2","STRING",false,"1","METASTATIC_TUMOR_INDICATOR","acbc_mskcc_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","acbc_mskcc_2015"
"MYB or MYBL1 Fusion","Description of MYB or MYBL1 fusions identified.","STRING",true,"1","MYB_MYBL1_FUSION","acbc_mskcc_2015"
"MYB-NFIB Fusion Gene Copy Number Alterations","MYB-NFIB Fusion Gene Copy Number Alterations","STRING",false,"1","MYB_NFIB_CNA","acbc_mskcc_2015"
"MYB-NFIB FISH","MYB-NFIB FISH.","STRING",false,"1","MYB_NFIB_FISH","acbc_mskcc_2015"
"MYB-NFIB Fusion Gene Non-synonymous Mutations","Count of non-synonymous mutations in MYB-NFIB Fusion Gene","STRING",false,"1","MYB_NFIB_NONSYNONYMOUS_COUNT","acbc_mskcc_2015"
"MYB-NFIB Rearrangement","MYB-NFIB Rearrangement Description","STRING",true,"1","MYB_NFIB_REARRANGEMENT","acbc_mskcc_2015"
"Neoadjuvant Chemotherapy","Neoadjuvant Chemotherapy.","STRING",true,"1","NEOADJUVANT_CHEMO","acbc_mskcc_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","acbc_mskcc_2015"
"Overall Patient Histology","Overall Patient Histology","STRING",true,"1","OVERALL_PATIENT_HISTOLOGY","acbc_mskcc_2015"
"Platform","Platform.","STRING",false,"1","PLATFORM","acbc_mskcc_2015"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","acbc_mskcc_2015"
"PR status by ihc","Breast carcinoma progesterone receptor status","STRING",false,"1","PR_STATUS_BY_IHC","acbc_mskcc_2015"
"Radiation Therapy","Radiation therapy description","STRING",true,"1","RADIATION_THERAPY","acbc_mskcc_2015"
"Sample Type","""The type of sample (i.e., normal, primary, met, recurrence).""","STRING",false,"1","SAMPLE_TYPE","acbc_mskcc_2015"
"Sex","Sex","STRING",true,"1","SEX","acbc_mskcc_2015"
"Time to Metastasis (months)","Time to metastasis (months).","NUMBER",true,"1","TIME_TO_MET_MONTHS","acbc_mskcc_2015"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","acbc_mskcc_2015"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","acbc_mskcc_2015"
"Type of Surgery","Type of Surgery.","STRING",false,"1","TYPE_OF_SURGERY","acbc_mskcc_2015"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","acbc_mskcc_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","acc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","acc_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","acc_tcga"
"Atypical Mitotic Figures","Atypical Mitotic Figures","STRING",true,"1","ATYPICAL_MITOTIC_FIGURES","acc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","acc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","acc_tcga"
"CAPSULAR INVASION","CAPSULAR INVASION","STRING",true,"1","CAPSULAR_INVASION","acc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","acc_tcga"
"Clinical Status Within 3 Mths Surgery","Clinical Status Within 3 Mths Surgery","STRING",true,"1","CLINICAL_STATUS_WITHIN_3_MTHS_SURGERY","acc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","acc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","acc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","acc_tcga"
"Ct scan preop results","Diagnostic ct result outcome","STRING",true,"1","CT_SCAN_PREOP_RESULTS","acc_tcga"
"Cytoplasm Presence Less Than Equal 25 Percent","Cytoplasm Presence Less Than Equal 25 Percent","STRING",true,"1","CYTOPLASM_PRESENCE_LESS_THAN_EQUAL_25_PERCENT","acc_tcga"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","acc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","acc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","acc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","acc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","acc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","acc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","acc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","acc_tcga"
"Diffuse Architecture","Diffuse Architecture","STRING",true,"1","DIFFUSE_ARCHITECTURE","acc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","acc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","acc_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","acc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","acc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","acc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","acc_tcga"
"Excess Adrenal Hormone History Type","Excess Adrenal Hormone History Type","STRING",true,"1","HISTORY_ADRENAL_HORMONE_EXCESS","acc_tcga"
"Excess Adrenal Hormone Diagnosis Method Type","Excess Adrenal Hormone Diagnosis Method Type","STRING",true,"1","HISTORY_BASIS_ADRENAL_HORMONE_DX","acc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","acc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","acc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","acc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","acc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","acc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","acc_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","acc_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","acc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","acc_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","acc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","acc_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","acc_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","acc_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","acc_tcga"
"Metastatic Neoplasm Confirmed Diagnosis Method Name","Metastatic Neoplasm Confirmed Diagnosis Method Name","STRING",true,"1","METASTATIC_DX_CONFIRMED_BY","acc_tcga"
"Metastatic Neoplasm Confirmed Diagnosis Method Text","Metastatic Neoplasm Confirmed Diagnosis Method Text","STRING",true,"1","METASTATIC_DX_CONFIRMED_BY_OTHER","acc_tcga"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",true,"1","METASTATIC_SITE","acc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","acc_tcga"
"Mitoses Count","Mitoses Count","NUMBER",true,"1","MITOSES_PER_50_HPF","acc_tcga"
"Mitotic Rate","Mitotic Rate","STRING",true,"1","MITOTIC_RATE","acc_tcga"
"Molecular Analysis Performed Indicator","Molecular Analysis Performed Indicator","STRING",true,"1","MOLECULAR_STUDIES_OTHERS_PERFORMED","acc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","acc_tcga"
"Necrosis","Necrosis","STRING",true,"1","NECROSIS","acc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","acc_tcga"
"Nuclear Grade III IV","Nuclear Grade III IV","STRING",true,"1","NUCLEAR_GRADE_III_IV","acc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","acc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","acc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","acc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","acc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","acc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","acc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","acc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","acc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","acc_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","acc_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","acc_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","acc_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","acc_tcga"
"Mitotane Therapy adjuvant setting","Mitotane Therapy Adjuvant Setting","STRING",true,"1","PHARM_TX_MITOTANE_ADJUVANT","acc_tcga"
"Mitotane Therapy for macroscopic residual disease","Mitotane Therapy For Macroscopic Residual Disease","STRING",true,"1","PHARM_TX_MITOTANE_FOR_MACRO_DISEASE","acc_tcga"
"Mitotane Therapy","Mitotane Therapy","STRING",true,"1","PHARM_TX_MITOTANE_INDICATOR","acc_tcga"
"Therapeutic Mitotane lvl progression","Therapeutic Mitotane Lvl Progression","STRING",true,"1","PHARM_TX_MITOTANE_THERAPUTIC_AT_PROG","acc_tcga"
"Therapeutic Mitotane lvl recurrence","Therapeutic Mitotane Lvl Recurrence","STRING",true,"1","PHARM_TX_MITOTANE_THERAPUTIC_AT_REC","acc_tcga"
"Therapeutic Mitotane levels achieved","Therapeutic Mitotane Levels Achieved","STRING",true,"1","PHARM_TX_MITOTANE_THERAPUTIC_LEVELS","acc_tcga"
"Therapeutic Mitotane lvl macroscopic residual","Therapeutic Mitotane Lvl Macroscopic Residual","STRING",true,"1","PHARM_TX_MITOTANE_THERAPUTIC_MACRO","acc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","acc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","acc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","acc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","acc_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","acc_tcga"
"RET","RET","STRING",true,"1","RET","acc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","acc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","acc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","acc_tcga"
"SDHA","SDHA","STRING",true,"1","SDHA","acc_tcga"
"SDHAF2 SDH5","SDHAF2 SDH5","STRING",true,"1","SDHAF2_SDH5","acc_tcga"
"SDHB","SDHB","STRING",true,"1","SDHB","acc_tcga"
"SDHC","SDHC","STRING",true,"1","SDHC","acc_tcga"
"SDHD","SDHD","STRING",true,"1","SDHD","acc_tcga"
"Sex","Sex","STRING",true,"1","SEX","acc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","acc_tcga"
"Sinusoid Invasion","Sinusoid Invasion","STRING",true,"1","SINUSOID_INVASION","acc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","acc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","acc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","acc_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","acc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","acc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","acc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","acc_tcga"
"Tmem127","Tmem127","STRING",true,"1","TMEM127","acc_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","acc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","acc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","acc_tcga"
"Von Hippel-Lindau","Von Hippel-Lindau syndrome (VHL) is a hereditary condition associated with hemangioblastomas, which are blood vessel tumors of the brain, spinal cord, and eye.","STRING",true,"1","VHL","acc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","acc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","acc_tcga"
"Weiss Score Overall","Weiss Score Overall","STRING",true,"1","WEISS_SCORE_OVERALL","acc_tcga"
"Weiss Venous Invasion","Weiss Venous Invasion","STRING",true,"1","WEISS_VENOUS_INVASION","acc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","acc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","acc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","acc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","acc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","acc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","acc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","acc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","acc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","acc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","acc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","acc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","acc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","acc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","acc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","acc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","acc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","acc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","acc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","acc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","acc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","acc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","acc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","acc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","acc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","acc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","acc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","acc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","acc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","acc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","acc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","acc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","acc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","acc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","acc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","acc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","acc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","acc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","acc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","acc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","acc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","acc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","acc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","acc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","acc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","acc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","acc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","acc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","acc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","acc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","acc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","acc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","acc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","acc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","acc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","acc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","acc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","acc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","acc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","acc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","acc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","acc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","acc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","acc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","acc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","acc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","acc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","acc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","acc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","acc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","acc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","acc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","acc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","acc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","acc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","acc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","acc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","acc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","acc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","acc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","acc_tcga_pan_can_atlas_2018"
"Actionable Alterations","Number of actionable alterations","NUMBER",false,"1","ACTIONABLE_ALTERATIONS","acyc_fmi_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","acyc_fmi_2014"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","acyc_fmi_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","acyc_fmi_2014"
"Fusion Status","Fusion Status","STRING",false,"1","FUSION_STATUS","acyc_fmi_2014"
"Genomic Alterations","Number of genomic alterations","NUMBER",false,"1","GENOMIC_ALTERATIONS","acyc_fmi_2014"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","acyc_fmi_2014"
"Metastatic tumor indicator","Distant metastasis present ind2","STRING",false,"1","METASTATIC_TUMOR_INDICATOR","acyc_fmi_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","acyc_fmi_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","acyc_fmi_2014"
"Patient Tumor Grade","Patient Tumor Grade","STRING",true,"1","PATIENT_GRADE","acyc_fmi_2014"
"Platform","Platform.","STRING",false,"1","PLATFORM","acyc_fmi_2014"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","acyc_fmi_2014"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","acyc_fmi_2014"
"Sex","Sex","STRING",true,"1","SEX","acyc_fmi_2014"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","acyc_fmi_2014"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","acyc_fmi_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","acyc_mda_2015"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","acyc_mda_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","acyc_mda_2015"
"Other Gene Fusion","Description of other gene fusions identified by RT-PCR/qPCR/WGS (non-MYB/MYBL1/NFIB).","STRING",true,"1","FUSION_OTHER","acyc_mda_2015"
"Fusion Status","Fusion Status","STRING",false,"1","FUSION_STATUS","acyc_mda_2015"
"Genomic Alterations","Number of genomic alterations","NUMBER",false,"1","GENOMIC_ALTERATIONS","acyc_mda_2015"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","acyc_mda_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","acyc_mda_2015"
"MYB or MYBL1 Fusion","Description of MYB or MYBL1 fusions identified.","STRING",true,"1","MYB_MYBL1_FUSION","acyc_mda_2015"
"MYB or MYBL1 Fusion Method","Method used to validate MYB or MYBL1 gene fusions.","STRING",true,"1","MYB_MYBL1_FUSION_METHOD","acyc_mda_2015"
"MYB-NFIB FISH","MYB-NFIB FISH.","STRING",false,"1","MYB_NFIB_FISH","acyc_mda_2015"
"MYB-NFIB Rearrangement","MYB-NFIB Rearrangement Description","STRING",true,"1","MYB_NFIB_REARRANGEMENT","acyc_mda_2015"
"MYB-NFIB Translocation","Description of translocations resulting in MYB-NFIB gene fusions.","STRING",true,"1","MYB_NFIB_TRANSLOCATION","acyc_mda_2015"
"Other NFIB Fusion","Description of other NFIB fusions.","STRING",true,"1","NFIB_FUSION_OTHER","acyc_mda_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","acyc_mda_2015"
"Perineural Invasion","Perineural invasion.","STRING",false,"1","PERINEURAL_INVASION","acyc_mda_2015"
"Platform","Platform.","STRING",false,"1","PLATFORM","acyc_mda_2015"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","acyc_mda_2015"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","acyc_mda_2015"
"Sex","Sex","STRING",true,"1","SEX","acyc_mda_2015"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","acyc_mda_2015"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","acyc_mda_2015"
"Adjuvant Treatment","Adjuvant treatment.","STRING",true,"1","ADJUVANT_TX","acyc_mskcc_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","acyc_mskcc_2013"
"Angiolymphatic Invasion","Presence of angiolymphatic invasion.","STRING",true,"1","ANGIOLYMPHATIC_INVASION","acyc_mskcc_2013"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","acyc_mskcc_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","acyc_mskcc_2013"
"DiseaseFree (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","acyc_mskcc_2013"
"DiseaseFree Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","acyc_mskcc_2013"
"Disease Status","Disease Status","STRING",true,"1","DISEASE_STATUS","acyc_mskcc_2013"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","acyc_mskcc_2013"
"Fusion Status","Fusion Status","STRING",false,"1","FUSION_STATUS","acyc_mskcc_2013"
"Genomic Alterations","Number of genomic alterations","NUMBER",false,"1","GENOMIC_ALTERATIONS","acyc_mskcc_2013"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","acyc_mskcc_2013"
"Katabi Path","Katabi path.","STRING",true,"1","KATABI_PATH","acyc_mskcc_2013"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","acyc_mskcc_2013"
"Metastatic tumor indicator","Distant metastasis present ind2","STRING",false,"1","METASTATIC_TUMOR_INDICATOR","acyc_mskcc_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","acyc_mskcc_2013"
"MYB or MYBL1 Fusion","Description of MYB or MYBL1 fusions identified.","STRING",true,"1","MYB_MYBL1_FUSION","acyc_mskcc_2013"
"MYB-NFIB FISH","MYB-NFIB FISH.","STRING",false,"1","MYB_NFIB_FISH","acyc_mskcc_2013"
"Official Pathology","Official pathology.","STRING",true,"1","OFFICIAL_PATH","acyc_mskcc_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","acyc_mskcc_2013"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","acyc_mskcc_2013"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","acyc_mskcc_2013"
"Patient Tumor Grade","Patient Tumor Grade","STRING",true,"1","PATIENT_GRADE","acyc_mskcc_2013"
"Perineural Invasion","Perineural invasion.","STRING",false,"1","PERINEURAL_INVASION","acyc_mskcc_2013"
"Platform","Platform.","STRING",false,"1","PLATFORM","acyc_mskcc_2013"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","acyc_mskcc_2013"
"Radiation Therapy","Radiation therapy description","STRING",true,"1","RADIATION_THERAPY","acyc_mskcc_2013"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","acyc_mskcc_2013"
"Sex","Sex","STRING",true,"1","SEX","acyc_mskcc_2013"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","acyc_mskcc_2013"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","acyc_mskcc_2013"
"Aberrant Cell Fraction","Aberrant Cell Fraction","STRING",false,"1","ABERRANT_CELL_FRACTION","acyc_sanger_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","acyc_sanger_2013"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","acyc_sanger_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","acyc_sanger_2013"
"Fusion Status","Fusion Status","STRING",false,"1","FUSION_STATUS","acyc_sanger_2013"
"Genomic Alterations","Number of genomic alterations","NUMBER",false,"1","GENOMIC_ALTERATIONS","acyc_sanger_2013"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","acyc_sanger_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","acyc_sanger_2013"
"MYB Activation","Presence of MYB activation","STRING",true,"1","MYB_ACTIVATION","acyc_sanger_2013"
"MYB Validation Method","Method used for validating MYB activation","STRING",true,"1","MYB_VALIDATION","acyc_sanger_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","acyc_sanger_2013"
"Platform","Platform.","STRING",false,"1","PLATFORM","acyc_sanger_2013"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","acyc_sanger_2013"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","acyc_sanger_2013"
"Sex","Sex","STRING",true,"1","SEX","acyc_sanger_2013"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","acyc_sanger_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","all_phase2_target_2018_pub"
"Diagnosis Age (days)","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE_IN_DAYS","all_phase2_target_2018_pub"
"Alternative Therapy Given","Alternative Therapy Given","STRING",true,"1","ALTERNATE_THERAPY","all_phase2_target_2018_pub"
"Other Alternative Therapy Given","Other Alternative Therapy Given","STRING",true,"1","ALTERNATE_THERAPY_OTHER","all_phase2_target_2018_pub"
"Analysis Cohort","Analysis Cohort","STRING",false,"1","ANALYSIS_COHORT","all_phase2_target_2018_pub"
"BCR ABL1 Status","BCR ABL1 status","STRING",false,"1","BCR_ABL1_STATUS","all_phase2_target_2018_pub"
"Bone Marrow Blasts Day 15","Bone Marrow Blasts Day 15","NUMBER",true,"1","BM_DAY_15","all_phase2_target_2018_pub"
"Bone Marrow Blasts Day 29","Bone Marrow Blasts Day 29","NUMBER",true,"1","BM_DAY_29","all_phase2_target_2018_pub"
"Bone Marrow Blasts Day 43","Bone Marrow Blasts Day 43","NUMBER",true,"1","BM_DAY_43","all_phase2_target_2018_pub"
"Bone Marrow Blasts Day 8","Bone Marrow Blasts Day 8","NUMBER",true,"1","BM_DAY_8","all_phase2_target_2018_pub"
"Bone Marrow Site of Relapse","Bone Marrow Site of Relapse","STRING",false,"1","BONE_MARROW_SITE_OF_RELAPSE","all_phase2_target_2018_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","all_phase2_target_2018_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","all_phase2_target_2018_pub"
"Cell of tumor origin","Cell of tumor origin","STRING",false,"1","CELL_OF_ORIGIN","all_phase2_target_2018_pub"
"CNS Site of Relapse","CNS Site of Relapse","STRING",false,"1","CNS_SITE_OF_RELAPSE","all_phase2_target_2018_pub"
"CNS Status","CNS status.","STRING",true,"1","CNS_STATUS","all_phase2_target_2018_pub"
"Congenital Abnormality","Congentital abnormality.","STRING",true,"1","CONGENITAL_ABNORMALITY","all_phase2_target_2018_pub"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","all_phase2_target_2018_pub"
"Time To Event (days)","Time To Event (days)","NUMBER",true,"1","DAYS_TO_EVENT","all_phase2_target_2018_pub"
"DNA Index","DNA index.","STRING",false,"1","DNA_INDEX","all_phase2_target_2018_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","all_phase2_target_2018_pub"
"ETV6-RUNX1 Fusion Status","ETV6-RUNX1 Fusion Status","STRING",false,"1","ETV6_RUNX1_FUSION_STATUS","all_phase2_target_2018_pub"
"First Event","First Event","STRING",true,"1","FIRST_EVENT","all_phase2_target_2018_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","all_phase2_target_2018_pub"
"Karyotype","Karyotype.","STRING",true,"1","KARYOTYPE","all_phase2_target_2018_pub"
"MLL Status","MLL status.","STRING",false,"1","MLL_STATUS","all_phase2_target_2018_pub"
"Molecular Subtype","Molecular subtype.","STRING",false,"1","MOLECULAR_SUBTYPE","all_phase2_target_2018_pub"
"MRD Percentage at end of Consolidation","MRD percentage at end of consolidation","NUMBER",true,"1","MRD_END_CONSOLIDATION","all_phase2_target_2018_pub"
"MRD Percentage at end of Consolidation Sensitivity","MRD percentage at end of consolidation Sensitivity","NUMBER",true,"1","MRD_END_CONSOLIDATION_SENSITIVITY","all_phase2_target_2018_pub"
"MRD Percentage Day 29","MRD percentage at day 29.","NUMBER",true,"1","MRD_PERCENT_DAY_29","all_phase2_target_2018_pub"
"MRD Percentage Day 29 Sensitivity","MRD percentage at day 29 Sensitivity","NUMBER",true,"1","MRD_PERCENT_DAY_29_SENSITIVITY","all_phase2_target_2018_pub"
"MRD Percentage Day 43","MRD percentage at day 43","NUMBER",true,"1","MRD_PERCENT_DAY_43","all_phase2_target_2018_pub"
"MRD Percentage Day 43 Sensitivity","MRD percentage at day 43 Sensitivity","NUMBER",true,"1","MRD_PERCENT_DAY_43_SENSITIVITY","all_phase2_target_2018_pub"
"MRD Percentage Day 8","MRD percentage at day 8","NUMBER",true,"1","MRD_PERCENT_DAY_8","all_phase2_target_2018_pub"
"MRD Percentage Day 8 Sensitivity","MRD percentage at day 8 Sensitivity","NUMBER",true,"1","MRD_PERCENT_DAY_8_SENSITIVITY","all_phase2_target_2018_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","all_phase2_target_2018_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","all_phase2_target_2018_pub"
"Overall Survival Days","Overall patient survival days","NUMBER",true,"1","OS_DAYS","all_phase2_target_2018_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","all_phase2_target_2018_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","all_phase2_target_2018_pub"
"Other Site of Relapse","Other Site of Relapse","STRING",false,"1","OTHER_SITE_OF_RELAPSE","all_phase2_target_2018_pub"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","all_phase2_target_2018_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","all_phase2_target_2018_pub"
"Sex","Sex","STRING",true,"1","SEX","all_phase2_target_2018_pub"
"TCF3-PBX1 Status","TCF3-PBX1 Status","STRING",false,"1","TCF3_PBX1_STATUS","all_phase2_target_2018_pub"
"Testes Site of Relapse","Testes Site of Relapse","STRING",false,"1","TESTES_SITE_OF_RELAPSE","all_phase2_target_2018_pub"
"Testicular Involvement","Yes or No indicator for testicular involvement","STRING",true,"1","TESTICULAR_INVOLVEMENT","all_phase2_target_2018_pub"
"Trisomy 4_10","Trisomy 4_10.","STRING",false,"1","TRISOMY_4_10","all_phase2_target_2018_pub"
"WBC","White bloodcell count.","NUMBER",true,"1","WBC","all_phase2_target_2018_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","all_stjude_2013"
"Bone Marrow Leukemic Blast Percentage","Bone marrow leukemic percentage.","STRING",true,"1","BONE_MARROW_LEUKEMIC_BLAST_PERCENTAGE","all_stjude_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","all_stjude_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","all_stjude_2013"
"Cytogenetics","Cytogenetics.","STRING",true,"1","CYTOGENETICS","all_stjude_2013"
"DNA Index","DNA index.","STRING",false,"1","DNA_INDEX","all_stjude_2013"
"Focal Lesions At Relapse","Focal Lesions At Relapse","STRING",false,"1","FOCAL_LESIONS_AT_RELAPSE","all_stjude_2013"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","all_stjude_2013"
"Known Molecular Classifier","Known Molecular Classifier","STRING",true,"1","KNOWN_MOLECULAR_CLASSIFIER","all_stjude_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","all_stjude_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","all_stjude_2013"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","all_stjude_2013"
"Sex","Sex","STRING",true,"1","SEX","all_stjude_2013"
"snapshot mutations","snapshot mutations","STRING",false,"1","SNAPSHOT_MUTATIONS","all_stjude_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","all_stjude_2015"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","all_stjude_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","all_stjude_2015"
"Cohort","Cohort.","STRING",true,"1","COHORT","all_stjude_2015"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","all_stjude_2015"
"Leukemia Type","Leukemia Type","STRING",false,"1","LEUKEMIA_TYPE","all_stjude_2015"
"MLL Status","MLL status.","STRING",false,"1","MLL_STATUS","all_stjude_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","all_stjude_2015"
"Mutation Rate","Mutation Rate","NUMBER",false,"1","MUTATION_RATE","all_stjude_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","all_stjude_2015"
"Sex","Sex","STRING",true,"1","SEX","all_stjude_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","all_stjude_2016"
"Age Class","Age Class","STRING",true,"1","AGE_CLASS","all_stjude_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","all_stjude_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","all_stjude_2016"
"Cytogenetics","Cytogenetics.","STRING",true,"1","CYTOGENETICS","all_stjude_2016"
"Institute Source","Institute Source","STRING",true,"1","INSTITUTE","all_stjude_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","all_stjude_2016"
"NGS Tested","Sample was NGS tested","STRING",true,"1","NGS_TEST","all_stjude_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","all_stjude_2016"
"Platform","Platform.","STRING",false,"1","PLATFORM","all_stjude_2016"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","all_stjude_2016"
"Sex","Sex","STRING",true,"1","SEX","all_stjude_2016"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","aml_target_2018_pub"
"Diagnosis Age (days)","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE_IN_DAYS","aml_target_2018_pub"
"Analysis Cohort","Analysis Cohort","STRING",false,"1","ANALYSIS_COHORT","aml_target_2018_pub"
"Bone Marrow Leukemic Blast Percentage","Bone marrow leukemic percentage.","NUMBER",true,"1","BONE_MARROW_LEUKEMIC_BLAST_PERCENTAGE","aml_target_2018_pub"
"Bone Marrow Site of Relapse","Bone Marrow Site of Relapse","STRING",false,"1","BONE_MARROW_SITE_OF_RELAPSE","aml_target_2018_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","aml_target_2018_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","aml_target_2018_pub"
"CBFT2A3-GLIS","CBFT2A3 GLIS gene fusion","STRING",false,"1","CBFT2A3_GLIS","aml_target_2018_pub"
"CEBPA Mutation","CEBPA mutation.","STRING",false,"1","CEBPA_MUTATION","aml_target_2018_pub"
"Chloroma","Chloroma","STRING",true,"1","CHLOROMA","aml_target_2018_pub"
"Chloroma Site of Relapse","Recurrent Disease Chloroma Present Indicator","STRING",true,"1","CHLOROMA_RELAPSE_SITE","aml_target_2018_pub"
"C-Kit Mutation Exon 17","Gene Mutation C-KIT Exon 17 Status Indicator","STRING",true,"1","CKIT_EXON_17_MUTATION","aml_target_2018_pub"
"C-Kit Mutation Exon 8","Gene Mutation C-KIT Exon 8 Status Indicator","STRING",true,"1","CKIT_EXON_8_MUTATION","aml_target_2018_pub"
"CNS Disease","CNS disease.","STRING",true,"1","CNS_DISEASE","aml_target_2018_pub"
"CNS Site of Relapse","CNS Site of Relapse","STRING",false,"1","CNS_SITE_OF_RELAPSE","aml_target_2018_pub"
"CR Status at End of Course 1","CR status at end of course 1.","STRING",true,"1","CR_STATUS_AT_END_OF_COURSE_1","aml_target_2018_pub"
"CR Status at End of Course 2","CR status at end of course 2.","STRING",true,"1","CR_STATUS_AT_END_OF_COURSE_2","aml_target_2018_pub"
"Cytogenetic Code (Other)","Cytogenetic code (other).","STRING",true,"1","CYTOGENETIC_CODE_OTHER","aml_target_2018_pub"
"Cytogenetic Complexity","Cytogenetic Abnormality Number of abnormalities","STRING",true,"1","CYTOGENETIC_COMPLEXITY","aml_target_2018_pub"
"Cytogenetic Relapse Site","Recurrent Disease Cytogenetics Present Indicator","STRING",true,"1","CYTOGENETIC_RELAPSE_SITE","aml_target_2018_pub"
"Time To Event (days)","Time To Event (days)","NUMBER",true,"1","DAYS_TO_EVENT","aml_target_2018_pub"
"5Q Deletion","5Q deletion.","STRING",false,"1","DEL_5Q","aml_target_2018_pub"
"7Q Deletion","7Q deletion.","STRING",false,"1","DEL_7Q","aml_target_2018_pub"
"9Q Deletion","9Q deletion.","STRING",false,"1","DEL_9Q","aml_target_2018_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","aml_target_2018_pub"
"FAB","FAB.","STRING",true,"1","FAB","aml_target_2018_pub"
"First Event","First Event","STRING",true,"1","FIRST_EVENT","aml_target_2018_pub"
"FLT3-ITD Allelic Ratio.","FLT3-ITD allelic ratio.","STRING",false,"1","FLT3_ITD_ALLELIC_RATIO","aml_target_2018_pub"
"FLT3-ITD Postive","FLT3-ITD positive.","STRING",false,"1","FLT3_ITD_POSITIVE","aml_target_2018_pub"
"FLT3-PM","FLT3-PM.","STRING",false,"1","FLT3_PM","aml_target_2018_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","aml_target_2018_pub"
"inv(16)","inv(16) gene fusion status","STRING",false,"1","INV_16","aml_target_2018_pub"
"ISCN","ISCN.","STRING",true,"1","ISCN","aml_target_2018_pub"
"Minus-X","Minus-X.","STRING",false,"1","MINUS_X","aml_target_2018_pub"
"Minus-Y","Minus-Y.","STRING",false,"1","MINUS_Y","aml_target_2018_pub"
"MLL","MLL.","STRING",false,"1","MLL","aml_target_2018_pub"
"Monosomy 5","Monosomy 5.","STRING",false,"1","MONOSOMY_5","aml_target_2018_pub"
"Monosomy 7","Monosomy 7.","STRING",false,"1","MONOSOMY_7","aml_target_2018_pub"
"MRD at end of Course 1","MRD at end of course 1.","STRING",true,"1","MRD_AT_END_OF_COURSE_1","aml_target_2018_pub"
"MRD at end of Course 2","MRD at end of course 2.","STRING",true,"1","MRD_AT_END_OF_COURSE_2","aml_target_2018_pub"
"MRD Percentage at end of Course 1","MRD percentage at end of course 1.","NUMBER",true,"1","MRD_PERCENTAGE_AT_END_OF_COURSE_1","aml_target_2018_pub"
"MRD Percentage at end of Course 2","MRD percentage at end of course 2.","NUMBER",true,"1","MRD_PERCENTAGE_AT_END_OF_COURSE_2","aml_target_2018_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","aml_target_2018_pub"
"NPM Mutation","NPM mutation.","STRING",false,"1","NPM_MUTATION","aml_target_2018_pub"
"NUP98-NSD1","NUP98 NSD1 gene fusion","STRING",false,"1","NUP98_NSD1","aml_target_2018_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","aml_target_2018_pub"
"Overall Survival Days","Overall patient survival days","NUMBER",true,"1","OS_DAYS","aml_target_2018_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","aml_target_2018_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","aml_target_2018_pub"
"Other MLL","Other MLL.","STRING",true,"1","OTHER_MLL","aml_target_2018_pub"
"Other Site of Relapse","Other Site of Relapse","STRING",false,"1","OTHER_SITE_OF_RELAPSE","aml_target_2018_pub"
"Peripheral Blasts Percentage","Peripheral blasts percentage.","NUMBER",true,"1","PERIPHERAL_BLASTS_PERCENTAGE","aml_target_2018_pub"
"Primary Cytogenetic Code","Primary cytogenetic code.","STRING",true,"1","PRIMARY_CYTOGENETIC_CODE","aml_target_2018_pub"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","aml_target_2018_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","aml_target_2018_pub"
"Risk Group","Risk group.","STRING",true,"1","RISK_GROUP","aml_target_2018_pub"
"SCT in First CR","SCT in first CR.","STRING",true,"1","SCT_IN_FIRST_CR","aml_target_2018_pub"
"Sex","Sex","STRING",true,"1","SEX","aml_target_2018_pub"
"Trisomy 21","Trisomy 21.","STRING",false,"1","TRISOMY_21","aml_target_2018_pub"
"Trisomy 8","Trisomy 8.","STRING",false,"1","TRISOMY_8","aml_target_2018_pub"
"t(10;11)(p11.2;q23)","t(10;11)(p11.2;q23) gene fusion status","STRING",false,"1","T_10_11_P11_2_Q23","aml_target_2018_pub"
"t(11:19)(q23:p13.1)","t(11:19)(q23:p13.1) gene fusion status","STRING",false,"1","T_11_19_Q23_P13_1","aml_target_2018_pub"
"t(3;5)(q25;q34)","t(3;5)(q25;q34) gene fusion status","STRING",false,"1","T_3_5_Q25_Q34","aml_target_2018_pub"
"t(6;11)(q27;q23)","t(6;11)(q27;q23) gene fusion status","STRING",false,"1","T_6_11_Q27_Q23","aml_target_2018_pub"
"t(6;9)","t(6;9) gene fusion status","STRING",false,"1","T_6_9","aml_target_2018_pub"
"t(8;21)","t(8;21) gene fusion status","STRING",false,"1","T_8_21","aml_target_2018_pub"
"t(9;11)(p22;q23)","t(9;11)(p22;q23) gene fusion status","STRING",false,"1","T_9_11_P22_Q23","aml_target_2018_pub"
"WBC","White bloodcell count.","NUMBER",true,"1","WBC","aml_target_2018_pub"
"WT1 Mutation","WT1 mutation.","STRING",false,"1","WT1_MUTATION","aml_target_2018_pub"
"Cllularity based on allele frequency","Cllularity based on allele frequency","NUMBER",false,"1","ALLELE_FREQUENCY_CELLULARITY","ampca_bcm_2016"
"Associated Adenoma","Associated Adenoma","STRING",true,"1","ASSOCIATED_ADENOMA","ampca_bcm_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ampca_bcm_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ampca_bcm_2016"
"Data Source","Data Source","STRING",true,"1","DATA_SOURCE","ampca_bcm_2016"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","ampca_bcm_2016"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ampca_bcm_2016"
"Immunohistochemistry Subtype","Immunohistochemistry Subtype","STRING",false,"1","IHC_SUBTYPE","ampca_bcm_2016"
"% Intestinal","% Intestinal","NUMBER",false,"1","INTESTINAL_PERCENTAGE","ampca_bcm_2016"
"Morphology Other Features","Morphology Other Features","STRING",false,"1","MORPHOLOGY_OTHER_FEATURES","ampca_bcm_2016"
"Morphology Subtype","Morphology Subtype","STRING",false,"1","MORPHOLOGY_SUBTYPE","ampca_bcm_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ampca_bcm_2016"
"Note","Note.","STRING",false,"1","NOTE","ampca_bcm_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ampca_bcm_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","ampca_bcm_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","ampca_bcm_2016"
"PB Blast Percentage","PB blast percentage","NUMBER",true,"1","PB_BLAST_PERCENTAGE","ampca_bcm_2016"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","ampca_bcm_2016"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","ampca_bcm_2016"
"Tumor cellularity dominant pathology review","Tumor cellularity dominant pathology review","STRING",false,"1","TUMOR_CELLULARITY_PATHOLOGY_REVIEW","ampca_bcm_2016"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","ampca_bcm_2016"
"MedR Age at Diagnosis","Patient's age at the time of primary diagnosis with cancer grouped into 5 year intervals.","STRING",true,"79","AGE_AT_DIAGNOSIS_GROUP","angs_project_painter_2018"
"PATH Epithelioid","Sample has epithelioid characteristics","STRING",false,"18","BX_EPITHELIOID","angs_project_painter_2018"
"PATH Procedure Location","For each sample, the anatomical location where the biopsy or surgery was performed as listed in the pathology report (Note: some patients in this dataset have more than one sample)","STRING",false,"28","BX_LOCATION","angs_project_painter_2018"
"PATH Nuclear Grade","Nuclear grade of the sample","STRING",false,"16","BX_NUCLEAR_GRADE","angs_project_painter_2018"
"PATH Spindle Cell","Sample has spindle cell characteristics","STRING",false,"17","BX_SPINDLE_CELL","angs_project_painter_2018"
"PATH Sample Collection Time","Sample collection time in days from primary diagnosis","NUMBER",false,"1","BX_TIME_DAYS","angs_project_painter_2018"
"PATH Procedure Type ","The procedure performed to obtain the sample","STRING",false,"1","BX_TYPE","angs_project_painter_2018"
"PATH Vasoformative","Sample has vasoformative characteristics","STRING",false,"19","BX_VASOFORMATIVE","angs_project_painter_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","angs_project_painter_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","angs_project_painter_2018"
"MedR Diagnositc Biopsy Location","Location of first biopsy that showed presence of angiosarcoma","STRING",true,"1","DX_BIOPSY_LOCATION","angs_project_painter_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","angs_project_painter_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","angs_project_painter_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","angs_project_painter_2018"
"PRD Diagnosis Location","Patient reported response to the question: When you were first diagnosed with angiosarcoma, where in your body was it found (select all that apply)?","STRING",true,"22","PRD_DIAGNOSIS_LOC","angs_project_painter_2018"
"PRD Ever Location","Patient reported response to the question: Please select all of the places in your body that you have ever had angiosarcoma (select all that apply).","STRING",true,"21","PRD_EVER_LOCATION","angs_project_painter_2018"
"PRD Hispanic","Patient reported response to the question: Do you consider yourself Hispanic, Latino/a or Spanish?","STRING",true,"15","PRD_HISPANIC","angs_project_painter_2018"
"PRD Location of Disease at Time of Enrollment","Patient reported response to the question: Please select all of the places in your body where you currently have angiosarcoma (select all that apply). If you don't have evidence of disease, please select No Evidence of Disease (NED).","STRING",true,"20","PRD_LOCATION_AT_ENROLLMENT","angs_project_painter_2018"
"PRD Other Cancer","Patient reported response to the question: Were you ever diagnosed with any other kind of cancer(s)?","STRING",true,"1","PRD_OTHER_CANCER","angs_project_painter_2018"
"PRD Other Cancer Type","Patient reported response to the question: Please list which cancer(s) and approximate year(s) of diagnosis.","STRING",true,"24","PRD_OTHER_CANCER_LIST","angs_project_painter_2018"
"PRD Radiation for Other Cancers","Patient reported response to the question: Have you had radiation as a treatment for another cancer(s)?","STRING",true,"23","PRD_OTHER_CANCER_RADIATION","angs_project_painter_2018"
"PRD Radiation for the Tumor","Patient reported response to the question: Have you had radiation as a treatment for angiosarcoma? If you had radiation for other cancers, we will ask you about that later.","STRING",true,"1","PRD_RADIATION","angs_project_painter_2018"
"PRD Time of Radiation","Patient reported response to the question: Was your radiation before or after surgery?","STRING",true,"11","PRD_RADIATION_SURGERY","angs_project_painter_2018"
"PRD Surgical Resection","Patient reported response to the question: Have you had surgery to remove angiosarcoma?","STRING",true,"27","PRD_SURGERY","angs_project_painter_2018"
"PRD Surgical Margins","Patient reported response to the question: If [surgery], did the surgery remove all known cancer tissue (also known as clean margins)?","STRING",true,"26","PRD_SURGERY_CLEAN_MARGINS","angs_project_painter_2018"
"PRD In Treatment At Time of Enrollment","Patient reported response to the question: Are you currently being treated for your angiosarcoma?","STRING",true,"25","PRD_TREATED_AT_ENROLLMENT","angs_project_painter_2018"
"MedR Primary Tumor Site_Notes","Notes regarding site of origin of angiosarcoma","STRING",true,"1","PRIMARY_SITE_NOTES","angs_project_painter_2018"
"MedR Primary Tumor Site","Site of origin of disease","STRING",true,"29","PRIMARY_SITE_PATIENT","angs_project_painter_2018"
"PRD Race","Patient-reported response to the question: What is your race (select all that apply)? Infrequent responses have been categorized as Other for confidentiality.","STRING",true,"14","RACE","angs_project_painter_2018"
"Sample Timepoint","Sample sequential timepoint (T1 = timepoint 1, T2 = timepoint 2, etc.)","STRING",false,"1","SAMPLE_TIMEPOINT","angs_project_painter_2018"
"MedR Biological Sex","Patient's biological sex as reported in the medical record","STRING",true,"39","SEX","angs_project_painter_2018"
"Tumor Mutation Burdenn","Total number of mutations divided by the length of the total genomic target region captured (mutations/Mbs)","NUMBER",false,"1","TMB","angs_project_painter_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","bfn_duke_nus_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","bfn_duke_nus_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","bfn_duke_nus_2015"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","bfn_duke_nus_2015"
"Matched Normal","Has matched normal.","STRING",false,"1","HAS_MATCHED_NORMAL","bfn_duke_nus_2015"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","bfn_duke_nus_2015"
"Mean Coverage (x)","Mean Coverage (x)","NUMBER",false,"1","MEAN_COVERAGE","bfn_duke_nus_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","bfn_duke_nus_2015"
"Total Number of Somatic Mutations","Total Number of Somatic Mutations","NUMBER",false,"1","NUM_SOMATIC_MUTATION","bfn_duke_nus_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","bfn_duke_nus_2015"
"Surgery","Surgery.","STRING",true,"1","SURGERY","bfn_duke_nus_2015"
"Tumor Size","Tumor size.","NUMBER",false,"1","TUMOR_SIZE","bfn_duke_nus_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_bgi"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_bgi"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_bgi"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","blca_bgi"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","blca_bgi"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_bgi"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_bgi"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","blca_bgi"
"Sex","Sex","STRING",true,"1","SEX","blca_bgi"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","blca_bgi"
"TNM","TNM.","STRING",false,"1","TNM","blca_bgi"
"Age At Last Follow-Up","Age At Last Follow-Up","NUMBER",true,"1","AGE_AT_LAST_FOLLOWUP","blca_cornell_2016"
"Body site","Body site where sample was collected","STRING",false,"1","BODY_SITE","blca_cornell_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_cornell_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_cornell_2016"
"Chemotherapy or intravesical therapy received prior to sample acquisition","Chemotherapy or intravesical therapy received prior to sample acquisition: None , Gemcitabine and Cisplati=Gemcitabine and Cisplatin , Bacillus Calmette-Guerin=Bacillus Calmette-Guerin , DR=Docetaxel and Ramucirumab , D=Docetaxel , MVAC , Gemcitabine and Carboplatin=Gemcitabine and Carboplatin , Mitomycin","STRING",false,"1","CHEMOTHERAPY_PRIOR_SAMPLE_ACQUIRED","blca_cornell_2016"
"Highest clinical TNM stage","The highest clinical TNM stage of the patient recorded","STRING",true,"1","HIGHEST_RECORDED_CLINICAL_TNM_STAGE","blca_cornell_2016"
"Histopathology of the primary tumor ","Histopathology of the primary tumor of the patient: UC=Urothelial Carcinoma","STRING",true,"1","HISTOPATOLOGY_PRIMARY_TUMOR","blca_cornell_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_cornell_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_cornell_2016"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","blca_cornell_2016"
"Sex","Sex","STRING",true,"1","SEX","blca_cornell_2016"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","blca_cornell_2016"
"Specimen Collection Pre or Post Chemo","Specimen Collection Pre or Post Chemo","STRING",false,"1","SPECIMEN_COLLECTION_PRE_OR_POST_CHEMO","blca_cornell_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_dfarber_mskcc_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_dfarber_mskcc_2014"
"Chemotherapy Details","Chemotherapy details","STRING",true,"1","CHEMO_DETAILS","blca_dfarber_mskcc_2014"
"Germline Type","Germline Type","STRING",false,"1","GERMLINE_TYPE","blca_dfarber_mskcc_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_dfarber_mskcc_2014"
"Non-synonymous Mutation Rate","Non-synonymous Mutation Rate","NUMBER",false,"1","NONSYNONYMOUS_MUTATION_RATE","blca_dfarber_mskcc_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_dfarber_mskcc_2014"
"Silent Mutation Rate","Silent Mutation Rate","NUMBER",false,"1","SILENT_RATE","blca_dfarber_mskcc_2014"
"Status","Status.","STRING",true,"1","STATUS","blca_dfarber_mskcc_2014"
"Total Mutations","Total Mutations","NUMBER",false,"1","TOTAL_MUTATIONS","blca_dfarber_mskcc_2014"
"TOTAL PER Mb","TOTAL PER Mb","STRING",false,"1","TOTAL_PER_MB","blca_dfarber_mskcc_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_mskcc_solit_2012"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_mskcc_solit_2012"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","blca_mskcc_solit_2012"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","blca_mskcc_solit_2012"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","blca_mskcc_solit_2012"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_mskcc_solit_2012"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_mskcc_solit_2012"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","blca_mskcc_solit_2012"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","blca_mskcc_solit_2012"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_mskcc_solit_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_mskcc_solit_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_mskcc_solit_2014"
"Concomitant Carcinoma in situ","Concomitant Carcinoma in situ","STRING",false,"1","CONCOMITANT_CIS","blca_mskcc_solit_2014"
"Death due to disease","Death due to disease","STRING",true,"1","DEATH_FROM_DISEASE","blca_mskcc_solit_2014"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","blca_mskcc_solit_2014"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","blca_mskcc_solit_2014"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","blca_mskcc_solit_2014"
"LN_STATUS","LN_STATUS","STRING",true,"1","LN_STATUS","blca_mskcc_solit_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_mskcc_solit_2014"
"Neoadjuvant Chemotherapy","Neoadjuvant Chemotherapy.","STRING",true,"1","NEOADJUVANT_CHEMO","blca_mskcc_solit_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_mskcc_solit_2014"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","blca_mskcc_solit_2014"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","blca_mskcc_solit_2014"
"Primary histology","Primary Histology","STRING",true,"1","PRIMARY_HISTOLOGY","blca_mskcc_solit_2014"
"pT_STAGE","pT_STAGE","STRING",true,"1","PT_STAGE","blca_mskcc_solit_2014"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","blca_mskcc_solit_2014"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","blca_mskcc_solit_2014"
"Sex","Sex","STRING",true,"1","SEX","blca_mskcc_solit_2014"
"SMOKING_STATUS","SMOKING_STATUS","STRING",true,"1","SMOKING_STATUS","blca_mskcc_solit_2014"
"SURGICAL_TREATMENT","SURGICAL_TREATMENT","STRING",true,"1","SURGICAL_TREATMENT","blca_mskcc_solit_2014"
"Tissue Sequenced","Tissue Sequnced","STRING",false,"1","TISSUE_SEQUENCED","blca_mskcc_solit_2014"
"Variant Histology","Variant Histology","STRING",true,"1","VARIANT_HISTOLOGY","blca_mskcc_solit_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_nmibc_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_nmibc_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_nmibc_2017"
"Concomitant Carcinoma in situ","Concomitant Carcinoma in situ","STRING",false,"1","CONCOMITANT_CIS","blca_nmibc_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","blca_nmibc_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_nmibc_2017"
"Number of Tumors","Number of Tumors","STRING",true,"1","NUMBER_OF_TUMORS","blca_nmibc_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_nmibc_2017"
"Recurrence","Recurrence","STRING",true,"1","RECURRENCE","blca_nmibc_2017"
"Sex","Sex","STRING",true,"1","SEX","blca_nmibc_2017"
"Specimen Type","The broad cancer phenotype and site information values for a sample to be processed.","STRING",false,"1","SPECIMEN_TYPE","blca_nmibc_2017"
"Stage","Stage","STRING",true,"1","STAGE","blca_nmibc_2017"
"Treatment","Treatment","STRING",true,"1","TREATMENT","blca_nmibc_2017"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","blca_nmibc_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_plasmacytoid_mskcc_2016"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","blca_plasmacytoid_mskcc_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_plasmacytoid_mskcc_2016"
"CLINICAL_STATUS","CLINICAL_STATUS","STRING",true,"1","CLINICAL_STATUS","blca_plasmacytoid_mskcc_2016"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","blca_plasmacytoid_mskcc_2016"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","blca_plasmacytoid_mskcc_2016"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","blca_plasmacytoid_mskcc_2016"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","blca_plasmacytoid_mskcc_2016"
"Lymph Node Status","Lymph Node Status","STRING",false,"1","LYMPH_NODE_STATUS","blca_plasmacytoid_mskcc_2016"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","blca_plasmacytoid_mskcc_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_plasmacytoid_mskcc_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_plasmacytoid_mskcc_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","blca_plasmacytoid_mskcc_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","blca_plasmacytoid_mskcc_2016"
"Patient Display Name","Patient Display Name","STRING",true,"1","PATIENT_DISPLAY_NAME","blca_plasmacytoid_mskcc_2016"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","blca_plasmacytoid_mskcc_2016"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","blca_plasmacytoid_mskcc_2016"
"Sample Display Name","Sample Display Name","STRING",false,"1","SAMPLE_DISPLAY_NAME","blca_plasmacytoid_mskcc_2016"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","blca_plasmacytoid_mskcc_2016"
"Sex","Sex","STRING",true,"1","SEX","blca_plasmacytoid_mskcc_2016"
"Site of Recurrence","Site of Recurrence","STRING",false,"1","SITE_OF_RECURRENCE","blca_plasmacytoid_mskcc_2016"
"Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING",false,"1","SPECIMEN_PRESERVATION_TYPE","blca_plasmacytoid_mskcc_2016"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","blca_plasmacytoid_mskcc_2016"
"TUMOR_PATH_STAGE","TUMOR_PATH_STAGE","STRING",true,"1","TUMOR_PATH_STAGE","blca_plasmacytoid_mskcc_2016"
"Year of Surgery","Year of surgery.","NUMBER",false,"1","YEAR_OF_SURGERY","blca_plasmacytoid_mskcc_2016"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_tcga"
"AJCC Incidental Prostate Cancer","American Joint Committee on Cancer Code Incidental Prostate Cancer","STRING",true,"1","AJCC_INCIDENTAL_PROSTATE_CANCER","blca_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","blca_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","blca_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","blca_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","blca_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","blca_tcga"
"Angiolymphatic Invasion","Presence of angiolymphatic invasion.","STRING",true,"1","ANGIOLYMPHATIC_INVASION","blca_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","blca_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","blca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","blca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","blca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","blca_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","blca_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","blca_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_DEATH","blca_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","blca_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","blca_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","blca_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","blca_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","blca_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","blca_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","blca_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","blca_tcga"
"Extracapsular Extension","The yes/no/unknown indicator that asks whether or not there is extracapsular extension.","STRING",true,"1","EXTRACAPSULAR_EXTENSION","blca_tcga"
"Extracapsular Extension present","Text term to describe the extent of extracapsular extension present in a case of bladder carcinoma.","STRING",true,"1","EXTRACAPSULAR_EXTENSION_PRESENT","blca_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","blca_tcga"
"Family History Cancer Relationship","Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individuals genes is shared (i.e., parent, sibling, offspring).","STRING",true,"1","FAMILY_HISTORY_CANCER_RELATIONSHIP","blca_tcga"
"Family History Cancer Type","Family history cancer type.","STRING",true,"1","FAMILY_HISTORY_CANCER_TYPE","blca_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","blca_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","blca_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","blca_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","blca_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","blca_tcga"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","blca_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","blca_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","blca_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","blca_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","blca_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","blca_tcga"
"Incidental Prostate Cancer Indicator","Incidental Prostate Cancer Indicator","STRING",true,"1","INCIDENTAL_PROSTATE_CANCER","blca_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","blca_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","blca_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","blca_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","blca_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","blca_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","blca_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","blca_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","blca_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","blca_tcga"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",true,"1","METASTATIC_SITE","blca_tcga"
"Metastatic Site Other","Metastatic Site Other","STRING",true,"1","METASTATIC_SITE_OTHER","blca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","blca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","blca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","blca_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","blca_tcga"
"Noninvasive Bladder Cancer Treatment Type","Noninvasive Bladder Cancer Treatment Type","STRING",true,"1","NONINVASIVE_BLADDER_CA_TX_TYPE","blca_tcga"
"History of Noninvasive Bladder Cancer","History of Noninvasive Bladder Cancer","STRING",true,"1","NONINVASIVE_BLADDER_HISTORY","blca_tcga"
"Occupation Current","The text that describes the type of business or industry associated with a person's job.","STRING",true,"1","OCCUPATION_CURRENT","blca_tcga"
"Occupation Primary","The primary occupation of the participant for most of their adult employment.","STRING",true,"1","OCCUPATION_PRIMARY","blca_tcga"
"Occupation Primary Chemical Exposure","To specify an exposure to a substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties at work.","STRING",true,"1","OCCUPATION_PRIMARY_CHEMICAL_EXPOSURE","blca_tcga"
"Occupation Primary Industry","Text to describe the industry in which a person's primary occupation time was spent.","STRING",true,"1","OCCUPATION_PRIMARY_INDUSTRY","blca_tcga"
"Occupation Primary Years Worked","The number that describes the duration of time expressed in number of years that a person has worked in a job.","NUMBER",true,"1","OCCUPATION_PRIMARY_YEARS_WORKED","blca_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","blca_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","blca_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","blca_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","blca_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","blca_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","blca_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","blca_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","blca_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","blca_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","blca_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","blca_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","blca_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","blca_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","blca_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","blca_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","blca_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","blca_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","blca_tcga"
"Sex","Sex","STRING",true,"1","SEX","blca_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","blca_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","blca_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","blca_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","blca_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","blca_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","blca_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","blca_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","blca_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","blca_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","blca_tcga"
"Time To Complete Response (months)","Time To Complete Response (months)","NUMBER",true,"1","TIME_TO_COMPLETE_RESPONSE","blca_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","blca_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","blca_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","blca_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","blca_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","blca_tcga"
"Treatment (90 Days Post Resection)","Treatment (90 Days Post Resection)","STRING",true,"1","TX_90DAYS_POST_RESECTION","blca_tcga"
"Treatment (Complete Response)","Treatment (Complete Response)","STRING",true,"1","TX_COMPLETE_RESPONSE","blca_tcga"
"Treatment (Induction Courses Indicator)","Treatment (Induction Courses Indicator)","STRING",true,"1","TX_INDUCTION_COURSES_INDICATOR","blca_tcga"
"Treatment (Maintenance Courses Indicator)","Treatment (Maintenance Courses Indicator)","STRING",true,"1","TX_MAINTENANCE_COURSES_INDICATOR","blca_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","blca_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","blca_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","blca_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","blca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","blca_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","blca_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","blca_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","blca_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","blca_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","blca_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","blca_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","blca_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","blca_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","blca_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","blca_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","blca_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","blca_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","blca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","blca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","blca_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","blca_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","blca_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","blca_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","blca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","blca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","blca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","blca_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","blca_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","blca_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","blca_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","blca_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","blca_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","blca_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","blca_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","blca_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","blca_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","blca_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","blca_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","blca_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","blca_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","blca_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","blca_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","blca_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","blca_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","blca_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","blca_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","blca_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","blca_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","blca_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","blca_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","blca_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","blca_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","blca_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","blca_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","blca_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","blca_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","blca_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","blca_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","blca_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","blca_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","blca_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","blca_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","blca_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","blca_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","blca_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","blca_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","blca_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","blca_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","blca_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","blca_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","blca_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","blca_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","blca_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","blca_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","blca_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","blca_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","blca_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","blca_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_tcga_pub"
"Angiolymphatic Invasion","Presence of angiolymphatic invasion.","STRING",true,"1","ANGIOLYMPHATIC_INVASION","blca_tcga_pub"
"Batch Number","Batch number.","STRING",false,"1","BATCH_NUMBER","blca_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_tcga_pub"
"Clinical Assessment","Clinical Assessment","STRING",true,"1","CLINICAL_ASSESSMENT","blca_tcga_pub"
"Complete TCGA ID","Complete TCGA ID","STRING",false,"1","COMPLETE_TCGA_ID","blca_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","blca_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","blca_tcga_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","blca_tcga_pub"
"extracapsular spread ","extracapsular spread (ECS), can be yes or no","STRING",false,"1","EXTRACAPSULAR_SPREAD","blca_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","blca_tcga_pub"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","blca_tcga_pub"
"If Extracapsular Spread Present ","If Extracapsular Spread Present ","STRING",false,"1","IF_EXTRACAPSULAR_SPREAD_PRESENT","blca_tcga_pub"
"Incidental Prostate Cancer Indicator","Incidental Prostate Cancer Indicator","STRING",false,"1","INCIDENTAL_PROSTATE_CANCER","blca_tcga_pub"
"Lost To Followup","Lost To Followup","STRING",true,"1","LOST_TO_FOLLOWUP","blca_tcga_pub"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","blca_tcga_pub"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","blca_tcga_pub"
"Metastatic Site Other","Metastatic Site Other","STRING",false,"1","METASTATIC_SITE_OTHER","blca_tcga_pub"
"Method Of Initial Pathologic Diagnosis","Method Of Initial Pathologic Diagnosis","STRING",true,"1","METHOD_OF_INITIAL_PATH_DIAGNOSIS","blca_tcga_pub"
"Other Method Of Initial Pathological Diagnosis","Other Method Of Initial Pathological Diagnosis","STRING",true,"1","METHOD_OF_INITIAL_PATH_DIAGNOSIS_OTHER","blca_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_tcga_pub"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","blca_tcga_pub"
"Other Site of New Tumor Event ","Other Site of New Tumor Event ","STRING",true,"1","NEW_TUMOR_EVENT_OTHER_SITE","blca_tcga_pub"
"New Tumor Event Site","New Tumor Event Site","STRING",false,"1","NEW_TUMOR_EVENT_SITE","blca_tcga_pub"
"New Tumor Event Type","New Tumor Event Type","STRING",false,"1","NEW_TUMOR_EVENT_TYPE","blca_tcga_pub"
"Nodes Ex","Nodes Ex","NUMBER",false,"1","NODES_EX","blca_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","blca_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","blca_tcga_pub"
"Pathologic Distant Spread","Pathologic Distant Spread","STRING",true,"1","PATHOLOGIC_DISTANT_SPREAD","blca_tcga_pub"
"Pathologic Spread Incidental Prostate Cancer","Pathologic Spread Incidental Prostate Cancer","STRING",true,"1","PATHOLOGIC_SPREAD_INCIDENTAL_PROSTATE_CANCER","blca_tcga_pub"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","blca_tcga_pub"
"Primary Tumor Pathologic Spread","Primary tumor pathologic spread.","STRING",true,"1","PRIMARY_TUMOR_PATHOLOGIC_SPREAD","blca_tcga_pub"
"Prior Tumor","Prior Tumor","STRING",false,"1","PRIOR_TUMOR","blca_tcga_pub"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","blca_tcga_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","blca_tcga_pub"
"Regional Nodes Pathologic Spread","Regional Nodes Pathologic Spread","STRING",false,"1","REGIONAL_NODES_PATHOLOGIC_SPREAD","blca_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","blca_tcga_pub"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","blca_tcga_pub"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","blca_tcga_pub"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","blca_tcga_pub"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","blca_tcga_pub"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","blca_tcga_pub"
"T Stage","T Stage","STRING",false,"1","T_STAGE","blca_tcga_pub"
"Year of Diagnosis","Year of Diagnosis","NUMBER",true,"1","YEAR_OF_DIAGNOSIS","blca_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","blca_tcga_pub_2017"
"AJCC Incidental Prostate Cancer","American Joint Committee on Cancer Code Incidental Prostate Cancer","STRING",true,"1","AJCC_INCIDENTAL_PROSTATE_CANCER","blca_tcga_pub_2017"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","blca_tcga_pub_2017"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","blca_tcga_pub_2017"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","blca_tcga_pub_2017"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","blca_tcga_pub_2017"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","blca_tcga_pub_2017"
"Angiolymphatic Invasion","Presence of angiolymphatic invasion.","STRING",true,"1","ANGIOLYMPHATIC_INVASION","blca_tcga_pub_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","blca_tcga_pub_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","blca_tcga_pub_2017"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","blca_tcga_pub_2017"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","blca_tcga_pub_2017"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","blca_tcga_pub_2017"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","blca_tcga_pub_2017"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","blca_tcga_pub_2017"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","blca_tcga_pub_2017"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_DEATH","blca_tcga_pub_2017"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","blca_tcga_pub_2017"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","blca_tcga_pub_2017"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","blca_tcga_pub_2017"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","blca_tcga_pub_2017"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","blca_tcga_pub_2017"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","blca_tcga_pub_2017"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","blca_tcga_pub_2017"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","blca_tcga_pub_2017"
"Extracapsular Extension","The yes/no/unknown indicator that asks whether or not there is extracapsular extension.","STRING",true,"1","EXTRACAPSULAR_EXTENSION","blca_tcga_pub_2017"
"Extracapsular Extension present","Text term to describe the extent of extracapsular extension present in a case of bladder carcinoma.","STRING",true,"1","EXTRACAPSULAR_EXTENSION_PRESENT","blca_tcga_pub_2017"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","blca_tcga_pub_2017"
"Family History Cancer Relationship","Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individual""s genes is shared (i.e., parent, sibling, offspring).","STRING",true,"1","FAMILY_HISTORY_CANCER_RELATIONSHIP","blca_tcga_pub_2017"
"Family History Cancer Type","Family history cancer type.","STRING",true,"1","FAMILY_HISTORY_CANCER_TYPE","blca_tcga_pub_2017"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","blca_tcga_pub_2017"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","blca_tcga_pub_2017"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","blca_tcga_pub_2017"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","blca_tcga_pub_2017"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","blca_tcga_pub_2017"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","blca_tcga_pub_2017"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","blca_tcga_pub_2017"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","blca_tcga_pub_2017"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","blca_tcga_pub_2017"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","blca_tcga_pub_2017"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","blca_tcga_pub_2017"
"Incidental Prostate Cancer Indicator","Incidental Prostate Cancer Indicator","STRING",true,"1","INCIDENTAL_PROSTATE_CANCER","blca_tcga_pub_2017"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","blca_tcga_pub_2017"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","blca_tcga_pub_2017"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","blca_tcga_pub_2017"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","blca_tcga_pub_2017"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","blca_tcga_pub_2017"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","blca_tcga_pub_2017"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","blca_tcga_pub_2017"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","blca_tcga_pub_2017"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","blca_tcga_pub_2017"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",true,"1","METASTATIC_SITE","blca_tcga_pub_2017"
"Metastatic Site Other","Metastatic Site Other","STRING",true,"1","METASTATIC_SITE_OTHER","blca_tcga_pub_2017"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","blca_tcga_pub_2017"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","blca_tcga_pub_2017"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","blca_tcga_pub_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","blca_tcga_pub_2017"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","blca_tcga_pub_2017"
"Noninvasive Bladder Cancer Treatment Type","Noninvasive Bladder Cancer Treatment Type","STRING",true,"1","NONINVASIVE_BLADDER_CA_TX_TYPE","blca_tcga_pub_2017"
"History of Noninvasive Bladder Cancer","History of Noninvasive Bladder Cancer","STRING",true,"1","NONINVASIVE_BLADDER_HISTORY","blca_tcga_pub_2017"
"Occupation Current","The text that describes the type of business or industry associated with a person's job.","STRING",true,"1","OCCUPATION_CURRENT","blca_tcga_pub_2017"
"Occupation Primary","The primary occupation of the participant for most of their adult employment.","STRING",true,"1","OCCUPATION_PRIMARY","blca_tcga_pub_2017"
"Occupation Primary Chemical Exposure","To specify an exposure to a substance with a defined atomic or molecular structure that results from, or takes part in, reactions involving changes in its structure, composition, or properties at work.","STRING",true,"1","OCCUPATION_PRIMARY_CHEMICAL_EXPOSURE","blca_tcga_pub_2017"
"Occupation Primary Industry","Text to describe the industry in which a person's primary occupation time was spent.","STRING",true,"1","OCCUPATION_PRIMARY_INDUSTRY","blca_tcga_pub_2017"
"Occupation Primary Years Worked","The number that describes the duration of time expressed in number of years that a person has worked in a job.","NUMBER",true,"1","OCCUPATION_PRIMARY_YEARS_WORKED","blca_tcga_pub_2017"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","blca_tcga_pub_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","blca_tcga_pub_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","blca_tcga_pub_2017"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","blca_tcga_pub_2017"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","blca_tcga_pub_2017"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","blca_tcga_pub_2017"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","blca_tcga_pub_2017"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","blca_tcga_pub_2017"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","blca_tcga_pub_2017"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","blca_tcga_pub_2017"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","blca_tcga_pub_2017"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","blca_tcga_pub_2017"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","blca_tcga_pub_2017"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","blca_tcga_pub_2017"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","blca_tcga_pub_2017"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","blca_tcga_pub_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","blca_tcga_pub_2017"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","blca_tcga_pub_2017"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","blca_tcga_pub_2017"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","blca_tcga_pub_2017"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","blca_tcga_pub_2017"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","blca_tcga_pub_2017"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","blca_tcga_pub_2017"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","blca_tcga_pub_2017"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","blca_tcga_pub_2017"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","blca_tcga_pub_2017"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","blca_tcga_pub_2017"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","blca_tcga_pub_2017"
"Time To Complete Response (months)","Time To Complete Response (months)","NUMBER",true,"1","TIME_TO_COMPLETE_RESPONSE","blca_tcga_pub_2017"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","blca_tcga_pub_2017"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","blca_tcga_pub_2017"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","blca_tcga_pub_2017"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","blca_tcga_pub_2017"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","blca_tcga_pub_2017"
"Treatment (90 Days Post Resection)","Treatment (90 Days Post Resection)","STRING",true,"1","TX_90DAYS_POST_RESECTION","blca_tcga_pub_2017"
"Treatment (Complete Response)","Treatment (Complete Response)","STRING",true,"1","TX_COMPLETE_RESPONSE","blca_tcga_pub_2017"
"Treatment (Induction Courses Indicator)","Treatment (Induction Courses Indicator)","STRING",true,"1","TX_INDUCTION_COURSES_INDICATOR","blca_tcga_pub_2017"
"Treatment (Maintenance Courses Indicator)","Treatment (Maintenance Courses Indicator)","STRING",true,"1","TX_MAINTENANCE_COURSES_INDICATOR","blca_tcga_pub_2017"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","blca_tcga_pub_2017"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","blca_tcga_pub_2017"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","blca_tcga_pub_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","brca_bccrc"
"Angiolymphatic Invasion","Presence of angiolymphatic invasion.","STRING",true,"1","ANGIOLYMPHATIC_INVASION","brca_bccrc"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_bccrc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_bccrc"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","brca_bccrc"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","brca_bccrc"
"ER Status","ER Status","STRING",false,"1","ER_STATUS","brca_bccrc"
"Estimated Tumor Cellularity","Estimated tumor cellularity.","STRING",false,"1","EST_TUMOR_CELLULARITY","brca_bccrc"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","brca_bccrc"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","brca_bccrc"
"IHC_BASAL","Basal carcinoma by immunohistochemistry for EGFR and CK5/6","STRING",false,"1","IHC_BASAL","brca_bccrc"
"IHC_CK5/6","IHC_CK5/6","STRING",false,"1","IHC_CK5_6","brca_bccrc"
"IHC_EGFR","IHC_EGFR","STRING",false,"1","IHC_EGFR","brca_bccrc"
"IHC-HER2","IHC-HER2","STRING",false,"1","IHC_HER2","brca_bccrc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_bccrc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_bccrc"
"PAM50 subtype","PAM50 subtype","STRING",false,"1","PAM50_SUBTYPE","brca_bccrc"
"PR Status","PR Status","STRING",false,"1","PR_STATUS","brca_bccrc"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","brca_bccrc"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_bccrc_xenograft_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_bccrc_xenograft_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_bccrc_xenograft_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_bccrc_xenograft_2014"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","brca_bccrc_xenograft_2014"
"Sequencing Type","Sequencing Type","STRING",false,"1","SEQUENCING_TYPE","brca_bccrc_xenograft_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","brca_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_broad"
"Country","Country of procurement.","STRING",true,"1","COUNTRY","brca_broad"
"ER Status","ER Status","STRING",false,"1","ER_STATUS","brca_broad"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","brca_broad"
"HER2 Amplification Status","HER2 Amplification Status","STRING",false,"1","HER2_AMPLIFICATION_STATUS","brca_broad"
"HER2 Status","HER2 Status","STRING",false,"1","HER2_STATUS","brca_broad"
"Menopause Status","Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.","STRING",true,"1","MENOPAUSE_STATUS","brca_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_broad"
"Nonsilent Mutation Rate","Nonsilent Mutation Rate","NUMBER",false,"1","NONSILENT_RATE","brca_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_broad"
"Ploidy","Ploidy.","STRING",false,"1","PLOIDY","brca_broad"
"PR Status","PR Status","STRING",false,"1","PR_STATUS","brca_broad"
"Purity","Purity","NUMBER",false,"1","PURITY","brca_broad"
"Sex","Sex","STRING",true,"1","SEX","brca_broad"
"Silent Mutation Rate","Silent Mutation Rate","NUMBER",false,"1","SILENT_RATE","brca_broad"
"Stage","Stage","STRING",true,"1","STAGE","brca_broad"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","brca_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_igr_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_igr_2015"
"IHC-HER2","IHC-HER2","STRING",false,"1","IHC_HER2","brca_igr_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_igr_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_igr_2015"
"Sample Type","""The type of sample (i.e., normal, primary, met, recurrence).""","STRING",false,"1","SAMPLE_TYPE","brca_igr_2015"
"Study ID","Study ID","STRING",true,"1","STUDY_ID","brca_igr_2015"
"MedR Adjuvant Radiation","Status of adjuvant radiation therapy. Adjuvant therapy is therapy received after surgery. ","STRING",true,"1","ADJ_XRT","brca_mbcproject_wagle_2017"
"MedR Age at Diagnosis","Patient's age at the time of primary diagnosis with breast cancer grouped into 5 year intervals.","STRING",true,"79","AGE_AT_DIAGNOSIS_GROUP","brca_mbcproject_wagle_2017"
"PRD Any Therapy More Than 2 Years","Patient-reported response to the question: Since your diagnosis with metastatic breast cancer, have you been on any of your cancer therapies for more than 2 years?","STRING",true,"25","ANY_THERAPY_2YRS","brca_mbcproject_wagle_2017"
"PATH CEP17 Copy","Copy number of CEP17 in the pathology report. This is the number of copies of the CEP17 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. ","STRING",false,"1","BXCEP17_COPY","brca_mbcproject_wagle_2017"
"PATH HER2 Copy ","Copy number of HER2 in the pathology report. This is the number of copies of the HER2 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. ","STRING",false,"1","BXHER2_COPY","brca_mbcproject_wagle_2017"
"PATH HER2 CEP17 Ratio","Ratio of HER2/CEP17 in the pathology report. This is one component of the Flourescence In Situ Hybridization (FISH) test. This ratio is used to determine if the HER2 gene is overexpressed, relative to the CEP17 protein, which acts as a baseline measurement. HER2/CEP17 ratios >2.2 indicate a HER2 Positive tumor.","STRING",false,"1","BXHER2_RATIO","brca_mbcproject_wagle_2017"
"PATH DCIS Reported","Notes if Ductal Carcinoma In Situ was reported in the pathology report","STRING",false,"17","BX_DCIS","brca_mbcproject_wagle_2017"
"PATH Estrogen Receptor Status","Estrogen Receptor (ER) status reported in the pathology report","STRING",false,"22","BX_ER","brca_mbcproject_wagle_2017"
"PATH Sample Grade","Sample grade reported in the pathology report ","STRING",false,"26","BX_GRADE","brca_mbcproject_wagle_2017"
"PATH HER2 FISH","HER2 Flourescence In Situ Hyrbridization (FISH) results in the pathology report. This is most commonly performed on tumor samples with a HER2 Immunohistochemistry (IHC) score of 2+, or equivocal. This is an additional test that aims to measure whether or not the HER2 gene is overexpressed in a tumor sample.","STRING",false,"1","BX_HER2FISH","brca_mbcproject_wagle_2017"
"PATH HER2 IHC ","HER2 Immunohistochemistry (IHC) results in the pathology report. This test involves staining tissue samples and looking at them under a microscope to determine if the HER2 protein is overexpressed in the sample. Results can be reported as 0+, 1+, 2+, or 3+. 0+ and 1+ indicate a HER2 negative tumor, 2+ is considered equivocal and may require further testing, and 3+ indicates a HER2 Positive tumor.","STRING",false,"1","BX_HER2IHC","brca_mbcproject_wagle_2017"
"PATH HER2 Status ","HER2 status reported in the pathology report","STRING",false,"20","BX_HER2OVERALL","brca_mbcproject_wagle_2017"
"PATH Sample Histology","The sample's histology reported in the pathology report (IDC = Invasive Ductal Carcinoma, ILC = Invasive Lobular Carcinoma).","STRING",false,"27","BX_HISTOLOGY","brca_mbcproject_wagle_2017"
"PATH Ki67 Percentage","The percentage of Ki67 reported in the pathology report","STRING",false,"1","BX_KI67","brca_mbcproject_wagle_2017"
"PATH LCIS Reported","Notes if Lobular Carcinoma In Situ was reported in the pathology report","STRING",false,"16","BX_LCIS","brca_mbcproject_wagle_2017"
"PATH Procedure Location","The location in the body where the biopsy or surgery was performed","STRING",false,"28","BX_LOCATION","brca_mbcproject_wagle_2017"
"PATH Sample notes","Additional information regarding the sample","STRING",false,"1","BX_NOTES","brca_mbcproject_wagle_2017"
"PATH Estrogen Receptor Percentage","Percentage of Estrogen Receptor (ER) reported in the pathology report. A value of >= 1% indicates an ER Positive tumor.","STRING",false,"1","BX_PERCENT_ER","brca_mbcproject_wagle_2017"
"PATH Progesterone Receptor Percentage","Progesterone Receptor (PR) percentage reported in the pathology report. A value of >=1% indicates a PR Positive tumor.","STRING",false,"1","BX_PERCENT_PR","brca_mbcproject_wagle_2017"
"PATH Progesterone Receptor Status","Progesterone Receptor (PR) status as reported in the pathology report ","STRING",false,"21","BX_PR","brca_mbcproject_wagle_2017"
"PATH Breast Procedure Laterality","Left or right sidedness for breast procedures","STRING",false,"1","BX_SIDEDNESS_BREAST","brca_mbcproject_wagle_2017"
"PATH Sample Collection Time","Sample collection time in days from primary diagnosis ","NUMBER",false,"1","BX_TIME_DAYS","brca_mbcproject_wagle_2017"
"PATH Procedure Type ","The procedure performed to obtain the sample","STRING",false,"1","BX_TYPE","brca_mbcproject_wagle_2017"
"PATH Sample In Metastatic Setting","Calculated variable to classify if samples were taken while the patient had metastatic disease, or prior to metastatic disease. Samples taken less than 4 months prior to the diagnosis of metastatic disease are classified as METASTATIC DISEASE PRESENT","STRING",false,"18","CALC_MET_SETTING","brca_mbcproject_wagle_2017"
"MedR Time to Metastatic Diagnosis (Calculated Days)","Calculated elapsed time, in days, between the patient's primary diagnosis with breast cancer and diagnosis with metastatic breast cancer as reported in the medical record","NUMBER",true,"1","CALC_TIME_TO_METS_DX_DAYS","brca_mbcproject_wagle_2017"
"MedR Time to Metastatic Diagnosis (Calculated Months)","Calculated elapsed time, in months, between patient's primary diagnosis with breast cancer and diagnosis with metastatic breast cancer as reported in the medical record","NUMBER",true,"39","CALC_TIME_TO_METS_DX_MONTHS","brca_mbcproject_wagle_2017"
"PATH Sample Treatment Naive","Calculated variable that is set to YES if a sample was taken prior to the start of any medical therapy","STRING",false,"19","CALC_TREATMENT_NAIVE","brca_mbcproject_wagle_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_mbcproject_wagle_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_mbcproject_wagle_2017"
"MedR Diagnostic CEP17 Copy","Copy number of CEP17 in diagnostic sample. This is the number of copies of the CEP17 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. ","STRING",true,"1","DX_CEP17_COPY","brca_mbcproject_wagle_2017"
"MedR Diagnostic ER Status","Estrogen Receptor (ER) status of diagnostic sample","STRING",true,"1","DX_ER","brca_mbcproject_wagle_2017"
"MedR Diagnostic Grade","Grade of diagnostic sample","STRING",true,"1","DX_GRADE","brca_mbcproject_wagle_2017"
"MedR Diagnostic HER2 FISH","HER2 Flourescence In Situ Hyrbridization (FISH) results in diagnostic sample. This is most commonly performed on tumor samples with a HER2 Immunohistochemistry (IHC) score of 2+, or equivocal. This is an additional test that aims to measure whether or not the HER2 gene is overexpressed in a tumor sample.","STRING",true,"1","DX_HER2FISH","brca_mbcproject_wagle_2017"
"MedR Diagnostic HER2 IHC","HER2 Immunohistochemistry (IHC) results of diagnostic sample. This test involves staining tissue samples and looking at them under a microscope to determine if the HER2 protein is overexpressed in the sample. Results can be reported as 0+, 1+, 2+, or 3+. 0+ and 1+ indicate a HER2 negative tumor, 2+ is considered equivocal and may require further testing, and 3+ indicates a HER2 Positive tumor.","STRING",true,"1","DX_HER2IHC","brca_mbcproject_wagle_2017"
"MedR Diagnostic HER2 Status","HER2 status of diagnostic sample","STRING",true,"1","DX_HER2OVERALL","brca_mbcproject_wagle_2017"
"MedR Diagnostic HER2 Copy","Copy number of HER2 in diagnostic sample. This is the number of copies of the HER2 gene seen in the sample, which is used to calculate the HER2/CEP17 ratio. Having multiple copies of a gene means that the tumor's DNA has many consecutive repetitions of the region that codes for a given gene. Having multiple extra copies of a gene is also described as an amplification, while losing copies of a gene is described as a deletion. ","STRING",true,"1","DX_HER2_COPY","brca_mbcproject_wagle_2017"
"MedR Diagnostic HER2 Ratio","Ratio of HER2/CEP17 in diagnostic sample. This is one component of the Flourescence In Situ Hybridization (FISH) test. This ratio is used to determine if the HER2 gene is overexpressed, relative to the CEP17 protein, which acts as a baseline measurement. HER2/CEP17 ratios >2.2 indicate a HER2 Positive tumor.","STRING",true,"1","DX_HER2_RATIO","brca_mbcproject_wagle_2017"
"MedR Diagnostic Histology","Histology of diagnostic sample","STRING",true,"1","DX_HISTOLOGY","brca_mbcproject_wagle_2017"
"MedR Diagnosis Location","Location in the body of initial breast cancer diagnosis ","STRING",true,"1","DX_LOCATION","brca_mbcproject_wagle_2017"
"MedR Diagnostic ER %","Percentage of Estrogen Receptor (ER) reported in diagnostic sample. A value of >= 1% indicates an ER Positive tumor .","STRING",true,"1","DX_PERCENT_ER","brca_mbcproject_wagle_2017"
"MedR Diagnostic PR %","Progesterone Receptor (PR) percentage reported in diagnostic sample. A value of >=1% indicates a PR Positive tumor.","STRING",true,"1","DX_PERCENT_PR","brca_mbcproject_wagle_2017"
"MedR Diagnostic PR Status","Progesterone Receptor (PR) status of diagnostic sample","STRING",true,"1","DX_PR","brca_mbcproject_wagle_2017"
"MedR Diagnosis Laterality","Left or right sidedness of diagnostic sample","STRING",true,"1","DX_SIDEDNESS","brca_mbcproject_wagle_2017"
"MedR Stage at Diagnosis","American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV ","STRING",true,"29","DX_STAGE","brca_mbcproject_wagle_2017"
"MedR Diagnostic Procedure","Type of procedure used to obtain diagnostic sample","STRING",true,"1","DX_TYPE","brca_mbcproject_wagle_2017"
"MedR Ever Metastatic Sites","All locations in the body where breast cancer spread at any point in the patient's treatment","STRING",true,"1","EVER_METS_SITES","brca_mbcproject_wagle_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","brca_mbcproject_wagle_2017"
"MedR BRCA1 Mutation","Reported germline BRCA1 mutation","STRING",true,"1","GERMLINE_MUTKNOWN_BRCA1","brca_mbcproject_wagle_2017"
"MedR BRCA2 Mutation","Reported germline BRCA2 mutation","STRING",true,"1","GERMLINE_MUTKNOWN_BRCA2","brca_mbcproject_wagle_2017"
"MedR PALB2 Mutation","Reported germline PALB2 mutation","STRING",true,"1","GERMLINE_MUTKNOWN_PALB2","brca_mbcproject_wagle_2017"
"PRD Ever HER2 Positive","Patient-reported response to the question: At any time, was your breast cancer found to be HER2 positive (HER2+)?","STRING",true,"1","HER2_STATUS_REPORTED","brca_mbcproject_wagle_2017"
"PRD Hispanic ","Patient-reported response to the question: Do you consider yourself Hispanic, Latino/a or Spanish?","STRING",true,"1","HISPANIC","brca_mbcproject_wagle_2017"
"PRD Ever Hormone Receptor Positive","Patient-reported response to the question: At any time, was your breast cancer found to be hormone receptor positive (HR+, ER+ and/or PR+)?","STRING",true,"1","HORMONE_RECEPTOR_STATUS","brca_mbcproject_wagle_2017"
"PRD Ever Inflammatory","Patient-reported response to the question: At any time, were you diagnosed with inflammatory breast cancer?","STRING",true,"23","INFLAMMATORY_STATUS","brca_mbcproject_wagle_2017"
"MedR Metastatic Sites at Metastatic Diagnosis","All locations in the body where breast cancer spread at the time of diagnosis with metastatic breast cancer.","STRING",true,"1","METS_SITES_AT_DX","brca_mbcproject_wagle_2017"
"MedR Ever Adrenal Gland Mets","Metastasis to adrenal gland noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_ADRENAL_GLAND","brca_mbcproject_wagle_2017"
"MedR Ever Ascites Mets","Metastasis to ascites noted during the patient's course of treatment. Ascites is the accumulation of fluid in the abdominal cavity.","STRING",true,"1","METS_SITES_AT_METS_ABST_ASCITES","brca_mbcproject_wagle_2017"
"MedR Ever Bone Mets","Metastasis to bone noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_BONE","brca_mbcproject_wagle_2017"
"MedR Ever Brain/CNS Mets","Metastasis to brain or central nervous system noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_BRAIN_CNS","brca_mbcproject_wagle_2017"
"MedR Ever Chest Wall Mets","Metastasis to chest wall noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_CHEST_WALL","brca_mbcproject_wagle_2017"
"MedR Ever Distant Lymph Node Mets","Metastasis to distant lymph nodes noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_DIST_LYMPH","brca_mbcproject_wagle_2017"
"MedR Ever Intraabdominal Mets","Metastasis to intraabdominal area noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_INTRA_ABDOMINAL","brca_mbcproject_wagle_2017"
"MedR Ever Liver Mets","Metastasis to liver noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_LIVER","brca_mbcproject_wagle_2017"
"MedR Ever Lung Mets","Metastasis to lung noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_LUNG","brca_mbcproject_wagle_2017"
"MedR Ever Ovary Mets","Metastasis to ovary noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_OVARY","brca_mbcproject_wagle_2017"
"MedR Ever Pleural Effusion Mets","Metastasis to pleural effusion noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_PLEURAL_EFFUSION","brca_mbcproject_wagle_2017"
"MedR Ever Regional Lymph Node Mets","Metastasis to regional lymph nodes noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_REG_LYMPH","brca_mbcproject_wagle_2017"
"MedR Ever Skin Mets","Metastasis to skin noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_SKIN","brca_mbcproject_wagle_2017"
"MedR Ever Soft Tissue Mets","Metastasis to soft tissue noted during the patient's course of treatment","STRING",true,"1","METS_SITES_AT_METS_ABST_SOFT_TISSUE","brca_mbcproject_wagle_2017"
"MedR Ever Unknown Mets","Metastases unknown or not reported during patient's course of treatment. This is set to YES if metastatic sites could not be determined from available medical records.","STRING",true,"1","METS_SITES_AT_METS_ABST_UNKNOWN","brca_mbcproject_wagle_2017"
"MedR Adrenal Gland Mets at Mets Dx","Metastasis to adrenal gland noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_ADRENAL_GLAND","brca_mbcproject_wagle_2017"
"MedR Ascites Mets at Mets Dx","Metastasis to ascites noted at time of diagnosis with metastatic disease. Ascites is the accumulation of fluid in the abdominal cavity. ","STRING",true,"1","METS_SITES_AT_METS_DX_ASCITES","brca_mbcproject_wagle_2017"
"MedR Bone Mets at Mets Dx","Metastasis to bone noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_BONE","brca_mbcproject_wagle_2017"
"MedR Brain/CNS Mets at Mets Dx","Metastasis to Brain or Central Nervous System noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_BRAIN_CNS","brca_mbcproject_wagle_2017"
"MedR Chest Wall Mets at Mets Dx","Metastasis to chest wall noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_CHEST_WALL","brca_mbcproject_wagle_2017"
"MedR Distant Lymph Node Mets at Mets Dx","Metastasis to distant lymph nodes noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_DIST_LYMPH","brca_mbcproject_wagle_2017"
"MedR Intraabdominal Mets at Mets Dx","Metastasis to intraabdominal area noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_INTRA_ABDOMINAL","brca_mbcproject_wagle_2017"
"MedR Liver Mets at Mets Dx","Metastasis to liver noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_LIVER","brca_mbcproject_wagle_2017"
"MedR Lung Mets at Mets Dx","Metastasis to lung noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_LUNG","brca_mbcproject_wagle_2017"
"MedR Ovary Mets at Mets Dx","Metastasis to ovary noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_OVARY","brca_mbcproject_wagle_2017"
"MedR Pleural Effusion Mets at Mets Dx","Metastasis to pleural effusion noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_PLEURAL_EFFUSION","brca_mbcproject_wagle_2017"
"MedR Regional Lymph Node Mets at Mets Dx","Metastasis to regional lymph nodes noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_REG_LYMPH","brca_mbcproject_wagle_2017"
"MedR Skin Mets at Mets Dx","Metastasis to skin noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_SKIN","brca_mbcproject_wagle_2017"
"MedR Soft Tissue Mets at Mets Dx","Metastasis to soft tissue noted at time of diagnosis with metastatic disease","STRING",true,"1","METS_SITES_AT_METS_DX_SOFT_TISSUE","brca_mbcproject_wagle_2017"
"MedR Unknown Mets at Mets Dx","Metastatic sites unknown or not reported at time of diagnosis with metastatic disease. This is set to YES if metastatic sites could not be determined from available medical records.","STRING",true,"1","METS_SITES_AT_METS_DX_UNKNOWN","brca_mbcproject_wagle_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_mbcproject_wagle_2017"
"MedR N Stage at Diagnosis","American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV","STRING",true,"1","N_STAGE_REPORTED","brca_mbcproject_wagle_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_mbcproject_wagle_2017"
"MedR Patient Notes","Additional notes about patient's clinical history","STRING",true,"1","PATIENT_NOTES","brca_mbcproject_wagle_2017"
"PRD Race","Patient-reported response to the question: What is your race (select all that apply)? Infrequent responses have been categorized as Other for confidentiality. ","STRING",true,"1","RACE_CATEGORIZED","brca_mbcproject_wagle_2017"
"Sample Timepoint","Sample sequential timepoint (T1 = timepoint 1, T2 = timepoint 2, etc.)","STRING",false,"1","SAMPLE_TIMEPOINT","brca_mbcproject_wagle_2017"
"Sex","Sex","STRING",true,"1","SEX","brca_mbcproject_wagle_2017"
"MedR Surgery at Diagnosis","Surgery performed within 6 months of diagnosis","STRING",true,"1","SURGERY_AT_DX","brca_mbcproject_wagle_2017"
"PRD Ever Triple Negative","Patient-reported response to the question: At any time, was your breast cancer found to be triple negative (e.g. NOT ER+, PR+, or HER2+)?","STRING",true,"1","TRIPLE_NEG_STATUS","brca_mbcproject_wagle_2017"
"MedR T Stage at Diagnosis","American Joint Committee on Cancer (AJCC) Summary Stage at Diagnosis. Using the AJCC method, a breast cancer is characterized by the size of the tumor (T), the number of lymph nodes it has spread to (N), and whether or not it has metastatsized (M). Together, the T, N, and M values are used to determine the Summary stage, e.g. Stage I, Stage II, Stage III, Stage IV","STRING",true,"1","T_STAGE_REPORTED","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Aromatase Inhibitors","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an aromatase inhibitors for more than 2 years.","STRING",true,"1","X2YR_AIS","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Alkylating Agent","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an alkylating agent for more than 2 years.","STRING",true,"1","X2YR_ALKYLATING_AGENT","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Anthracycline","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on an anthracycline for more than 2 years.","STRING",true,"1","X2YR_ANTHRACYCLINE","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Anti-HER2","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on anti-HER2 therapy for more than 2 years.","STRING",true,"1","X2YR_ANTIHER2","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Capecitabine","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on capecitabine for more than 2 years.","STRING",true,"1","X2YR_CAPECITABINE","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years CDK4/6 Inhibitor","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a CDK4/6 inhibitor for more than 2 years.","STRING",true,"1","X2YR_CDK46","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Fulvestrant","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on fulvestrant for more than 2 years.","STRING",true,"1","X2YR_FULVESTRANT","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Tamoxifen","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on tamoxifen for more than 2 years.","STRING",true,"1","X2YR_TAMOXIFEN","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years Taxane","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a taxane for more than 2 years.","STRING",true,"1","X2YR_TAXANE","brca_mbcproject_wagle_2017"
"PRD More Than 2 Years VEGF Inhibitor","Calculated based on patient-reported response to the question:  If [you have been on any therapies for more than two years], please list the cancer therapies you have been on for more than 2 years, if you know their names. Listed as TRUE if patients reported being on a VEGF inhibitor for more than 2 years.","STRING",true,"1","X2YR_VEGF_INHIBITOR","brca_mbcproject_wagle_2017"
"Age at Diagnosis","Age at Diagnosis","NUMBER",true,"1","AGE_AT_DIAGNOSIS","brca_metabric"
"Type of Breast Surgery","Type of Breast Surgery","STRING",true,"1","BREAST_SURGERY","brca_metabric"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","brca_metabric"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_metabric"
"Cellularity","Tumor Content","STRING",true,"1","CELLULARITY","brca_metabric"
"Chemotherapy","Chemotherapy.","STRING",true,"1","CHEMOTHERAPY","brca_metabric"
"Pam50 + Claudin-low subtype","Pam50 + Claudin-low subtype","STRING",true,"1","CLAUDIN_SUBTYPE","brca_metabric"
"Cohort","Cohort.","STRING",true,"1","COHORT","brca_metabric"
"ER status measured by IHC","ER status measured by IHC","STRING",true,"1","ER_IHC","brca_metabric"
"ER Status","ER Status","STRING",false,"1","ER_STATUS","brca_metabric"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","brca_metabric"
"HER2 status measured by SNP6","HER2 status measured by SNP6","STRING",true,"1","HER2_SNP6","brca_metabric"
"HER2 Status","HER2 Status","STRING",false,"1","HER2_STATUS","brca_metabric"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","brca_metabric"
"Hormone Therapy","Hormone Therapy","STRING",true,"1","HORMONE_THERAPY","brca_metabric"
"Inferred Menopausal State","Inferred Menopausal State","STRING",true,"1","INFERRED_MENOPAUSAL_STATE","brca_metabric"
"Integrative Cluster","Integrative Cluster","STRING",true,"1","INTCLUST","brca_metabric"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","brca_metabric"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_metabric"
"Nottingham prognostic index","Nottingham prognostic index","NUMBER",true,"1","NPI","brca_metabric"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_metabric"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","brca_metabric"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","brca_metabric"
"PR Status","PR Status","STRING",false,"1","PR_STATUS","brca_metabric"
"Radio Therapy","Radio Therapy","STRING",true,"1","RADIO_THERAPY","brca_metabric"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","brca_metabric"
"3-Gene classifier subtype","3-Gene classifier subtype","STRING",true,"1","THREEGENE","brca_metabric"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","brca_metabric"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","brca_metabric"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","brca_metabric"
"Aberrant Cell Fraction","Aberrant Cell Fraction","STRING",false,"1","ABERRANT_CELL_FRACTION","brca_sanger"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","brca_sanger"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_sanger"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_sanger"
"ER Status","ER Status","STRING",false,"1","ER_STATUS","brca_sanger"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","brca_sanger"
"HER2 Status","HER2 Status","STRING",false,"1","HER2_STATUS","brca_sanger"
"Histopathology","Histopathology","STRING",true,"1","HISTOPATHOLOGY","brca_sanger"
"Mitotic Count","Mitotic Count","NUMBER",false,"1","MITOTIC_COUNT","brca_sanger"
"Mitotic Score","Mitotic Score","NUMBER",false,"1","MITOTIC_SCORE","brca_sanger"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_sanger"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_sanger"
"Pleomorphism Score","Pleomorphism Score","STRING",false,"1","PLEOMORPHISM_SCORE","brca_sanger"
"PR Status","PR Status","STRING",false,"1","PR_STATUS","brca_sanger"
"Tubule Score","Tubule Score","STRING",false,"1","TUBULE_SCORE","brca_sanger"
"Tumor Ploidy","Tumor Ploidy","STRING",false,"1","TUMOR_PLOIDY","brca_sanger"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","brca_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","""Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).""","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","brca_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","brca_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","""The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.""","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","brca_tcga"
"American Joint Committee on Cancer Publication Version Type","""The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.""","STRING",true,"1","AJCC_STAGING_EDITION","brca_tcga"
"American Joint Committee on Cancer Tumor Stage Code","""Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).""","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","brca_tcga"
"Brachytherapy first reference point administered total dose","Brachytherapy first reference point administered total dose","STRING",true,"1","BRACHYTHERAPY_TOTAL_DOSE_POINT_A","brca_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","brca_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_tcga"
"Cent17 Copy Number","Fluorescence in situ hybridization diagnostic procedure chromosome 17 signal result range","STRING",true,"1","CENT17_COPY_NUMBER","brca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","""Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.""","STRING",true,"1","CLINICAL_STAGE","brca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","brca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","brca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","brca_tcga"
"Birth from Initial Pathologic Diagnosis Date","""Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.""","NUMBER",true,"1","DAYS_TO_BIRTH","brca_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","brca_tcga"
"Death from Initial Pathologic Diagnosis Date","""Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.""","NUMBER",true,"1","DAYS_TO_DEATH","brca_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","""Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.""","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","brca_tcga"
"Days to Last Followup","""Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.""","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","brca_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","brca_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","brca_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","brca_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","brca_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","brca_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","brca_tcga"
"ER positivity scale other","Positive finding estrogen receptor other measurement scale text","STRING",true,"1","ER_POSITIVITY_SCALE_OTHER","brca_tcga"
"ER positivity scale used","Breast carcinoma immunohistochemistry er pos finding scale","STRING",true,"1","ER_POSITIVITY_SCALE_USED","brca_tcga"
"ER Status By IHC","breast carcinoma progesterone receptor status","STRING",true,"1","ER_STATUS_BY_IHC","brca_tcga"
"ER Status IHC Percent Positive","progesterone receptor level cell percent category","STRING",true,"1","ER_STATUS_IHC_PERCENT_POSITIVE","brca_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","brca_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","brca_tcga"
"First surgical procedure other","Surgical procedure purpose other text","STRING",true,"1","FIRST_SURGICAL_PROCEDURE_OTHER","brca_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","brca_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","brca_tcga"
"HER2 and cent17 cells count","HER2 neu and centromere 17 copy number analysis input total number count","NUMBER",true,"1","HER2_AND_CENT17_CELLS_COUNT","brca_tcga"
"HER2 and cent17 scale other","HER2 and centromere 17 positive finding other measurement scale text","STRING",true,"1","HER2_AND_CENT17_SCALE_OTHER","brca_tcga"
"HER2 cent17 counted cells count","HER2 neu and centromere 17 copy number metastatic breast carcinoma analysis input total number count","NUMBER",true,"1","HER2_CENT17_COUNTED_CELLS_COUNT","brca_tcga"
"HER2 cent17 ratio","HER2 neu chromosone 17 signal ratio value","NUMBER",true,"1","HER2_CENT17_RATIO","brca_tcga"
"HER2 copy number","HER2 neu breast carcinoma copy analysis input total number","STRING",true,"1","HER2_COPY_NUMBER","brca_tcga"
"HER2 fish method","HER2 erbb pos finding fluorescence in situ hybridization calculation method text","STRING",true,"1","HER2_FISH_METHOD","brca_tcga"
"HER2 fish status","Lab procedure HER2 neu in situ hybrid outcome type","STRING",true,"1","HER2_FISH_STATUS","brca_tcga"
"HER2 ihc percent positive","HER2 erbb pos finding cell percent category","STRING",true,"1","HER2_IHC_PERCENT_POSITIVE","brca_tcga"
"HER2 ihc score","HER2 immunohistochemistry level result","NUMBER",true,"1","HER2_IHC_SCORE","brca_tcga"
"HER2 positivity method text","HER2 erbb method calculation method text","STRING",true,"1","HER2_POSITIVITY_METHOD_TEXT","brca_tcga"
"HER2 positivity scale other","Pos finding HER2 erbb2 other measurement scale text","STRING",true,"1","HER2_POSITIVITY_SCALE_OTHER","brca_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","brca_tcga"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","brca_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","brca_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","brca_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","brca_tcga"
"""International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code""","""The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.""","STRING",true,"1","ICD_O_3_HISTOLOGY","brca_tcga"
"""International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code""","""The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.""","STRING",true,"1","ICD_O_3_SITE","brca_tcga"
"IHC-HER2","IHC-HER2","STRING",true,"1","IHC_HER2","brca_tcga"
"IHC Score","IHC Score","NUMBER",true,"1","IHC_SCORE","brca_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","brca_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","STRING",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","brca_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","brca_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","brca_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","brca_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","brca_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","brca_tcga"
"Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","""Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,""","NUMBER",true,"1","LYMPH_NODES_EXAMINED_IHC_COUNT","brca_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","brca_tcga"
"Margin status reexcision","Breast cancer surgery margin status","STRING",true,"1","MARGIN_STATUS_REEXCISION","brca_tcga"
"Menopause Status","""Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.""","STRING",true,"1","MENOPAUSE_STATUS","brca_tcga"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",true,"1","METASTATIC_SITE","brca_tcga"
"Metastatic Site Other","Metastatic Site Other","STRING",true,"1","METASTATIC_SITE_OTHER","brca_tcga"
"Metastatic tumor indicator","Distant metastasis present ind2","STRING",true,"1","METASTATIC_TUMOR_INDICATOR","brca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","brca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","brca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","brca_tcga"
"Micromet detection by ihc","Cytokeratin immunohistochemistry staining method micrometastasis indicator","STRING",true,"1","MICROMET_DETECTION_BY_IHC","brca_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","brca_tcga"
"Nte cent17 HER2 other scale","Metastatic breast carcinoma pos finding other scale measurement text","STRING",true,"1","NTE_CENT17_HER2_OTHER_SCALE","brca_tcga"
"Nte cent 17 HER2 ratio","Metastatic breast carcinoma HER2 neu chromosone 17 signal ratio value","NUMBER",true,"1","NTE_CENT_17_HER2_RATIO","brca_tcga"
"Nte cent 17 signal number","Metastatic breast carcinoma fluorescence in situ hybridization diagnostic proc centromere 17 signal result range","STRING",true,"1","NTE_CENT_17_SIGNAL_NUMBER","brca_tcga"
"Nte er ihc intensity score","Metastatic breast carcinoma immunohistochemistry er pos cell score","STRING",true,"1","NTE_ER_IHC_INTENSITY_SCORE","brca_tcga"
"Nte er positivity define method","Metastatic breast carcinoma estrogen receptor detection method text","STRING",true,"1","NTE_ER_POSITIVITY_DEFINE_METHOD","brca_tcga"
"Nte er positivity other scale","Pos finding metastatic breast carcinoma estrogen receptor other measuremenet scale text","STRING",true,"1","NTE_ER_POSITIVITY_OTHER_SCALE","brca_tcga"
"Nte er status","Metastatic breast carcinoma estrogen receptor status","STRING",true,"1","NTE_ER_STATUS","brca_tcga"
"Nte er status ihc positive","Metastatic breast carcinoma estrogen receptor level cell percent category","STRING",true,"1","NTE_ER_STATUS_IHC_POSITIVE","brca_tcga"
"Nte HER2 fish define method","Metastatic breast carcinoma HER2 erbb pos finding fluorescence in situ hybridization calculation method text","STRING",true,"1","NTE_HER2_FISH_DEFINE_METHOD","brca_tcga"
"Nte HER2 fish status","Metastatic breast carcinoma lab proc HER2 neu in situ hybridization outcome type","STRING",true,"1","NTE_HER2_FISH_STATUS","brca_tcga"
"Nte HER2 positivity ihc score","Metastatic breast carcinoma erbb2 immunohistochemistry level result","STRING",true,"1","NTE_HER2_POSITIVITY_IHC_SCORE","brca_tcga"
"Nte HER2 positivity method","Metastatic breast carcinoma HER2 erbb method calculation method text","STRING",true,"1","NTE_HER2_POSITIVITY_METHOD","brca_tcga"
"Nte HER2 positivity other scale","Metastatic breast carcinoma pos finding HER2 erbb2 other measure scale text","STRING",true,"1","NTE_HER2_POSITIVITY_OTHER_SCALE","brca_tcga"
"Nte HER2 signal number","HER2 neu metastatic breast carcinoma copy analysis input total number","STRING",true,"1","NTE_HER2_SIGNAL_NUMBER","brca_tcga"
"Nte HER2 status","Metastatic breast carcinoma lab proc HER2 neu immunohistochemistry receptor status","STRING",true,"1","NTE_HER2_STATUS","brca_tcga"
"Nte HER2 status ihc positive","Metastatic breast carcinoma HER2 erbb pos finding cell percent category","STRING",true,"1","NTE_HER2_STATUS_IHC_POSITIVE","brca_tcga"
"Nte pr ihc intensity score","Metastatic breast carcinoma immunohistochemistry pr pos cell score","NUMBER",true,"1","NTE_PR_IHC_INTENSITY_SCORE","brca_tcga"
"Nte pr positivity define method","Metastatic breast carcinoma progesterone receptor detection method text","STRING",true,"1","NTE_PR_POSITIVITY_DEFINE_METHOD","brca_tcga"
"Nte pr positivity other scale","Metastatic breast carcinoma pos finding progesterone receptor other measure scale text","STRING",true,"1","NTE_PR_POSITIVITY_OTHER_SCALE","brca_tcga"
"Nte pr status by ihc","Metastatic breast carcinoma progesterone receptor status","STRING",true,"1","NTE_PR_STATUS_BY_IHC","brca_tcga"
"Nte pr status ihc positive","Metastatic breast carcinoma progesterone receptor level cell percent category","STRING",true,"1","NTE_PR_STATUS_IHC_POSITIVE","brca_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","brca_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","brca_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","brca_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","brca_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","brca_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","brca_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","brca_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","brca_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","brca_tcga"
"Disease Surgical Margin Status","Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.","STRING",true,"1","PATH_MARGIN","brca_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","brca_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","brca_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","brca_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","brca_tcga"
"Tissue Prospective Collection Indicator","""Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.""","STRING",true,"1","PROSPECTIVE_COLLECTION","brca_tcga"
"PR positivity define method","Pgr detection method text","STRING",true,"1","PR_POSITIVITY_DEFINE_METHOD","brca_tcga"
"PR positivity ihc intensity score","Breast carcinoma immunohistochemistry pos cell score","STRING",true,"1","PR_POSITIVITY_IHC_INTENSITY_SCORE","brca_tcga"
"PR positivity scale other","Pos finding progesterone receptor other measurement scale text","STRING",true,"1","PR_POSITIVITY_SCALE_OTHER","brca_tcga"
"PR positivity scale used","Breast carcinoma immunohistochemistry progesterone receptor pos finding scale","STRING",true,"1","PR_POSITIVITY_SCALE_USED","brca_tcga"
"PR status by ihc","Breast carcinoma progesterone receptor status","STRING",true,"1","PR_STATUS_BY_IHC","brca_tcga"
"PR status ihc percent positive","Progesterone receptor level cell percent category","STRING",true,"1","PR_STATUS_IHC_PERCENT_POSITIVE","brca_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","brca_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","brca_tcga"
"Tissue Retrospective Collection Indicator","""Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.""","STRING",true,"1","RETROSPECTIVE_COLLECTION","brca_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","brca_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","brca_tcga"
"Sex","Sex","STRING",true,"1","SEX","brca_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","brca_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","brca_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","brca_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","brca_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","brca_tcga"
"Staging System","Staging System.","STRING",true,"1","STAGING_SYSTEM","brca_tcga"
"Staging System","Staging System Other","STRING",true,"1","STAGING_SYSTEM_OTHER","brca_tcga"
"Surgery for positive margins","Breast carcinoma primary surgical procedure name","STRING",true,"1","SURGERY_FOR_POSITIVE_MARGINS","brca_tcga"
"Surgery for positive margins other","Breast neoplasm other surgical procedure descriptive text","STRING",true,"1","SURGERY_FOR_POSITIVE_MARGINS_OTHER","brca_tcga"
"Surgical procedure first","Breast carcinoma surgical procedure name","STRING",true,"1","SURGICAL_PROCEDURE_FIRST","brca_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","brca_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","brca_tcga"
"Tissue Source Site","""A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.""","STRING",true,"1","TISSUE_SOURCE_SITE","brca_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","brca_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","brca_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","brca_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","brca_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","brca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","brca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","brca_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","brca_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","brca_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","brca_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","brca_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","brca_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","brca_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","brca_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","brca_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","brca_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","brca_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","brca_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","brca_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","brca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","brca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","brca_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","brca_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","brca_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","brca_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","brca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","brca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","brca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","brca_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","brca_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","brca_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","brca_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","brca_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","brca_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","brca_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","brca_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","brca_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","brca_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","brca_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","brca_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","brca_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","brca_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","brca_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","brca_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","brca_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","brca_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","brca_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","brca_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","brca_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","brca_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","brca_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","brca_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","brca_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","brca_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","brca_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","brca_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","brca_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","brca_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","brca_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","brca_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","brca_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","brca_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","brca_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","brca_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","brca_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","brca_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","brca_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","brca_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","brca_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","brca_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","brca_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","brca_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","brca_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","brca_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","brca_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","brca_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","brca_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","brca_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","brca_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","brca_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","brca_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_tcga_pub"
"CN Cluster","CN cluster.","STRING",false,"1","CN_CLUSTER","brca_tcga_pub"
"Converted Stage","Converted Stage","STRING",false,"1","CONVERTED_STAGE","brca_tcga_pub"
"ER Status","ER Status","STRING",false,"1","ER_STATUS","brca_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","brca_tcga_pub"
"HER2 Status","HER2 Status","STRING",false,"1","HER2_STATUS","brca_tcga_pub"
"Integrated Clusters (no exp)","Integrated Clusters (no exp)","STRING",false,"1","INTEGRATED_CLUSTERS_NO_EXP","brca_tcga_pub"
"Integrated Clusters (unsup exp)","Integrated Clusters (unsup exp)","STRING",false,"1","INTEGRATED_CLUSTERS_UNSUP_EXP","brca_tcga_pub"
"Integrated Clusters (with PAM50)","Integrated Clusters (with PAM50)","STRING",false,"1","INTEGRATED_CLUSTERS_WITH_PAM50","brca_tcga_pub"
"Metastasis","Metastasis.","STRING",true,"1","METASTASIS","brca_tcga_pub"
"Metastasis-Coded","Metastasis-Coded","STRING",false,"1","METASTASIS_CODED","brca_tcga_pub"
"Methylation Cluster","Methylation cluster.","STRING",false,"1","METHYLATION_CLUSTER","brca_tcga_pub"
"MIRNA Cluster","MICRNA cluster","STRING",false,"1","MIRNA_CLUSTER","brca_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_tcga_pub"
"Node","Node","STRING",false,"1","NODES","brca_tcga_pub"
"Node-Coded","Node-Coded","STRING",false,"1","NODE_CODED","brca_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","brca_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","brca_tcga_pub"
"PAM50 subtype","PAM50 subtype","STRING",false,"1","PAM50_SUBTYPE","brca_tcga_pub"
"PR Status","PR Status","STRING",false,"1","PR_STATUS","brca_tcga_pub"
"RPPA Cluster","RPPA Cluster.","STRING",false,"1","RPPA_CLUSTER","brca_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","brca_tcga_pub"
"SigClust Intrinsic mRNA","SigClust Intrinsic mRNA","STRING",false,"1","SIGCLUST_INTRINSIC_MRNA","brca_tcga_pub"
"SigClust Unsupervised mRNA","SigClust Unsupervised mRNA","STRING",false,"1","SIGCLUST_UNSUPERVISED_MRNA","brca_tcga_pub"
"Survival Data Form","Survival Data Form","STRING",false,"1","SURVIVAL_DATA_FORM","brca_tcga_pub"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","brca_tcga_pub"
"Tumor--T1 Coded","Tumor--T1 Coded","STRING",false,"1","TUMOR_T1_CODED","brca_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"0","AGE","brca_tcga_pub2015"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","brca_tcga_pub2015"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","brca_tcga_pub2015"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","brca_tcga_pub2015"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","brca_tcga_pub2015"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","brca_tcga_pub2015"
"Brachytherapy first reference point administered total dose","Brachytherapy first reference point administered total dose","STRING",true,"1","BRACHYTHERAPY_TOTAL_DOSE_POINT_A","brca_tcga_pub2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","brca_tcga_pub2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","brca_tcga_pub2015"
"Cent17 Copy Number","Fluorescence in situ hybridization diagnostic procedure chromosome 17 signal result range","STRING",false,"1","CENT17_COPY_NUMBER","brca_tcga_pub2015"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","brca_tcga_pub2015"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","brca_tcga_pub2015"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","brca_tcga_pub2015"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","brca_tcga_pub2015"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","brca_tcga_pub2015"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"0","DFS_MONTHS","brca_tcga_pub2015"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"0","DFS_STATUS","brca_tcga_pub2015"
"Disease code","Disease code","STRING",false,"1","DISEASE_CODE","brca_tcga_pub2015"
"ER positivity scale other","Positive finding estrogen receptor other measurement scale text","STRING",false,"1","ER_POSITIVITY_SCALE_OTHER","brca_tcga_pub2015"
"ER positivity scale used","Breast carcinoma immunohistochemistry er pos finding scale","STRING",false,"1","ER_POSITIVITY_SCALE_USED","brca_tcga_pub2015"
"ER Status By IHC","breast carcinoma progesterone receptor status","STRING",false,"1","ER_STATUS_BY_IHC","brca_tcga_pub2015"
"ER Status IHC Percent Positive","progesterone receptor level cell percent category","STRING",false,"1","ER_STATUS_IHC_PERCENT_POSITIVE","brca_tcga_pub2015"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","brca_tcga_pub2015"
"First surgical procedure other","Surgical procedure purpose other text","STRING",false,"1","FIRST_SURGICAL_PROCEDURE_OTHER","brca_tcga_pub2015"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","brca_tcga_pub2015"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","brca_tcga_pub2015"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","brca_tcga_pub2015"
"HER2 and cent17 cells count","HER2 neu and centromere 17 copy number analysis input total number count","NUMBER",false,"1","HER2_AND_CENT17_CELLS_COUNT","brca_tcga_pub2015"
"HER2 and cent17 scale other","HER2 and centromere 17 positive finding other measurement scale text","STRING",false,"1","HER2_AND_CENT17_SCALE_OTHER","brca_tcga_pub2015"
"HER2 cent17 ratio","HER2 neu chromosone 17 signal ratio value","NUMBER",false,"1","HER2_CENT17_RATIO","brca_tcga_pub2015"
"HER2 copy number","HER2 neu breast carcinoma copy analysis input total number","STRING",false,"1","HER2_COPY_NUMBER","brca_tcga_pub2015"
"HER2 fish method","HER2 erbb pos finding fluorescence in situ hybridization calculation method text","STRING",false,"1","HER2_FISH_METHOD","brca_tcga_pub2015"
"HER2 fish status","Lab procedure HER2 neu in situ hybrid outcome type","STRING",false,"1","HER2_FISH_STATUS","brca_tcga_pub2015"
"HER2 ihc percent positive","HER2 erbb pos finding cell percent category","STRING",false,"1","HER2_IHC_PERCENT_POSITIVE","brca_tcga_pub2015"
"HER2 ihc score","HER2 immunohistochemistry level result","NUMBER",false,"1","HER2_IHC_SCORE","brca_tcga_pub2015"
"HER2 positivity method text","HER2 erbb method calculation method text","STRING",false,"1","HER2_POSITIVITY_METHOD_TEXT","brca_tcga_pub2015"
"HER2 positivity scale other","Pos finding HER2 erbb2 other measurement scale text","STRING",false,"1","HER2_POSITIVITY_SCALE_OTHER","brca_tcga_pub2015"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","brca_tcga_pub2015"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","brca_tcga_pub2015"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","brca_tcga_pub2015"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","brca_tcga_pub2015"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","brca_tcga_pub2015"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","brca_tcga_pub2015"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","brca_tcga_pub2015"
"IHC-HER2","IHC-HER2","STRING",false,"1","IHC_HER2","brca_tcga_pub2015"
"IHC Score","IHC Score","NUMBER",false,"1","IHC_SCORE","brca_tcga_pub2015"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","brca_tcga_pub2015"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","brca_tcga_pub2015"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","brca_tcga_pub2015"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","brca_tcga_pub2015"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","brca_tcga_pub2015"
"Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,","NUMBER",true,"1","LYMPH_NODES_EXAMINED_IHC_COUNT","brca_tcga_pub2015"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","brca_tcga_pub2015"
"Margin status reexcision","Breast cancer surgery margin status","STRING",false,"1","MARGIN_STATUS_REEXCISION","brca_tcga_pub2015"
"Menopause Status","Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.","STRING",true,"1","MENOPAUSE_STATUS","brca_tcga_pub2015"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","brca_tcga_pub2015"
"Metastatic Site Other","Metastatic Site Other","STRING",false,"1","METASTATIC_SITE_OTHER","brca_tcga_pub2015"
"Metastatic tumor indicator","Distant metastasis present ind2","STRING",false,"1","METASTATIC_TUMOR_INDICATOR","brca_tcga_pub2015"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","brca_tcga_pub2015"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","brca_tcga_pub2015"
"Micromet detection by ihc","Cytokeratin immunohistochemistry staining method micrometastasis indicator","STRING",false,"1","MICROMET_DETECTION_BY_IHC","brca_tcga_pub2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","brca_tcga_pub2015"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",false,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","brca_tcga_pub2015"
"Nte cent 17 HER2 ratio","Metastatic breast carcinoma HER2 neu chromosone 17 signal ratio value","NUMBER",false,"1","NTE_CENT_17_HER2_RATIO","brca_tcga_pub2015"
"Nte er ihc intensity score","Metastatic breast carcinoma immunohistochemistry er pos cell score","STRING",false,"1","NTE_ER_IHC_INTENSITY_SCORE","brca_tcga_pub2015"
"Nte er status","Metastatic breast carcinoma estrogen receptor status","STRING",false,"1","NTE_ER_STATUS","brca_tcga_pub2015"
"Nte er status ihc positive","Metastatic breast carcinoma estrogen receptor level cell percent category","STRING",false,"1","NTE_ER_STATUS_IHC__POSITIVE","brca_tcga_pub2015"
"Nte HER2 fish status","Metastatic breast carcinoma lab proc HER2 neu in situ hybridization outcome type","STRING",false,"1","NTE_HER2_FISH_STATUS","brca_tcga_pub2015"
"Nte HER2 positivity ihc score","Metastatic breast carcinoma erbb2 immunohistochemistry level result","STRING",false,"1","NTE_HER2_POSITIVITY_IHC_SCORE","brca_tcga_pub2015"
"Nte HER2 status","Metastatic breast carcinoma lab proc HER2 neu immunohistochemistry receptor status","STRING",false,"1","NTE_HER2_STATUS","brca_tcga_pub2015"
"Nte HER2 status ihc positive","Metastatic breast carcinoma HER2 erbb pos finding cell percent category","STRING",false,"1","NTE_HER2_STATUS_IHC__POSITIVE","brca_tcga_pub2015"
"Nte pr ihc intensity score","Metastatic breast carcinoma immunohistochemistry pr pos cell score","NUMBER",false,"1","NTE_PR_IHC_INTENSITY_SCORE","brca_tcga_pub2015"
"Nte pr status by ihc","Metastatic breast carcinoma progesterone receptor status","STRING",false,"1","NTE_PR_STATUS_BY_IHC","brca_tcga_pub2015"
"Nte pr status ihc positive","Metastatic breast carcinoma progesterone receptor level cell percent category","STRING",false,"1","NTE_PR_STATUS_IHC__POSITIVE","brca_tcga_pub2015"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","brca_tcga_pub2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","brca_tcga_pub2015"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","brca_tcga_pub2015"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","brca_tcga_pub2015"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","brca_tcga_pub2015"
"Other Sample ID","Other sample identifier","STRING",false,"1","OTHER_SAMPLE_ID","brca_tcga_pub2015"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","brca_tcga_pub2015"
"Disease Surgical Margin Status","Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.","STRING",true,"1","PATH_MARGIN","brca_tcga_pub2015"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","brca_tcga_pub2015"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","brca_tcga_pub2015"
"Project code","Project code","STRING",false,"1","PROJECT_CODE","brca_tcga_pub2015"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","brca_tcga_pub2015"
"PR positivity define method","Pgr detection method text","STRING",false,"1","PR_POSITIVITY_DEFINE_METHOD","brca_tcga_pub2015"
"PR positivity ihc intensity score","Breast carcinoma immunohistochemistry pos cell score","STRING",false,"1","PR_POSITIVITY_IHC_INTENSITY_SCORE","brca_tcga_pub2015"
"PR positivity scale other","Pos finding progesterone receptor other measurement scale text","STRING",false,"1","PR_POSITIVITY_SCALE_OTHER","brca_tcga_pub2015"
"PR positivity scale used","Breast carcinoma immunohistochemistry progesterone receptor pos finding scale","STRING",false,"1","PR_POSITIVITY_SCALE_USED","brca_tcga_pub2015"
"PR status by ihc","Breast carcinoma progesterone receptor status","STRING",false,"1","PR_STATUS_BY_IHC","brca_tcga_pub2015"
"PR status ihc percent positive","Progesterone receptor level cell percent category","STRING",false,"1","PR_STATUS_IHC_PERCENT_POSITIVE","brca_tcga_pub2015"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","brca_tcga_pub2015"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","brca_tcga_pub2015"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","brca_tcga_pub2015"
"Sample Type","""The type of sample (i.e., normal, primary, met, recurrence).""","STRING",false,"9","SAMPLE_TYPE","brca_tcga_pub2015"
"Staging System","Staging System.","STRING",true,"1","STAGING_SYSTEM","brca_tcga_pub2015"
"Staging System","Staging System Other ","STRING",false,"1","STAGING_SYSTEM_OTHER","brca_tcga_pub2015"
"Surgery for positive margins","Breast carcinoma primary surgical procedure name","STRING",false,"1","SURGERY_FOR_POSITIVE_MARGINS","brca_tcga_pub2015"
"Surgery for positive margins other","Breast neoplasm other surgical procedure descriptive text","STRING",false,"1","SURGERY_FOR_POSITIVE_MARGINS_OTHER","brca_tcga_pub2015"
"Surgical procedure first","Breast carcinoma surgical procedure name","STRING",false,"1","SURGICAL_PROCEDURE_FIRST","brca_tcga_pub2015"
"Tissue Source Site","""A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.""","STRING",false,"1","TISSUE_SOURCE_SITE","brca_tcga_pub2015"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","brca_tcga_pub2015"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","brca_tcga_pub2015"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","brca_tcga_pub2015"
"Disease Free Event","Disease Free Event","STRING",true,"1","DFS_EVENT","breast_msk_2018"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","breast_msk_2018"
"ER PCT Primary","ER Percent Positivity of the Primary Tumor","STRING",false,"1","ER_PCT_PRIMARY","breast_msk_2018"
"ER Status of Sequenced Sample","ER Status of the Sample that Underwent Sequencing.","STRING",false,"1","ER_STATUS","breast_msk_2018"
"ER Status of the Primary","ER Status of the Primary Tumor","STRING",false,"1","ER_STATUS_PRIMARY","breast_msk_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","breast_msk_2018"
"HER2 FISH Status of Sequenced Sample","HER2 FISH Status of the Sample that Underwent Sequencing.","STRING",false,"1","HER2_FISH","breast_msk_2018"
"HER2 FISH Ratio Value of Sequenced Sample","HER2 FISH Ratio Value of the Sample that Underwent Sequencing.","STRING",false,"1","HER2_FISH_RATIO","breast_msk_2018"
"HER2 FISH Ratio Primary","HER2 FISH Ratio of the Primary Tumor","STRING",false,"1","HER2_FISH_RATIO_PRIMARY","breast_msk_2018"
"HER2 FISH Status (Report and ASCO) of Primary","HER2 FISH Status of the Primary Tumor as per Pathology Report and ASCO/CAP 2013 guideline.","STRING",false,"1","HER2_FISH_STATUS","breast_msk_2018"
"HER2 IHC Status Primary","HER2 IHC Status of Primary Tumor","STRING",false,"1","HER2_IHC_PRIMARY","breast_msk_2018"
"HER2 IHC Score of Sequenced Sample","HER2 IHC Value of the Sample that Underwent Sequencing.","STRING",false,"1","HER2_IHC_SCORE","breast_msk_2018"
"HER2 IHC Status of Sequenced Sample","HER2 IHC Status of the Sample that Underwent Sequencing.","STRING",false,"1","HER2_IHC_STATUS","breast_msk_2018"
"HER2 IHC Score Primary","HER2 IHC Value of the Primary Tumor","STRING",false,"1","HER2_IHC_VALUE_PRIMARY","breast_msk_2018"
"HER2 Primary Status","Overall HER2 status of the primary tumor.","STRING",true,"1","HER2_STATUS_PRIMARY","breast_msk_2018"
"Overall HR Status of Sequenced Sample","Overall HR Status of the Sample that Underwent Sequencing.","STRING",false,"1","HR_STATUS","breast_msk_2018"
"Invasive Carcinoma Diagnosis Age","Invasive Carcinoma Diagnosis Age","NUMBER",false,"1","INVASIVE_CARCINOMA_DX_AGE","breast_msk_2018"
"Time to Diagnosis Invasive Carcinoma","Time to Diagnosis Invasive Carcinoma","NUMBER",false,"1","INVASIVE_CARCINOMA_DX_TIME","breast_msk_2018"
"Last Communication Contact","Time of the last follow up in days (reference: date of birth).","NUMBER",true,"1","LAST_CONTACT_DAYS_TO","breast_msk_2018"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","breast_msk_2018"
"Menopausal Status At Diagnosis","Menopausal Status At Diagnosis","STRING",true,"1","MENOPAUSAL_STATUS_AT_DIAGNOSIS","breast_msk_2018"
"Metastatic Disease at Last Follow-up","Indicate metastatic disease at last followup.","STRING",true,"1","METASTATIC_DZ_FUP","breast_msk_2018"
"Metastatic Recurrence Time","Months between diagnosis of the primary tumor and metastatic recurrence.","NUMBER",true,"1","METASTATIC_RECURRENCE_TIME_MONTHS","breast_msk_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","breast_msk_2018"
"M Stage","M Stage","STRING",true,"1","M_STAGE","breast_msk_2018"
"NGS Sample Collection Time Period","NGS Sample Collection Time Period","NUMBER",false,"1","NGS_SAMPLE_COLLECTION_TIME","breast_msk_2018"
"N Stage","N Stage","STRING",true,"1","N_STAGE","breast_msk_2018"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","breast_msk_2018"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","breast_msk_2018"
"Overall HER2 Status of Sequenced Sample","Overall HER2 Status of the Sample that Underwent Sequencing.","STRING",false,"1","OVERALL_HER2_STATUS","breast_msk_2018"
"Overall Patient HER2 Status","Overall patient tumor HER2 status based on the reivew of the primary and metastatic tumors and the clinical history.","STRING",true,"1","OVERALL_HER2_STATUS_PATIENT","breast_msk_2018"
"Overall Patient HR Status","Overall patient tumor hormone receptor status based on the reivew of the primary and metastatic tumors and the clinical history.","STRING",true,"1","OVERALL_HR_STATUS_PATIENT","breast_msk_2018"
"Overall Patient Receptor Status","Overall patient tumor receptor subtype based on the reivew of the primary and metastatic tumors and the clinical history. ","STRING",true,"1","OVERALL_RECEPTOR_STATUS_PATIENT","breast_msk_2018"
"Overall Primary Tumor Grade","Overall Primary Tumor Histological Grade.","STRING",false,"1","OVERALL_TUMOR_GRADE","breast_msk_2018"
"Primary Nuclear Grade","Primary Nuclear Grade","STRING",false,"1","PRIMARY_NUCLEAR_GRADE","breast_msk_2018"
"Prior Breast Primary","Prior Breast Primary","STRING",false,"1","PRIOR_BREAST_PRIMARY","breast_msk_2018"
"Prior Local Recurrence","Prior Local Recurrence","STRING",true,"1","PRIOR_LOCAL_RECURRENCE","breast_msk_2018"
"PR PCT Primary","PR Percent Positivity of the Primary Tumor","STRING",false,"1","PR_PCT_PRIMARY","breast_msk_2018"
"PR Status of Sequenced Sample","PR status of the Sample that Underwent Sequencing.","STRING",false,"1","PR_STATUS","breast_msk_2018"
"PR Status of the Primary","PR Status of the Primary Tumor","STRING",false,"1","PR_STATUS_PRIMARY","breast_msk_2018"
"Receptor Status Primary","Receptor Status of the Primary Tumor","STRING",false,"1","RECEPTOR_STATUS_PRIMARY","breast_msk_2018"
"Site of Sample","Sample Site","STRING",false,"1","SAMPLE_SITE","breast_msk_2018"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","breast_msk_2018"
"Sex","Sex","STRING",true,"1","SEX","breast_msk_2018"
"Stage At Diagnosis","Stage At Diagnosis","STRING",false,"1","STAGE_AT_DIAGNOSIS","breast_msk_2018"
"Time To Death (Months)","Time To Death (Months)","NUMBER",true,"1","TIME_TO_DEATH_MONTHS","breast_msk_2018"
"Tumor Sample Histology","Tumor Sample Histology","STRING",false,"1","TUMOR_SAMPLE_HISTOLOGY","breast_msk_2018"
"Tumor Tissue Origin","Tumor Tissue of Origin of the Sequnced Tumor.","STRING",false,"1","TUMOR_TISSUE_ORIGIN","breast_msk_2018"
"T Stage","T Stage","STRING",true,"1","T_STAGE","breast_msk_2018"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","breast_msk_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ccrcc_irc_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ccrcc_irc_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ccrcc_irc_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANER_TYPE_DETAILED","ccrcc_irc_2014"
"Fuhrman Grade","Fuhrman Grade","STRING",false,"1","FUHRMAN_GRADE","ccrcc_irc_2014"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","ccrcc_irc_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ccrcc_irc_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ccrcc_irc_2014"
"Sex","Sex","STRING",true,"1","SEX","ccrcc_irc_2014"
"Stage","Stage","STRING",true,"1","STAGE","ccrcc_irc_2014"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","ccrcc_irc_2014"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","ccrcc_irc_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ccrcc_utokyo_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ccrcc_utokyo_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ccrcc_utokyo_2013"
"Cohort","Cohort.","STRING",true,"1","COHORT","ccrcc_utokyo_2013"
"Follow up time months","Follow up time months","NUMBER",true,"1","FOLLOW_UP_TIME_MONTHS","ccrcc_utokyo_2013"
"Gene Expression Cluster","Gene expression cluster.","STRING",false,"1","GENE_EXPRESSION_CLUSTER","ccrcc_utokyo_2013"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","ccrcc_utokyo_2013"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ccrcc_utokyo_2013"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","ccrcc_utokyo_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ccrcc_utokyo_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ccrcc_utokyo_2013"
"Sarcomatoid Component","Sarcomatoid Component","STRING",false,"1","SARCOMATOID_COMPONENT","ccrcc_utokyo_2013"
"Sex","Sex","STRING",true,"1","SEX","ccrcc_utokyo_2013"
"Stage At Diagnosis","Stage At Diagnosis","STRING",false,"1","STAGE_AT_DIAGNOSIS","ccrcc_utokyo_2013"
"VHL Mutation (AA)","VHL Mutation (AA)","STRING",false,"1","VHL_MUTATION_AA","ccrcc_utokyo_2013"
"VHL Mutation (Codon)","VHL Mutation (Codon)","STRING",false,"1","VHL_MUTATION_CODON","ccrcc_utokyo_2013"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","ccrcc_utokyo_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","cellline_ccle_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cellline_ccle_broad"
"Data Source","Data Source","STRING",true,"1","DATA_SOURCE","cellline_ccle_broad"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","cellline_ccle_broad"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","cellline_ccle_broad"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","cellline_ccle_broad"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","cellline_ccle_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cellline_ccle_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","cellline_ccle_broad"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","cellline_ccle_broad"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","cellline_ccle_broad"
"Sex","Sex","STRING",true,"1","SEX","cellline_ccle_broad"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","cellline_ccle_broad"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","cellline_nci60"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","cellline_nci60"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cellline_nci60"
"Doubling Time (hrs)","Doubling time  (hrs)","NUMBER",false,"1","DOUBLING_TIME","cellline_nci60"
"Epithelial","Epithelial.","STRING",false,"1","EPITHELIAL","cellline_nci60"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","cellline_nci60"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","cellline_nci60"
"MDR","MDR.","NUMBER",false,"1","MDR","cellline_nci60"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cellline_nci60"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","cellline_nci60"
"P53","P53.","STRING",false,"1","P53","cellline_nci60"
"Ploidy","Ploidy.","STRING",false,"1","PLOIDY","cellline_nci60"
"Prior Treatment","Prior treatment.","STRING",true,"1","PRIOR_TREATMENT","cellline_nci60"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","cellline_nci60"
"Sex","Sex","STRING",true,"1","SEX","cellline_nci60"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","cesc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","cesc_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","cesc_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CN","cesc_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CT","cesc_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","cesc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","cesc_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","cesc_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","cesc_tcga"
"Brachytherapy first reference point administered total dose","Brachytherapy first reference point administered total dose","STRING",true,"1","BRACHYTHERAPY_TOTAL_DOSE_POINT_A","cesc_tcga"
"Brachytherapy Type","Brachytherapy Type","STRING",true,"1","BRACHYTHERAPY_TYPE","cesc_tcga"
"Brachytherapy Type Other","Brachytherapy Type Other","STRING",true,"1","BRACHYTHERAPY_TYPE_OTHER","cesc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","cesc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cesc_tcga"
"Cause of death other","Death cause text","STRING",true,"1","CAUSE_OF_DEATH_OTHER","cesc_tcga"
"Standardized uptake value cervix uteri assessment measurement","Standardized uptake value cervix uteri assessment measurement","NUMBER",true,"1","CERVIX_SUV_RESULTS","cesc_tcga"
"Dose Frequency Text","The text that represents the planned dosage frequency for a agent.","STRING",true,"1","CHEMO_CONCURRENT_COURSE","cesc_tcga"
"Concurrent Chemotherapy Dose","Occurring or operating at the same time. The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","STRING",true,"1","CHEMO_CONCURRENT_DOSE","cesc_tcga"
"Agent Total Dose Count","A total number of doses of a drug, vaccine or other agent administered to a patient.","STRING",true,"1","CHEMO_CONCURRENT_FRACTIONS_TOTAL","cesc_tcga"
"Chemo Concurrent Reason Not Given","Text term to capture the explanation for a chemotherapy not being given concurrent to radiation therapy.","STRING",true,"1","CHEMO_CONCURRENT_REASON_NOT_GIVEN","cesc_tcga"
"Chemo Concurrent Reason Not Other","Another reason that is not already specified or mentioned for why concurrent chemotherapy was not given.","STRING",true,"1","CHEMO_CONCURRENT_REASON_NOT_OTHER","cesc_tcga"
"Chemotherapy Regimen Type","The chemotherapy regimen or schedule and agent in the therapy of patient","STRING",true,"1","CHEMO_CONCURRENT_TYPE","cesc_tcga"
"Other Chemotherapy Agent Administration Specify","Specify the other chemotherapy agent administered.","STRING",true,"1","CHEMO_CONCURRENT_TYPE_OTHER","cesc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","cesc_tcga"
"Cervical carcinoma corpus uteri involvement indicator","Cervical carcinoma corpus uteri involvement indicator","STRING",true,"1","CORPUS_INVOLVEMENT","cesc_tcga"
"Ct scan preop results","Diagnostic ct result outcome","STRING",true,"1","CT_SCAN_PREOP_RESULTS","cesc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","cesc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","cesc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","cesc_tcga"
"Days to diagnostic computed tomography performed","Days to diagnostic computed tomography performed","NUMBER",true,"1","DAYS_TO_DIAGNOSTIC_COMPUTED_TOMOGRAPHY_PERFORMED","cesc_tcga"
"Days to diagnostic mri performed","Days to diagnostic mri performed","NUMBER",true,"1","DAYS_TO_DIAGNOSTIC_MRI_PERFORMED","cesc_tcga"
"Days to fdg or ct pet performed","Days to fdg or ct pet performed","NUMBER",true,"1","DAYS_TO_FDG_OR_CT_PET_PERFORMED","cesc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","cesc_tcga"
"Days to laboratory procedure tumor marker squamous cell carcinoma antigen result","Days to laboratory procedure tumor marker squamous cell carcinoma antigen result","NUMBER",true,"1","DAYS_TO_LABORATORY_PROCEDURE_TUMOR_MARKER_SQUAMOUS_CELL_CARCINOMA_ANTIGEN_RESULT","cesc_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","cesc_tcga"
"Days to performance status assessment","Days to performance status assessment","NUMBER",true,"1","DAYS_TO_PERFORMANCE_STATUS_ASSESSMENT","cesc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","cesc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","cesc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","cesc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","cesc_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","cesc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","cesc_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","cesc_tcga"
"Fdg or ct pet performed outcome","Fdg or ct pet performed outcome","STRING",true,"1","FEDPET_OR_CT_RESULTS","cesc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","cesc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","cesc_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","cesc_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","cesc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","cesc_tcga"
"History hormonal contraceptives use","History hormonal contraceptives use","STRING",true,"1","HISTORY_HORMONAL_CONTRACEPTIVES_USE","cesc_tcga"
"Prior immunologic disease type","Prior immunologic disease type","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE","cesc_tcga"
"Prior immunologic disease other","Prior immunologic disease other","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE_OTHER","cesc_tcga"
"Prior immunosuppressive therapy type","Prior immunosuppressive therapy type","STRING",true,"1","HISTORY_IMMUNOSUPPRESIVE_DX","cesc_tcga"
"Prior immunosuppressive therapy other","Prior immunosuppressive therapy other","STRING",true,"1","HISTORY_IMMUNOSUPPRESIVE_DX_OTHER","cesc_tcga"
"Patient history immune system and related disorders name","Patient history immune system and related disorders name","STRING",true,"1","HISTORY_IMMUNOSUPPRESSIVE_DISEASE","cesc_tcga"
"Prior infectious disease other","Prior infectious disease other","STRING",true,"1","HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER","cesc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","cesc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","cesc_tcga"
"Prior infectious disease","Prior infectious disease","STRING",true,"1","HISTORY_RELEVANT_INFECTIOUS_DX","cesc_tcga"
"HIV Status","HIV Status","STRING",true,"1","HIV_STATUS","cesc_tcga"
"Human papillomavirus other type text","Human papillomavirus other type text","STRING",true,"1","HPV_TYPES_OTHER","cesc_tcga"
"Human papillomavirus type","Human papillomavirus type","STRING",true,"1","HPV_TYPES_POSITIVE","cesc_tcga"
"Human papillomavirus laboratory procedure performed name","Human papillomavirus laboratory procedure performed name","STRING",true,"1","HPV_TYPING_METHOD","cesc_tcga"
"Human papillomavirus laboratory procedure performed text","Human papillomavirus laboratory procedure performed text","STRING",true,"1","HPV_TYPING_METHOD_OTHER","cesc_tcga"
"Hysterectomy performed type","Hysterectomy performed type","STRING",true,"1","HYSTERECTOMY_TYPE","cesc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","cesc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","cesc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","cesc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","cesc_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","cesc_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","cesc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","cesc_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","cesc_tcga"
"Keratinizing squamous cell carcinoma present indicator","Keratinizing squamous cell carcinoma present indicator","STRING",true,"1","KERATINIZATION_SQUAMOUS_CELL","cesc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","cesc_tcga"
"Lymphovascular involvement","Lymphovascular invasion indicator","STRING",true,"1","LYMPHOVASCULAR_INVOLVEMENT","cesc_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","cesc_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","cesc_tcga"
"Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,","NUMBER",true,"1","LYMPH_NODES_EXAMINED_IHC_COUNT","cesc_tcga"
"Diagnostic mri result outcome","Diagnostic mri result outcome","STRING",true,"1","LYMPH_NODES_SUPRACLAVICULAR","cesc_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","cesc_tcga"
"Cervical neoplasm pathologic margin involved type","Cervical neoplasm pathologic margin involved type","STRING",true,"1","MARGINS_INVOLVED_HYSTERECTOMY","cesc_tcga"
"Menopause Status","Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.","STRING",true,"1","MENOPAUSE_STATUS","cesc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","cesc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","cesc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","cesc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cesc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","cesc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","cesc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","cesc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","cesc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","cesc_tcga"
"Hysterectomy performed text","Hysterectomy performed text","STRING",true,"1","OTHER_HYSTERECTOMY_TYPE","cesc_tcga"
"Patient history immune system and related disorders text","Patient history immune system and related disorders text","STRING",true,"1","OTHER_IMMUNOSUPPRESSIVE_DISEASE","cesc_tcga"
"Cervical neoplasm pathologic margin involved text","Cervical neoplasm pathologic margin involved text","STRING",true,"1","OTHER_INVOLVED_MARGINS","cesc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","cesc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","cesc_tcga"
"Lymph node location positive pathology text","Lymph node location positive pathology text","STRING",true,"1","OTHER_POS_NODE_LOCATION","cesc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","cesc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","cesc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","cesc_tcga"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","cesc_tcga"
"Oligonucleotide primer pair laboratory procedure performed name","Oligonucleotide primer pair laboratory procedure performed name","STRING",true,"1","PCR_PRIMER_PAIRS","cesc_tcga"
"Oligonucleotide primer pair laboratory procedure performed text","Oligonucleotide primer pair laboratory procedure performed text","STRING",true,"1","PCR_PRIMER_PAIRS_OTHER","cesc_tcga"
"Cervical carcinoma pelvic extension text","Cervical carcinoma pelvic extension text","STRING",true,"1","PELVIC_EXTENSION_COMMENT","cesc_tcga"
"Performance status other timing","Performance status assessment timepoint category other text","STRING",true,"1","PERFORMANCE_STATUS_OTHER_TIMING","cesc_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","cesc_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","cesc_tcga"
"Lymph node location positive pathology name","Lymph node location positive pathology name","STRING",true,"1","POS_LYMPH_NODE_LOCATION","cesc_tcga"
"Ectopic pregnancy count","Ectopic pregnancy count","NUMBER",true,"1","PREGNANCIES_COUNT_ECTOPIC","cesc_tcga"
"Patient pregnancy therapeutic abortion count","Patient pregnancy therapeutic abortion count","NUMBER",true,"1","PREGNANCIES_COUNT_INDUCED_ABORTION","cesc_tcga"
"Number of successful pregnancies which resulted in at least 1 live birth","Number of successful pregnancies which resulted in at least 1 live birth","NUMBER",true,"1","PREGNANCIES_COUNT_LIVE_BIRTH","cesc_tcga"
"Patient pregnancy spontaneous abortion count","Patient pregnancy spontaneous abortion count","NUMBER",true,"1","PREGNANCIES_COUNT_MISCARRIAGE","cesc_tcga"
"Pregnancy stillbirth count","Pregnancy stillbirth count","NUMBER",true,"1","PREGNANCIES_COUNT_STILLBIRTH","cesc_tcga"
"Total number of pregnancies","Total number of pregnancies","NUMBER",true,"1","PREGNANCIES_COUNT_TOTAL","cesc_tcga"
"Pregnant at diagnosis","Pregnant at diagnosis","STRING",true,"1","PREGNANT_AT_DIAGNOSIS","cesc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","cesc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","cesc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","cesc_tcga"
"External beam radiation therapy administered paraaortic region lymph node dose","External beam radiation therapy administered paraaortic region lymph node dose","STRING",true,"1","RADIATION_THERAPY_DOSE_PARAAORTIC_NODES","cesc_tcga"
"Rt administered type","Rt administered type","STRING",true,"1","RADIATION_THERAPY_XRT_TYPE","cesc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","cesc_tcga"
"Radiation type notes","Radiation type notes","STRING",true,"1","RADIATION_TYPE_OTHER","cesc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","cesc_tcga"
"Radiation therapy not administered reason","Radiation therapy not administered reason","STRING",true,"1","RT_TX_REASON_NOT_COMPLETED","cesc_tcga"
"Radiation therapy not administered specify","Radiation therapy not administered specify","STRING",true,"1","RT_TX_REASON_NOT_COMPLETED_OTHER","cesc_tcga"
"Rt pelvis administered total dose","Rt pelvis administered total dose","STRING",true,"1","RT_TX_TOTAL_DOSE_TO_PELVIS","cesc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","cesc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","cesc_tcga"
"Laboratory procedure tumor marker squamous cell carcinoma antigen result value","Laboratory procedure tumor marker squamous cell carcinoma antigen result value","STRING",true,"1","SCCA_TUMOR_MARKER","cesc_tcga"
"Sex","Sex","STRING",true,"1","SEX","cesc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","cesc_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","cesc_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","cesc_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","cesc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","cesc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","cesc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","cesc_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","cesc_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","cesc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","cesc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","cesc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","cesc_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","cesc_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","cesc_tcga"
"Tumor response cdus type","Tumor response cdus type","STRING",true,"1","TUMOR_RESPONSE","cesc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","cesc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","cesc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","cesc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","cesc_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","cesc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","cesc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","cesc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","cesc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","cesc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","cesc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","cesc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cesc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","cesc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","cesc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","cesc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","cesc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","cesc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","cesc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","cesc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","cesc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","cesc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","cesc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","cesc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","cesc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","cesc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","cesc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","cesc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cesc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","cesc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","cesc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","cesc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","cesc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","cesc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","cesc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","cesc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","cesc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","cesc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","cesc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","cesc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","cesc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","cesc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","cesc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","cesc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","cesc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","cesc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","cesc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","cesc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","cesc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","cesc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","cesc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","cesc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","cesc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","cesc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","cesc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","cesc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","cesc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","cesc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","cesc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","cesc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","cesc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","cesc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","cesc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","cesc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","cesc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","cesc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","cesc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","cesc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","cesc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","cesc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","cesc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","cesc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","cesc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","cesc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","cesc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","cesc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","cesc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","cesc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","cesc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","cesc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","cesc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","cesc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","cesc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","cesc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","cesc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","cesc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","chol_jhu_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","chol_jhu_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","chol_jhu_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","chol_jhu_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","chol_nccs_2013"
"Anatomical Subtype","Anatomical Subtype","STRING",false,"1","ANATOMICAL_SUBTYPE","chol_nccs_2013"
"anti_O_viverrini_IgG","anti_O_viverrini_IgG","STRING",false,"1","ANTI_O_VIVERRINI_IGG","chol_nccs_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","chol_nccs_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","chol_nccs_2013"
"Country","Country of procurement.","STRING",true,"1","COUNTRY","chol_nccs_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","chol_nccs_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","chol_nccs_2013"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","chol_nccs_2013"
"Sex","Sex","STRING",true,"1","SEX","chol_nccs_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","chol_nus_2012"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","chol_nus_2012"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","chol_nus_2012"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","chol_nus_2012"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","chol_nus_2012"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","chol_nus_2012"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","chol_nus_2012"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","chol_nus_2012"
"Sex","Sex","STRING",true,"1","SEX","chol_nus_2012"
"Stage","Stage","STRING",true,"1","STAGE","chol_nus_2012"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","chol_nus_2012"
"Ablation embolization tx adjuvant","Ablation embolization tx adjuvant","STRING",true,"1","ABLATION_EMBOLIZATION_TX_ADJUVANT","chol_tcga"
"AFP At Procurement","Alpha Fetoprotein At Procurement","STRING",true,"1","AFP_AT_PROCUREMENT","chol_tcga"
"AFP Normal Range Lower Bound","AFP Normal Range Lower Bound","STRING",true,"1","AFP_NORM_RANGE_LOWER","chol_tcga"
"AFP Normal Range Higher Bound","AFP Normal Range Higher Bound","STRING",true,"1","AFP_NORM_RANGE_UPPER","chol_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","chol_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","chol_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","chol_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","chol_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","chol_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","chol_tcga"
"Bilirubin Total","Bilirubin Total","STRING",true,"1","BILIRUBIN_TOTAL","chol_tcga"
"Bilirubin Total Norm Range Lower","Bilirubin Total Norm Range Lower","NUMBER",true,"1","BILIRUBIN_TOTAL_NORM_RANGE_LOWER","chol_tcga"
"Bilirubin Total Norm Range Upper","Bilirubin Total Norm Range Upper","NUMBER",true,"1","BILIRUBIN_TOTAL_NORM_RANGE_UPPER","chol_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","chol_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","chol_tcga"
"Child pugh classification grade","Child pugh classification grade","STRING",true,"1","CHILD_PUGH_CLASSIFICATION","chol_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","chol_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","chol_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","chol_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","chol_tcga"
"Hematology serum creatinine laboratory result value in mg dl","Hematology serum creatinine laboratory result value in mg dl","NUMBER",true,"1","CREATININE_LEVEL_PRERESECTION","chol_tcga"
"Laboratory procedure creatinine result lower limit of normal value","Laboratory procedure creatinine result lower limit of normal value","NUMBER",true,"1","CREATININE_NORM_RANGE_LOWER","chol_tcga"
"Laboratory procedure creatinine result upper limit of normal value","Laboratory procedure creatinine result upper limit of normal value","NUMBER",true,"1","CREATININE_NORM_RANGE_UPPER","chol_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","chol_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","chol_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","chol_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","chol_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","chol_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","chol_tcga"
"Specimen collection method name","Specimen collection method name","STRING",true,"1","DEFINITIVE_SURGICAL_PROCEDURE","chol_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","chol_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","chol_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","chol_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","chol_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","chol_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","chol_tcga"
"Cancer diagnosis first degree relative number","Cancer diagnosis first degree relative number","STRING",true,"1","FAMILY_HISTORY_CANCER_NUMBER_RELATIVES","chol_tcga"
"Family History Cancer Relationship","Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individuals genes is shared (i.e., parent, sibling, offspring).","STRING",true,"1","FAMILY_HISTORY_CANCER_RELATIONSHIP","chol_tcga"
"Family History of Cancer","Family history of cancer.","STRING",true,"1","FAMILY_HISTORY_OF_CANCER","chol_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","chol_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","chol_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","chol_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","chol_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","chol_tcga"
"History hepato carcinoma risk factor","History hepato carcinoma risk factor","STRING",true,"1","HISTORY_HEPATO_CARCINOMA_RISK_FACTORS","chol_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","chol_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","chol_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","chol_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","chol_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","chol_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","chol_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","chol_tcga"
"Liver fibrosis ishak score category","Liver fibrosis ishak score category","STRING",true,"1","ISHAK_FIBROSIS_SCORE","chol_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","chol_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","chol_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","chol_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","chol_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","chol_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","chol_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","chol_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","chol_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","chol_tcga"
"History hepato carcinoma risk factor other","History hepato carcinoma risk factor other","STRING",true,"1","OTHER_HEPATO_CARCINOMA_RISK_FACTORS","chol_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","chol_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","chol_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","chol_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","chol_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","chol_tcga"
"Perineural Invasion","Perineural invasion.","STRING",true,"1","PERINEURAL_INVASION","chol_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","chol_tcga"
"Platelet count preresection","Platelet count preresection","NUMBER",true,"1","PLATELET_COUNT_PRERESECTION","chol_tcga"
"Laboratory prcoedure platelet result lower limit of normal value","Laboratory prcoedure platelet result lower limit of normal value","NUMBER",true,"1","PLATELET_NORM_RANGE_LOWER","chol_tcga"
"Laboratory prcoedure platelet result upper limit of normal value","Laboratory prcoedure platelet result upper limit of normal value","NUMBER",true,"1","PLATELET_NORM_RANGE_UPPER","chol_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","chol_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","chol_tcga"
"Laboratory procedure prothrombin time result value","Laboratory procedure prothrombin time result value","NUMBER",true,"1","PROTHROMBIN_TIME_INR_AT_PROCUREMENT","chol_tcga"
"Laboratory procedure international normalization ratio result upper limit of normal value","Laboratory procedure international normalization ratio result upper limit of normal value","NUMBER",true,"1","PROTHROMBIN_TIME_NORM_RANGE_UPPER","chol_tcga"
"Laboratory procedure international normalization ratio result lower limit of normal value","Laboratory procedure international normalization ratio result lower limit of normal value","NUMBER",true,"1","PROTHROM_TIME_INR_NORM_RANGE_LOWER","chol_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","chol_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","chol_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","chol_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","chol_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","chol_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","chol_tcga"
"Laboratory procedure albumin result lower limit of normal value","Laboratory procedure albumin result lower limit of normal value","NUMBER",true,"1","SERUM_ALBUMIN_NORM_RANGE_LOWER","chol_tcga"
"Laboratory procedure albumin result upper limit of normal value","Laboratory procedure albumin result upper limit of normal value","NUMBER",true,"1","SERUM_ALBUMIN_NORM_RANGE_UPPER","chol_tcga"
"Laboratory procedure albumin result specified value","Laboratory procedure albumin result specified value","NUMBER",true,"1","SERUM_ALBUMIN_PRERESECTION","chol_tcga"
"Sex","Sex","STRING",true,"1","SEX","chol_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","chol_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","chol_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","chol_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","chol_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","chol_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","chol_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","chol_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","chol_tcga"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","chol_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","chol_tcga"
"Vascular Invasion","Vascular invasion.","STRING",true,"1","VASCULAR_INVASION","chol_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","chol_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","chol_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","chol_tcga"
"Year of initial pathologic diagnosis","Year of initial pathologic diagnosis.","NUMBER",true,"1","YEAR_OF_INITIAL_PATHOLOGIC_DIAGNOSIS","chol_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","chol_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","chol_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","chol_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","chol_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","chol_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","chol_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","chol_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","chol_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","chol_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","chol_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","chol_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","chol_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","chol_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","chol_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","chol_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","chol_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","chol_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","chol_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","chol_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","chol_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","chol_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","chol_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","chol_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","chol_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","chol_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","chol_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","chol_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","chol_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","chol_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","chol_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","chol_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","chol_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","chol_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","chol_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","chol_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","chol_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","chol_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","chol_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","chol_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","chol_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","chol_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","chol_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","chol_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","chol_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","chol_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","chol_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","chol_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","chol_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","chol_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","chol_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","chol_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","chol_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","chol_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","chol_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","chol_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","chol_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","chol_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","chol_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","chol_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","chol_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","chol_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","chol_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","chol_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","chol_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","chol_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","chol_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","chol_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","chol_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","chol_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","chol_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","chol_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","chol_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","chol_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","chol_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","chol_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","chol_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","chol_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","chol_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","chol_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","chol_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","cllsll_icgc_2011"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cllsll_icgc_2011"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cllsll_icgc_2011"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","cllsll_icgc_2011"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","cll_iuopa_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cll_iuopa_2015"
"Epigenetic","Epigenetic","STRING",true,"1","EPIGENETIC","cll_iuopa_2015"
"Exome Capture","Exome Capture","STRING",false,"1","EXOME_CAPTURE","cll_iuopa_2015"
"IGHV Gene","IGHV Gene","STRING",false,"1","IGHV_GENE","cll_iuopa_2015"
"IGHV Identity (%)","IGHV Identity (%)","NUMBER",false,"1","IGHV_IDENTITY","cll_iuopa_2015"
"IGHV Mutated","IGHV Mutated","STRING",false,"1","IGHV_MUTATED","cll_iuopa_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cll_iuopa_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","coadread_dfci_2016"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","coadread_dfci_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","coadread_dfci_2016"
"CIMP Category","CIMP category.","STRING",false,"1","CIMP_CATEGORY","coadread_dfci_2016"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","coadread_dfci_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","coadread_dfci_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","coadread_dfci_2016"
"Percent Necrosis","Percent necrosis.","NUMBER",true,"1","PERCENTAGE_NECROSIS","coadread_dfci_2016"
"Tumor Grade","""Histologic grading criteria for adenoid cystic carcinoma (Szanto, et. al, 1984)""","STRING",false,"1","PRIMARY_TUMOR_GRADE","coadread_dfci_2016"
"Sex","Sex","STRING",true,"1","SEX","coadread_dfci_2016"
"tumor purity","tumor purity","STRING",false,"1","TUMOR_PURITY","coadread_dfci_2016"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","coadread_dfci_2016"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","coadread_dfci_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","coadread_genentech"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","coadread_genentech"
"Diagnosis","Diagnosis.","STRING",true,"1","DIAGNOSIS","coadread_genentech"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","coadread_genentech"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","coadread_genentech"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","coadread_genentech"
"STR (affected/tested)","Short Tandem Repeat Ratio","STRING",false,"1","STR_STATUS","coadread_genentech"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","coadread_genentech"
"tumor content","tumor content","NUMBER",false,"1","TUMOR_CONTENT","coadread_genentech"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","coadread_genentech"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","coadread_mskcc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","coadread_mskcc"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","coadread_mskcc"
"Months_followup","Months_followup","NUMBER",true,"1","MONTHS_FOLLOWUP","coadread_mskcc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","coadread_mskcc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","coadread_mskcc"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","coadread_mskcc"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","coadread_mskcc"
"Resection timing","Resection timing","STRING",false,"1","RESECTION_TIMING","coadread_mskcc"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","coadread_mskcc"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","coadread_mskcc"
"Tumor treated","Tumor treated","STRING",false,"1","TUMOR_TREATED","coadread_mskcc"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","coadread_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","coadread_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","coadread_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","coadread_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","coadread_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","coadread_tcga"
"BRAF Gene Analysis Indicator","BRAF Gene Analysis Indicator","STRING",true,"1","BRAF_GENE_ANALYSIS_INDICATOR","coadread_tcga"
"BRAF Gene Analysis Result","BRAF Gene Analysis Result","STRING",true,"1","BRAF_GENE_ANALYSIS_RESULT","coadread_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","coadread_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","coadread_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","coadread_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","coadread_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","coadread_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","coadread_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","coadread_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","coadread_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","coadread_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","coadread_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","coadread_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","coadread_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","coadread_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","coadread_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","coadread_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","coadread_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","coadread_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","coadread_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","coadread_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","coadread_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","coadread_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","coadread_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","coadread_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","coadread_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","coadread_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","coadread_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","coadread_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","coadread_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","coadread_tcga"
"Initial pathologic diagnosis method","Initial pathologic diagnosis method","STRING",true,"1","INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD","coadread_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","coadread_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","coadread_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","coadread_tcga"
"Kras gene analysis indicator","Kras gene analysis indicator","STRING",true,"1","KRAS_GENE_ANALYSIS_INDICATOR","coadread_tcga"
"KRAS Mutation","KRAS mutation is present.","STRING",true,"1","KRAS_MUTATION","coadread_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","coadread_tcga"
"Lymphovascular invasion indicator","Lymphovascular invasion indicator","STRING",true,"1","LYMPHOVASCULAR_INVASION_INDICATOR","coadread_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","coadread_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","STRING",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","coadread_tcga"
"Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,","NUMBER",true,"1","LYMPH_NODES_EXAMINED_IHC_COUNT","coadread_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","STRING",true,"1","LYMPH_NODE_EXAMINED_COUNT","coadread_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","coadread_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","coadread_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","coadread_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","coadread_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","coadread_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","coadread_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","coadread_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","coadread_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","coadread_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","coadread_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","coadread_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","coadread_tcga"
"Perineural Invasion","Perineural invasion.","STRING",true,"1","PERINEURAL_INVASION","coadread_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","coadread_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","coadread_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","coadread_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","coadread_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","coadread_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","coadread_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","coadread_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","coadread_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","coadread_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","coadread_tcga"
"Sex","Sex","STRING",true,"1","SEX","coadread_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","coadread_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","coadread_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","coadread_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","coadread_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","coadread_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","coadread_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","coadread_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","coadread_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","coadread_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","coadread_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","coadread_tcga"
"Vascular invasion indicator","Vascular invasion indicator","STRING",true,"1","VASCULAR_INVASION_INDICATOR","coadread_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","coadread_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","coadread_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","coadread_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","coadread_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","coadread_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","coadread_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","coadread_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","coadread_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","coadread_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","coadread_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","coadread_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","coadread_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","coadread_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","coadread_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","coadread_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","coadread_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","coadread_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","coadread_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","coadread_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","coadread_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","coadread_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","coadread_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","coadread_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","coadread_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","coadread_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","coadread_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","coadread_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","coadread_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","coadread_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","coadread_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","coadread_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","coadread_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","coadread_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","coadread_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","coadread_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","coadread_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","coadread_tcga_pan_can_atlas_2018"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","coadread_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","coadread_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","coadread_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","coadread_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","coadread_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","coadread_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","coadread_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","coadread_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","coadread_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","coadread_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","coadread_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","coadread_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","coadread_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","coadread_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","coadread_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","coadread_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","coadread_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","coadread_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","coadread_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","coadread_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","coadread_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","coadread_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","coadread_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","coadread_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","coadread_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","coadread_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","coadread_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","coadread_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","coadread_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","coadread_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","coadread_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","coadread_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","coadread_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","coadread_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","coadread_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","coadread_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","coadread_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","coadread_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","coadread_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","coadread_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","coadread_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","coadread_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","coadread_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","coadread_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","coadread_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","coadread_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","coadread_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","coadread_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","coadread_tcga_pub"
"Copy Number","Copy Number","STRING",false,"1","COPY_NUMBER","coadread_tcga_pub"
"Gene Expression Subtype","Gene Expression Subtype","STRING",false,"1","EXPRESSION_SUBTYPE","coadread_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","coadread_tcga_pub"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","coadread_tcga_pub"
"Hyper-mutated","Hyper-mutated.","STRING",false,"1","HYPERMUTATED","coadread_tcga_pub"
"iCluster","ICluster.","STRING",false,"1","ICLUSTER","coadread_tcga_pub"
"Methylation Status","Yes/No indicator for methylation data","STRING",false,"1","METHYLATION_STATUS","coadread_tcga_pub"
"Methylation Subtype","Methylation subtype.","STRING",false,"1","METHYLATION_SUBTYPE","coadread_tcga_pub"
"MLH1 Silencing","Epigenetic silencing status of MLH1.","STRING",false,"1","MLH1_SILENCING","coadread_tcga_pub"
"MRNA Data","MRNA data.","STRING",false,"1","MRNA_DATA","coadread_tcga_pub"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","coadread_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","coadread_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","coadread_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","coadread_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","coadread_tcga_pub"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","coadread_tcga_pub"
"Primary Tumor Pathologic Spread","Primary tumor pathologic spread.","STRING",true,"1","PRIMARY_TUMOR_PATHOLOGIC_SPREAD","coadread_tcga_pub"
"Sequenced","Sequenced.","STRING",false,"1","SEQUENCED","coadread_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","coadread_tcga_pub"
"Tumor Stage 2009","Tumor stage 2009.","STRING",false,"1","TUMOR_STAGE_2009","coadread_tcga_pub"
"Age at Diagnosis","Age at Diagnosis","NUMBER",true,"1","AGE_AT_DIAGNOSIS","crc_msk_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","crc_msk_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","crc_msk_2018"
"Chemo Exposure of sequenced specimen","Chemo Exposure of sequenced specimen","STRING",false,"1","CHEMO_EXP_SEQ_SPECIMEN","crc_msk_2018"
"First Site of Metastasis","First Site of Metastasis","STRING",false,"1","FIRST_SITE_OF_METS","crc_msk_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","crc_msk_2018"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","crc_msk_2018"
"mCRC Type","mCRC Type","STRING",false,"1","MCRC_TYPE","crc_msk_2018"
"Metastasectomy","Metastasectomy","STRING",false,"1","METASTASECTOMY","crc_msk_2018"
"Metastasectomy Site","Metastasectomy Site","STRING",false,"1","METASTASECTOMY_SITE","crc_msk_2018"
"Metastases Site First: Bone","Metastases Site First: Bone","STRING",false,"1","METASTASES_SITE_FIRST_BONE","crc_msk_2018"
"Metastases Site First: Brain","Metastases Site First: Brain","STRING",false,"1","METASTASES_SITE_FIRST_BRAIN","crc_msk_2018"
"Metastases Site First: Gynecological","Metastases Site First: Gynecological","STRING",false,"1","METASTASES_SITE_FIRST_GYN","crc_msk_2018"
"Metastases Site First: Liver","Metastases Site First: Liver","STRING",false,"1","METASTASES_SITE_FIRST_LIVER","crc_msk_2018"
"Metastases Site First: Ln","Metastases Site First: Ln","STRING",false,"1","METASTASES_SITE_FIRST_LN","crc_msk_2018"
"Metastases Site First: Lung","Metastases Site First: Lung","STRING",false,"1","METASTASES_SITE_FIRST_LUNG","crc_msk_2018"
"Metastases Site First: Pelvis","Metastases Site First: Pelvis","STRING",false,"1","METASTASES_SITE_FIRST_PELVIS","crc_msk_2018"
"Metastases Site First: Peritoneum, omentum, abdomen","Metastases Site First: Peritoneum, omentum, abdomen","STRING",false,"1","METASTASES_SITE_FIRST_PERITONEUM_OMENTUM_ABDOMEN","crc_msk_2018"
"Metastatic Biopsy Site","Metastatic Biopsy Site","STRING",false,"1","METASTATIC_BIOPSY_SITE","crc_msk_2018"
"Molecular Subtype","Molecular subtype.","STRING",false,"1","MOLECULAR_SUBTYPE","crc_msk_2018"
"MSI Score","MSI Score","NUMBER",false,"1","MSI_SCORE","crc_msk_2018"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","crc_msk_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","crc_msk_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","crc_msk_2018"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","crc_msk_2018"
"OS Months (Additonal Data)","OS Months (Additonal Data)","NUMBER",true,"1","OS_MONTHS_ADDITIONAL","crc_msk_2018"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","crc_msk_2018"
"Other Metastasis Sites","Other Metastasis Sites Description","STRING",false,"1","OTHER_SITES_OF_METS","crc_msk_2018"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","crc_msk_2018"
"Primary Tumor Location","Primary Tumor Location","STRING",false,"1","PRIMARY_TUMOR_LOCATION","crc_msk_2018"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","crc_msk_2018"
"Sex","Sex","STRING",true,"1","SEX","crc_msk_2018"
"Specimen Type","The broad cancer phenotype and site information values for a sample to be processed.","STRING",false,"1","SPECIMEN_TYPE","crc_msk_2018"
"Stage At Diagnosis","Stage At Diagnosis","STRING",false,"1","STAGE_AT_DIAGNOSIS","crc_msk_2018"
"Time from Met Dx to Sequencing","Time from Met Dx to Sequencing","NUMBER",false,"1","TIME_FROM_MET_DX_SEQUENCING","crc_msk_2018"
"TIme to Metastasis Months","TIme to Metastasis Months","STRING",false,"1","TIME_TO_METASTASIS_MONTHS","crc_msk_2018"
"Tumor Grade","Histologic grading criteria of Tumors","STRING",true,"1","TUMOR_GRADE","crc_msk_2018"
"Tumor Sample Histology","Tumor Sample Histology","STRING",false,"1","TUMOR_SAMPLE_HISTOLOGY","crc_msk_2018"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","crc_msk_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","cscc_dfarber_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","cscc_dfarber_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cscc_dfarber_2015"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","cscc_dfarber_2015"
"Immune Status","Immune Status","STRING",false,"1","IMMUNE_STATUS","cscc_dfarber_2015"
"Merkel Cell","Merkel cells are oval receptor cells found in the skin of vertebrates that have synaptic contacts with somatosensory afferents.","STRING",false,"1","MERKEL_CELL","cscc_dfarber_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cscc_dfarber_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","cscc_dfarber_2015"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","cscc_dfarber_2015"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","cscc_dfarber_2015"
"Other Sample ID","Other sample identifier","STRING",false,"1","OTHER_SAMPLE_ID","cscc_dfarber_2015"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","cscc_dfarber_2015"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","cscc_dfarber_2015"
"Second Primary Cancer","Refers to a new primary cancer in a person with a history of cancer","STRING",false,"1","SECOND_PRIMARY_CANCER","cscc_dfarber_2015"
"Sex","Sex","STRING",true,"1","SEX","cscc_dfarber_2015"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","cscc_dfarber_2015"
"Absolute cancer dna fraction","Absolute cancer dna fraction","STRING",false,"1","ABSOLUTE_CANCER_DNA_FRACTION","cscc_hgsc_bcm_2014"
"Absolute Extract Ploidy","Absolute extract ploidy.","STRING",false,"1","ABSOLUTE_EXTRACT_PLOIDY","cscc_hgsc_bcm_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","cscc_hgsc_bcm_2014"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","cscc_hgsc_bcm_2014"
"A>C","A>C","STRING",false,"1","A_C","cscc_hgsc_bcm_2014"
"A>G","A>G","STRING",false,"1","A_G","cscc_hgsc_bcm_2014"
"A>T","A>T","STRING",false,"1","A_T","cscc_hgsc_bcm_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","cscc_hgsc_bcm_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","cscc_hgsc_bcm_2014"
"CC>TT","CC>TT","STRING",false,"1","CC_TT","cscc_hgsc_bcm_2014"
"Clark level at diagnosis","Melanoma clark level value","STRING",true,"1","CLARK_LEVEL_AT_DIAGNOSIS","cscc_hgsc_bcm_2014"
"C>A","C>A","STRING",false,"1","C_A","cscc_hgsc_bcm_2014"
"C>G","C>G","STRING",false,"1","C_G","cscc_hgsc_bcm_2014"
"C>T","C>T","STRING",false,"1","C_T","cscc_hgsc_bcm_2014"
"Detailed Metastatic Site","Detailed Metastatic Site","STRING",false,"1","DETAILED_METASTATIC_SITE","cscc_hgsc_bcm_2014"
"Differentiation","Differentiation","STRING",false,"1","DIFFERENTIATION","cscc_hgsc_bcm_2014"
"Disease Recurrence or Persistence","Disease Recurrence or Persistence","STRING",true,"1","DISEASE_RECURRENCE_OR_PERSISTENCE","cscc_hgsc_bcm_2014"
"Disease Status","Disease Status","STRING",true,"1","DISEASE_STATUS","cscc_hgsc_bcm_2014"
"Distant Metastasis","Distant Metastasis","STRING",false,"1","DISTANT_METS","cscc_hgsc_bcm_2014"
"Number of Distant Recurrence","Number of Distant Recurrence","NUMBER",true,"1","DISTANT_RECURRENCE_NUM","cscc_hgsc_bcm_2014"
"Event Free Survival (Months)","In cancer, the length of time after primary treatment for a cancer ends that the patient remains free of certain complications or events that the treatment was intended to prevent or delay. These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone.","NUMBER",true,"1","EFS_MONTHS","cscc_hgsc_bcm_2014"
"Event Free Status","Event Free Status","STRING",true,"1","EFS_STATUS","cscc_hgsc_bcm_2014"
"Event Details","Event Details","STRING",true,"1","EVENT_DETAILS","cscc_hgsc_bcm_2014"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","cscc_hgsc_bcm_2014"
"Other Cancer","Has other cancer.","STRING",true,"1","HAS_OTHER_CANCER","cscc_hgsc_bcm_2014"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","cscc_hgsc_bcm_2014"
"Immunosuppression","Suppression of the immune system.","STRING",true,"1","IMMUNOSUPPRESSION","cscc_hgsc_bcm_2014"
"Interval From Index Lesion to Present Lesion (months)","Interval From Index Lesion to Present Lesion (months)","STRING",true,"1","INTERVAL_FROM_INDEX_LESION_TO_PRESENT_LESION","cscc_hgsc_bcm_2014"
"Interval From Previous Lesion to Tumor Studied (months)","Interval From Previous Lesion to Tumor Studied (months)","STRING",true,"1","INTERVAL_FROM_LAST_LESION_TO_STUDY","cscc_hgsc_bcm_2014"
"Invade Bone","Invade Bone","STRING",true,"1","INVADE_BONE","cscc_hgsc_bcm_2014"
"Invade > Subcutaneous Tissue","Invade > Subcutaneous Tissue","STRING",false,"1","INVADE_LARGER_THAN_SUBCUTANEOUS_TISSUE","cscc_hgsc_bcm_2014"
"Invade Parotid","Invade Parotid","STRING",true,"1","INVADE_PAROTID","cscc_hgsc_bcm_2014"
"Invade Skull Base","Invade Skull Base","STRING",true,"1","INVADE_SKULL_BASE","cscc_hgsc_bcm_2014"
"Invasion Depth (mm)","Invasion depth (mm).","STRING",false,"1","INVASION_DEPTH","cscc_hgsc_bcm_2014"
"Number of Local Recurrence","Number of Local Recurrence","NUMBER",true,"1","LOCAL_RECURRENCE_NUM","cscc_hgsc_bcm_2014"
"Multiple HN cSCC","Multiple Head and Neck cSCC","STRING",true,"1","MULTIPLE_HN_CSCC","cscc_hgsc_bcm_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","cscc_hgsc_bcm_2014"
"M Stage","M Stage","STRING",true,"1","M_STAGE","cscc_hgsc_bcm_2014"
"N Stage","N Stage","STRING",true,"1","N_STAGE","cscc_hgsc_bcm_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","cscc_hgsc_bcm_2014"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","cscc_hgsc_bcm_2014"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","cscc_hgsc_bcm_2014"
"Types of Other Cancers","Types of Other Cancers","STRING",true,"1","OTHER_CANCER_TYPE","cscc_hgsc_bcm_2014"
"other DNP","other DNP","STRING",false,"1","OTHER_DNP","cscc_hgsc_bcm_2014"
"Other Skin Tumors","Other Skin Tumors","STRING",true,"1","OTHER_SKIN_TUMORS","cscc_hgsc_bcm_2014"
"Parotid LN","Parotid Lymph Node","STRING",true,"1","PAROTID_LN","cscc_hgsc_bcm_2014"
"Persistant Disease Tumor Studied","Persistant Disease Tumor Studied","STRING",true,"1","PERSISTANT_DISEASE_TUMOR_STUDIED","cscc_hgsc_bcm_2014"
"PNI","PNI.","STRING",true,"1","PNI","cscc_hgsc_bcm_2014"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","cscc_hgsc_bcm_2014"
"Prior Treatment","Prior treatment.","STRING",true,"1","PRIOR_TREATMENT","cscc_hgsc_bcm_2014"
"Purity","Purity","STRING",false,"1","PURITY","cscc_hgsc_bcm_2014"
"Absolute Purity","Absolute purity.","STRING",false,"1","PURITY_ABSOLUTE","cscc_hgsc_bcm_2014"
"Patient received Radiation or Chemotherapy","Patient received Radiation or Chemotherapy","STRING",true,"1","RADIATION_OR_CHEMOTHERAPY","cscc_hgsc_bcm_2014"
"Recurrent Disease Tumor Studies","Recurrent Disease Tumor Studied","STRING",true,"1","RECURRENT_DISEASE_TUMOR_STUDIED","cscc_hgsc_bcm_2014"
"Recurrent Free Interval (Months)","Recurrent Free Interval (Months)","STRING",true,"1","RECURRENT_FREE_INTERVAL_MONTHS","cscc_hgsc_bcm_2014"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","cscc_hgsc_bcm_2014"
"Subsequent Cancers","Subsequent Cancers","STRING",true,"1","SUBSEQUENT_CANCERS","cscc_hgsc_bcm_2014"
"Total Mutations","Total Mutations","NUMBER",true,"1","TOTAL_MUTATIONS","cscc_hgsc_bcm_2014"
"Treatment Type","Treatment Type","STRING",true,"1","TREATMENT_TYPE","cscc_hgsc_bcm_2014"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","cscc_hgsc_bcm_2014"
"T Stage","T Stage","STRING",false,"1","T_STAGE","cscc_hgsc_bcm_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ctcl_columbia_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ctcl_columbia_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ctcl_columbia_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ctcl_columbia_2015"
"Tumor Subtype","Tumor Subtype","STRING",false,"1","TUMOR_SUBTYPE","ctcl_columbia_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","desm_broad_2015"
"Anatomic Region","Anatomic Region.","STRING",true,"1","ANATOMIC_REGION","desm_broad_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","desm_broad_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","desm_broad_2015"
"Cohort","Cohort.","STRING",true,"1","COHORT","desm_broad_2015"
"Detailed Sample Histology Category","Detailed Sample Histology Category","STRING",false,"1","DETAILED_SAMPLE_HISTOLOGY_CATEGORY","desm_broad_2015"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","desm_broad_2015"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","desm_broad_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","desm_broad_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","desm_broad_2015"
"Platform","Platform.","STRING",false,"1","PLATFORM","desm_broad_2015"
"Secondary Platform","Secondary Platform","STRING",false,"1","SECONDARY_PLATFORM","desm_broad_2015"
"SOURCE","SOURCE","STRING",true,"1","SOURCE","desm_broad_2015"
"Total Mutations","Total Mutations","NUMBER",true,"1","TOTAL_MUTATIONS","desm_broad_2015"
"Age at Diagnosis","Age at Diagnosis","NUMBER",true,"1","AGE_AT_DIAGNOSIS","dlbcl_dfci_2018"
"COO by Any (GEP + Nanostring)","Cell of origin by gene expression profiling or nanostring","STRING",false,"0","ANY_COO","dlbcl_dfci_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","dlbcl_dfci_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","dlbcl_dfci_2018"
"Consensus Clustering Category","Consensus Clustering Category","STRING",false,"0","CCC","dlbcl_dfci_2018"
"Cluster","Cluster","NUMBER",false,"1","CLUSTER","dlbcl_dfci_2018"
"CNS Involvement","Yes or No indicator for CNS involvement","STRING",true,"1","CNS_INVOLVEMENT","dlbcl_dfci_2018"
"Cohort","Cohort.","STRING",true,"1","COHORT","dlbcl_dfci_2018"
"COO by GEP","Cell of origin category by Gene Expression Profiling (Affy)","STRING",false,"0","COO_GEP","dlbcl_dfci_2018"
"COO by Lymph2CX","Cell of origin category by Lymph2CX (nanostring)","STRING",false,"0","COO_LYMPH2CX","dlbcl_dfci_2018"
"dbSNP Mutation Density","dbSNP Mutation Density","NUMBER",false,"0","DBSNP_MUTATION_DENSITY","dlbcl_dfci_2018"
"Driver Mutations","Driver Mutations","NUMBER",false,"1","DRIVER_MUTATIONS","dlbcl_dfci_2018"
"Driver Mutation Density","Driver mutations per megabase","NUMBER",false,"0","DRIVER_MUTATION_DENSITY","dlbcl_dfci_2018"
"Matched Normal","Has matched normal.","STRING",false,"1","HAS_MATCHED_NORMAL","dlbcl_dfci_2018"
"IPI","International Prognostic Index (IPI)","NUMBER",true,"1","IPI","dlbcl_dfci_2018"
"Age IPI Factor","IPI factor age; 1 = age > 60 years; 0 = age <=60 years","NUMBER",true,"1","IPI_AGE","dlbcl_dfci_2018"
"ECOG IPI Score","IPI factor ECOG; 0 = ECOG <= 1; 1 = ECOG > 1","NUMBER",true,"1","IPI_ECOG","dlbcl_dfci_2018"
"Extralymphatic Involvement IPI Factor","IPI factor Extralymphatic Involvement; 0 = E <= 1; 1 = E > 1","NUMBER",true,"1","IPI_EXBM","dlbcl_dfci_2018"
"LDH IPI Factor","IPI factor LDH; LDH > normal reference, 1;  LDH <= normal reference, 0","NUMBER",true,"1","IPI_LDH","dlbcl_dfci_2018"
"STAGE IPI Factor","IPI factor stage; 0 = stage I/II or 1 = stage III/IV","NUMBER",true,"1","IPI_STAGE","dlbcl_dfci_2018"
"mean target coverage tumor","mean target coverage tumor","STRING",false,"0","MEAN_TARGET_COVERAGE_TUMOR","dlbcl_dfci_2018"
"Morphology Subtype","Morphology Subtype","STRING",false,"1","MORPHOLOGY_SUBTYPE","dlbcl_dfci_2018"
"Mutation Count","Mutation Count","NUMBER",false,"1","MUTATION_COUNT","dlbcl_dfci_2018"
"Mutation Density","Mutations per megabase","NUMBER",false,"0","MUTATION_DENSITY","dlbcl_dfci_2018"
"Nonsilent Mutation Density","Nonsilent Mutation Density","NUMBER",false,"0","NONSILENT_MUTATION_DENSITY","dlbcl_dfci_2018"
"Number of dbSNP Mutations","dbSNP mutations per megabase","NUMBER",false,"0","NUM_DBSNP_MUTATIONS","dlbcl_dfci_2018"
"Number of Driver SCNAs","Number of Driver SCNAs","NUMBER",false,"0","NUM_DRIVER_SCNA","dlbcl_dfci_2018"
"Number of Driver Structural Variants","Number of Driver Structural Variants","NUMBER",false,"1","NUM_DRIVER_SV","dlbcl_dfci_2018"
"Total Number of Nonsilent Mutation","Total Number of Nonsilent Mutation","NUMBER",false,"1","NUM_NONSILENT_MUTATION","dlbcl_dfci_2018"
"Total Number of Silent Mutation","Total Number of Silent Mutation","NUMBER",false,"1","NUM_SILENT_MUTATION","dlbcl_dfci_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","dlbcl_dfci_2018"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","dlbcl_dfci_2018"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","dlbcl_dfci_2018"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","dlbcl_dfci_2018"
"Progression Free Status","Progression Free Status","STRING",true,"1","PFS_STATUS","dlbcl_dfci_2018"
"Absolute Ploidy","Absolute Ploidy","NUMBER",false,"1","PLOIDY_ABSOLUTE","dlbcl_dfci_2018"
"Absolute Purity","Absolute purity.","NUMBER",false,"1","PURITY_ABSOLUTE","dlbcl_dfci_2018"
"R-CHOP like chemo","Patient received R-CHOP-like chemo; yes,no","STRING",true,"1","R_CHOP_LIKE_CHEMO","dlbcl_dfci_2018"
"Sample Collection Source","Sample Collection Source","STRING",false,"1","SAMPLE_COLLECTION_SOURCE","dlbcl_dfci_2018"
"Sex","Sex","STRING",true,"1","SEX","dlbcl_dfci_2018"
"Silent Mutation Density","Silent mutations per megabase","NUMBER",false,"0","SILENT_MUTATION_DENSITY","dlbcl_dfci_2018"
"Testicular Involvement","Yes or No indicator for testicular involvement","STRING",true,"1","TESTICULAR_INVOLVEMENT","dlbcl_dfci_2018"
"Total CNA","Total CNA","NUMBER",false,"0","TOTAL_CNA","dlbcl_dfci_2018"
"Total Rearrangement","Total Rearrangement","NUMBER",false,"1","TOTAL_REARRANGEMENT","dlbcl_dfci_2018"
"Tumor in Normal Estimate","Fraction of tumor cells in normal sample estimated by deTIN","NUMBER",false,"0","TUMOR_IN_NORMAL_ESTIMATE","dlbcl_dfci_2018"
"Age at Diagnosis","Age at Diagnosis","NUMBER",true,"1","AGE_AT_DIAGNOSIS","dlbcl_duke_2017"
"BCL2 Fish Status","BCL2 Fish Status","STRING",false,"1","BCL2_FISH_STATUS","dlbcl_duke_2017"
"BCL6 Fish Status","BCL6 Fish Status","STRING",false,"1","BCL6_FISH_STATUS","dlbcl_duke_2017"
"B Symptoms at Diagnosis","Presence of B Symptoms at Diagnosis?","STRING",true,"1","B_SYMPTOMS_AT_DIAGNOSIS","dlbcl_duke_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","dlbcl_duke_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","dlbcl_duke_2017"
"Censored","Survival Time Censored; True or False","STRING",false,"1","CENSORED","dlbcl_duke_2017"
"CNS Relapse","CNS Relapse","STRING",true,"1","CNS_RELAPSE","dlbcl_duke_2017"
"CNS Status","CNS status.","STRING",true,"1","CNS_STATUS","dlbcl_duke_2017"
"Initial Treatment Response","Initial Treatment Response","STRING",true,"1","INITIAL_TX_RESPONSE","dlbcl_duke_2017"
"IPI","International Prognostic Index (IPI)","NUMBER",true,"1","IPI","dlbcl_duke_2017"
"Age IPI Factor","IPI factor age; 1 = age > 60 years; 0 = age <=60 years","NUMBER",true,"1","IPI_AGE","dlbcl_duke_2017"
"AnnArbor Stage IPI","Ann Arbor staging as an IPI Factor","NUMBER",true,"1","IPI_ANNARBOR_STAGE","dlbcl_duke_2017"
"ECOG IPI Score","IPI factor ECOG; 0 = ECOG <= 1; 1 = ECOG > 1","NUMBER",true,"1","IPI_ECOG","dlbcl_duke_2017"
"Extranodal IPI Factor","IPI factor Extranodal; 1 = Extranodal sites > 1; 0 = Extranodal sites <= 1","NUMBER",true,"1","IPI_EXTRANODAL_SITES","dlbcl_duke_2017"
"LDH IPI Factor","IPI factor LDH; LDH > normal reference, 1;  LDH <= normal reference, 0","NUMBER",true,"1","IPI_LDH","dlbcl_duke_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","dlbcl_duke_2017"
"MYC Fish Status","MYC Fish Status","STRING",false,"1","MYC_FISH","dlbcl_duke_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","dlbcl_duke_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","dlbcl_duke_2017"
"Prognostic Model","Genomic Risk Model Classification","STRING",false,"1","PROGNOSTIC_MODEL","dlbcl_duke_2017"
"Sex","Sex","STRING",true,"1","SEX","dlbcl_duke_2017"
"Testicular Involvement","Yes or No indicator for testicular involvement","STRING",true,"1","TESTICULAR_INVOLVEMENT","dlbcl_duke_2017"
"Tumor Purity","Tumor Purity","STRING",false,"1","TUMOR_PURITY","dlbcl_duke_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","dlbc_broad_2012"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","dlbc_broad_2012"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","dlbc_broad_2012"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","dlbc_broad_2012"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","dlbc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","dlbc_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","dlbc_tcga"
"Bone Marrow Biopsy Performed","Bone Marrow Biopsy Performed","STRING",true,"1","BONE_MARROW_BIOPSY_PERFORMED","dlbc_tcga"
"Bone Marrow Involvement","Bone Marrow Involvement","STRING",true,"1","BONE_MARROW_INVOLVEMENT","dlbc_tcga"
"Bone Marrow Sample Histology","Bone Marrow Sample Histology","STRING",true,"1","BONE_MARROW_SAMPLE_HISTOLOGY","dlbc_tcga"
"B Cell Genotype Method","B Cell Genotype Method","STRING",true,"1","B_CELL_GENOTYPE_METHOD","dlbc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","dlbc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","dlbc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","dlbc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","dlbc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","dlbc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","dlbc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","dlbc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","dlbc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","dlbc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","dlbc_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","dlbc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","dlbc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","dlbc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","dlbc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","dlbc_tcga"
"EBV Positive Malignant Cells Percent","EBV Positive Malignant Cells Percent","NUMBER",true,"1","EBV_POSITIVE_MALIGNANT_CELLS_PERCENT","dlbc_tcga"
"EBV Status","Epstein-Barr Virus (EBV) Status","STRING",true,"1","EBV_STATUS","dlbc_tcga"
"EBV Status Malignant Cells Method","EBV Status Malignant Cells Method","STRING",true,"1","EBV_STATUS_MALIGNANT_CELLS_METHOD","dlbc_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","dlbc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","dlbc_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","dlbc_tcga"
"Extranodal disease involvement site","Extranodal disease involvement site","STRING",true,"1","EXTRANODAL_INVOLVMENT_OTHER","dlbc_tcga"
"Extranodal involvement","Extranodal involvement","STRING",true,"1","EXTRANODAL_LYMPHOMATOUS_INVOLVEMENT","dlbc_tcga"
"Percentage of follicular component","Percentage of follicular component","STRING",true,"1","FOLLICULAR_COMPONENT_PERCENT","dlbc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","dlbc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","dlbc_tcga"
"Abnormality tested methodology","Abnormality tested methodology","STRING",true,"1","GENETIC_ABNORMALITY_METHOD_OTHER","dlbc_tcga"
"Abnormality tested results","Abnormality tested results","STRING",true,"1","GENETIC_ABNORMALITY_RESULTS","dlbc_tcga"
"Genetic abnormality tested","Genetic abnormality tested","STRING",true,"1","GENETIC_ABNORMALITY_TESTED","dlbc_tcga"
"Other genetic abnormality tested","Other genetic abnormality tested","STRING",true,"1","GENETIC_ABNORMALITY_TESTED_OTHER","dlbc_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","dlbc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","dlbc_tcga"
"Prior immunologic disease type","Prior immunologic disease type","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE","dlbc_tcga"
"Prior immunologic disease other","Prior immunologic disease other","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE_OTHER","dlbc_tcga"
"Prior immunosuppressive therapy type","Prior immunosuppressive therapy type","STRING",true,"1","HISTORY_IMMUNOSUPPRESIVE_DX","dlbc_tcga"
"Prior immunosuppressive therapy other","Prior immunosuppressive therapy other","STRING",true,"1","HISTORY_IMMUNOSUPPRESIVE_DX_OTHER","dlbc_tcga"
"Prior infectious disease other","Prior infectious disease other","STRING",true,"1","HISTORY_IMMUNOSUPPRESSIVE_TX_OTHER","dlbc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","dlbc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","dlbc_tcga"
"Prior infectious disease","Prior infectious disease","STRING",true,"1","HISTORY_RELEVANT_INFECTIOUS_DX","dlbc_tcga"
"HIV Status","HIV Status","STRING",true,"1","HIV_STATUS","dlbc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","dlbc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","dlbc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","dlbc_tcga"
"Idh level","Idh level","STRING",true,"1","IDH_LEVEL","dlbc_tcga"
"Igh genotype results","Igh genotype results","STRING",true,"1","IGH_GENOTYPE_RESULT","dlbc_tcga"
"Igk genotype results","Igk genotype results","STRING",true,"1","IGK_GENOTYPE_RESULT","dlbc_tcga"
"Immunophenotypic analysis methodology","Immunophenotypic analysis methodology","STRING",true,"1","IMMUNOPHENOTYPIC_ANALYSIS_METHOD","dlbc_tcga"
"Result of immunophenotypic analysis","Result of immunophenotypic analysis","STRING",true,"1","IMMUNOPHENOTYPIC_ANALYSIS_RESULTS","dlbc_tcga"
"Immunophenotypic analysis test","Immunophenotypic analysis test","STRING",true,"1","IMMUNOPHENOTYPIC_ANALYSIS_TESTED","dlbc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","dlbc_tcga"
"Initial pathologic diagnosis method","Initial pathologic diagnosis method","STRING",true,"1","INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD","dlbc_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","dlbc_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","dlbc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","dlbc_tcga"
"Ldh upper limit","Ldh upper limit","STRING",true,"1","LDH_NORM_RANGE_UPPER","dlbc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","dlbc_tcga"
"Nodal anatomic site","Nodal anatomic site","STRING",true,"1","LYMPH_NODE_INVOLVEMENT_SITE","dlbc_tcga"
"Maximum tumor bulk anatomic location","Maximum tumor bulk anatomic location","STRING",true,"1","MAXIMUM_TUMOR_BULK_ANATOMIC_SITE","dlbc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","dlbc_tcga"
"Mib1 positive percentage range","Mib1 positive percentage range","STRING",true,"1","MIB_1_POSITIVE_PERCENT_RANGE","dlbc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","dlbc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","dlbc_tcga"
"Number of lymphnodes positive by ihc","Number of lymphnodes positive by ihc","STRING",true,"1","NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC","dlbc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","dlbc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","dlbc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","dlbc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","dlbc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","dlbc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","dlbc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","dlbc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","dlbc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","dlbc_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","dlbc_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","dlbc_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","dlbc_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","dlbc_tcga"
"Lymph node location positive pathology name","Lymph node location positive pathology name","STRING",true,"1","POS_LYMPH_NODE_LOCATION","dlbc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","dlbc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","dlbc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","dlbc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","dlbc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","dlbc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","dlbc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","dlbc_tcga"
"Sex","Sex","STRING",true,"1","SEX","dlbc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","dlbc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","dlbc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","dlbc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","dlbc_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","dlbc_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","dlbc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","dlbc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","dlbc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","dlbc_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","dlbc_tcga"
"Tumor resected max dimension","Tumor resected max dimension","NUMBER",true,"1","TUMOR_RESECTED_MAX_DIMENSION","dlbc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","dlbc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","dlbc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","dlbc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","dlbc_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","dlbc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","dlbc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","dlbc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","dlbc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","dlbc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","dlbc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","dlbc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","dlbc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","dlbc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","dlbc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","dlbc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","dlbc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","dlbc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","dlbc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","dlbc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","dlbc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","dlbc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","dlbc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","dlbc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","dlbc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","dlbc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","dlbc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","dlbc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","dlbc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","dlbc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","dlbc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","dlbc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","dlbc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","dlbc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","dlbc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","dlbc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","dlbc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","dlbc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","dlbc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","dlbc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","dlbc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","dlbc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","dlbc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","dlbc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","dlbc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","dlbc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","dlbc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","dlbc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","dlbc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","dlbc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","dlbc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","dlbc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","dlbc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","dlbc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","dlbc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","dlbc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","dlbc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","dlbc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","dlbc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","dlbc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","dlbc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","dlbc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","dlbc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","dlbc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","dlbc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","dlbc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","dlbc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","dlbc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","dlbc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","dlbc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","dlbc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","dlbc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","dlbc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","dlbc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","dlbc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","dlbc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","dlbc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","dlbc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","dlbc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","dlbc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","dlbc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","dlbc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","dlbc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","dlbc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","dlbc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","dlbc_tcga_pan_can_atlas_2018"
"Age at Diagnosis","Age at Diagnosis","NUMBER",true,"1","AGE_AT_DIAGNOSIS","egc_msk_2017"
"Biopsy Obtained at MSK or OSH","Biopsy Obtained at MSK or OSH","STRING",false,"1","BIOPSY_OBTAINED","egc_msk_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","egc_msk_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","egc_msk_2017"
"Clinical Trial 1L","Clinical Trial 1L","STRING",true,"1","CLINICAL_TRIAL_1L","egc_msk_2017"
"Clinical Trial 2L","Clinical Trial 2L","STRING",true,"1","CLINICAL_TRIAL_2L","egc_msk_2017"
"Clinical Trial 3L","Clinical Trial 3L","STRING",true,"1","CLINICAL_TRIAL_3L","egc_msk_2017"
"Details on First Line & Comments","Details on First Line & Comments","STRING",true,"1","DETAILS_FIRST_LINE_COMMENTS","egc_msk_2017"
"EBV Tested","EBV Tested","STRING",true,"1","EBV_TESTED","egc_msk_2017"
"ECOG At Stage IV Diagnosis","ECOG Score Recorded at Stage IV Diagnosis","NUMBER",true,"1","ECOG_AT_STAGE_4_DX","egc_msk_2017"
"FGA","FGA","NUMBER",false,"1","FGA","egc_msk_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","egc_msk_2017"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","egc_msk_2017"
"HER2 FISH","HER2 FISH","STRING",false,"1","HER2_FISH","egc_msk_2017"
"HER2 IHC or FISH","HER2 IHC or FISH","STRING",false,"1","HER2_IHC_OR_FISH","egc_msk_2017"
"HER2 IMPACT","HER2 IMPACT","STRING",false,"1","HER2_IMPACT","egc_msk_2017"
"HER2 IMPACT LR","HER2 IMPACT LR","STRING",false,"1","HER2_IMPACT_LR","egc_msk_2017"
"HER2 Response","HER2 Response","STRING",false,"1","HER2_RESPONSE","egc_msk_2017"
"HER2 Total Time Period on First Line (Months)","HER2 Total Time Period on First Line (Months)","NUMBER",false,"1","HER2_TTP_ON_1ST_LINE_MONTHS","egc_msk_2017"
"HER2 Treatment Status","HER2 Treatment Status","STRING",false,"1","HER2_TX_STATUS","egc_msk_2017"
"HER2 Vital Status","HER2 Vital Status","STRING",false,"1","HER2_VITAL_STATUS","egc_msk_2017"
"H-PYLORI","H-PYLORI.","STRING",false,"1","H_PYLORI","egc_msk_2017"
"IHC-HER2","IHC-HER2","STRING",false,"1","IHC_HER2","egc_msk_2017"
"IMPACT pre/post","IMPACT pre/post","STRING",false,"1","IMPACT_PRE_POST","egc_msk_2017"
"IO EBV Tested","IO EBV Tested","STRING",false,"1","IO_EBV_TESTED","egc_msk_2017"
"EGC Overall Survival from start of IO to date of death/follow up/POD","EGC Overall Survival from start of IO to date of death/follow up/POD","STRING",false,"1","IO_EGC_SURVIVAL_OS_MONTHS_START_OF_IO_TO_DATE_OF_DEATH_LAST_FOLLOW_UP","egc_msk_2017"
"IO Mutation Group","IO Mutation Group","STRING",false,"1","IO_MUT_GROUPS","egc_msk_2017"
"IO OS Months From Start of IO","IO OS Months From Start of IO","NUMBER",true,"1","IO_OS_MONTHS_START_OF_IO","egc_msk_2017"
"IO PDL1 Tested","IO PDL1 Tested","STRING",false,"1","IO_PDL1_TESTED","egc_msk_2017"
"IO PFS from Start of IO to POD","IO PFS from Start of IO to POD","NUMBER",true,"1","IO_PFS_MONTHS_START_OF_IO_TO_POD","egc_msk_2017"
"IO Progression Free Status","IO Progression Free Status","STRING",true,"1","IO_PFS_STATUS","egc_msk_2017"
"IO Regimen Monotherapy Vs Combination","IO Regimen Monotherapy Vs Combination","STRING",false,"1","IO_REGIMEN_MONOTHERAPY_VS_COMBINATION","egc_msk_2017"
"IO Response","IO Response","STRING",false,"1","IO_RESPONSE","egc_msk_2017"
"Lauren Class","Lauren class.","STRING",true,"1","LAUREN_CLASS","egc_msk_2017"
"Metastatic Site Other","Metastatic Site Other","STRING",false,"1","METASTATIC_SITE_OTHER","egc_msk_2017"
"Liver Metastasis","Liver Metastasis","STRING",false,"1","MET_LIVER","egc_msk_2017"
"Lung Metastasis","Lung Metastasis","STRING",false,"1","MET_LUNG","egc_msk_2017"
"Peritoneum Metastasis","Peritoneum Metastasis","STRING",false,"1","MET_PERITONEUM","egc_msk_2017"
"Molecular Subtype","Molecular subtype.","STRING",false,"1","MOLECULAR_SUBTYPE","egc_msk_2017"
"MSI Sensor Score","MSI Sensor Score","NUMBER",false,"1","MSI_SENSOR_SCORE","egc_msk_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","egc_msk_2017"
"Mutation Rate","Mutation Rate","NUMBER",false,"1","MUTATION_RATE","egc_msk_2017"
"Number of Lines of Treatment For Met Disease","Number of Lines of Treatment For Met Disease","NUMBER",true,"1","NUMBER_OF_LINES_OF_TREATMENT_FOR_MET_DISEASE","egc_msk_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","egc_msk_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"0","OS_MONTHS","egc_msk_2017"
"Overall Survival Stage IV Diagnosis (Months)","Overall survival in months since stage IV diagonosis","NUMBER",true,"1","OS_MONTHS_STAGE_IV","egc_msk_2017"
"Platinum Best Response","Platinum Best Response","STRING",true,"1","PLATINUM_BEST_RESPONSE","egc_msk_2017"
"Platinum Germline Tested","Platinum Germline Tested","STRING",true,"1","PLATINUM_GERMLINE_TESTED","egc_msk_2017"
"Platinum HRD Mutation","Platinum HRD Mutation","STRING",true,"1","PLATINUM_HRD_MUTATION","egc_msk_2017"
"Platinum LST Score","Platinum LST Score","STRING",true,"1","PLATINUM_LST_SCORE","egc_msk_2017"
"Platinum Overall Survival Months","Platinum Overall Survival Months","NUMBER",true,"1","PLATINUM_OS_MONTHS","egc_msk_2017"
"Platinum Overall Survival Status","Platinum Overall Survival Status","STRING",true,"1","PLATINUM_OS_STATUS","egc_msk_2017"
"Platinum Progression Free Months","Platinum Progression Free Months","NUMBER",true,"1","PLATINUM_PFS_MONTHS","egc_msk_2017"
"Platinum Progression Free Status","Platinum Progression Free Status","STRING",true,"1","PLATINUM_PFS_STATUS","egc_msk_2017"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","egc_msk_2017"
"Received IO after First Line","Did the patient receive IO after first line therapy","STRING",true,"1","RECEIVED_IO_AFTER_1ST_LINE","egc_msk_2017"
"Retrospective or Prospective","Is the sample retrospective or prospective","STRING",false,"1","RETROSPECTIVE_OR_PROSPECTIVE","egc_msk_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","egc_msk_2017"
"Sex","Sex","STRING",true,"1","SEX","egc_msk_2017"
"Site of Tissue Biopsy","Site of Tissue Biopsy","STRING",false,"1","SITE_OF_TISSUE_BIOPSY","egc_msk_2017"
"Stage At Diagnosis","Stage At Diagnosis","STRING",false,"1","STAGE_AT_DIAGNOSIS","egc_msk_2017"
"Total Time Period in Months","Total Time Period in Months","NUMBER",true,"1","TOTAL_TIME_PERIOD_MONTHS","egc_msk_2017"
"Treatment","Treatment","STRING",true,"1","TREATMENT","egc_msk_2017"
"Tumor Grade","Histologic grading criteria for adenoid cystic carcinoma (Szanto, et. al, 1984)","STRING",true,"1","TUMOR_GRADE","egc_msk_2017"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","egc_msk_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","egc_tmucih_2015"
"ARID1A Mutation","ARID1A mutation is present.","STRING",false,"1","ARID1A_MUTATION","egc_tmucih_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","egc_tmucih_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","egc_tmucih_2015"
"CDH1 Status","CDH1 Status","STRING",false,"1","CDH1_STATUS","egc_tmucih_2015"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","egc_tmucih_2015"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","egc_tmucih_2015"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","egc_tmucih_2015"
"Clonal Label","Clonal Label","STRING",false,"1","CLONAL_LABEL","egc_tmucih_2015"
"DNA Repair Status","DNA Repair Status","STRING",false,"1","DNA_REPAIR_STATUS","egc_tmucih_2015"
"EBV Present","EBV present.","STRING",true,"1","EBV_PRESENT","egc_tmucih_2015"
"EBV Status","Epstein-Barr Virus (EBV) Status","STRING",true,"1","EBV_STATUS","egc_tmucih_2015"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","egc_tmucih_2015"
"Location","Location","STRING",true,"1","LOCATION","egc_tmucih_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","egc_tmucih_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","egc_tmucih_2015"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","egc_tmucih_2015"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","egc_tmucih_2015"
"Platform","Platform.","STRING",false,"1","PLATFORM","egc_tmucih_2015"
"Sex","Sex","STRING",true,"1","SEX","egc_tmucih_2015"
"Stage","Stage","STRING",true,"1","STAGE","egc_tmucih_2015"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","egc_tmucih_2015"
"TP53 Mutation","TP53 mutation is present.","STRING",false,"1","TP53_MUTATION","egc_tmucih_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","esca_broad"
"Barretts Esophagus","Barretts esophagus.","STRING",true,"1","BARRETTS_ESOPHAGUS","esca_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","esca_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","esca_broad"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","esca_broad"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","esca_broad"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","esca_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","esca_broad"
"Non Silent per Mb","Non Silent per Mb","STRING",false,"1","NONSILENT_PER_MB","esca_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","esca_broad"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","esca_broad"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","esca_broad"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",false,"1","PRIMARY_SITE_OTHER","esca_broad"
"Sex","Sex","STRING",true,"1","SEX","esca_broad"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","esca_broad"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","esca_broad"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","esca_broad"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","esca_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_CLINICAL_TUMOR_STAGE","esca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","esca_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","esca_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CN","esca_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CT","esca_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","esca_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","esca_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","esca_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","esca_tcga"
"Alcohol Consumption Frequency","Alcohol Consumption Frequency","STRING",true,"1","ALCOHOL_CONSUMPTION_FREQUENCY","esca_tcga"
"Alcohol History Documented","Alcohol History Documented","STRING",true,"1","ALCOHOL_HISTORY_DOCUMENTED","esca_tcga"
"Birth Country","Birth Country","STRING",true,"1","BIRTH_COUNTRY","esca_tcga"
"Cancer Procurement State Province","Cancer Procurement State Province","STRING",true,"1","CANCER_PROCUREMENT_STATE_PROVINCE","esca_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","esca_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","esca_tcga"
"City of Procurement","City of procurement.","STRING",true,"1","CITY_OF_PROCUREMENT","esca_tcga"
"Columnar mucosa goblet cell present","Columnar mucosa goblet cell present","STRING",true,"1","COLUMNAR_METAPLASIA_GOBLET_CELL_INDICATOR","esca_tcga"
"Daily Alcohol","Daily alcohol","STRING",true,"1","DAILY_ALCOHOL","esca_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","esca_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","esca_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","esca_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","esca_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","esca_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","esca_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","esca_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","esca_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","esca_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","esca_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","esca_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","esca_tcga"
"Esophageal tumor cental location","Esophageal tumor cental location","STRING",true,"1","ESOPHAGEAL_TUMOR_LOCATION_CENTERED","esca_tcga"
"Esophageal tumor involvement site","Esophageal tumor involvement site","STRING",true,"1","ESOPHAGEAL_TUMOR_LOCATION_INVOLVED","esca_tcga"
"Columnar metaplasia present","Columnar metaplasia present","STRING",true,"1","ESOPH_COLUMNAR_METAPLASIA_INDICATOR","esca_tcga"
"Columnar mucosa dysplasia","Columnar mucosa dysplasia","STRING",true,"1","ESOPH_NON_CA_DEGREE_OF_DYSPLASIA","esca_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","esca_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","esca_tcga"
"History of esophageal cancer","History of esophageal cancer","STRING",true,"1","FAMILY_HISTORY_ESOPH_GASTIC_CANCER","esca_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","esca_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","esca_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","esca_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","esca_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","esca_tcga"
"Barretts esophagus","Barretts esophagus","STRING",true,"1","HISTORY_BARRETTS_ESOPHAGEAL_INDICATOR","esca_tcga"
"Goblet cells present","Goblet cells present","STRING",true,"1","HISTORY_IF_BARRETTS_GOBLET_CELL_INDICATOR","esca_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","esca_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","esca_tcga"
"Antireflux treatment type","Antireflux treatment type","STRING",true,"1","HISTORY_REFLUX_DISEASE_TREATMENT","esca_tcga"
"H-PYLORI Infection","H-PYLORI infection.","STRING",true,"1","H_PYLORI_INFECTION","esca_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","esca_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","esca_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","esca_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","esca_tcga"
"Initial diagnosis by","Initial diagnosis by","STRING",true,"1","INITIAL_DIAGNOSIS_ESOPHAGEAL_CA_TYPE","esca_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","esca_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","esca_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","esca_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","esca_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","esca_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","esca_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","esca_tcga"
"Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,","NUMBER",true,"1","LYMPH_NODES_EXAMINED_IHC_COUNT","esca_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","esca_tcga"
"Lymph node metastasis radiographic evidence","Lymph node metastasis radiographic evidence","STRING",true,"1","LYMPH_NODE_SPRD_RADIOGRAPH_EVIDENCE","esca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","esca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","esca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","esca_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","esca_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","esca_tcga"
"Number of relatives diagnosed","Number of relatives diagnosed","NUMBER",true,"1","NUMBER_OF_RELATIVES_DIAGNOSED","esca_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","esca_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","esca_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","esca_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","esca_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","esca_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","esca_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","esca_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","esca_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","esca_tcga"
"Planned surgery status","Planned surgery status","STRING",true,"1","PATIENT_TO_UNDERGO_SURGERY","esca_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","esca_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","esca_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","esca_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","esca_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","esca_tcga"
"Reflux History","History of reflux.","STRING",true,"1","REFLUX_HISTORY","esca_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","esca_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","esca_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","esca_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","esca_tcga"
"Sex","Sex","STRING",true,"1","SEX","esca_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","esca_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","esca_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","esca_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","esca_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","esca_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","esca_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","esca_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","esca_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","esca_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","esca_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","esca_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","esca_tcga"
"Treatment prior to surgery","Treatment prior to surgery","STRING",true,"1","TREATMENT_PRIOR_TO_SURGERY_INDICATOR","esca_tcga"
"Tumor sample procurement country","Tumor sample procurement country","STRING",true,"1","TUMOR_SAMPLE_PROCUREMENT_COUNTRY","esca_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","esca_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","esca_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","esca_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","esca_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","esca_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","esca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","esca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","esca_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","esca_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","esca_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","esca_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","esca_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","esca_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","esca_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","esca_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","esca_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","esca_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","esca_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","esca_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","esca_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","esca_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","esca_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","esca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","esca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","esca_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","esca_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","esca_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","esca_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","esca_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","esca_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","esca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","esca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","esca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","esca_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","esca_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","esca_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","esca_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","esca_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","esca_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","esca_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","esca_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","esca_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","esca_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","esca_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","esca_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","esca_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","esca_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","esca_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","esca_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","esca_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","esca_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","esca_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","esca_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","esca_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","esca_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","esca_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","esca_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","esca_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","esca_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","esca_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","esca_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","esca_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","esca_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","esca_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","esca_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","esca_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","esca_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","esca_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","esca_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","esca_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","esca_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","esca_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","esca_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","esca_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","esca_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","esca_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","esca_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","esca_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","esca_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","esca_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","esca_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","esca_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","esca_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","esca_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","esca_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","escc_icgc"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","escc_icgc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","escc_icgc"
"Drinker","Drinker.","STRING",true,"1","DRINKER","escc_icgc"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","escc_icgc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","escc_icgc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","escc_icgc"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","escc_icgc"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","escc_icgc"
"Platform","Platform.","STRING",false,"1","PLATFORM","escc_icgc"
"Sex","Sex","STRING",true,"1","SEX","escc_icgc"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","escc_icgc"
"TNM","TNM.","STRING",false,"1","TNM","escc_icgc"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","escc_icgc"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","escc_ucla_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","escc_ucla_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","escc_ucla_2014"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","escc_ucla_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","escc_ucla_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","escc_ucla_2014"
"Pathological Diagnosis","Pathological Diagnosis","STRING",true,"1","PATHOLOGICAL_DIAGNOSIS","escc_ucla_2014"
"Primary Tumor Size","Primary Tumor Size","STRING",false,"1","PRIMARY_TUMOR_SIZE","escc_ucla_2014"
"Regional Lymph Node","Regional Lymph Node","STRING",false,"1","REGIONAL_LYMPH_NODE","escc_ucla_2014"
"Sex","Sex","STRING",true,"1","SEX","escc_ucla_2014"
"Tumor Differentiation","Tumor Differentiation","STRING",false,"1","TUMOR_DIFFERENTIATION","escc_ucla_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","es_dfarber_broad_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","es_dfarber_broad_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","es_dfarber_broad_2014"
"Chemo First Line","Chemo First Line","STRING",true,"1","CHEMO_FIRST_LINE","es_dfarber_broad_2014"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","es_dfarber_broad_2014"
"Fusion By RNA PCR","Fusion By RNA PCR","STRING",false,"1","FUSION_BY_RNA_PCR","es_dfarber_broad_2014"
"Metastasis","Metastasis.","STRING",true,"1","METASTASIS","es_dfarber_broad_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","es_dfarber_broad_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","es_dfarber_broad_2014"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","es_dfarber_broad_2014"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","es_dfarber_broad_2014"
"Sample Class","""The sample classification (i.e., tumor, cellline, xenograph).""","STRING",false,"1","SAMPLE_CLASS","es_dfarber_broad_2014"
"Sample Type","""The type of sample (i.e., normal, primary, met, recurrence).""","STRING",false,"9","SAMPLE_TYPE","es_dfarber_broad_2014"
"Sex","Sex","STRING",true,"1","SEX","es_dfarber_broad_2014"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","es_dfarber_broad_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","es_iocurie_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","es_iocurie_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","es_iocurie_2014"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","es_iocurie_2014"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","es_iocurie_2014"
"Event Free Status","Event Free Status","STRING",true,"1","EFS_STATUS","es_iocurie_2014"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","es_iocurie_2014"
"Fusion","Fusion","STRING",false,"1","FUSION","es_iocurie_2014"
"Localized or Metastaic at Diagnosis","Localized or Metastaic at Diagnosis","STRING",true,"1","LOCALIZED_VS_METS_AT_DX","es_iocurie_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","es_iocurie_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","es_iocurie_2014"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","es_iocurie_2014"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","es_iocurie_2014"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","es_iocurie_2014"
"Primary tissue","Primary tissue","STRING",true,"1","PRIMARY_TISSUE","es_iocurie_2014"
"Sex","Sex","STRING",true,"1","SEX","es_iocurie_2014"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","es_iocurie_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","gbc_shanghai_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","gbc_shanghai_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","gbc_shanghai_2014"
"ErbB Pathway Mutation","ErbB Pathway Mutation","STRING",false,"1","ERBB_PATHWAY_MUTATION","gbc_shanghai_2014"
"Gallbladder Stone","Gallbladder Stone","STRING",false,"1","GALLBLADDER_STONES","gbc_shanghai_2014"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","gbc_shanghai_2014"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","gbc_shanghai_2014"
"Jaundice","Jaundice","STRING",true,"1","JAUNDICE","gbc_shanghai_2014"
"Lymph Nodes Metastasis","Lymph nodes metastasis.","STRING",false,"1","LYMPH_NODE_METASTASIS","gbc_shanghai_2014"
"Margin Status","Margin Status","STRING",false,"1","MARGIN_STATUS","gbc_shanghai_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","gbc_shanghai_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","gbc_shanghai_2014"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","gbc_shanghai_2014"
"Perineural Invasion","Perineural invasion.","STRING",false,"1","PERINEURAL_INVASION","gbc_shanghai_2014"
"Sex","Sex","STRING",true,"1","SEX","gbc_shanghai_2014"
"Time to Last Followup","Time to last followup.","NUMBER",true,"1","TIME_TO_LAST_FOLLOWUP","gbc_shanghai_2014"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","gbc_shanghai_2014"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","gbc_shanghai_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","gbm_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","gbm_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","gbm_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","gbm_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","gbm_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","gbm_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","gbm_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","gbm_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","gbm_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","gbm_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","gbm_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","gbm_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","gbm_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","gbm_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","gbm_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","gbm_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","gbm_tcga"
"History lgg dx of brain tissue","History lgg dx of brain tissue","STRING",true,"1","HISTORY_LGG_DX_OF_BRAIN_TISSUE","gbm_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","gbm_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","gbm_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","gbm_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","gbm_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","gbm_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","gbm_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","gbm_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","gbm_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","gbm_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","gbm_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","gbm_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","gbm_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","gbm_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","gbm_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","gbm_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","gbm_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","gbm_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","gbm_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","gbm_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","gbm_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","gbm_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","gbm_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","gbm_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","gbm_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","gbm_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","gbm_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","gbm_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","gbm_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","gbm_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","gbm_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","gbm_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","gbm_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","gbm_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","gbm_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","gbm_tcga"
"Sex","Sex","STRING",true,"1","SEX","gbm_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","gbm_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","gbm_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","gbm_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","gbm_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","gbm_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","gbm_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","gbm_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","gbm_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","gbm_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","gbm_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","gbm_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","gbm_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","gbm_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","gbm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","gbm_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","gbm_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","gbm_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","gbm_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","gbm_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","gbm_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","gbm_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","gbm_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","gbm_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","gbm_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","gbm_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","gbm_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","gbm_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","gbm_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","gbm_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","gbm_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","gbm_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","gbm_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","gbm_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","gbm_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","gbm_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","gbm_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","gbm_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","gbm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","gbm_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","gbm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","gbm_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","gbm_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","gbm_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","gbm_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","gbm_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","gbm_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","gbm_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","gbm_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","gbm_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","gbm_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","gbm_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","gbm_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","gbm_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","gbm_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","gbm_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","gbm_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","gbm_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","gbm_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","gbm_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","gbm_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","gbm_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","gbm_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","gbm_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","gbm_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","gbm_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","gbm_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","gbm_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","gbm_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","gbm_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","gbm_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","gbm_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","gbm_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","gbm_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","gbm_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","gbm_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","gbm_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","gbm_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","gbm_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","gbm_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","gbm_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","gbm_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","gbm_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","gbm_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","gbm_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","gbm_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","gbm_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","gbm_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","gbm_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","gbm_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","gbm_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","gbm_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","gbm_tcga_pan_can_atlas_2018"
"ACGH Data","ACGH Data.","STRING",false,"1","ACGH_DATA","gbm_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","gbm_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","gbm_tcga_pub"
"Complete Data","Complete data.","STRING",false,"1","COMPLETE_DATA","gbm_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","gbm_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","gbm_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","gbm_tcga_pub"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","gbm_tcga_pub"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","gbm_tcga_pub"
"MRNA Data","MRNA data.","STRING",false,"1","MRNA_DATA","gbm_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","gbm_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","gbm_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","gbm_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","gbm_tcga_pub"
"Pre-treatment History","Pre-treatment history.","STRING",true,"1","PRETREATMENT_HISTORY","gbm_tcga_pub"
"Prior Glioma","Prior glioma.","STRING",true,"1","PRIOR_GLIOMA","gbm_tcga_pub"
"Sequenced","Sequenced.","STRING",false,"1","SEQUENCED","gbm_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","gbm_tcga_pub"
"Treatment Status","Treatment status (pre or Post treatment sample)","STRING",false,"1","TREATMENT_STATUS","gbm_tcga_pub"
"2012_METHYLATION_CLASS","2012_METHYLATION_CLASS","STRING",true,"1","2012_METHYLATION_CLASS","gbm_tcga_pub2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","gbm_tcga_pub2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","gbm_tcga_pub2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","gbm_tcga_pub2013"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","gbm_tcga_pub2013"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","gbm_tcga_pub2013"
"Gene Expression Subtype","Gene Expression Subtype","STRING",false,"1","EXPRESSION_SUBTYPE","gbm_tcga_pub2013"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","gbm_tcga_pub2013"
"G-CIMP_METHYLATION","G-CIMP_METHYLATION","STRING",true,"1","G-CIMP_METHYLATION","gbm_tcga_pub2013"
"IDH1_STATUS","IDH1_STATUS","STRING",true,"1","IDH1_STATUS","gbm_tcga_pub2013"
"MGMT Status","MGMT Status","STRING",false,"1","MGMT_STATUS","gbm_tcga_pub2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","gbm_tcga_pub2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","gbm_tcga_pub2013"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","gbm_tcga_pub2013"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","gbm_tcga_pub2013"
"Sex","Sex","STRING",true,"1","SEX","gbm_tcga_pub2013"
"THERAPY_CLASS","THERAPY_CLASS","STRING",true,"1","THERAPY_CLASS","gbm_tcga_pub2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","gct_msk_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","gct_msk_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","gct_msk_2016"
"Chemotherapy Cycles","Chemotherapy Cycles","STRING",true,"1","CHEMO_CYCLES","gct_msk_2016"
"Chemo First Line","Chemo First Line","STRING",true,"1","CHEMO_FIRST_LINE","gct_msk_2016"
"Chemo Regimen Category","Chemo Regimen Category","STRING",true,"1","CHEMO_REGIMEN_CATEGORY","gct_msk_2016"
"Chemo Resistance","Chemo Resistance","STRING",true,"1","CHEMO_RESISTANT","gct_msk_2016"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","gct_msk_2016"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","gct_msk_2016"
"Cohort","Cohort.","STRING",true,"1","COHORT","gct_msk_2016"
"Detailed Sample Histology Category","Detailed Sample Histology Category","STRING",false,"1","DETAILED_SAMPLE_HISTOLOGY_CATEGORY","gct_msk_2016"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","gct_msk_2016"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","gct_msk_2016"
"Follow up time months","Follow up time months","NUMBER",true,"1","FOLLOW_UP_TIME_MONTHS","gct_msk_2016"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","gct_msk_2016"
"Igcccg stage","Igcccg stage","STRING",true,"1","IGCCCG_STAGE","gct_msk_2016"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","gct_msk_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","gct_msk_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","gct_msk_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","gct_msk_2016"
"Overall Patient Histology","Overall Patient Histology","STRING",true,"1","OVERALL_PATIENT_HISTOLOGY","gct_msk_2016"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","gct_msk_2016"
"RPLND","RPLND","STRING",false,"1","PC_RPLND","gct_msk_2016"
"Primary histology","Primary Histology","STRING",true,"1","PRIMARY_HISTOLOGY","gct_msk_2016"
"Primary RPLND","Primary RPLND","STRING",false,"1","PRIMARY_RPLND","gct_msk_2016"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","gct_msk_2016"
"Progression of Disease","Progression of Disease","STRING",true,"1","PROGRESSION_OF_DISEASE","gct_msk_2016"
"Risk Group","Risk group.","STRING",true,"1","RISK_GROUP","gct_msk_2016"
"RPLND Path","RPLND Path","STRING",false,"1","RPLND_PATH","gct_msk_2016"
"Salvage Chemo","Salvage Chemo","STRING",true,"1","SALVAGE_CHEMO","gct_msk_2016"
"Sample Detailed Subhistologies","Sample Detailed Subhistologies","STRING",false,"1","SAMPLE_DETAILED_SUBHISTOLOGIES","gct_msk_2016"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","gct_msk_2016"
"Sex","Sex","STRING",true,"1","SEX","gct_msk_2016"
"Specimen Collection Pre or Post Chemo","Specimen Collection Pre or Post Chemo","STRING",false,"1","SPECIMEN_COLLECTION_PRE_OR_POST_CHEMO","gct_msk_2016"
"Stage at Presentation","Stage at Presentation","STRING",false,"1","STAGE_AT_PRESENTATION","gct_msk_2016"
"Staging System","Staging System.","STRING",true,"1","STAGING_SYSTEM","gct_msk_2016"
"S Stage","S indicates the serum (blood) levels of tumor markers that are made by some testicular cancers","STRING",false,"1","S_STAGE","gct_msk_2016"
"Time to Progression of Disease (Months)","Time to Progression of Disease (Months)","NUMBER",true,"1","TIME_TO_PROGRESSION_OF_DISEASE","gct_msk_2016"
"Chemotherapy","Chemotherapy.","STRING",true,"1","TREATMENT_CHEMOTHERAPY","gct_msk_2016"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","gct_msk_2016"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","hcc_inserm_fr_2015"
"BCLC Stage","BCLC Stage","STRING",true,"1","BCLC_STAGE","hcc_inserm_fr_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","hcc_inserm_fr_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hcc_inserm_fr_2015"
"Differentiation","Differentiation","STRING",false,"1","DIFFERENTIATION","hcc_inserm_fr_2015"
"Disease Stage","Disease Stage","STRING",false,"1","DISEASE_STAGE","hcc_inserm_fr_2015"
"Etiology","Etiology","STRING",true,"1","ETIOLOGY","hcc_inserm_fr_2015"
"Liver fibrosis ishak score category","Liver fibrosis ishak score category","STRING",true,"1","ISHAK_FIBROSIS_SCORE","hcc_inserm_fr_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hcc_inserm_fr_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hcc_inserm_fr_2015"
"Serum Alpha Foeto Protein (ng/ml)","Serum Alpha Foeto Protein (ng/ml)","STRING",true,"1","SERUM_ALPHA_FOETO_PROTEIN","hcc_inserm_fr_2015"
"Sex","Sex","STRING",true,"1","SEX","hcc_inserm_fr_2015"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","hcc_inserm_fr_2015"
"Vascular Invasion","Vascular invasion.","STRING",false,"1","VASCULAR_INVASION","hcc_inserm_fr_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","hcc_msk_venturaa_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hcc_msk_venturaa_2018"
"Collaboration Id","Collaboration id.","STRING",false,"1","COLLAB_ID","hcc_msk_venturaa_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","hcc_msk_venturaa_2018"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","hcc_msk_venturaa_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hcc_msk_venturaa_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hcc_msk_venturaa_2018"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","hcc_msk_venturaa_2018"
"Sample origin","Sample origin","STRING",false,"1","SAMPLE_ORIGIN","hcc_msk_venturaa_2018"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","hcc_msk_venturaa_2018"
"Sex","Sex","STRING",true,"1","SEX","hcc_msk_venturaa_2018"
"Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING",false,"1","SPECIMEN_PRESERVATION_TYPE","hcc_msk_venturaa_2018"
"Tissue Site","Tissue Site","STRING",false,"1","TISSUE_SITE","hcc_msk_venturaa_2018"
"12-245","12-245","STRING",true,"1","12_245","hnc_mskcc_2016"
"12-245 Part C Consented","12-245 Part C Consented","STRING",true,"1","12_245_PARTC_CONSENTED","hnc_mskcc_2016"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","hnc_mskcc_2016"
"AGENT","AGENT","STRING",true,"1","AGENT","hnc_mskcc_2016"
"Alcohol Consumption Frequency","Alcohol Consumption Frequency","STRING",true,"1","ALCOHOL_CONSUMPTION_FREQUENCY","hnc_mskcc_2016"
"Alcohol History Documented","Alcohol History Documented","STRING",true,"1","ALCOHOL_HISTORY_DOCUMENTED","hnc_mskcc_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","hnc_mskcc_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hnc_mskcc_2016"
"Clinical Trial","Clinical Trial","STRING",true,"1","CLINICAL_TRIAL","hnc_mskcc_2016"
"Detailed Metastatic Site","Detailed Metastatic Site","STRING",false,"1","DETAILED_METASTATIC_SITE","hnc_mskcc_2016"
"Detailed Primary Site","Detailed Primary Site","STRING",true,"1","DETAILED_PRIMARY_SITE","hnc_mskcc_2016"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","hnc_mskcc_2016"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","hnc_mskcc_2016"
"Disease Extent At Time IMPACT Was Sent","Disease Extent At Time IMPACT Was Sent","STRING",true,"1","DISEASE_EXTENT","hnc_mskcc_2016"
"Distant Metastasis Pathologic Spread","Distant metastasis pathologic spread.","STRING",false,"1","DISTANT_METASTASIS_PATHOLOGIC_SPREAD","hnc_mskcc_2016"
"Distant Metastasis","Distant Metastasis","STRING",false,"1","DISTANT_METS","hnc_mskcc_2016"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","hnc_mskcc_2016"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","hnc_mskcc_2016"
"Histology","Histology","STRING",true,"1","HISTOLOGY","hnc_mskcc_2016"
"HPV Status","HPV status.","STRING",true,"1","HPV_STATUS","hnc_mskcc_2016"
"Immunosuppression","Suppression of the immune system.","STRING",true,"1","IMMUNOSUPPRESSION","hnc_mskcc_2016"
"Initial Treatment","Initial Treatment","STRING",true,"1","INITIAL_TREATMENT","hnc_mskcc_2016"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","hnc_mskcc_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hnc_mskcc_2016"
"MYB-NFIB_FISH","MYB-NFIB_FISH","STRING",true,"1","MYB-NFIB_FISH","hnc_mskcc_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hnc_mskcc_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","hnc_mskcc_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","hnc_mskcc_2016"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","hnc_mskcc_2016"
"Prior Treatment to IMPACT Sample","Prior Treatment to IMPACT Sample","STRING",true,"1","PRIOR_TX_TO_IMPACT_SAMPLE","hnc_mskcc_2016"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","hnc_mskcc_2016"
"Run","Run-IMPACT","NUMBER",false,"1","RUN","hnc_mskcc_2016"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","hnc_mskcc_2016"
"Sample coverage","Sample coverage","STRING",false,"1","SAMPLE_COVERAGE","hnc_mskcc_2016"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","hnc_mskcc_2016"
"Sex","Sex","STRING",true,"1","SEX","hnc_mskcc_2016"
"Site of Recurrence","Site of Recurrence","STRING",false,"1","SITE_OF_RECURRENCE","hnc_mskcc_2016"
"Site Sequenced","Site Sequenced","STRING",false,"1","SITE_SEQUENCED","hnc_mskcc_2016"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","hnc_mskcc_2016"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","hnc_mskcc_2016"
"SO comments","Sign-out comments","STRING",false,"1","SO_COMMENTS","hnc_mskcc_2016"
"TABACCO_TYPE","TABACCO_TYPE","STRING",true,"1","TABACCO_TYPE","hnc_mskcc_2016"
"TNM","TNM.","STRING",false,"1","TNM","hnc_mskcc_2016"
"Tumor Purity","Tumor Purity","STRING",false,"1","TUMOR_PURITY","hnc_mskcc_2016"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","hnc_mskcc_2016"
"WHO Class","WHO class.","STRING",true,"1","WHO_CLASS","hnc_mskcc_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","hnsc_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hnsc_broad"
"Drinker","Drinker.","STRING",true,"1","DRINKER","hnsc_broad"
"Tumor HPV ISH","Tumor human papilloma virus status by in situ hybridization: Positive/Negative/Not Evaluated","STRING",false,"1","HPV_ISH","hnsc_broad"
"Tumor HPV PATHSEQ","Tumor human papilloma virus status by PathSeq: Positive/Negative","STRING",false,"1","HPV_PATHSEQ","hnsc_broad"
"Tumor HPV PCR","Tumor human papilloma virus status by HPV-16 PCR: Positive/Negative/Not Evaluated","STRING",false,"1","HPV_PCR","hnsc_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hnsc_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hnsc_broad"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","hnsc_broad"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","hnsc_broad"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","hnsc_broad"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","hnsc_broad"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","hnsc_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","hnsc_jhu"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hnsc_jhu"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","hnsc_jhu"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","hnsc_jhu"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","hnsc_jhu"
"HPV Status","HPV status.","STRING",true,"1","HPV_STATUS","hnsc_jhu"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hnsc_jhu"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hnsc_jhu"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","hnsc_jhu"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","hnsc_jhu"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","hnsc_mdanderson_2013"
"Average Ploidy ","Average ploidy ","NUMBER",false,"1","AVE_PLOIDY","hnsc_mdanderson_2013"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","hnsc_mdanderson_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hnsc_mdanderson_2013"
"Cell Differentiation","Cell Differentiation","STRING",false,"1","CELL_DIFFERENTIATION","hnsc_mdanderson_2013"
"Conserved Noncoding Element","Conserved Noncoding Element","NUMBER",false,"1","CNE","hnsc_mdanderson_2013"
"Daily Alcohol","Daily alcohol","STRING",true,"1","DAILY_ALCOHOL","hnsc_mdanderson_2013"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","hnsc_mdanderson_2013"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","hnsc_mdanderson_2013"
"extracapsular spread ","extracapsular spread (ECS), can be yes or no","STRING",false,"1","EXTRACAPSULAR_SPREAD","hnsc_mdanderson_2013"
"Gene Expression Cluster","Gene expression cluster.","STRING",false,"1","GENE_EXPRESSION_CLUSTER","hnsc_mdanderson_2013"
"HPV Status","HPV status.","STRING",true,"1","HPV_STATUS","hnsc_mdanderson_2013"
"Methylation Cluster","Methylation cluster.","STRING",false,"1","METHYLATION_CLUSTER","hnsc_mdanderson_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hnsc_mdanderson_2013"
"Nodal stage","Nodal stage","STRING",true,"1","NODAL_STAGE","hnsc_mdanderson_2013"
"Non Silent Mutations","Non Silent Mutations","STRING",false,"1","NON_SILENT_MUTATION","hnsc_mdanderson_2013"
"Positive Finding Lymph Node","Positive Finding Lymph Node","STRING",false,"1","NUMBER_OF_LYMPHNODES_POSITIVE","hnsc_mdanderson_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hnsc_mdanderson_2013"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","hnsc_mdanderson_2013"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","hnsc_mdanderson_2013"
"Percent Tumor Purity","Percent tumor purity.","NUMBER",true,"1","PERCENTAGE_TUMOR_PURITY","hnsc_mdanderson_2013"
"Perineural Invasion","Perineural invasion.","STRING",false,"1","PERINEURAL_INVASION","hnsc_mdanderson_2013"
"Previous Treatment","Previous treatment.","STRING",true,"1","PREVIOUS_TREATMENT","hnsc_mdanderson_2013"
"Sex","Sex","STRING",true,"1","SEX","hnsc_mdanderson_2013"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","hnsc_mdanderson_2013"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","hnsc_mdanderson_2013"
"Total CNA ","Total CNA","NUMBER",false,"1","TOTAL_CNA","hnsc_mdanderson_2013"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","hnsc_mdanderson_2013"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","hnsc_mdanderson_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","hnsc_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","hnsc_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","hnsc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","hnsc_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","hnsc_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","hnsc_tcga"
"Alcohol Consumption Frequency","Alcohol Consumption Frequency","STRING",true,"1","ALCOHOL_CONSUMPTION_FREQUENCY","hnsc_tcga"
"Alcohol History Documented","Alcohol History Documented","STRING",true,"1","ALCOHOL_HISTORY_DOCUMENTED","hnsc_tcga"
"Amplification Status","Amplification Status","STRING",true,"1","AMPLIFICATION_STATUS","hnsc_tcga"
"Angiolymphatic Invasion","Presence of angiolymphatic invasion.","STRING",true,"1","ANGIOLYMPHATIC_INVASION","hnsc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","hnsc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hnsc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","hnsc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","hnsc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","hnsc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","hnsc_tcga"
"Daily Alcohol","Daily alcohol","STRING",true,"1","DAILY_ALCOHOL","hnsc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","hnsc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","hnsc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","hnsc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","hnsc_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","hnsc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","hnsc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","hnsc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","hnsc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","hnsc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","hnsc_tcga"
"Extracapsular spread pathologic","Presence of pathological nodal extracapsular spread","STRING",true,"1","EXTRACAPSULAR_SPREAD_PATHOLOGIC","hnsc_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","hnsc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","hnsc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","hnsc_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","hnsc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","hnsc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","hnsc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","hnsc_tcga"
"Hpv status ish","Hpv status by ish testing","STRING",true,"1","HPV_STATUS_ISH","hnsc_tcga"
"Hpv status p16","Hpv status by p16 testing","STRING",true,"1","HPV_STATUS_P16","hnsc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","hnsc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","hnsc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","hnsc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","hnsc_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","hnsc_tcga"
"Initial Sample Weight Grams","Initial Sample Weight Grams","NUMBER",false,"1","INITIAL_SAMPLE_WEIGHT_GRAMS","hnsc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","hnsc_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","hnsc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","hnsc_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","hnsc_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","hnsc_tcga"
"Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,","NUMBER",true,"1","LYMPH_NODES_EXAMINED_IHC_COUNT","hnsc_tcga"
"Lymph node dissection method","Lymphnode dissection method left","STRING",true,"1","LYMPH_NODE_DISSECTION_METHOD","hnsc_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","hnsc_tcga"
"Lymph node neck dissection indicator","Lymphnode neck dissection","STRING",true,"1","LYMPH_NODE_NECK_DISSECTION_INDICATOR","hnsc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","hnsc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hnsc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","hnsc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","hnsc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","hnsc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","hnsc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","hnsc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","hnsc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","hnsc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","hnsc_tcga"
"P53 gene analysis","P53 gene analysis","STRING",true,"1","P53_GENE_ANALYSIS","hnsc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","hnsc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","hnsc_tcga"
"Disease Surgical Margin Status","Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.","STRING",true,"1","PATH_MARGIN","hnsc_tcga"
"Perineural Invasion","Perineural invasion.","STRING",true,"1","PERINEURAL_INVASION","hnsc_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","hnsc_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","hnsc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","hnsc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","hnsc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","hnsc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","hnsc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","hnsc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","hnsc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","hnsc_tcga"
"Sex","Sex","STRING",true,"1","SEX","hnsc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","hnsc_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","hnsc_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","hnsc_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","hnsc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","hnsc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","hnsc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","hnsc_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","hnsc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","hnsc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","hnsc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","hnsc_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","hnsc_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","hnsc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","hnsc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","hnsc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","hnsc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","hnsc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","hnsc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","hnsc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","hnsc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","hnsc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","hnsc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","hnsc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hnsc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","hnsc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","hnsc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","hnsc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","hnsc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","hnsc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","hnsc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","hnsc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","hnsc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","hnsc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","hnsc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","hnsc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","hnsc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","hnsc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","hnsc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","hnsc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hnsc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","hnsc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hnsc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","hnsc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","hnsc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","hnsc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","hnsc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","hnsc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","hnsc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","hnsc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","hnsc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","hnsc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","hnsc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","hnsc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","hnsc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","hnsc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","hnsc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","hnsc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","hnsc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","hnsc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","hnsc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","hnsc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","hnsc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","hnsc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","hnsc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","hnsc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","hnsc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","hnsc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","hnsc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","hnsc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","hnsc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","hnsc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","hnsc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","hnsc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","hnsc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","hnsc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","hnsc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","hnsc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","hnsc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","hnsc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","hnsc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","hnsc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","hnsc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","hnsc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","hnsc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","hnsc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","hnsc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","hnsc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","hnsc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","hnsc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","hnsc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","hnsc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","hnsc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","hnsc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","hnsc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","hnsc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","hnsc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","hnsc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","hnsc_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","hnsc_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","hnsc_tcga_pub"
"HPV Status","HPV status.","STRING",true,"1","HPV_STATUS","hnsc_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","hnsc_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","hnsc_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","hnsc_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","hnsc_tcga_pub"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","hnsc_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kich_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","kich_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","kich_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","kich_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","kich_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","kich_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","kich_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","kich_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kich_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","kich_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","kich_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","kich_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","kich_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","kich_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","kich_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","kich_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","kich_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","kich_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","kich_tcga"
"Erythrocyte sedimentation rate","Erythrocyte sedimentation rate result","STRING",true,"1","ERYTHROCYTE_SEDIMENTATION_RATE","kich_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","kich_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","kich_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kich_tcga"
"Hemoglobin level","Hemoglobin result","STRING",true,"1","HEMOGLOBIN_LEVEL","kich_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","kich_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","kich_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","kich_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","kich_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","kich_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","kich_tcga"
"Idh level","Idh level","STRING",true,"1","IDH_LEVEL","kich_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","kich_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","kich_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","kich_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","kich_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","kich_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","kich_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","kich_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","kich_tcga"
"Lymph nodes examined positive","Number of lymphnodes positive","STRING",true,"1","LYMPH_NODES_EXAMINED_POSITIVE","kich_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","kich_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","kich_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kich_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","kich_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","kich_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","kich_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","kich_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","kich_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","kich_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","kich_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","kich_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","kich_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","kich_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","kich_tcga"
"Platelet count","Platelet qualitative result","STRING",true,"1","PLATELET_COUNT","kich_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","kich_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","kich_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","kich_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","kich_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","kich_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","kich_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","kich_tcga"
"Sarcomatoid features","Presence of sarcomatoid features","STRING",true,"1","SARCOMATOID_FEATURES","kich_tcga"
"Sarcomatoid percent of tumor","Percent tumor sarcomatoid","STRING",true,"1","SARCOMATOID_PERCENT_OF_TUMOR","kich_tcga"
"Serum calcium level","Serum calcium result","STRING",true,"1","SERUM_CALCIUM_LEVEL","kich_tcga"
"Sex","Sex","STRING",true,"1","SEX","kich_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","kich_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","kich_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","kich_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","kich_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","kich_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","kich_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","kich_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","kich_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","kich_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","kich_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","kich_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","kich_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","kich_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","kich_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","kich_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","kich_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","kich_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","kich_tcga"
"WBC","White bloodcell count.","STRING",true,"1","WBC","kich_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kich_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","kich_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","kich_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","kich_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","kich_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","kich_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kich_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","kich_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","kich_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","kich_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","kich_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","kich_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","kich_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kich_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","kich_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","kich_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","kich_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","kich_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","kich_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","kich_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","kich_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","kich_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kich_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","kich_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","kich_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","kich_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","kich_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","kich_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","kich_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","kich_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","kich_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","kich_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","kich_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","kich_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","kich_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","kich_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","kich_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","kich_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","kich_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","kich_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","kich_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","kich_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","kich_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","kich_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","kich_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","kich_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","kich_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","kich_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","kich_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","kich_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","kich_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","kich_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","kich_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","kich_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","kich_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","kich_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","kich_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","kich_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","kich_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","kich_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","kich_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","kich_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","kich_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","kich_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","kich_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","kich_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","kich_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","kich_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","kich_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","kich_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","kich_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","kich_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","kich_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","kich_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","kich_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","kich_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","kich_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","kich_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","kich_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","kich_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kich_tcga_pub"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","kich_tcga_pub"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","kich_tcga_pub"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","kich_tcga_pub"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","kich_tcga_pub"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","kich_tcga_pub"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","kich_tcga_pub"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","kich_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kich_tcga_pub"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","kich_tcga_pub"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","kich_tcga_pub"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","kich_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","kich_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","kich_tcga_pub"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","kich_tcga_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","kich_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kich_tcga_pub"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","kich_tcga_pub"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","kich_tcga_pub"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","kich_tcga_pub"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","kich_tcga_pub"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","kich_tcga_pub"
"Idh level","Idh level","STRING",true,"1","IDH_LEVEL","kich_tcga_pub"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","kich_tcga_pub"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","kich_tcga_pub"
"Last Communication Contact","Time interval from a person's date of death to the date of initial pathologic diagnosis.","NUMBER",true,"1","LAST_CONTACT_DAYS_TO","kich_tcga_pub"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","kich_tcga_pub"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","kich_tcga_pub"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","kich_tcga_pub"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_SAMPLE_PROCUREMENT","kich_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kich_tcga_pub"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","kich_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","kich_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","kich_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","kich_tcga_pub"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",true,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","kich_tcga_pub"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","kich_tcga_pub"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","kich_tcga_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","kich_tcga_pub"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","kich_tcga_pub"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","kich_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","kich_tcga_pub"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","kich_tcga_pub"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","kich_tcga_pub"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","kich_tcga_pub"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","kich_tcga_pub"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","kich_tcga_pub"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","kich_tcga_pub"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","kich_tcga_pub"
"Tissue Source Site","""A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.""","STRING",false,"1","TISSUE_SOURCE_SITE","kich_tcga_pub"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","kich_tcga_pub"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","kich_tcga_pub"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","kich_tcga_pub"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","kich_tcga_pub"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","kich_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kirc_bgi"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","kirc_bgi"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kirc_bgi"
"Cohort","Cohort.","STRING",true,"1","COHORT","kirc_bgi"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kirc_bgi"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","kirc_bgi"
"Sex","Sex","STRING",true,"1","SEX","kirc_bgi"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","kirc_bgi"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kirc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","kirc_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","kirc_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","kirc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","kirc_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","kirc_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","kirc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","kirc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kirc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","kirc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","kirc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","kirc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","kirc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","kirc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","kirc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","kirc_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","kirc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","kirc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","kirc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","kirc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","kirc_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","kirc_tcga"
"Erythrocyte sedimentation rate","Erythrocyte sedimentation rate result","STRING",true,"1","ERYTHROCYTE_SEDIMENTATION_RATE","kirc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","kirc_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","kirc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","kirc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kirc_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","kirc_tcga"
"Hemoglobin level","Hemoglobin result","STRING",true,"1","HEMOGLOBIN_LEVEL","kirc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","kirc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","kirc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","kirc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","kirc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","kirc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","kirc_tcga"
"Idh level","Idh level","STRING",true,"1","IDH_LEVEL","kirc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","kirc_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","kirc_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","kirc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","kirc_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","kirc_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","kirc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","kirc_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","kirc_tcga"
"Lymph nodes examined positive","Number of lymphnodes positive","STRING",true,"1","LYMPH_NODES_EXAMINED_POSITIVE","kirc_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","kirc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","kirc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kirc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","kirc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","kirc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","kirc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","kirc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","kirc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","kirc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","kirc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","kirc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","kirc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","kirc_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","kirc_tcga"
"Platelet count","Platelet qualitative result","STRING",true,"1","PLATELET_COUNT","kirc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","kirc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","kirc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","kirc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","kirc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","kirc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","kirc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","kirc_tcga"
"Serum calcium level","Serum calcium result","STRING",true,"1","SERUM_CALCIUM_LEVEL","kirc_tcga"
"Sex","Sex","STRING",true,"1","SEX","kirc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","kirc_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","kirc_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","kirc_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","kirc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","kirc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","kirc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","kirc_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","kirc_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","kirc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","kirc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","kirc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","kirc_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","kirc_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","kirc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","kirc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","kirc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","kirc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","kirc_tcga"
"WBC","White bloodcell count.","STRING",true,"1","WBC","kirc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kirc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","kirc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","kirc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","kirc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","kirc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","kirc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kirc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","kirc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","kirc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","kirc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","kirc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","kirc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","kirc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kirc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","kirc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","kirc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","kirc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","kirc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","kirc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","kirc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","kirc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","kirc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kirc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","kirc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","kirc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","kirc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","kirc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","kirc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","kirc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","kirc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","kirc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","kirc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","kirc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","kirc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","kirc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","kirc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","kirc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","kirc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","kirc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","kirc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","kirc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","kirc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","kirc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","kirc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","kirc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","kirc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","kirc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","kirc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","kirc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","kirc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","kirc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","kirc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","kirc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","kirc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","kirc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","kirc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","kirc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","kirc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","kirc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","kirc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","kirc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","kirc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","kirc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","kirc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","kirc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","kirc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","kirc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","kirc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","kirc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","kirc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","kirc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","kirc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","kirc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","kirc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","kirc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","kirc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","kirc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","kirc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","kirc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","kirc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","kirc_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kirc_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kirc_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kirc_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","kirc_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","kirc_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","kirc_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kirp_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_CLINICAL_TUMOR_STAGE","kirp_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","kirp_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","kirp_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CN","kirp_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CT","kirp_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","kirp_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","kirp_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","kirp_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","kirp_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","kirp_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kirp_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","kirp_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","kirp_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","kirp_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","kirp_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","kirp_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","kirp_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","kirp_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","kirp_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","kirp_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","kirp_tcga"
"Erythrocyte sedimentation rate","Erythrocyte sedimentation rate result","STRING",true,"1","ERYTHROCYTE_SEDIMENTATION_RATE","kirp_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","kirp_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","kirp_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","kirp_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kirp_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","kirp_tcga"
"Hemoglobin level","Hemoglobin result","STRING",true,"1","HEMOGLOBIN_LEVEL","kirp_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","kirp_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","kirp_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","kirp_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","kirp_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","kirp_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","kirp_tcga"
"Idh level","Idh level","STRING",true,"1","IDH_LEVEL","kirp_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","kirp_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","kirp_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","kirp_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","kirp_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","kirp_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","kirp_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","kirp_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","kirp_tcga"
"Lymph nodes examined positive","Number of lymphnodes positive","STRING",true,"1","LYMPH_NODES_EXAMINED_POSITIVE","kirp_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","kirp_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","kirp_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kirp_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","kirp_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","kirp_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","kirp_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","kirp_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","kirp_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","kirp_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","kirp_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","kirp_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","kirp_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","kirp_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","kirp_tcga"
"Platelet count","Platelet qualitative result","STRING",true,"1","PLATELET_COUNT","kirp_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","kirp_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","kirp_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","kirp_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","kirp_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","kirp_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","kirp_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","kirp_tcga"
"Serum calcium level","Serum calcium result","STRING",true,"1","SERUM_CALCIUM_LEVEL","kirp_tcga"
"Sex","Sex","STRING",true,"1","SEX","kirp_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","kirp_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","kirp_tcga"
"Started Smoking Year","The year in which the participant began smoking.","STRING",true,"1","SMOKING_YEAR_STARTED","kirp_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","kirp_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","kirp_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","kirp_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","kirp_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","kirp_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","kirp_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","kirp_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","kirp_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","kirp_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","kirp_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","kirp_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","kirp_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","kirp_tcga"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","kirp_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","kirp_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","kirp_tcga"
"WBC","White bloodcell count.","STRING",true,"1","WBC","kirp_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","kirp_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","kirp_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","kirp_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","kirp_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","kirp_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","kirp_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","kirp_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","kirp_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","kirp_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","kirp_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","kirp_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","kirp_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","kirp_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","kirp_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","kirp_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","kirp_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","kirp_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","kirp_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","kirp_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","kirp_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","kirp_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","kirp_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","kirp_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","kirp_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","kirp_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","kirp_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","kirp_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","kirp_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","kirp_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","kirp_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","kirp_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","kirp_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","kirp_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","kirp_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","kirp_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","kirp_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","kirp_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","kirp_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","kirp_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","kirp_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","kirp_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","kirp_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","kirp_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","kirp_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","kirp_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","kirp_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","kirp_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","kirp_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","kirp_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","kirp_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","kirp_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","kirp_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","kirp_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","kirp_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","kirp_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","kirp_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","kirp_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","kirp_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","kirp_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","kirp_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","kirp_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","kirp_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","kirp_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","kirp_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","kirp_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","kirp_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","kirp_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","kirp_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","kirp_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","kirp_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","kirp_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","kirp_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","kirp_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","kirp_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","kirp_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","kirp_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","kirp_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","kirp_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","kirp_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","kirp_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","kirp_tcga_pan_can_atlas_2018"
"Abnormal Lymphocyte Percent","Abnormal Lymphocyte Percent","NUMBER",true,"1","ABNORMAL_LYMPHOCYTE_PERCENT","laml_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","laml_tcga"
"Atra Exposure","Atra Exposure","STRING",true,"1","ATRA_EXPOSURE","laml_tcga"
"Basophils Cell Count","Basophils Cell Count","NUMBER",true,"1","BASOPHILS_COUNT","laml_tcga"
"Blast Count","Blast Count","NUMBER",true,"1","BLAST_COUNT","laml_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","laml_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","laml_tcga"
"Cytogenetic abnormality type","Cytogenetic abnormality type","STRING",true,"1","CYTOGENETIC_ABNORMALITY_TYPE","laml_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","laml_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","laml_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","laml_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","laml_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","laml_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","laml_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","laml_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","laml_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","laml_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","laml_tcga"
"FAB","FAB.","STRING",true,"1","FAB","laml_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","laml_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","laml_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","laml_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","laml_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","laml_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","laml_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","laml_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","laml_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","laml_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","laml_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","laml_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","laml_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","laml_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","laml_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","laml_tcga"
"Molecular Analysis Performed Indicator","Molecular Analysis Performed Indicator","STRING",true,"1","MOLECULAR_STUDIES_OTHERS_PERFORMED","laml_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","laml_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","laml_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","laml_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","laml_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","laml_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","laml_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","laml_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","laml_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","laml_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","laml_tcga"
"Performance status other timing","Performance status assessment timepoint category other text","STRING",true,"1","PERFORMANCE_STATUS_OTHER_TIMING","laml_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","laml_tcga"
"Platelet count preresection","Platelet count preresection","NUMBER",true,"1","PLATELET_COUNT_PRERESECTION","laml_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","laml_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","laml_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","laml_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","laml_tcga"
"Sample Type","""The type of sample (i.e., normal, primary, met, recurrence).""","STRING",false,"1","SAMPLE_TYPE","laml_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","laml_tcga"
"Sex","Sex","STRING",true,"1","SEX","laml_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","laml_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","laml_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","laml_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","laml_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","laml_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","laml_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","laml_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","laml_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","laml_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","laml_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","laml_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","laml_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","laml_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","laml_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","laml_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","laml_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","laml_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","laml_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","laml_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","laml_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","laml_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","laml_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","laml_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","laml_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","laml_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","laml_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","laml_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","laml_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","laml_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","laml_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","laml_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","laml_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","laml_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","laml_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","laml_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","laml_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","laml_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","laml_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","laml_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","laml_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","laml_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","laml_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","laml_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","laml_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","laml_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","laml_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","laml_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","laml_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","laml_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","laml_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","laml_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","laml_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","laml_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","laml_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","laml_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","laml_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","laml_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","laml_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","laml_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","laml_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","laml_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","laml_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","laml_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","laml_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","laml_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","laml_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","laml_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","laml_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","laml_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","laml_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","laml_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","laml_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","laml_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","laml_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","laml_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","laml_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","laml_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","laml_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","laml_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","laml_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","laml_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","laml_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","laml_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","laml_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","laml_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","laml_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","laml_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","laml_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","laml_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","laml_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","laml_tcga_pub"
"AML in Skin Percentage","AML in skin, determined by WGS.","STRING",true,"1","AML_IN_SKIN_PERCENTAGE","laml_tcga_pub"
"Bone Marrow Blast Percentage","Bone marrow blast percentage.","STRING",true,"1","BM_BLAST_PERCENTAGE","laml_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","laml_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","laml_tcga_pub"
"Cytogenetics","Cytogenetics.","STRING",true,"1","CYTOGENETICS","laml_tcga_pub"
"Cytogenetic Code (Other)","Cytogenetic code (other).","STRING",true,"1","CYTOGENETIC_CODE_OTHER","laml_tcga_pub"
"DZ Stat","Dark zone stat at transplant.","STRING",true,"1","DARK_ZONE_STAT","laml_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","laml_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","laml_tcga_pub"
"FAB","FAB.","STRING",true,"1","FAB","laml_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","laml_tcga_pub"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","laml_tcga_pub"
"Induction","Induction.","STRING",true,"1","INDUCTION","laml_tcga_pub"
"Inferred Genomic Rearrangement","Inferred genomic rearrangement (from RNA-Seq fusion).","STRING",false,"1","INFERRED_GENOMIC_REARRANGEMENT","laml_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","laml_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","laml_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","laml_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","laml_tcga_pub"
"PB Blast Percentage","PB blast percentage","NUMBER",true,"1","PB_BLAST_PERCENTAGE","laml_tcga_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","laml_tcga_pub"
"Risk (Cyto)","Risk (Cyto).","STRING",true,"1","RISK_CYTO","laml_tcga_pub"
"Risk (Molecular)","Risk (Molecular).","STRING",true,"1","RISK_MOLECULAR","laml_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","laml_tcga_pub"
"Structural Variants","Structural variants from WGS.","STRING",false,"1","STRUCTURAL_VARIANTS","laml_tcga_pub"
"Subclones","Subclones detected by WGS.","STRING",false,"1","SUB_CLONES","laml_tcga_pub"
"Transplant Type","Type of transplant (sib Allo, MUD, Auto, etc).","STRING",true,"1","TRANSPLANT_TYPE","laml_tcga_pub"
"WBC","White bloodcell count.","NUMBER",true,"1","WBC","laml_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lcll_broad_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lcll_broad_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lcll_broad_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lcll_broad_2013"
"Absolute Extract Ploidy","Absolute extract ploidy.","NUMBER",false,"1","ABSOLUTE_EXTRACT_PLOIDY","lgggbm_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lgggbm_tcga_pub"
"ATRX status","ATRX status","STRING",false,"1","ATRX_STATUS","lgggbm_tcga_pub"
"BCR Status","BCR status.","STRING",true,"1","BCR_STATUS","lgggbm_tcga_pub"
"BRAF-KIAA1549 fusion","BRAF-KIAA1549 fusion","STRING",false,"1","BRAF_KIAA1549_FUSION","lgggbm_tcga_pub"
"BRAF V600E status","BRAF V600E status","STRING",false,"1","BRAF_V600E_STATUS","lgggbm_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lgggbm_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lgggbm_tcga_pub"
"Chr 19/20 co-gain","Chr 19/20 co-gain","STRING",false,"1","CHR_19_20_CO_GAIN","lgggbm_tcga_pub"
"Chr 7 gain/Chr 10 loss","Chr 7 gain/Chr 10 loss","STRING",false,"1","CHR_7_GAIN_CHR_10_LOSS","lgggbm_tcga_pub"
"DAXX status","DAXX status","STRING",false,"1","DAXX_STATUS","lgggbm_tcga_pub"
"ESTIMATE combined score","ESTIMATE Score by ESTIMATE","NUMBER",false,"1","ESTIMATE_COMBINED_SCORE","lgggbm_tcga_pub"
"ESTIMATE immune score","Immune Score by ESTIMATE","NUMBER",false,"1","ESTIMATE_IMMUNE_SCORE","lgggbm_tcga_pub"
"ESTIMATE stromal score","Stromal Score by ESTIMATE","NUMBER",false,"1","ESTIMATE_STROMAL_SCORE","lgggbm_tcga_pub"
"Neoplasm Histologic Grade","""Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.""","STRING",false,"1","GRADE","lgggbm_tcga_pub"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","lgggbm_tcga_pub"
"HM27","HM27","STRING",false,"1","HM27","lgggbm_tcga_pub"
"HM450","HM450","STRING",false,"1","HM450","lgggbm_tcga_pub"
"IDH-1P10Q Subtype","IDH-1P10Q subtype.","STRING",false,"1","IDH_1P19Q_SUBTYPE","lgggbm_tcga_pub"
"IDH/codel subtype","IDH/codel subtype","STRING",false,"1","IDH_CODEL_SUBTYPE","lgggbm_tcga_pub"
"IDH-specific DNA Methylation Cluster","IDH-specific DNA Methylation Cluster","STRING",false,"1","IDH_SPECIFIC_DNA_METHYLATION_CLUSTER","lgggbm_tcga_pub"
"IDH-specific RNA Expression Cluster","IDH-specific RNA Expression Cluster","STRING",false,"1","IDH_SPECIFIC_RNA_EXPRESSION_CLUSTER","lgggbm_tcga_pub"
"IDH status","IDH status","STRING",false,"1","IDH_STATUS","lgggbm_tcga_pub"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","lgggbm_tcga_pub"
"MGMT promoter status","MGMT promoter status","STRING",false,"1","MGMT_PROMOTER_STATUS","lgggbm_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lgggbm_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lgggbm_tcga_pub"
"Original Subtype","Original Subtype","STRING",false,"1","ORIGINAL_SUBTYPE","lgggbm_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","lgggbm_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","lgggbm_tcga_pub"
"Pan-Glioma DNA Methylation Cluster","Pan-Glioma DNA Methylation Cluster","STRING",false,"1","PAN_GLIOMA_DNA_METHYLATION_CLUSTER","lgggbm_tcga_pub"
"Pan-Glioma RNA Expression Cluster","Pan-Glioma RNA Expression Cluster","STRING",false,"1","PAN_GLIOMA_RNA_EXPRESSION_CLUSTER","lgggbm_tcga_pub"
"Percent aneuploidy","Percent aneuploidy","STRING",false,"1","PERCENT_ANEUPLOIDY","lgggbm_tcga_pub"
"Absolute Purity","Absolute purity.","NUMBER",false,"1","PURITY_ABSOLUTE","lgggbm_tcga_pub"
"Random Forest Sturm Cluster","Random Forest Sturm Cluster","STRING",false,"1","RANDOM_FOREST_STURM_CLUSTER","lgggbm_tcga_pub"
"RNA-SEQ Data","RNA-SEQ data.","STRING",false,"1","RNASEQ_DATA","lgggbm_tcga_pub"
"RPPA","RPPA","STRING",false,"1","RPPA","lgggbm_tcga_pub"
"RPPA Cluster","RPPA Cluster.","STRING",false,"1","RPPA_CLUSTER","lgggbm_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","lgggbm_tcga_pub"
"SNP6","SNP6","STRING",false,"1","SNP6","lgggbm_tcga_pub"
"Study","Study.","STRING",true,"1","STUDY","lgggbm_tcga_pub"
"Supervised DNA Methylation Cluster","Supervised DNA Methylation Cluster","STRING",false,"1","SUPERVISED_DNA_METHYLATION_CLUSTER","lgggbm_tcga_pub"
"Telomere length estimate in blood normal (Kb)","Telomere length estimate in blood normal (Kb)","STRING",false,"1","TELOMERE_LENGTH_ESTIMATE_IN_BLOOD_NORMAL_KB","lgggbm_tcga_pub"
"Telomere length estimate in tumor (Kb)","Telomere length estimate in tumor (Kb)","STRING",false,"1","TELOMERE_LENGTH_ESTIMATE_IN_TUMOR_KB","lgggbm_tcga_pub"
"Telomere Maintenance","Telomere Maintenance","STRING",false,"1","TELOMERE_MAINTENANCE","lgggbm_tcga_pub"
"TERT expression (log2)","TERT expression (log2)","STRING",false,"1","TERT_EXPRESSION_LOG2","lgggbm_tcga_pub"
"TERT expression status","TERT expression status","STRING",false,"1","TERT_EXPRESSION_STATUS","lgggbm_tcga_pub"
"TERT promoter status","TERT promoter status","STRING",false,"1","TERT_PROMOTER_STATUS","lgggbm_tcga_pub"
"Tissue Source Site","""A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.""","STRING",false,"1","TISSUE_SOURCE_SITE","lgggbm_tcga_pub"
"Transcriptome Subtype","Transcriptome Subtype","STRING",false,"1","TRANSCRIPTOME_SUBTYPE","lgggbm_tcga_pub"
"U133a","U133a","STRING",false,"1","U133A","lgggbm_tcga_pub"
"Whole Exome Sequencing","Whole Exome Sequencing","STRING",false,"1","WHOLE_EXOME_SEQUENCING","lgggbm_tcga_pub"
"Whole Genome Sequencing","Whole Genome Sequencing","STRING",false,"1","WHOLE_GENOME_SEQUENCING","lgggbm_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lgg_tcga"
"Animal Insect Allergy Age","Animal Insect Allergy Age","STRING",true,"1","ANIMAL_INSECT_ALLERGY_AGE","lgg_tcga"
"Animal Insect Allergy History","Animal insect allergy history.","STRING",true,"1","ANIMAL_INSECT_ALLERGY_HIST","lgg_tcga"
"First Diagnosis of Asthma Eczema Allergy","First Diagnosis of Asthma Eczema Allergy","STRING",true,"1","ASTHMA_ECZEMA_ALLERGY_FIRST_DIAGNOSIS","lgg_tcga"
"Asthma History","Asthma history.","STRING",true,"1","ASTHMA_HISTORY","lgg_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","lgg_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lgg_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","lgg_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","lgg_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","lgg_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","lgg_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","lgg_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","lgg_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","lgg_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","lgg_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","lgg_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","lgg_tcga"
"Eczema History","History of eczema.","STRING",true,"1","ECZEMA_HISTORY","lgg_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","lgg_tcga"
"Family History of Cancer","Family history of cancer.","STRING",true,"1","FAMILY_HISTORY_OF_CANCER","lgg_tcga"
"Family History of Primary Brain Tumor","Family history of primary brain tumor.","STRING",true,"1","FAMILY_HISTORY_OF_PRIMARY_BRAIN_TUMOR","lgg_tcga"
"First symptom longest duration","First symptom longest duration","STRING",true,"1","FIRST_SYMPTOM_LONGEST_DURATION","lgg_tcga"
"Age of Food Allergy","Age of Food Allergy","STRING",true,"1","FOOD_ALLERGY_AGE","lgg_tcga"
"Food Allergy History","Food allergy history.","STRING",true,"1","FOOD_ALLERGY_HISTORY","lgg_tcga"
"Food Allergy Types","Food allergy types.","STRING",true,"1","FOOD_ALLERGY_TYPES","lgg_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","lgg_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lgg_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","lgg_tcga"
"Fever History","Has history of fever.","STRING",true,"1","HAY_FEVER_HISTORY","lgg_tcga"
"Headache History","Has history of headaches.","STRING",true,"1","HEADACHE_HISTORY","lgg_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","lgg_tcga"
"History ionizing rt to head","History ionizing rt to head","STRING",true,"1","HISTORY_IONIZING_RT_TO_HEAD","lgg_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_MEDICATION","lgg_tcga"
"Preoperative corticosteroids","Preoperative corticosteroids","STRING",true,"1","HISTORY_NEOADJUVANT_STEROID_TX","lgg_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","lgg_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","lgg_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","lgg_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","lgg_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","lgg_tcga"
"IDH1 Mutation","IDH1 mutation is present","STRING",true,"1","IDH1_MUTATION","lgg_tcga"
"IDH1 Mutation Test Indicator","IDH1 mutation test was performed.","STRING",true,"1","IDH1_MUTATION_TEST_INDICATOR","lgg_tcga"
"Ldh1 mutation test method","Ldh1 mutation test method","STRING",true,"1","IDH1_MUTATION_TEST_METHOD","lgg_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","lgg_tcga"
"Inherited genetic syndrome found","Inherited genetic syndrome found","STRING",true,"1","INHERITED_GENETIC_SYNDROME_INDICATOR","lgg_tcga"
"Inherited genetic syndrome result","Inherited genetic syndrome result","STRING",true,"1","INHERITED_GENETIC_SYNDROME_SPECIFIED","lgg_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","lgg_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","lgg_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","lgg_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","lgg_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","lgg_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","lgg_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","lgg_tcga"
"Mold or Dust Allergy History","History of mold or dust allergy.","STRING",true,"1","MOLD_OR_DUST_ALLERGY_HISTORY","lgg_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lgg_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","lgg_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","lgg_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","lgg_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","lgg_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","lgg_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","lgg_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","lgg_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","lgg_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","lgg_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","lgg_tcga"
"Days to initial score performance status scale","Days to initial score performance status scale","STRING",true,"1","PERFORMANCE_STATUS_DAYS_TO","lgg_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","lgg_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","lgg_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","lgg_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","lgg_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","lgg_tcga"
"Related symptom first present","Related symptom first present","STRING",true,"1","RELATED_SYMPTOM_FIRST_PRESENT","lgg_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","lgg_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","lgg_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","lgg_tcga"
"Seizure History","Seizure history.","STRING",true,"1","SEIZURE_HISTORY","lgg_tcga"
"Sex","Sex","STRING",true,"1","SEX","lgg_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","lgg_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","lgg_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","lgg_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","lgg_tcga"
"Supratentorial Localization","Supratentorial localization.","STRING",true,"1","SUPRATENTORIAL_LOCALIZATION","lgg_tcga"
"Symp changes mental status","Symp changes mental status","STRING",true,"1","SYMP_CHANGES_MENTAL_STATUS","lgg_tcga"
"Symp changes motor movement","Symp changes motor movement","STRING",true,"1","SYMP_CHANGES_MOTOR_MOVEMENT","lgg_tcga"
"Symp changes sensory","Symp changes sensory","STRING",true,"1","SYMP_CHANGES_SENSORY","lgg_tcga"
"Symp changes visual","Symp changes visual","STRING",true,"1","SYMP_CHANGES_VISUAL","lgg_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","lgg_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","lgg_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","lgg_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","lgg_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","lgg_tcga"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","lgg_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","lgg_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","lgg_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","lgg_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","lgg_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lgg_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","lgg_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","lgg_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","lgg_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lgg_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","lgg_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lgg_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","lgg_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","lgg_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","lgg_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","lgg_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","lgg_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","lgg_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lgg_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","lgg_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","lgg_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","lgg_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","lgg_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","lgg_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","lgg_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","lgg_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","lgg_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lgg_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","lgg_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lgg_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","lgg_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","lgg_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","lgg_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","lgg_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","lgg_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","lgg_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","lgg_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","lgg_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","lgg_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","lgg_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","lgg_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","lgg_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","lgg_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","lgg_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","lgg_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","lgg_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","lgg_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","lgg_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","lgg_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","lgg_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","lgg_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","lgg_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","lgg_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","lgg_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","lgg_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","lgg_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","lgg_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","lgg_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","lgg_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","lgg_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","lgg_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","lgg_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","lgg_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","lgg_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","lgg_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","lgg_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","lgg_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","lgg_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","lgg_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","lgg_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","lgg_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","lgg_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","lgg_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","lgg_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","lgg_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","lgg_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","lgg_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","lgg_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","lgg_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","lgg_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","lgg_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","lgg_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","lgg_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","lgg_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","lgg_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"0","AGE","lgg_ucsf_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lgg_ucsf_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lgg_ucsf_2014"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","lgg_ucsf_2014"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","lgg_ucsf_2014"
"IDH1 Mutation","IDH1 mutation is present","STRING",false,"1","IDH1_MUTATION","lgg_ucsf_2014"
"MGMT Status","MGMT Status","STRING",false,"1","MGMT_STATUS","lgg_ucsf_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lgg_ucsf_2014"
"Non-silent mutations in TP53, ATRX, CIC, FUBP1","Non-silent mutations in TP53, ATRX, CIC, FUBP1","STRING",false,"1","NON_SILENT_MUT_TP53_ATRX_CIC_FUBP1","lgg_ucsf_2014"
"Note","Note.","STRING",false,"1","NOTE","lgg_ucsf_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lgg_ucsf_2014"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","lgg_ucsf_2014"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","lgg_ucsf_2014"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","lgg_ucsf_2014"
"1p/19q Status","1p/19q Status","STRING",false,"1","STATUS_1P_19Q","lgg_ucsf_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","liad_inserm_fr_2014"
"BMI","Body Mass Index","NUMBER",true,"1","BMI","liad_inserm_fr_2014"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","liad_inserm_fr_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","liad_inserm_fr_2014"
"Liver fibrosis ishak score category","Liver fibrosis ishak score category","STRING",true,"1","ISHAK_FIBROSIS_SCORE","liad_inserm_fr_2014"
"Known Molecular Classifier","Known Molecular Classifier","STRING",true,"1","KNOWN_MOLECULAR_CLASSIFIER","liad_inserm_fr_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","liad_inserm_fr_2014"
"Number of Nodules","Number of Nodules","STRING",true,"1","NODULE_NUMBER","liad_inserm_fr_2014"
"Nodule Size (mm)","Nodule Size (mm)","NUMBER",false,"1","NODULE_SIZE","liad_inserm_fr_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","liad_inserm_fr_2014"
"Oral Contraception ","Oral Contraception ","STRING",true,"1","ORAL_CONTRACEPTION","liad_inserm_fr_2014"
"Pathological Diagnosis","Pathological Diagnosis","STRING",true,"1","PATHOLOGICAL_DIAGNOSIS","liad_inserm_fr_2014"
"Sex","Sex","STRING",true,"1","SEX","liad_inserm_fr_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lihc_amc_prv"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lihc_amc_prv"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lihc_amc_prv"
"Cirrhosis","Cirrhosis.","STRING",true,"1","CIRRHOSIS","lihc_amc_prv"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","lihc_amc_prv"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","lihc_amc_prv"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","lihc_amc_prv"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","lihc_amc_prv"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lihc_amc_prv"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lihc_amc_prv"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","lihc_amc_prv"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","lihc_amc_prv"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lihc_riken"
"Alcohol","Alcohol","STRING",true,"1","ALCOHOL","lihc_riken"
"AFP At Procurement","Alpha Fetoprotein At Procurement","STRING",true,"1","ALPHA_FETOPROTIEN_AT_PROCUREMENT","lihc_riken"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lihc_riken"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lihc_riken"
"Chronic viral hepatitis","History of chronic viral hepatitis","STRING",true,"1","CHRONIC_HEPATITIS_ANY_TYPE","lihc_riken"
"Edmondson tumor grading","Edmondson tumor grading","STRING",false,"1","EDMONDSON_GRADE","lihc_riken"
"Family History Cancer Type","Family history cancer type.","STRING",true,"1","FAMILY_HISTORY_CANCER_TYPE","lihc_riken"
"Hepatic Vein Invasion","Hepatic vein invasion","STRING",true,"1","HEPATIC_VEIN_INVASION","lihc_riken"
"Fibrosis in non-cacerous liver tissue is determined according to the New Inuyama Classification.","Fibrosis in non-cacerous liver tissue is determined according to the New Inuyama Classification.","STRING",true,"1","LIVER_FIBROSIS","lihc_riken"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lihc_riken"
"Multiple Nodules","Synchronous or metachronous nodules","STRING",false,"1","MUTIPLE_NODULES","lihc_riken"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lihc_riken"
"Other Diseases","Other diagnosed diseases","STRING",true,"1","OTHER_DISEASES","lihc_riken"
"Platelet count(x10^4)/mm2","Platelet qualitative result","STRING",true,"1","PLATELET_COUNT","lihc_riken"
"Portal Vein Invasion","Portal vein invasion","STRING",true,"1","PORTAL_VEIN_INVASION","lihc_riken"
"Pre-treatment History","Pre-treatment history.","STRING",true,"1","PRETREATMENT_HISTORY","lihc_riken"
"Sex","Sex","STRING",true,"1","SEX","lihc_riken"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","lihc_riken"
"Ablation embolization tx adjuvant","Ablation embolization tx adjuvant","STRING",true,"1","ABLATION_EMBOLIZATION_TX_ADJUVANT","lihc_tcga"
"AFP At Procurement","Alpha Fetoprotein At Procurement","STRING",true,"1","AFP_AT_PROCUREMENT","lihc_tcga"
"AFP Normal Range Lower Bound","AFP Normal Range Lower Bound","STRING",true,"1","AFP_NORM_RANGE_LOWER","lihc_tcga"
"AFP Normal Range Higher Bound","AFP Normal Range Higher Bound","STRING",true,"1","AFP_NORM_RANGE_UPPER","lihc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lihc_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","lihc_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","lihc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","lihc_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","lihc_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","lihc_tcga"
"Bilirubin Total","Bilirubin Total","STRING",true,"1","BILIRUBIN_TOTAL","lihc_tcga"
"Bilirubin Total Norm Range Lower","Bilirubin Total Norm Range Lower","NUMBER",true,"1","BILIRUBIN_TOTAL_NORM_RANGE_LOWER","lihc_tcga"
"Bilirubin Total Norm Range Upper","Bilirubin Total Norm Range Upper","NUMBER",true,"1","BILIRUBIN_TOTAL_NORM_RANGE_UPPER","lihc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","lihc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lihc_tcga"
"Child pugh classification grade","Child pugh classification grade","STRING",true,"1","CHILD_PUGH_CLASSIFICATION","lihc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","lihc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","lihc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","lihc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","lihc_tcga"
"Hematology serum creatinine laboratory result value in mg dl","Hematology serum creatinine laboratory result value in mg dl","NUMBER",true,"1","CREATININE_LEVEL_PRERESECTION","lihc_tcga"
"Laboratory procedure creatinine result lower limit of normal value","Laboratory procedure creatinine result lower limit of normal value","NUMBER",true,"1","CREATININE_NORM_RANGE_LOWER","lihc_tcga"
"Laboratory procedure creatinine result upper limit of normal value","Laboratory procedure creatinine result upper limit of normal value","NUMBER",true,"1","CREATININE_NORM_RANGE_UPPER","lihc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","lihc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","lihc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","lihc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","lihc_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","lihc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","lihc_tcga"
"Specimen collection method name","Specimen collection method name","STRING",true,"1","DEFINITIVE_SURGICAL_PROCEDURE","lihc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","lihc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","lihc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","lihc_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","lihc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","lihc_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","lihc_tcga"
"Cancer diagnosis first degree relative number","Cancer diagnosis first degree relative number","STRING",true,"1","FAMILY_HISTORY_CANCER_NUMBER_RELATIVES","lihc_tcga"
"Family History of Cancer","Family history of cancer.","STRING",true,"1","FAMILY_HISTORY_OF_CANCER","lihc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","lihc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lihc_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","lihc_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","lihc_tcga"
"Adjacent hepatic tissue inflammation extent type","Adjacent hepatic tissue inflammation extent type","STRING",true,"1","HEPATIC_INFLAMMATION_ADJ_TISSUE","lihc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","lihc_tcga"
"History hepato carcinoma risk factor","History hepato carcinoma risk factor","STRING",true,"1","HISTORY_HEPATO_CARCINOMA_RISK_FACTORS","lihc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","lihc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","lihc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","lihc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","lihc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","lihc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","lihc_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","lihc_tcga"
"Liver fibrosis ishak score category","Liver fibrosis ishak score category","STRING",true,"1","ISHAK_FIBROSIS_SCORE","lihc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","lihc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","lihc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","lihc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lihc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","lihc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","lihc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","lihc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","lihc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","lihc_tcga"
"History hepato carcinoma risk factor other","History hepato carcinoma risk factor other","STRING",true,"1","OTHER_HEPATO_CARCINOMA_RISK_FACTORS","lihc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","lihc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","lihc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","lihc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","lihc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","lihc_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","lihc_tcga"
"Platelet count preresection","Platelet count preresection","NUMBER",true,"1","PLATELET_COUNT_PRERESECTION","lihc_tcga"
"Laboratory prcoedure platelet result lower limit of normal value","Laboratory prcoedure platelet result lower limit of normal value","NUMBER",true,"1","PLATELET_NORM_RANGE_LOWER","lihc_tcga"
"Laboratory prcoedure platelet result upper limit of normal value","Laboratory prcoedure platelet result upper limit of normal value","NUMBER",true,"1","PLATELET_NORM_RANGE_UPPER","lihc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","lihc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","lihc_tcga"
"Laboratory procedure prothrombin time result value","Laboratory procedure prothrombin time result value","NUMBER",true,"1","PROTHROMBIN_TIME_INR_AT_PROCUREMENT","lihc_tcga"
"Laboratory procedure international normalization ratio result upper limit of normal value","Laboratory procedure international normalization ratio result upper limit of normal value","NUMBER",true,"1","PROTHROMBIN_TIME_NORM_RANGE_UPPER","lihc_tcga"
"Laboratory procedure international normalization ratio result lower limit of normal value","Laboratory procedure international normalization ratio result lower limit of normal value","NUMBER",true,"1","PROTHROM_TIME_INR_NORM_RANGE_LOWER","lihc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","lihc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","lihc_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","lihc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","lihc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","lihc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","lihc_tcga"
"Laboratory procedure albumin result lower limit of normal value","Laboratory procedure albumin result lower limit of normal value","NUMBER",true,"1","SERUM_ALBUMIN_NORM_RANGE_LOWER","lihc_tcga"
"Laboratory procedure albumin result upper limit of normal value","Laboratory procedure albumin result upper limit of normal value","NUMBER",true,"1","SERUM_ALBUMIN_NORM_RANGE_UPPER","lihc_tcga"
"Laboratory procedure albumin result specified value","Laboratory procedure albumin result specified value","NUMBER",true,"1","SERUM_ALBUMIN_PRERESECTION","lihc_tcga"
"Sex","Sex","STRING",true,"1","SEX","lihc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","lihc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","lihc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","lihc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","lihc_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","lihc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","lihc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","lihc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","lihc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","lihc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","lihc_tcga"
"Vascular Invasion","Vascular invasion.","STRING",true,"1","VASCULAR_INVASION","lihc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","lihc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","lihc_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","lihc_tcga"
"Year of initial pathologic diagnosis","Year of initial pathologic diagnosis.","NUMBER",true,"1","YEAR_OF_INITIAL_PATHOLOGIC_DIAGNOSIS","lihc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lihc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","lihc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","lihc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","lihc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lihc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","lihc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lihc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","lihc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","lihc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","lihc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","lihc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","lihc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","lihc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lihc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","lihc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","lihc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","lihc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","lihc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","lihc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","lihc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","lihc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","lihc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lihc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","lihc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lihc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","lihc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","lihc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","lihc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","lihc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","lihc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","lihc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","lihc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","lihc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","lihc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","lihc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","lihc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","lihc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","lihc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","lihc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","lihc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","lihc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","lihc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","lihc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","lihc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","lihc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","lihc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","lihc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","lihc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","lihc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","lihc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","lihc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","lihc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","lihc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","lihc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","lihc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","lihc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","lihc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","lihc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","lihc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","lihc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","lihc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","lihc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","lihc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","lihc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","lihc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","lihc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","lihc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","lihc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","lihc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","lihc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","lihc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","lihc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","lihc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","lihc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","lihc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","lihc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","lihc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","lihc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","lihc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","lihc_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","luad_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","luad_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","luad_broad"
"Censored","Survival Time Censored; True or False","STRING",false,"1","CENSORED","luad_broad"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","luad_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","luad_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","luad_broad"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","luad_broad"
"Sample Collection Source","Sample Collection Source","STRING",false,"1","SAMPLE_COLLECTION_SOURCE","luad_broad"
"Sex","Sex","STRING",true,"1","SEX","luad_broad"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","luad_broad"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","luad_broad"
"Stage","Stage","STRING",true,"1","STAGE","luad_broad"
"Tumor cellularity dominant pathology review","Tumor cellularity dominant pathology review","STRING",false,"1","TUMOR_CELLULARITY_PATHOLOGY_REVIEW","luad_broad"
"Administration Of Drug Weeks","Administration Of Drug Weeks","NUMBER",true,"1","ADMINISTRATION_OF_DRUG_WEEKS","luad_mskcc_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","luad_mskcc_2015"
"AGENT","AGENT","STRING",true,"1","AGENT","luad_mskcc_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","luad_mskcc_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","luad_mskcc_2015"
"Durable Clinical Benefit","Durable Clinical Benefit","STRING",true,"1","DURABLE_CLINICAL_BENEFIT","luad_mskcc_2015"
"Event Type","Event Type","STRING",true,"1","EVENT_TYPE","luad_mskcc_2015"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","luad_mskcc_2015"
"Histology","Histology","STRING",true,"1","HISTOLOGY","luad_mskcc_2015"
"Molecular Smoking Signature","Molecular Smoking Signature","STRING",true,"1","MOLECULAR_SMOKING_SIGNATURE","luad_mskcc_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","luad_mskcc_2015"
"Neoantigen Burden","Neoantigen Burden","NUMBER",true,"1","NEOANTIGEN_BURDEN","luad_mskcc_2015"
"Nonsynonymous Mutation Burden","Nonsynonymous Mutation Burden","NUMBER",true,"1","NONSYNONYMOUS_MUTATION_BURDEN","luad_mskcc_2015"
"Note","Note.","STRING",false,"1","NOTE","luad_mskcc_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","luad_mskcc_2015"
"PDL1 Expression","PDL1 Expression","STRING",true,"1","PDL1_EXPRESSION","luad_mskcc_2015"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","luad_mskcc_2015"
"Prior Treatment Of Cytotoxic Chemotherapy","Prior Treatment Of Cytotoxic Chemotherapy","NUMBER",true,"1","PRIOR_TREATMENT_OF_CYTOTOXIC_CHEMOTHERAPY","luad_mskcc_2015"
"Sex","Sex","STRING",true,"1","SEX","luad_mskcc_2015"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","luad_mskcc_2015"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","luad_mskcc_2015"
"Total Exonic Mutation Burden","Total Exonic Mutation Burden","NUMBER",true,"1","TOTAL_EXONIC_MUTATION_BURDEN","luad_mskcc_2015"
"Treatment best response","Treatment best response","STRING",true,"1","TREATMENT_BEST_RESPONSE","luad_mskcc_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","luad_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_CLINICAL_TUMOR_STAGE","luad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","luad_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","luad_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CN","luad_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CT","luad_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","luad_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","luad_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","luad_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","luad_tcga"
"ALK Analysis Type","ALK Analysis Type","STRING",true,"1","ALK_ANALYSIS_TYPE","luad_tcga"
"ALK Translocation Status","ALK Translocation Status","STRING",true,"1","ALK_TRANSLOCATION_STATUS","luad_tcga"
"ALK Translocation Variant","ALK Translocation Variant","STRING",true,"1","ALK_TRANSLOCATION_VARIANT","luad_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","luad_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","luad_tcga"
"Carbon monoxide diffusion dlco","Carbon monoxide diffusion dlco","NUMBER",true,"1","CARBON_MONOXIDE_DIFFUSION_DLCO","luad_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","luad_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","luad_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","luad_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","luad_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","luad_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","luad_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","luad_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","luad_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","luad_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","luad_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","luad_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","luad_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","luad_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","luad_tcga"
"Fev1 fvc ratio postbroncholiator","Fev1 fvc ratio postbroncholiator","NUMBER",true,"1","FEV1_FVC_RATIO_POSTBRONCHOLIATOR","luad_tcga"
"Fev1 fvc ratio prebroncholiator","Fev1 fvc ratio prebroncholiator","NUMBER",true,"1","FEV1_FVC_RATIO_PREBRONCHOLIATOR","luad_tcga"
"Fev1 percent ref postbroncholiator","Fev1 percent ref postbroncholiator","NUMBER",true,"1","FEV1_PERCENT_REF_POSTBRONCHOLIATOR","luad_tcga"
"Fev1 percent ref prebroncholiator","Fev1 percent ref prebroncholiator","NUMBER",true,"1","FEV1_PERCENT_REF_PREBRONCHOLIATOR","luad_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","luad_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","luad_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","luad_tcga"
"Prior immunologic disease type","Prior immunologic disease type","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE","luad_tcga"
"Prior immunologic disease other","Prior immunologic disease other","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE_OTHER","luad_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","luad_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","luad_tcga"
"Prior infectious disease","Prior infectious disease","STRING",true,"1","HISTORY_RELEVANT_INFECTIOUS_DX","luad_tcga"
"HIV Status","HIV Status","STRING",true,"1","HIV_STATUS","luad_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","luad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","luad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","luad_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","luad_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","luad_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","luad_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","luad_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","STRING",true,"1","KARNOFSKY_PERFORMANCE_SCORE","luad_tcga"
"Kras gene analysis indicator","Kras gene analysis indicator","STRING",true,"1","KRAS_GENE_ANALYSIS_INDICATOR","luad_tcga"
"KRAS Mutation","KRAS mutation is present.","STRING",true,"1","KRAS_MUTATION","luad_tcga"
"Kras mutation identified type","Kras mutation identified type","STRING",true,"1","KRAS_MUTATION_IDENTIFIED_TYPE","luad_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","luad_tcga"
"Location lung parenchyma","Location lung parenchyma","STRING",true,"1","LOCATION_LUNG_PARENCHYMA","luad_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","luad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","luad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","luad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","luad_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","luad_tcga"
"Mutation Status","Mutation Status","STRING",true,"1","MUTATION_STATUS","luad_tcga"
"Mutation Type","Mutation Type","STRING",true,"1","MUTATION_TYPE","luad_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","luad_tcga"
"Number of lymphnodes positive by ihc","Number of lymphnodes positive by ihc","STRING",true,"1","NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC","luad_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","luad_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","luad_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","luad_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","luad_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","luad_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","luad_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","luad_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","luad_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","luad_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","luad_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","luad_tcga"
"Lymph node location positive pathology name","Lymph node location positive pathology name","STRING",true,"1","POS_LYMPH_NODE_LOCATION","luad_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","luad_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","luad_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","luad_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","luad_tcga"
"Pulmonary function test indicator","Pulmonary function test indicator","STRING",true,"1","PULMONARY_FUNCTION_TEST_INDICATOR","luad_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","luad_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","luad_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","luad_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","luad_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","luad_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","luad_tcga"
"Sex","Sex","STRING",true,"1","SEX","luad_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","luad_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","luad_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","luad_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","luad_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","luad_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","luad_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","luad_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","luad_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","luad_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","luad_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","luad_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","luad_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","luad_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","luad_tcga"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","luad_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","luad_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","luad_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","luad_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","luad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","luad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","luad_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","luad_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","luad_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","luad_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","luad_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","luad_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","luad_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","luad_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","luad_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","luad_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","luad_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","luad_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","luad_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","luad_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","luad_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","luad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","luad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","luad_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","luad_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","luad_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","luad_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","luad_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","luad_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","luad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","luad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","luad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","luad_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","luad_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","luad_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","luad_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","luad_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","luad_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","luad_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","luad_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","luad_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","luad_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","luad_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","luad_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","luad_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","luad_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","luad_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","luad_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","luad_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","luad_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","luad_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","luad_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","luad_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","luad_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","luad_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","luad_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","luad_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","luad_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","luad_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","luad_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","luad_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","luad_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","luad_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","luad_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","luad_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","luad_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","luad_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","luad_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","luad_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","luad_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","luad_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","luad_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","luad_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","luad_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","luad_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","luad_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","luad_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","luad_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","luad_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","luad_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","luad_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","luad_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","luad_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","luad_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","luad_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","luad_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","luad_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","luad_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","luad_tcga_pub"
"Distant Metastasis Pathologic Spread","Distant metastasis pathologic spread.","STRING",false,"1","DISTANT_METASTASIS_PATHOLOGIC_SPREAD","luad_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","luad_tcga_pub"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","luad_tcga_pub"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","luad_tcga_pub"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","luad_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","luad_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","luad_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","luad_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","luad_tcga_pub"
"Pre-treatment History","Pre-treatment history.","STRING",true,"1","PRETREATMENT_HISTORY","luad_tcga_pub"
"Primary Tumor Pathologic Spread","Primary tumor pathologic spread.","STRING",true,"1","PRIMARY_TUMOR_PATHOLOGIC_SPREAD","luad_tcga_pub"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DIAGNOSIS","luad_tcga_pub"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","luad_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","luad_tcga_pub"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","luad_tcga_pub"
"Tumor Stage 2009","Tumor stage 2009.","STRING",false,"1","TUMOR_STAGE_2009","luad_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","luad_tsp"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","luad_tsp"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","luad_tsp"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","luad_tsp"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lung_msk_2017"
"Cancer Type","Cancer Type","STRING",false,"5","CANCER_TYPE","lung_msk_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"5","CANCER_TYPE_DETAILED","lung_msk_2017"
"Clinical Trial","Clinical Trial","STRING",true,"1","CLINICAL_TRIAL","lung_msk_2017"
"Driver Mutations","Driver Mutations","STRING",false,"1","DRIVER_MUTATIONS","lung_msk_2017"
"Durable Clinical Benefit","Durable Clinical Benefit","STRING",true,"1","DURABLE_CLINICAL_BENEFIT","lung_msk_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lung_msk_2017"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","lung_msk_2017"
"Immunotherapy","Immunotherapy","STRING",true,"1","IMMUNE_TREATMENT","lung_msk_2017"
"Institute Source","Institute Source","STRING",false,"1","INSTITUTE","lung_msk_2017"
"Number Treatment Lines Prior To Receiving Impact Results","Number Treatment Lines Prior To Receiving Impact Results","NUMBER",false,"1","LINES_OF_TX_PRIOR_IMPACT","lung_msk_2017"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","lung_msk_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lung_msk_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lung_msk_2017"
"Overall Patient Histology","Overall Patient Histology","STRING",true,"1","OVERALL_PATIENT_HISTOLOGY","lung_msk_2017"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","lung_msk_2017"
"Recurrent/metastatic disease","Recurrent/metastatic disease","STRING",false,"1","RECURRENT_METASTATIC_DISEASE","lung_msk_2017"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","lung_msk_2017"
"Sample coverage","Sample coverage","NUMBER",false,"1","SAMPLE_COVERAGE","lung_msk_2017"
"Sample pre any Lung Therapy","Sample pre any Lung Therapy","STRING",false,"1","SAMPLE_PRE_LUNG_THERAPY","lung_msk_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","lung_msk_2017"
"Sex","Sex","STRING",true,"1","SEX","lung_msk_2017"
"Smoking History","Indicates if person has a history of smoking.","STRING",true,"1","SMOKING_HISTORY","lung_msk_2017"
"Somatic Status","Somatic Status","STRING",false,"1","SOMATIC_STATUS","lung_msk_2017"
"SO comments","Sign-out comments","STRING",false,"1","SO_COMMENTS","lung_msk_2017"
"Stage At Diagnosis","Stage At Diagnosis","STRING",false,"1","STAGE_AT_DIAGNOSIS","lung_msk_2017"
"Target Therapy","Did the patient recieve target therapy","STRING",true,"1","TARGET_THERAPY","lung_msk_2017"
"Chemotherapy","Chemotherapy.","STRING",true,"1","TREATMENT_CHEMOTHERAPY","lung_msk_2017"
"Tumor Purity","Tumor Purity","NUMBER",false,"1","TUMOR_PURITY","lung_msk_2017"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","lung_msk_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lusc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_CLINICAL_TUMOR_STAGE","lusc_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","lusc_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","lusc_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CN","lusc_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CT","lusc_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","lusc_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","lusc_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","lusc_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","lusc_tcga"
"ALK Analysis Type","ALK Analysis Type","STRING",true,"1","ALK_ANALYSIS_TYPE","lusc_tcga"
"ALK Translocation Status","ALK Translocation Status","STRING",true,"1","ALK_TRANSLOCATION_STATUS","lusc_tcga"
"ALK Translocation Variant","ALK Translocation Variant","STRING",true,"1","ALK_TRANSLOCATION_VARIANT","lusc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","lusc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lusc_tcga"
"Carbon monoxide diffusion dlco","Carbon monoxide diffusion dlco","NUMBER",true,"1","CARBON_MONOXIDE_DIFFUSION_DLCO","lusc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","lusc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","lusc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_DEATH","lusc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","lusc_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","lusc_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","lusc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","lusc_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","lusc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","lusc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","lusc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","lusc_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","lusc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","lusc_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","lusc_tcga"
"Fev1 fvc ratio postbroncholiator","Fev1 fvc ratio postbroncholiator","NUMBER",true,"1","FEV1_FVC_RATIO_POSTBRONCHOLIATOR","lusc_tcga"
"Fev1 fvc ratio prebroncholiator","Fev1 fvc ratio prebroncholiator","NUMBER",true,"1","FEV1_FVC_RATIO_PREBRONCHOLIATOR","lusc_tcga"
"Fev1 percent ref postbroncholiator","Fev1 percent ref postbroncholiator","NUMBER",true,"1","FEV1_PERCENT_REF_POSTBRONCHOLIATOR","lusc_tcga"
"Fev1 percent ref prebroncholiator","Fev1 percent ref prebroncholiator","NUMBER",true,"1","FEV1_PERCENT_REF_PREBRONCHOLIATOR","lusc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","lusc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lusc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","lusc_tcga"
"Prior immunologic disease type","Prior immunologic disease type","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE","lusc_tcga"
"Prior immunologic disease other","Prior immunologic disease other","STRING",true,"1","HISTORY_IMMUNOLOGICAL_DISEASE_OTHER","lusc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","lusc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","lusc_tcga"
"Prior infectious disease","Prior infectious disease","STRING",true,"1","HISTORY_RELEVANT_INFECTIOUS_DX","lusc_tcga"
"HIV Status","HIV Status","STRING",true,"1","HIV_STATUS","lusc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","lusc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","lusc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","lusc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","lusc_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","lusc_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","lusc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","lusc_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","lusc_tcga"
"Kras gene analysis indicator","Kras gene analysis indicator","STRING",true,"1","KRAS_GENE_ANALYSIS_INDICATOR","lusc_tcga"
"KRAS Mutation","KRAS mutation is present.","STRING",true,"1","KRAS_MUTATION","lusc_tcga"
"Kras mutation identified type","Kras mutation identified type","STRING",true,"1","KRAS_MUTATION_IDENTIFIED_TYPE","lusc_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","lusc_tcga"
"Location lung parenchyma","Location lung parenchyma","STRING",true,"1","LOCATION_LUNG_PARENCHYMA","lusc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","lusc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","lusc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","lusc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","lusc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lusc_tcga"
"Mutation Status","Mutation Status","STRING",true,"1","MUTATION_STATUS","lusc_tcga"
"Mutation Type","Mutation Type","STRING",true,"1","MUTATION_TYPE","lusc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","lusc_tcga"
"Number of lymphnodes positive by ihc","Number of lymphnodes positive by ihc","STRING",true,"1","NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC","lusc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","lusc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","lusc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","lusc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","lusc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","lusc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","lusc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","lusc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","lusc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","lusc_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","lusc_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","lusc_tcga"
"Lymph node location positive pathology name","Lymph node location positive pathology name","STRING",true,"1","POS_LYMPH_NODE_LOCATION","lusc_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","lusc_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","lusc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","lusc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","lusc_tcga"
"Pulmonary function test indicator","Pulmonary function test indicator","STRING",true,"1","PULMONARY_FUNCTION_TEST_INDICATOR","lusc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","lusc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","lusc_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","lusc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","lusc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","lusc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","lusc_tcga"
"Sex","Sex","STRING",true,"1","SEX","lusc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","lusc_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","lusc_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","lusc_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","lusc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","lusc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","lusc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","lusc_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","lusc_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","lusc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","lusc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","lusc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","lusc_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","lusc_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","lusc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","lusc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","lusc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","lusc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","lusc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lusc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","lusc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","lusc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","lusc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lusc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","lusc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lusc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","lusc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","lusc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","lusc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","lusc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","lusc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","lusc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lusc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","lusc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","lusc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","lusc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","lusc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","lusc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","lusc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","lusc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","lusc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lusc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","lusc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lusc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","lusc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","lusc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","lusc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","lusc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","lusc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","lusc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","lusc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","lusc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","lusc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","lusc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","lusc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","lusc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","lusc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","lusc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","lusc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","lusc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","lusc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","lusc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","lusc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","lusc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","lusc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","lusc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","lusc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","lusc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","lusc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","lusc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","lusc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","lusc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","lusc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","lusc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","lusc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","lusc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","lusc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","lusc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","lusc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","lusc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","lusc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","lusc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","lusc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","lusc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","lusc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","lusc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","lusc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","lusc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","lusc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","lusc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","lusc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","lusc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","lusc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","lusc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","lusc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","lusc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","lusc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","lusc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","lusc_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","lusc_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","lusc_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","lusc_tcga_pub"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","lusc_tcga_pub"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","lusc_tcga_pub"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","lusc_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","lusc_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","lusc_tcga_pub"
"Nonsense Mutations","Nonsense Mutations","STRING",false,"1","NONSENSE_MUTATION","lusc_tcga_pub"
"Non Silent per Mb","Non Silent per Mb","STRING",false,"1","NONSILENT_PER_MB","lusc_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","lusc_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","lusc_tcga_pub"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","lusc_tcga_pub"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","lusc_tcga_pub"
"snapshot mutations","snapshot mutations","STRING",false,"1","SNAPSHOT_MUTATIONS","lusc_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mbl_broad_2012"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mbl_broad_2012"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mbl_broad_2012"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mbl_broad_2012"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","mbl_icgc"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mbl_icgc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mbl_icgc"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","mbl_icgc"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","mbl_icgc"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","mbl_icgc"
"Histology ","Histology ","STRING",true,"1","HISTOLOGY","mbl_icgc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mbl_icgc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mbl_icgc"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","mbl_icgc"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","mbl_icgc"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","mbl_icgc"
"Primary Site Progression","Primary site progression.","STRING",true,"1","PRIMARY_SITE_PROGRESSION","mbl_icgc"
"Radicality Of Surgery ","Radicality of Surgery: GTR = Gross Total Resection, STR = Sub-Total Resection","STRING",false,"1","RADICALITY","mbl_icgc"
"Subgroup","Subgroup","STRING",true,"1","SUBGROUP","mbl_icgc"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","mbl_pcgp"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mbl_pcgp"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mbl_pcgp"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","mbl_pcgp"
"Follow up length (year)","Follow up length","STRING",true,"1","FOLLOWUP_LENGTH","mbl_pcgp"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mbl_pcgp"
"M Stage","M Stage","STRING",true,"1","M_STAGE","mbl_pcgp"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mbl_pcgp"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","mbl_pcgp"
"Sex","Sex","STRING",true,"1","SEX","mbl_pcgp"
"Tumor cellularity dominant pathology review","Tumor cellularity dominant pathology review","STRING",false,"1","TUMOR_CELLULARITY_PATHOLOGY_REVIEW","mbl_pcgp"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","mbl_pcgp"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","mbl_sickkids_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mbl_sickkids_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mbl_sickkids_2016"
"Germline Control","Germline Control","STRING",false,"1","GERMLINE_CONTROL","mbl_sickkids_2016"
"Histology","Histology","STRING",true,"1","HISTOLOGY","mbl_sickkids_2016"
"Location","Location","STRING",true,"1","LOCATION","mbl_sickkids_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mbl_sickkids_2016"
"M Stage","M Stage","STRING",true,"1","M_STAGE","mbl_sickkids_2016"
"Note","Note.","STRING",false,"1","NOTE","mbl_sickkids_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mbl_sickkids_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","mbl_sickkids_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","mbl_sickkids_2016"
"RNA-SEQ Data","RNA-SEQ data.","STRING",false,"1","RNASEQ_DATA","mbl_sickkids_2016"
"Sex","Sex","STRING",true,"1","SEX","mbl_sickkids_2016"
"Source of Recurrence Tissue","Source of Recurrence Tissue","STRING",true,"1","SOURCE_OF_RECURRENCE_TISSUE","mbl_sickkids_2016"
"Subgroup","Subgroup","STRING",true,"1","SUBGROUP","mbl_sickkids_2016"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","mcl_idibips_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mcl_idibips_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mcl_idibips_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mcl_idibips_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","mds_tokyo_2011"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","mds_tokyo_2011"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mds_tokyo_2011"
"Cytogenetics","Cytogenetics.","NUMBER",true,"1","CYTOGENETICS","mds_tokyo_2011"
"Germline Control","Germline Control","STRING",false,"1","GERMLINE_CONTROL","mds_tokyo_2011"
"IPSS Score","IPSS (the International Prognostic Scoring System) Score","STRING",true,"1","IPSS_SCORE","mds_tokyo_2011"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mds_tokyo_2011"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mds_tokyo_2011"
"Sex","Sex","STRING",true,"1","SEX","mds_tokyo_2011"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","mds_tokyo_2011"
"WHO Class","WHO class.","STRING",true,"1","WHO_CLASS","mds_tokyo_2011"
"Age at Diagnosis","Age at Diagnosis","NUMBER",true,"1","AGE_AT_DIAGNOSIS","mel_tsam_liang_2017"
"Other Alternative Therapy Given","Other Alternative Therapy Given","STRING",true,"1","ALTERNATE_THERAPY_OTHER","mel_tsam_liang_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mel_tsam_liang_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mel_tsam_liang_2017"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","mel_tsam_liang_2017"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","mel_tsam_liang_2017"
"Follow up time months","Follow up time months","NUMBER",true,"1","FOLLOW_UP_TIME_MONTHS","mel_tsam_liang_2017"
"In Transit","In Transit","STRING",true,"1","IN_TRANSIT","mel_tsam_liang_2017"
"Kbase Identifier","Kbase Identifier","STRING",true,"1","KBASE_ID","mel_tsam_liang_2017"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","mel_tsam_liang_2017"
"Metastasis","Metastasis.","STRING",true,"1","METASTASIS","mel_tsam_liang_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mel_tsam_liang_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mel_tsam_liang_2017"
"OR Date","OR Date from Diagnosis","NUMBER",true,"1","OR_TIME","mel_tsam_liang_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","mel_tsam_liang_2017"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","mel_tsam_liang_2017"
"Other Treatment Responses","Other Treatment Responses","STRING",true,"1","OTHER_TREATMENT_RESPONSE","mel_tsam_liang_2017"
"Primary Depth","Primary Depth","NUMBER",false,"1","PRIMARY_DEPTH","mel_tsam_liang_2017"
"Primary melanoma tumor ulceration","Melanoma ulceration indicator","STRING",true,"1","PRIMARY_MELANOMA_TUMOR_ULCERATION","mel_tsam_liang_2017"
"Primary Mitoses","Primary Mitoses","STRING",false,"1","PRIMARY_MITOSES","mel_tsam_liang_2017"
"Primary Tumor Location","Primary Tumor Location","STRING",false,"1","PRIMARY_TUMOR_LOCATION","mel_tsam_liang_2017"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","mel_tsam_liang_2017"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","mel_tsam_liang_2017"
"Site of Sample","Sample Site","STRING",false,"1","SAMPLE_SITE","mel_tsam_liang_2017"
"Sex","Sex","STRING",true,"1","SEX","mel_tsam_liang_2017"
"Site First Recurrence","Site First Recurrence","STRING",true,"1","SITE_FIRST_RECURRENCE","mel_tsam_liang_2017"
"Stage at Presentation","Stage at Presentation","STRING",false,"1","STAGE_AT_PRESENTATION","mel_tsam_liang_2017"
"Sub-site","Sub-site.","STRING",false,"1","SUB_SITE","mel_tsam_liang_2017"
"Time to Recurrence (months)","Time to Recurrence (months)","STRING",true,"1","TIME_TO_RECURRENCE_MONTHS","mel_tsam_liang_2017"
"Treatment","Treatment","STRING",true,"1","TREATMENT","mel_tsam_liang_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","meso_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","meso_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","meso_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","meso_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","meso_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","meso_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","meso_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","meso_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","meso_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","meso_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","meso_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","meso_tcga"
"Laboratory procedure creatinine result lower limit of normal value","Laboratory procedure creatinine result lower limit of normal value","NUMBER",true,"1","CREATININE_NORM_RANGE_LOWER","meso_tcga"
"Laboratory procedure creatinine result upper limit of normal value","Laboratory procedure creatinine result upper limit of normal value","NUMBER",true,"1","CREATININE_NORM_RANGE_UPPER","meso_tcga"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","meso_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","meso_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","meso_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_DEATH","meso_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","meso_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","meso_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","meso_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","meso_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","meso_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","meso_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","meso_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","meso_tcga"
"Family History Cancer Relationship","Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individuals genes is shared (i.e., parent, sibling, offspring).","STRING",true,"1","FAMILY_HISTORY_CANCER_RELATIONSHIP","meso_tcga"
"Family History Cancer Type","Family history cancer type.","STRING",true,"1","FAMILY_HISTORY_CANCER_TYPE","meso_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","meso_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","meso_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","meso_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","meso_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","meso_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","meso_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","meso_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","meso_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","meso_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","meso_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","meso_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","meso_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","meso_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","meso_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","meso_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","meso_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","meso_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","meso_tcga"
"Occupation Primary","The primary occupation of the participant for most of their adult employment.","STRING",true,"1","OCCUPATION_PRIMARY","meso_tcga"
"Occupation Primary Years Worked","The number that describes the duration of time expressed in number of years that a person has worked in a job.","NUMBER",true,"1","OCCUPATION_PRIMARY_YEARS_WORKED","meso_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","meso_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","meso_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","meso_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","meso_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","meso_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","meso_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","meso_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","meso_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","meso_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","meso_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","meso_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","meso_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","meso_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","meso_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","meso_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","meso_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","meso_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","meso_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","meso_tcga"
"Sex","Sex","STRING",true,"1","SEX","meso_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","meso_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","meso_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","meso_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","meso_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","meso_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","meso_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","meso_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","meso_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","meso_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","meso_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","meso_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","meso_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","meso_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","meso_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","meso_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","meso_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","meso_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","meso_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","meso_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","meso_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","meso_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","meso_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","meso_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","meso_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","meso_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","meso_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","meso_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","meso_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","meso_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","meso_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","meso_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","meso_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","meso_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","meso_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","meso_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","meso_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","meso_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","meso_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","meso_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","meso_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","meso_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","meso_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","meso_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","meso_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","meso_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","meso_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","meso_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","meso_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","meso_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","meso_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","meso_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","meso_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","meso_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","meso_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","meso_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","meso_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","meso_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","meso_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","meso_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","meso_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","meso_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","meso_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","meso_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","meso_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","meso_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","meso_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","meso_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","meso_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","meso_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","meso_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","meso_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","meso_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","meso_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","meso_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","meso_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","meso_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","meso_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","meso_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","meso_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","meso_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","meso_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","meso_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","meso_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","meso_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","meso_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","meso_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","meso_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","meso_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","meso_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","meso_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","meso_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","meso_tcga_pan_can_atlas_2018"
"Age Start IO","Age Start IO","STRING",true,"1","AGE_START_IO","mixed_allen_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mixed_allen_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mixed_allen_2018"
"Censored","Survival Time Censored; True or False","STRING",false,"1","CENSORED","mixed_allen_2018"
"Drug Type","What type of drug was administered?","STRING",true,"1","DRUG_TYPE","mixed_allen_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","mixed_allen_2018"
"Histology","Histology","STRING",true,"1","HISTOLOGY","mixed_allen_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mixed_allen_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mixed_allen_2018"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","mixed_allen_2018"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","mixed_allen_2018"
"Other Concurrent Therapy","Did the patient receive any other concurrent therapy","STRING",true,"1","OTHER_CONCURRENT_THERAPY","mixed_allen_2018"
"p16 ISH","p16 ISH","STRING",true,"1","P16_ISH","mixed_allen_2018"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","mixed_allen_2018"
"Progression Free Status","Progression Free Status","STRING",true,"1","PFS_STATUS","mixed_allen_2018"
"RECIST","RECIST Status","STRING",true,"1","RECIST","mixed_allen_2018"
"RECIST Response","RECIST Response","STRING",true,"1","RECIST_RESPONSE","mixed_allen_2018"
"ROH Response","ROH Response","STRING",true,"1","ROH_RESPONSE","mixed_allen_2018"
"Sex","Sex","STRING",true,"1","SEX","mixed_allen_2018"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","mixed_allen_2018"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","mixed_allen_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","mixed_allen_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","mixed_allen_2018"
"VA Response","VA Response","STRING",true,"1","VA_RESPONSE","mixed_allen_2018"
"Age at Diagnosis","Age at Diagnosis","NUMBER",true,"1","AGE_AT_DIAGNOSIS","mixed_pipseq_2017"
"Age at Testing (Years)","Age at Testing (Years)","NUMBER",true,"1","AGE_TESTING_YEARS","mixed_pipseq_2017"
"CANCER_TYPE","CANCER_TYPE","STRING",false,"1","CANCER_TYPE","mixed_pipseq_2017"
"CANCER_TYPE_DETAILED","CANCER_TYPE_DETAILED","STRING",false,"1","CANCER_TYPE_DETAILED","mixed_pipseq_2017"
"DIAGNOSTIC_CATEGORY","DIAGNOSTIC_CATEGORY","STRING",false,"1","DIAGNOSTIC_CATEGORY","mixed_pipseq_2017"
"GMED Overall Survival Months","GMED Overall Survival Months","NUMBER",true,"1","GMED_OS_MONTHS","mixed_pipseq_2017"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","mixed_pipseq_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mixed_pipseq_2017"
"NGS Test","Sample was NGS tested","STRING",false,"1","NGS_TEST","mixed_pipseq_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mixed_pipseq_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","mixed_pipseq_2017"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","mixed_pipseq_2017"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","mixed_pipseq_2017"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","mixed_pipseq_2017"
"Sample Tested Category","Sample Tested Category","STRING",false,"1","SAMPLE_TESTED_CATEGORY","mixed_pipseq_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","mixed_pipseq_2017"
"Sex","Sex","STRING",true,"1","SEX","mixed_pipseq_2017"
"Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING",false,"1","SPECIMEN_PRESERVATION_TYPE","mixed_pipseq_2017"
"Tissue Sequenced","Tissue Sequenced","STRING",false,"1","TISSUE_SEQUENCED","mixed_pipseq_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","mm_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mm_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mm_broad"
"Diagnosis","Diagnosis.","STRING",true,"1","DIAGNOSIS","mm_broad"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","mm_broad"
"FISH Translocation","FISH translocation.","STRING",false,"1","FISH_TRANSLOCATION","mm_broad"
"HEAVY CHAIN","HEAVY CHAIN","STRING",false,"1","HEAVY_CHAIN","mm_broad"
"Hyper-diploid","Hyper-diploid.","STRING",false,"1","HYPERDIPLOID","mm_broad"
"Light Chain","Light chain.","STRING",false,"1","LIGHT_CHAIN","mm_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mm_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mm_broad"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","mm_broad"
"Previous Treatment","Previous treatment.","STRING",true,"1","PREVIOUS_TREATMENT","mm_broad"
"Prior MGUS","Prior MGUS.","STRING",true,"1","PRIOR_MGUS","mm_broad"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","mm_broad"
"Sex","Sex","STRING",true,"1","SEX","mm_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mpnst_mskcc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mpnst_mskcc"
"Clinical Assocation","Clinical association.","STRING",true,"1","CLINICAL_ASSOCIATION","mpnst_mskcc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mpnst_mskcc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mpnst_mskcc"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","mpnst_mskcc"
"Age Group at Diagnosis in Years","Age Group at Diagnosis in Years","STRING",true,"1","AGE_GROUP","mrt_bcgsc_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","mrt_bcgsc_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","mrt_bcgsc_2016"
"Matched Normal","Has matched normal.","STRING",false,"1","HAS_MATCHED_NORMAL","mrt_bcgsc_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","mrt_bcgsc_2016"
"Normal location","Tissue where normal was derived.","STRING",false,"1","NORMAL_SITE","mrt_bcgsc_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","mrt_bcgsc_2016"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","mrt_bcgsc_2016"
"Stage","Stage","STRING",true,"1","STAGE","mrt_bcgsc_2016"
"Tumor Content","tumor content","NUMBER",false,"1","TUMOR_CONTENT","mrt_bcgsc_2016"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","mrt_bcgsc_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","msk_impact_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","msk_impact_2017"
"DNA Input","DNA Input","NUMBER",false,"1","DNA_INPUT","msk_impact_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","msk_impact_2017"
"Matched Status","Matched Status","STRING",false,"1","MATCHED_STATUS","msk_impact_2017"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","msk_impact_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","msk_impact_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","msk_impact_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","msk_impact_2017"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","msk_impact_2017"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","msk_impact_2017"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","msk_impact_2017"
"Sample Collection Source","Sample Collection Source","STRING",false,"1","SAMPLE_COLLECTION_SOURCE","msk_impact_2017"
"Sample coverage","Sample coverage","NUMBER",false,"1","SAMPLE_COVERAGE","msk_impact_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","msk_impact_2017"
"Sex","Sex","STRING",true,"1","SEX","msk_impact_2017"
"Smoking History","Indicates if person has a history of smoking.","STRING",true,"1","SMOKING_HISTORY","msk_impact_2017"
"Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING",false,"1","SPECIMEN_PRESERVATION_TYPE","msk_impact_2017"
"Specimen Type","The broad cancer phenotype and site information values for a sample to be processed.","STRING",false,"1","SPECIMEN_TYPE","msk_impact_2017"
"Tumor Purity","Tumor Purity","NUMBER",false,"1","TUMOR_PURITY","msk_impact_2017"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","msk_impact_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","nbl_amc_2012"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nbl_amc_2012"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nbl_amc_2012"
"CG_1P","CG_1P","STRING",false,"1","CG_1P","nbl_amc_2012"
"CHROMOTRYPSIS V2","CHROMOTRYPSIS V2","STRING",false,"1","CHROMOTRYPSIS_V2","nbl_amc_2012"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","nbl_amc_2012"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","nbl_amc_2012"
"INSS Stage","Staging according to the International Neuroblastoma Staging System","STRING",true,"1","INSS_STAGE","nbl_amc_2012"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nbl_amc_2012"
"MYCN","MYCN.","STRING",false,"1","MYCN","nbl_amc_2012"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nbl_amc_2012"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","nbl_amc_2012"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","nbl_amc_2012"
"Pf months","Pf months","STRING",true,"1","PF_MONTHS","nbl_amc_2012"
"Pf status","Pf status","STRING",true,"1","PF_STATUS","nbl_amc_2012"
"Sex","Sex","STRING",true,"1","SEX","nbl_amc_2012"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","nbl_amc_2012"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","nbl_broad_2013"
"analysis id","analysis id","STRING",false,"1","ANALYSIS_ID","nbl_broad_2013"
"ATRX Deletion","ATRX Deletion","STRING",false,"1","ATRX_DELETION","nbl_broad_2013"
"A>C","A>C","STRING",false,"1","A_C","nbl_broad_2013"
"A>G","A>G","STRING",false,"1","A_G","nbl_broad_2013"
"A>T","A>T","STRING",false,"1","A_T","nbl_broad_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nbl_broad_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nbl_broad_2013"
"Covered Bases","Covered Bases","STRING",false,"1","COVERED_BASES","nbl_broad_2013"
"C>A","C>A","STRING",false,"1","C_A","nbl_broad_2013"
"C>G","C>G","STRING",false,"1","C_G","nbl_broad_2013"
"C>T","C>T","STRING",false,"1","C_T","nbl_broad_2013"
"Data Source","Data Source","STRING",true,"1","DATA_SOURCE","nbl_broad_2013"
"de novo start outofframe","de novo start outofframe","STRING",false,"1","DE_NOVO_START_OUTOFFRAME","nbl_broad_2013"
"Event Free Survival (Months)","In cancer, the length of time after primary treatment for a cancer ends that the patient remains free of certain complications or events that the treatment was intended to prevent or delay. These events may include the return of the cancer or the onset of certain symptoms, such as bone pain from cancer that has spread to the bone.","NUMBER",true,"1","EFS_MONTHS","nbl_broad_2013"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","nbl_broad_2013"
"Frameshift Deletion","Frameshift Deletion","STRING",false,"1","FRAMESHIFT_DELETION","nbl_broad_2013"
"Frameshift Insertion","Frameshift Insertion","STRING",false,"1","FRAMESHIFT_INSERTION","nbl_broad_2013"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","nbl_broad_2013"
"Hyper-diploid","Hyper-diploid.","STRING",false,"1","HYPERDIPLOID","nbl_broad_2013"
"Insertion And Deletion","Insertion And Deletion","NUMBER",false,"1","INDEL","nbl_broad_2013"
"In frame Deletion","In frame Deletion","STRING",false,"1","IN_FRAME_DELETION","nbl_broad_2013"
"In frame Insertion","In frame Insertion","STRING",false,"1","IN_FRAME_INSERTION","nbl_broad_2013"
"Missense Mutations","Missense Mutations","NUMBER",false,"1","MISSENSE_MUTATIONS","nbl_broad_2013"
"MKI","MKI.","STRING",false,"1","MKI","nbl_broad_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nbl_broad_2013"
"MYCN Amplification","MYCN Amplification","STRING",false,"1","MYCN_AMP","nbl_broad_2013"
"Nonsense Mutations","Nonsense Mutations","STRING",false,"1","NONSENSE_MUTATION","nbl_broad_2013"
"Nonstop Mutations","Nonstop Mutations","STRING",false,"1","NONSTOP_MUTATION","nbl_broad_2013"
"Total Number of Nonsilent Mutation","Total Number of Nonsilent Mutation","NUMBER",false,"1","NUM_NONSILENT_MUTATION","nbl_broad_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nbl_broad_2013"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","nbl_broad_2013"
"Platform","Platform.","STRING",false,"1","PLATFORM","nbl_broad_2013"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","nbl_broad_2013"
"Sex","Sex","STRING",true,"1","SEX","nbl_broad_2013"
"Silent Mutations","Silent Mutations","STRING",false,"1","SILENT_MUTATION","nbl_broad_2013"
"Silent per Mb","Silent per Mb","STRING",false,"1","SILENT_PER_MB","nbl_broad_2013"
"Splice Site","Splice Site","STRING",false,"1","SPLICE_SITE","nbl_broad_2013"
"Splice Site Insertion","Splice Site Insertion","STRING",false,"1","SPLICE_SITE_INSERTION","nbl_broad_2013"
"Splice Site SNP","Splice Site SNP","STRING",false,"1","SPLICE_SITE_SNP","nbl_broad_2013"
"Substitution","Substitution Mutations","STRING",false,"1","SUBSTITUTION","nbl_broad_2013"
"target id","target id","STRING",false,"1","TARGET_ID","nbl_broad_2013"
"TOTAL PER Mb","TOTAL PER Mb","STRING",false,"1","TOTAL_PER_MB","nbl_broad_2013"
"10q-","10q-","STRING",false,"1","VAR_10Q_NEG","nbl_broad_2013"
"11q-","11q-","STRING",false,"1","VAR_11Q_NEG","nbl_broad_2013"
"12p+","12p+","STRING",false,"1","VAR_12P_POS","nbl_broad_2013"
"14q-","14q-","STRING",false,"1","VAR_14Q_NEG","nbl_broad_2013"
"17q+","17q+","STRING",false,"1","VAR_17Q_POS","nbl_broad_2013"
"1p-","1p-","STRING",false,"1","VAR_1P_NEG","nbl_broad_2013"
"1q+","1q+","STRING",false,"1","VAR_1Q_POS","nbl_broad_2013"
"2p+","2p+","STRING",false,"1","VAR_2P_POS","nbl_broad_2013"
"3p-","3p-","STRING",false,"1","VAR_3P_NEG","nbl_broad_2013"
"4p-","4p-","STRING",false,"1","VAR_4P_NEG","nbl_broad_2013"
"6q-","6q-","STRING",false,"1","VAR_6Q_NEG","nbl_broad_2013"
"7q+","7q+","STRING",false,"1","VAR_7Q_POS","nbl_broad_2013"
"9p-","9p-","STRING",false,"1","VAR_9P_NEG","nbl_broad_2013"
"Year","Year","NUMBER",true,"1","YEAR","nbl_broad_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","nbl_target_2018_pub"
"Diagnosis Age (days)","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE_IN_DAYS","nbl_target_2018_pub"
"Analysis Cohort","Analysis Cohort","STRING",false,"1","ANALYSIS_COHORT","nbl_target_2018_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nbl_target_2018_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nbl_target_2018_pub"
"CNS Site of Relapse","CNS Site of Relapse","STRING",false,"1","CNS_SITE_OF_RELAPSE","nbl_target_2018_pub"
"Diagnosis","Diagnosis.","STRING",true,"1","DIAGNOSIS","nbl_target_2018_pub"
"EFS-CENS","Event Free Survival Censored","STRING",true,"1","EFSCENS","nbl_target_2018_pub"
"EFS Time","EFS time.","STRING",true,"1","EFS_TIME","nbl_target_2018_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","nbl_target_2018_pub"
"First Event","First Event","STRING",true,"1","FIRST_EVENT","nbl_target_2018_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","nbl_target_2018_pub"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","nbl_target_2018_pub"
"ICDO","ICDO.","STRING",true,"1","ICDO","nbl_target_2018_pub"
"ICDO Snomed Description","ICDO snomed description.","STRING",true,"1","ICDO_SNOMED_DESCRIPTION","nbl_target_2018_pub"
"INSS Stage","Staging according to the International Neuroblastoma Staging System","STRING",true,"1","INSS_STAGE","nbl_target_2018_pub"
"Year of Last Followup","Year of Last Followup","STRING",true,"1","LAST_FOLLOWUP_YEAR","nbl_target_2018_pub"
"MKI","MKI.","STRING",false,"1","MKI","nbl_target_2018_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nbl_target_2018_pub"
"MYCN","MYCN.","STRING",false,"1","MYCN","nbl_target_2018_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nbl_target_2018_pub"
"Overall Survival Days","Overall patient survival days","NUMBER",true,"1","OS_DAYS","nbl_target_2018_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","nbl_target_2018_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","nbl_target_2018_pub"
"Percent Necrosis","Percent necrosis.","STRING",true,"1","PERCENTAGE_NECROSIS","nbl_target_2018_pub"
"Percent Tumor Purity","Percent tumor purity.","STRING",true,"1","PERCENTAGE_TUMOR_PURITY","nbl_target_2018_pub"
"Percent Tumor Cells from patient's relapse biopsy","Numeric value to represent the percentage of malignant cell tumor nuclei content in a tumor sample or specimen obtained at relapse stage","STRING",true,"1","PERCENT_TUMOR_CELLS_RELAPSE","nbl_target_2018_pub"
"Percent Tumor Vs. Stroma","Numeric representation of the ratio of tumor to stroma.","STRING",true,"1","PERCENT_TUMOR_VS_STROMA","nbl_target_2018_pub"
"Ploidy","Ploidy.","STRING",false,"1","PLOIDY","nbl_target_2018_pub"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","nbl_target_2018_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","nbl_target_2018_pub"
"Relapse Percent Necrosis","Numeric value to represent the percentage of cell death in a malignant tumor sample or specimen for the first relapse tissue.","NUMBER",true,"1","RELAPSE_PERCENT_NECROSIS","nbl_target_2018_pub"
"Relapse Percent Tumor Vs Stroma","Numeric representation of the percent of tumor versus stroma for first relapse sample.","STRING",true,"1","RELAPSE_PERCENT_STROMA","nbl_target_2018_pub"
"Risk Group","Risk group.","STRING",true,"1","RISK_GROUP","nbl_target_2018_pub"
"SCENS","SCENS.","STRING",true,"1","SCENS","nbl_target_2018_pub"
"Sex","Sex","STRING",true,"1","SEX","nbl_target_2018_pub"
"SNOMED","SNOMED","STRING",true,"1","SNOMED","nbl_target_2018_pub"
"STIME","STIME.","STRING",true,"1","STIME","nbl_target_2018_pub"
"Tumor Ploidy","Tumor Ploidy","STRING",false,"1","TUMOR_PLOIDY","nbl_target_2018_pub"
"Tumor Sample Histology","Tumor Sample Histology","STRING",true,"1","TUMOR_SAMPLE_HISTOLOGY","nbl_target_2018_pub"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","nbl_target_2018_pub"
"Year of Diagnosis","Year of Diagnosis","NUMBER",true,"1","YEAR_OF_DIAGNOSIS","nbl_target_2018_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","nbl_ucologne_2015"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","nbl_ucologne_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nbl_ucologne_2015"
"mean target coverage normal","mean target coverage normal","STRING",false,"1","MEAN_TARGET_COVERAGE_NORMAL","nbl_ucologne_2015"
"mean target coverage tumor","mean target coverage tumor","STRING",false,"1","MEAN_TARGET_COVERAGE_TUMOR","nbl_ucologne_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nbl_ucologne_2015"
"MYCN Amplification","MYCN Amplification","STRING",false,"1","MYCN_AMP","nbl_ucologne_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nbl_ucologne_2015"
"Ploidy","Ploidy.","NUMBER",false,"1","PLOIDY","nbl_ucologne_2015"
"Purity","Purity","NUMBER",false,"1","PURITY","nbl_ucologne_2015"
"Risk Group","Risk group.","STRING",true,"1","RISK_GROUP","nbl_ucologne_2015"
"Stage","Stage","STRING",true,"1","STAGE","nbl_ucologne_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","nccrcc_genentech_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nccrcc_genentech_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nccrcc_genentech_2014"
"Cohort","Cohort.","STRING",true,"1","COHORT","nccrcc_genentech_2014"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","nccrcc_genentech_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nccrcc_genentech_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nccrcc_genentech_2014"
"Sex","Sex","STRING",true,"1","SEX","nccrcc_genentech_2014"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","nccrcc_genentech_2014"
"tumor content","tumor content","NUMBER",false,"1","TUMOR_CONTENT","nccrcc_genentech_2014"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","nccrcc_genentech_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nepc_wcm_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nepc_wcm_2016"
"CLONET Purity","CLONET Purity","NUMBER",false,"1","CLONET_PURITY","nepc_wcm_2016"
"Control Site","Control Site","STRING",false,"1","CONTROL_SITE","nepc_wcm_2016"
"Disease code","Disease code","STRING",false,"1","DISEASE_CODE","nepc_wcm_2016"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","nepc_wcm_2016"
"Genomic Burden","Genomic Burden","STRING",false,"1","GENOMIC_BURDEN","nepc_wcm_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nepc_wcm_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nepc_wcm_2016"
"Other Sample ID","Other sample identifier","STRING",false,"1","OTHER_SAMPLE_ID","nepc_wcm_2016"
"Pathology Classification","Pathology Classification","STRING",false,"1","PATHOLOGY_CLASSIFICATION","nepc_wcm_2016"
"Ploidy","Ploidy.","NUMBER",false,"1","PLOIDY","nepc_wcm_2016"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","nepc_wcm_2016"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","nhl_bcgsc_2011"
"BCL2 Break Apart","BCL2 Break Apart","STRING",true,"1","BCL2_BA","nhl_bcgsc_2011"
"BCL6 Break Apart","BCL6 Break Apart","STRING",true,"1","BCL6_BA","nhl_bcgsc_2011"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nhl_bcgsc_2011"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nhl_bcgsc_2011"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","nhl_bcgsc_2011"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","nhl_bcgsc_2011"
"Disease Stage","Disease Stage","STRING",false,"1","DISEASE_STAGE","nhl_bcgsc_2011"
"IPI","International Prognostic Index (IPI)","STRING",true,"1","IPI","nhl_bcgsc_2011"
"Laboratory Procedure Lactate Dehydrogenase Result","Information related to the result of the medical procedure that involves testing a sample of blood for lactic dehydrogenase, a family of homotetrameric cytoplasmic enzymes involved in the conversion of L-lactate and NAD to pyruvate and NADH in the final step of anaerobic glycolysis.","STRING",false,"1","LDH_LEVEL","nhl_bcgsc_2011"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nhl_bcgsc_2011"
"Myc ba","Myc ba","STRING",true,"1","MYC_BA","nhl_bcgsc_2011"
"Number of Extranodal Sites of Disease","Number of Extranodal Sites of Disease","STRING",true,"1","NUM_EXTRANODAL_SITES","nhl_bcgsc_2011"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nhl_bcgsc_2011"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","nhl_bcgsc_2011"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","nhl_bcgsc_2011"
"Performance status","Performance status","STRING",true,"1","PERFORMANCE_STATUS","nhl_bcgsc_2011"
"Sex","Sex","STRING",true,"1","SEX","nhl_bcgsc_2011"
"Site","Site","STRING",true,"1","SITE","nhl_bcgsc_2011"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","nhl_bcgsc_2011"
"Treatment Details","Treatment Details","STRING",true,"1","TREATMENT_DETAILS","nhl_bcgsc_2011"
"Cllularity based on allele frequency","Cllularity based on allele frequency","NUMBER",false,"1","ALLELE_FREQUENCY_CELLULARITY","nhl_bcgsc_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nhl_bcgsc_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nhl_bcgsc_2013"
"Estimated Tumor Cellularity","Estimated tumor cellularity.","STRING",false,"1","EST_TUMOR_CELLULARITY","nhl_bcgsc_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nhl_bcgsc_2013"
"Normal Genome Coverage","Normal Genome Coverage","NUMBER",false,"1","NORMAL_GENOME_COVERAGE","nhl_bcgsc_2013"
"Normal Genome Library","Normal Genome Library","STRING",false,"1","NORMAL_GENOME_LIBRARY","nhl_bcgsc_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nhl_bcgsc_2013"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"9","SAMPLE_CLASS","nhl_bcgsc_2013"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","nhl_bcgsc_2013"
"Tumor Genome Coverage","Tumor Genome Coverage","NUMBER",false,"1","TUMOR_GENOME_COVERAGE","nhl_bcgsc_2013"
"Tumor Genome Library","Tumor Genome Library","STRING",false,"1","TUMOR_GENOME_LIBRARY","nhl_bcgsc_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","npc_nusingapore"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","npc_nusingapore"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","npc_nusingapore"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","npc_nusingapore"
"COPY_NUMBER_OF_CIRCULATING_EBV_GENOME","COPY_NUMBER_OF_CIRCULATING_EBV_GENOME","NUMBER",true,"1","COPY_NUMBER_OF_CIRCULATING_EBV_GENOME","npc_nusingapore"
"FOLLOW_UP_TIME","FOLLOW_UP_TIME","NUMBER",true,"1","FOLLOW_UP_TIME","npc_nusingapore"
"Metastasis","Metastasis.","STRING",true,"1","METASTASIS","npc_nusingapore"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","npc_nusingapore"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","npc_nusingapore"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","npc_nusingapore"
"Primary Tumor Size","Primary Tumor Size","STRING",false,"1","PRIMARY_TUMOR_SIZE","npc_nusingapore"
"Regional Lymph Node","Regional Lymph Node","STRING",false,"1","REGIONAL_LYMPH_NODE","npc_nusingapore"
"Sex","Sex","STRING",true,"1","SEX","npc_nusingapore"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","npc_nusingapore"
"Tumor cellularity dominant clone vaf","Tumor cellularity dominant clone vaf","STRING",false,"1","TUMOR_CELLULARITY_DOMINANT_CLONE_VAF","npc_nusingapore"
"Tumor cellularity dominant pathology review","Tumor cellularity dominant pathology review","STRING",false,"1","TUMOR_CELLULARITY_PATHOLOGY_REVIEW","npc_nusingapore"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"0","AGE","nsclc_pd1_msk_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nsclc_pd1_msk_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nsclc_pd1_msk_2018"
"Durable Clinical Benefit","Durable Clinical Benefit","STRING",true,"1","DURABLE_CLINICAL_BENEFIT","nsclc_pd1_msk_2018"
"FGA","FGA","NUMBER",false,"1","FGA","nsclc_pd1_msk_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","nsclc_pd1_msk_2018"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","nsclc_pd1_msk_2018"
"IRB","IRB","STRING",true,"1","IRB","nsclc_pd1_msk_2018"
"Lines of treatment","Lines of treatment","STRING",true,"1","LINES_OF_TX","nsclc_pd1_msk_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nsclc_pd1_msk_2018"
"Mutation Rate","Mutation Rate","NUMBER",false,"1","MUTATION_RATE","nsclc_pd1_msk_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nsclc_pd1_msk_2018"
"PD-L1 Score (%)","PD-L1 Score in percent","NUMBER",false,"1","PDL1_SCORE","nsclc_pd1_msk_2018"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","nsclc_pd1_msk_2018"
"Progression Free Status","Progression Free Status","STRING",true,"1","PFS_STATUS","nsclc_pd1_msk_2018"
"Sex","Sex","STRING",true,"1","SEX","nsclc_pd1_msk_2018"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","nsclc_pd1_msk_2018"
"Treatment Type","Treatment Type","STRING",true,"1","TREATMENT_TYPE","nsclc_pd1_msk_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","nsclc_tcga_broad_2016"
"Age At Surgery","Age at surgery.","NUMBER",true,"1","AGE_AT_SURGERY","nsclc_tcga_broad_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nsclc_tcga_broad_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nsclc_tcga_broad_2016"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","nsclc_tcga_broad_2016"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","nsclc_tcga_broad_2016"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","nsclc_tcga_broad_2016"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","nsclc_tcga_broad_2016"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","nsclc_tcga_broad_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nsclc_tcga_broad_2016"
"M Stage","M Stage","STRING",true,"1","M_STAGE","nsclc_tcga_broad_2016"
"N Stage","N Stage","STRING",true,"1","N_STAGE","nsclc_tcga_broad_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nsclc_tcga_broad_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","nsclc_tcga_broad_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","nsclc_tcga_broad_2016"
"Sex","Sex","STRING",true,"1","SEX","nsclc_tcga_broad_2016"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","nsclc_tcga_broad_2016"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","nsclc_tcga_broad_2016"
"Stage","Stage","STRING",true,"1","STAGE","nsclc_tcga_broad_2016"
"T Stage","T Stage","STRING",false,"1","T_STAGE","nsclc_tcga_broad_2016"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","nsclc_tcga_broad_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","nsclc_unito_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","nsclc_unito_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","nsclc_unito_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","nsclc_unito_2016"
"1p/19q status based on IMPACT","1p/19q status based on IMPACT","STRING",false,"1","1P19Q_IMPACT","odg_msk_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","odg_msk_2017"
"Best RANO Response","Best Response Assessment in Neuro-Oncology Criteria (RANO) Response","STRING",true,"1","BEST_RANO_RESPONSE","odg_msk_2017"
"Cancer Type","Disease type","STRING",false,"5","CANCER_TYPE","odg_msk_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"5","CANCER_TYPE_DETAILED","odg_msk_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","odg_msk_2017"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","odg_msk_2017"
"IDH-1P10Q Subtype","IDH-1P10Q subtype.","STRING",false,"1","IDH_1P19Q_SUBTYPE","odg_msk_2017"
"Institute Source","Institute Source","STRING",false,"1","INSTITUTE","odg_msk_2017"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","odg_msk_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","odg_msk_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","odg_msk_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","odg_msk_2017"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","odg_msk_2017"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","odg_msk_2017"
"Progression Free Status","Progression Free Status","STRING",true,"1","PFS_STATUS","odg_msk_2017"
"Radiation Therapy","Radiation therapy description","STRING",true,"1","RADIATION_THERAPY","odg_msk_2017"
"Sex","Sex","STRING",true,"1","SEX","odg_msk_2017"
"Treatment at msk","Treatment at msk","STRING",true,"1","TREATMENT_AT_MSK","odg_msk_2017"
"Year of Diagnosis","Year of Diagnosis","NUMBER",true,"1","YEAR_OF_DIAGNOSIS","odg_msk_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ov_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","ov_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","ov_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","ov_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ov_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","ov_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","ov_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","ov_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","ov_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","ov_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","ov_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","ov_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","ov_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","ov_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","ov_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","ov_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","ov_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","ov_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","ov_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","ov_tcga"
"Performance Status","The functional level of the patient based on the Zubrod performance scale.","NUMBER",true,"1","ECOG_SCORE","ov_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","ov_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","ov_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","ov_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ov_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","ov_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","ov_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","ov_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","ov_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","ov_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","ov_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","ov_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","ov_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","ov_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","ov_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","ov_tcga"
"Patient Jewish Heritage Text Category","Text names for Jewish heritage categories for a patient/participant on a clinical trial.","STRING",true,"1","JEWISH_RELIGION_HERITAGE_INDICATOR","ov_tcga"
"Karnofsky Performance Score","Score from the Karnofsky Performance status scale, representing the functional capabilities of a person.","NUMBER",true,"1","KARNOFSKY_PERFORMANCE_SCORE","ov_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","ov_tcga"
"Lymphovascular invasion indicator","Lymphovascular invasion indicator","STRING",true,"1","LYMPHOVASCULAR_INVASION_INDICATOR","ov_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","ov_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","ov_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","ov_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ov_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ov_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","ov_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","ov_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","ov_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","ov_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","ov_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","ov_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","ov_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","ov_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","ov_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","ov_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","ov_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","ov_tcga"
"Performance Status Assessment Timepoint Category","A timepoint in reference to a patient's therapy in which a performance status assessment is conducted.","STRING",true,"1","PERFORMANCE_STATUS_TIMING","ov_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","ov_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","ov_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","ov_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","ov_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","ov_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","ov_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","ov_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","ov_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","ov_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","ov_tcga"
"Sex","Sex","STRING",true,"1","SEX","ov_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","ov_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","ov_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","ov_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","ov_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","ov_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","ov_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","ov_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","ov_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","ov_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","ov_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","ov_tcga"
"Vascular invasion indicator","Vascular invasion indicator","STRING",true,"1","VASCULAR_INVASION_INDICATOR","ov_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","ov_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","ov_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ov_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","ov_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","ov_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","ov_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ov_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","ov_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ov_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","ov_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","ov_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","ov_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","ov_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","ov_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","ov_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ov_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","ov_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ov_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","ov_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","ov_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","ov_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","ov_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","ov_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","ov_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ov_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ov_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ov_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","ov_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","ov_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","ov_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","ov_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","ov_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","ov_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","ov_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","ov_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","ov_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","ov_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","ov_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","ov_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","ov_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","ov_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","ov_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","ov_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","ov_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","ov_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","ov_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","ov_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","ov_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","ov_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","ov_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","ov_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","ov_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","ov_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","ov_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","ov_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","ov_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","ov_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","ov_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","ov_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","ov_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","ov_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","ov_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","ov_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","ov_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","ov_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","ov_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","ov_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","ov_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","ov_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","ov_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","ov_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","ov_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","ov_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","ov_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","ov_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","ov_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","ov_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","ov_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","ov_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","ov_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","ov_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","ov_tcga_pan_can_atlas_2018"
"ACGH Data","ACGH Data.","STRING",false,"1","ACGH_DATA","ov_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ov_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ov_tcga_pub"
"Complete Data","Complete data.","STRING",false,"1","COMPLETE_DATA","ov_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","ov_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","ov_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ov_tcga_pub"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ov_tcga_pub"
"MRNA Data","MRNA data.","STRING",false,"1","MRNA_DATA","ov_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ov_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ov_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","ov_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","ov_tcga_pub"
"Platinum Status","Platinum status.","STRING",true,"1","PLATINUM_STATUS","ov_tcga_pub"
"Primary Therapy Outcome Success","Primary therapy outhcome success.","STRING",true,"1","PRIMARY_THERAPY_OUTCOME_SUCCESS","ov_tcga_pub"
"Sequenced","Sequenced.","STRING",false,"1","SEQUENCED","ov_tcga_pub"
"Tumor Residual Disease","Tumor residual disease.","STRING",false,"1","TUMOR_RESIDUAL_DISEASE","ov_tcga_pub"
"Tumor Stage 2009","Tumor stage 2009.","STRING",false,"1","TUMOR_STAGE_2009","ov_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","paac_jhu_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","paac_jhu_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","paac_jhu_2014"
"Diagnosis","Diagnosis.","STRING",true,"1","DIAGNOSIS","paac_jhu_2014"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","paac_jhu_2014"
"Immunohistochemistry","Immunohistochemistry","STRING",false,"1","IMMUNOHISTOCHEMISTRY","paac_jhu_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","paac_jhu_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","paac_jhu_2014"
"Sex","Sex","STRING",true,"1","SEX","paac_jhu_2014"
"Stage","Stage","STRING",true,"1","STAGE","paac_jhu_2014"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","paad_icgc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","paad_icgc"
"Cellularity","Tumor Content","STRING",true,"1","CELLULARITY","paad_icgc"
"Estimated Tumor Cellularity","Estimated tumor cellularity.","STRING",false,"1","EST_TUMOR_CELLULARITY","paad_icgc"
"KRAS Mutation","KRAS mutation is present.","STRING",false,"1","KRAS_MUTATION","paad_icgc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","paad_icgc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","paad_icgc"
"Sex","Sex","STRING",true,"1","SEX","paad_icgc"
"Tumor cellularity dominant pathology review","Tumor cellularity dominant pathology review","STRING",false,"1","TUMOR_CELLULARITY_PATHOLOGY_REVIEW","paad_icgc"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","paad_qcmg_uq_2016"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","paad_qcmg_uq_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","paad_qcmg_uq_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","paad_qcmg_uq_2016"
"Country","Country of procurement.","STRING",true,"1","COUNTRY","paad_qcmg_uq_2016"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","paad_qcmg_uq_2016"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","paad_qcmg_uq_2016"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","paad_qcmg_uq_2016"
"Location","Location","STRING",true,"1","LOCATION","paad_qcmg_uq_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","paad_qcmg_uq_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","paad_qcmg_uq_2016"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","paad_qcmg_uq_2016"
"Sex","Sex","STRING",true,"1","SEX","paad_qcmg_uq_2016"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","paad_qcmg_uq_2016"
"Status","Status.","STRING",true,"1","STATUS","paad_qcmg_uq_2016"
"Tumor Grade","Histologic grading criteria for adenoid cystic carcinoma (Szanto, et. al, 1984)","STRING",false,"1","TUMOR_GRADE","paad_qcmg_uq_2016"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","paad_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","paad_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","paad_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","paad_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","paad_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","paad_tcga"
"Alcohol Consumption Frequency","Alcohol Consumption Frequency","STRING",true,"1","ALCOHOL_CONSUMPTION_FREQUENCY","paad_tcga"
"Alcohol Exposure Intensity","Alcohol Exposure Intensity","STRING",true,"1","ALCOHOL_EXPOSURE_INTENSITY","paad_tcga"
"Alcohol History Documented","Alcohol History Documented","STRING",true,"1","ALCOHOL_HISTORY_DOCUMENTED","paad_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","paad_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","paad_tcga"
"Cause of death source","Source of patient death reason","STRING",true,"1","CAUSE_OF_DEATH_SOURCE","paad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","paad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","paad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","paad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","paad_tcga"
"Daily Alcohol","Daily alcohol","STRING",true,"1","DAILY_ALCOHOL","paad_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","paad_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","paad_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","paad_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","paad_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","paad_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","paad_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","paad_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","paad_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","paad_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","paad_tcga"
"Diabetes Onset Less Initial Pathologic Diagnosis Date Calculated Day Value","The number of days from the date the patient was diagnosed with cancer to the date of the patient's diagnosis of diabetes.","STRING",true,"1","DIABETES_DIAGNOSIS_DAYS_TO","paad_tcga"
"Participant Personal Medical History Diabetes Mellitus Ind-3","Participant medical history -diabetes mellitus: a metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization._A term that is used to indicate a question with permissible values of yes/no/unknown.","STRING",true,"1","DIABETES_DIAGNOSIS_INDICATOR","paad_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","paad_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","paad_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","paad_tcga"
"Family History Cancer Type","Family history cancer type.","STRING",true,"1","FAMILY_HISTORY_CANCER_TYPE","paad_tcga"
"Family History of Cancer","Family history of cancer.","STRING",true,"1","FAMILY_HISTORY_OF_CANCER","paad_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","paad_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","paad_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","paad_tcga"
"Histologic Grading System Tier Category","Term to describe the number of levels or 'tiers' in the system used to describe the cellular histologic grade in a tissue specimen.","STRING",true,"1","GRADE_TIER_SYSTEM","paad_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","paad_tcga"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","paad_tcga"
"Chronic Pancreatitis Personal Medical History Indicator","Indicator to signify whether or not the patient has a history of clinical chronic pancreatitis.","STRING",true,"1","HISTORY_CHRONIC_PANCREATITIS","paad_tcga"
"Chronic Pancreatitis Diagnosis Less Initial Pathologic Diagnosis Date Calculated Day Value","The number of days from the date the patient was diagnosed with cancer to the date of the patient's diagnosis of clinical chronic pancreatitis.","NUMBER",true,"1","HISTORY_CHRONIC_PANCREATITIS_DAYS_TO","paad_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","paad_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","paad_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","paad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","paad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","paad_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","paad_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","paad_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","paad_tcga"
"Invasive Adenocarcinoma Histology Diagnosis Indicator","Text term to indicate a histologic diagnosis of invasive adenocarcinoma in a tissue specimen.","STRING",true,"1","INVASIVE_ADENOCARCINOMA_INDICATOR","paad_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","paad_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","paad_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","paad_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","paad_tcga"
"Positive Finding Lymph Node Keratin Immunohistochemistry Staining Method Count","Numeric value to signify the count of positive lymph nodes identified through keratin immunohistochemistry (IHC) staining method,","NUMBER",true,"1","LYMPH_NODES_EXAMINED_IHC_COUNT","paad_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","paad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","paad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","paad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","paad_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","paad_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","paad_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","paad_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","paad_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","paad_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","paad_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","paad_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","paad_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","paad_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","paad_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","paad_tcga"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","paad_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","paad_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","paad_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","paad_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","paad_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","paad_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","paad_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","paad_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","paad_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","paad_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","paad_tcga"
"Sex","Sex","STRING",true,"1","SEX","paad_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","paad_tcga"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","paad_tcga"
"Started Smoking Year","The year in which the participant began smoking.","NUMBER",true,"1","SMOKING_YEAR_STARTED","paad_tcga"
"Stopped Smoking Year","The year in which the participant quit smoking.","NUMBER",true,"1","SMOKING_YEAR_STOPPED","paad_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","paad_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","paad_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","paad_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","paad_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","paad_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","paad_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","paad_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","paad_tcga"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","paad_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","paad_tcga"
"Tumor resected max dimension","Tumor resected max dimension","NUMBER",true,"1","TUMOR_RESECTED_MAX_DIMENSION","paad_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","paad_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","paad_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","paad_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","paad_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","paad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","paad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","paad_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","paad_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","paad_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","paad_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","paad_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","paad_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","paad_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","paad_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","paad_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","paad_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","paad_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","paad_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","paad_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","paad_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","paad_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","paad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","paad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","paad_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","paad_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","paad_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","paad_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","paad_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","paad_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","paad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","paad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","paad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","paad_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","paad_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","paad_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","paad_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","paad_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","paad_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","paad_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","paad_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","paad_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","paad_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","paad_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","paad_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","paad_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","paad_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","paad_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","paad_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","paad_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","paad_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","paad_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","paad_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","paad_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","paad_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","paad_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","paad_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","paad_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","paad_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","paad_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","paad_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","paad_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","paad_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","paad_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","paad_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","paad_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","paad_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","paad_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","paad_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","paad_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","paad_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","paad_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","paad_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","paad_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","paad_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","paad_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","paad_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","paad_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","paad_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","paad_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","paad_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","paad_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","paad_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","paad_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","paad_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"0","AGE","paad_utsw_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","paad_utsw_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","paad_utsw_2015"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","paad_utsw_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","paad_utsw_2015"
"Nodal Status","Nodal Status","STRING",false,"1","NODAL_STATUS","paad_utsw_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","paad_utsw_2015"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","paad_utsw_2015"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","paad_utsw_2015"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","paad_utsw_2015"
"Sex","Sex","STRING",true,"1","SEX","paad_utsw_2015"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","paad_utsw_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","pact_jhu_2011"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","pact_jhu_2011"
"Cyst Size (cm)","Cyst Size (cm)","NUMBER",false,"1","CYST_SIZE","pact_jhu_2011"
"Dysplasia","Dysplasia","STRING",false,"1","DYSPLASIA","pact_jhu_2011"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options","STRING",true,"1","HISTOLOGICAL_SUBTYPE","pact_jhu_2011"
"Location","Location","STRING",true,"1","LOCATION","pact_jhu_2011"
"Main vs. Branch Duct","Main vs Branch Duct","STRING",false,"1","MAIN_VS_BRANCH_DUCT","pact_jhu_2011"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","pact_jhu_2011"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","pact_jhu_2011"
"Relevant Medical History","Relevant Medical History","STRING",true,"1","RELEVANT_MEDICAL_HISTORY","pact_jhu_2011"
"SCA Type","Serous Cystadenomas (SCAs)","STRING",false,"1","SCA_TYPE","pact_jhu_2011"
"Sex","Sex","STRING",true,"1","SEX","pact_jhu_2011"
"Smoker","Indicates if person is a smoker","STRING",true,"1","SMOKER","pact_jhu_2011"
"Tumor focality","Primary neoplasm focus type","STRING",true,"1","TUMOR_FOCALITY","pact_jhu_2011"
"Type of Surgery","Type of Surgery","STRING",false,"1","TYPE_OF_SURGERY","pact_jhu_2011"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","panet_arcnet_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","panet_arcnet_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","panet_arcnet_2017"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","panet_arcnet_2017"
"Country","Country of procurement.","STRING",true,"1","COUNTRY","panet_arcnet_2017"
"Drinker","Drinker.","STRING",true,"1","DRINKER","panet_arcnet_2017"
"ENETS Staging","ENETS Staging","STRING",false,"1","ENETS_STAGING","panet_arcnet_2017"
"ENETS T-Staging","ENETS T-Staging","STRING",false,"1","ENETS_T_STAGING","panet_arcnet_2017"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","panet_arcnet_2017"
"Extra-Panc Spread","Extra-Panc Spread","STRING",false,"1","EXTRA_PANC_SPREAD","panet_arcnet_2017"
"Familial Syndrome","Familial Syndrome","STRING",true,"1","FAMILIAL_SYNDROME","panet_arcnet_2017"
"Functional","Functional","STRING",false,"1","FUNCTIONAL","panet_arcnet_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","panet_arcnet_2017"
"M Stage","M Stage","STRING",true,"1","M_STAGE","panet_arcnet_2017"
"N Stage","N Stage","STRING",true,"1","N_STAGE","panet_arcnet_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","panet_arcnet_2017"
"Overall survival in months since initial diagonosis.","Overall Survival (Months)","NUMBER",true,"1","OS_MONTHS","panet_arcnet_2017"
"Overall patient survival status.","Overall Survival Status","STRING",true,"1","OS_STATUS","panet_arcnet_2017"
"Overall Patient Histology","Overall Patient Histology","STRING",true,"1","OVERALL_PATIENT_HISTOLOGY","panet_arcnet_2017"
"Perineural Invasion","Perineural invasion.","STRING",false,"1","PERINEURAL_INVASION","panet_arcnet_2017"
"Personal History","Personal History","STRING",true,"1","PERSONAL_HISTORY","panet_arcnet_2017"
"Sex","Sex","STRING",true,"1","SEX","panet_arcnet_2017"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","panet_arcnet_2017"
"Surgical Margin","Surgical Margin","STRING",true,"1","SURGICAL_MARGIN","panet_arcnet_2017"
"Time to Last Followup","Time to last followup.","NUMBER",true,"1","TIME_TO_LAST_FOLLOWUP","panet_arcnet_2017"
"Tumor Size","Tumor size.","STRING",false,"1","TUMOR_SIZE","panet_arcnet_2017"
"T Stage","T Stage","STRING",false,"1","T_STAGE","panet_arcnet_2017"
"Vascular Invasion","Vascular invasion.","STRING",false,"1","VASCULAR_INVASION","panet_arcnet_2017"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","panet_arcnet_2017"
"WHO Grade","WHO Grade","STRING",false,"1","WHO_GRADE","panet_arcnet_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","panet_jhu_2011"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","panet_jhu_2011"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","panet_jhu_2011"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","panet_jhu_2011"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","panet_jhu_2011"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","panet_jhu_2011"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","panet_jhu_2011"
"Sex","Sex","STRING",true,"1","SEX","panet_jhu_2011"
"Tissue Sequenced","Tissue Sequnced","STRING",false,"1","TISSUE_SEQUENCED","panet_jhu_2011"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","panet_jhu_2011"
"Age At Surgery","Age at surgery.","NUMBER",true,"1","AGE_AT_SURGERY","panet_shanghai_2013"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","panet_shanghai_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","panet_shanghai_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","panet_shanghai_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","panet_shanghai_2013"
"Pathological Diagnosis","Pathological Diagnosis","STRING",true,"1","PATHOLOGICAL_DIAGNOSIS","panet_shanghai_2013"
"Sex","Sex","STRING",true,"1","SEX","panet_shanghai_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","past_dkfz_heidelberg_2013"
"Braf Status","Braf Status","STRING",false,"1","BRAF_STATUS","past_dkfz_heidelberg_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","past_dkfz_heidelberg_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","past_dkfz_heidelberg_2013"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","past_dkfz_heidelberg_2013"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","past_dkfz_heidelberg_2013"
"FGFR1 Mutation","FGFR1 Mutation","STRING",false,"1","FGFR1_MUTATION","past_dkfz_heidelberg_2013"
"KRAS Mutation","KRAS mutation is present.","STRING",false,"1","KRAS_MUTATION","past_dkfz_heidelberg_2013"
"MAPK Pathway Alteration","MAPK Pathway Alteration","STRING",false,"1","MAPK_PATHWAY_ALTERATION","past_dkfz_heidelberg_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","past_dkfz_heidelberg_2013"
"NF1 Mutation","NF1 Mutation","STRING",false,"1","NF1_MUTATION","past_dkfz_heidelberg_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","past_dkfz_heidelberg_2013"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","past_dkfz_heidelberg_2013"
"PTPN11 Mutation","PTPN1 Mutation","STRING",false,"1","PTPN11_MUTATION","past_dkfz_heidelberg_2013"
"Radicality Of Surgery","Radicality of Surgery: GTR = Gross Total Resection, STR = Sub-Total Resection","STRING",false,"1","RADICALITY","past_dkfz_heidelberg_2013"
"Sex","Sex","STRING",true,"1","SEX","past_dkfz_heidelberg_2013"
"Tumor Location","Tumor Location","STRING",false,"1","TUMOR_LOCATION","past_dkfz_heidelberg_2013"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","past_dkfz_heidelberg_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","pcnsl_mayo_2015"
"Cancer Type","Cancer Type","STRING",false,"2","CANCER_TYPE","pcnsl_mayo_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"3","CANCER_TYPE_DETAILED","pcnsl_mayo_2015"
"Diagnosis","Diagnosis.","STRING",true,"1","DIAGNOSIS","pcnsl_mayo_2015"
"First Presenting Symptom","First presenting symptom.","STRING",true,"1","FIRST_PRESENTING_SYMPTOM","pcnsl_mayo_2015"
"Imaging","Imaging","STRING",true,"1","IMAGING","pcnsl_mayo_2015"
"Initial Rx","Initial Rx","STRING",true,"1","INITIAL_RX","pcnsl_mayo_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","pcnsl_mayo_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","pcnsl_mayo_2015"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","pcnsl_mayo_2015"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","pcnsl_mayo_2015"
"Sex","Sex","STRING",true,"1","SEX","pcnsl_mayo_2015"
"Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING",false,"1","SPECIMEN_PRESERVATION_TYPE","pcnsl_mayo_2015"
"Specimen Site","Specimen Site","STRING",false,"1","SPECIMEN_SITE","pcnsl_mayo_2015"
"Subsequent Rx","Subsequent Rx","STRING",true,"1","SUBSEQUENT_RX","pcnsl_mayo_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","pcpg_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","pcpg_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","pcpg_tcga"
"Ct scan preop results","Diagnostic ct result outcome","STRING",true,"1","CT_SCAN_PREOP_RESULTS","pcpg_tcga"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","pcpg_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","pcpg_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","pcpg_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","pcpg_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","pcpg_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","pcpg_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","pcpg_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","pcpg_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","pcpg_tcga"
"Screening Diagnosis Disease Detection Indicator","Indicator to signify whether or not the disease was detected by screening.","STRING",true,"1","DISEASE_DETECTED_ON_SCREENING","pcpg_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","pcpg_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","pcpg_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","pcpg_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","pcpg_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","pcpg_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","pcpg_tcga"
"Prior History Pheochromocytoma Or Paraganglioma Anatomic Site Text","Text field to describe the anatomic site of the prior pheochromocytoma or paraganglioma.","STRING",true,"1","HISTORY_PHEO_OR_PARA_ANATOMIC_SITE","pcpg_tcga"
"Patient History Pheochromocytoma Or Paraganglioma Indicator","Indicator to signify whether or not a patient has a history of pheochromocytoma or paraganglioma.","STRING",true,"1","HISTORY_PHEO_OR_PARA_INCLUDE_BENIGN","pcpg_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","pcpg_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","pcpg_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","pcpg_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","pcpg_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","pcpg_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","pcpg_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","pcpg_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","pcpg_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","pcpg_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","pcpg_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","pcpg_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","pcpg_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","pcpg_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","pcpg_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","pcpg_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","pcpg_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","pcpg_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","pcpg_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","pcpg_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","pcpg_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","pcpg_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","pcpg_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","pcpg_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","pcpg_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","pcpg_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","pcpg_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","pcpg_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","pcpg_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","pcpg_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","pcpg_tcga"
"Tumor Specimen Outside Adrenal Gland Quantity Description Type","Text term to describe any tumor related to the specimen that is outside of the adrenal glands.","STRING",true,"1","RELATED_TUMORS_OUTSIDE_ADRENAL_GLANDS","pcpg_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","pcpg_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","pcpg_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","pcpg_tcga"
"Sex","Sex","STRING",true,"1","SEX","pcpg_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","pcpg_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","pcpg_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","pcpg_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","pcpg_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","pcpg_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","pcpg_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","pcpg_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","pcpg_tcga"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","pcpg_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","pcpg_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","pcpg_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","pcpg_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","pcpg_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","pcpg_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","pcpg_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","pcpg_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","pcpg_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","pcpg_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","pcpg_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","pcpg_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","pcpg_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","pcpg_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","pcpg_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","pcpg_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","pcpg_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","pcpg_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","pcpg_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","pcpg_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","pcpg_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","pcpg_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","pcpg_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","pcpg_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","pcpg_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","pcpg_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","pcpg_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","pcpg_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","pcpg_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","pcpg_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","pcpg_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","pcpg_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","pcpg_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","pcpg_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","pcpg_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","pcpg_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","pcpg_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","pcpg_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","pcpg_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","pcpg_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","pcpg_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","pcpg_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","pcpg_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","pcpg_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","pcpg_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","pcpg_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","pcpg_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","pcpg_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","pcpg_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","pcpg_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","pcpg_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","pcpg_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","pcpg_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","pcpg_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","pcpg_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","pcpg_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","pcpg_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","pcpg_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","pcpg_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","pcpg_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","pcpg_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","pcpg_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","pcpg_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","pcpg_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","pcpg_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","pcpg_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","pcpg_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","pcpg_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","pcpg_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","pcpg_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","pcpg_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","pcpg_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","pcpg_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","pcpg_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","pcpg_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","pcpg_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","pcpg_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","pcpg_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","pcpg_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","pcpg_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","pcpg_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","pcpg_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","pcpg_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","pcpg_tcga_pan_can_atlas_2018"
"Age at which a condition or disease was first diagnosed.","Diagnosis Age","NUMBER",true,"1","AGE","pediatric_dkfz_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","pediatric_dkfz_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","pediatric_dkfz_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","pediatric_dkfz_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","pediatric_dkfz_2017"
"Ploidy.","Ploidy","NUMBER",false,"1","PLOIDY","pediatric_dkfz_2017"
"Relapse/Sequenced","Relapse/Sequenced","STRING",false,"1","RELAPSE_SEQUENCED","pediatric_dkfz_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","pediatric_dkfz_2017"
"Sequencing Type","Sequencing Type","STRING",false,"1","SEQUENCING_TYPE","pediatric_dkfz_2017"
"Sex","Sex","STRING",true,"1","SEX","pediatric_dkfz_2017"
"Subtype Details","Subtype Details","STRING",false,"1","SUBTYPE_DETAILS","pediatric_dkfz_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","plmeso_nyu_2015"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","plmeso_nyu_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","plmeso_nyu_2015"
"Cause of death source","Source of patient death reason","STRING",true,"1","CAUSE_OF_DEATH_SOURCE","plmeso_nyu_2015"
"Histology ","Histology ","STRING",true,"1","HISTOLOGY","plmeso_nyu_2015"
"History Asbestos Exposure","History Asbestos Exposure","STRING",true,"1","HISTORY_ASBESTOS_EXPOSURE","plmeso_nyu_2015"
"Lymph nodes examined positive","Number of lymphnodes positive","STRING",true,"1","LYMPH_NODES_EXAMINED_POSITIVE","plmeso_nyu_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","plmeso_nyu_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","plmeso_nyu_2015"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","plmeso_nyu_2015"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","plmeso_nyu_2015"
"Recurrence","Recurrence","STRING",true,"1","RECURRENCE","plmeso_nyu_2015"
"Sex","Sex","STRING",true,"1","SEX","plmeso_nyu_2015"
"Site of Recurrence","Site of Recurrence","STRING",false,"1","SITE_OF_RECURRENCE","plmeso_nyu_2015"
"Stage","Stage","STRING",true,"1","STAGE","plmeso_nyu_2015"
"Treatment prior to surgery","Treatment prior to surgery","STRING",true,"1","TREATMENT_PRIOR_TO_SURGERY_INDICATOR","plmeso_nyu_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_broad"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_broad"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE","prad_broad"
"Gleason Score Percent 4 & 5","Gleason score percent 4 & 5.","NUMBER",false,"1","GLEASON_SCORE_PERCENT_4_AND_5","prad_broad"
"Modified Capra S Score Without Including Surgical Margins","Modified Capra S Score Without Including Surgical Margins","NUMBER",false,"1","MODIFIED_CAPRA_S_SCORE_WITHOUT_INCLUDING_SURGICAL_MARGINS","prad_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_broad"
"Serum PSA","Serum PSA.","NUMBER",true,"1","SERUM_PSA","prad_broad"
"TMPRSS2-ERG Fusion Status","TMPRESS2-ERG fusion status.","STRING",false,"1","TMPRSS2_ERG_FUSION_STATUS","prad_broad"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","prad_broad"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_broad_2013"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_broad_2013"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_broad_2013"
"Cohort","Cohort.","STRING",true,"1","COHORT","prad_broad_2013"
"ERG FISH Result","ERG Fish result.","STRING",false,"1","ERG_FISH_RESULT","prad_broad_2013"
"ETS Fusion SEQ","ETS fusion seq","STRING",false,"1","ETS_FUSION_SEQ","prad_broad_2013"
"Exome Sequenced in Barbieri et al.","Exome sequenced in Barbieri et al.","STRING",false,"1","EXOME_SEQUENCED_IN_BARBIERI_ET_AL_2012","prad_broad_2013"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_broad_2013"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE","prad_broad_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_broad_2013"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_broad_2013"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","prad_broad_2013"
"Gleason Score Percent 4 & 5","Gleason Score Percent 4 & 5.","NUMBER",true,"1","PERCENT_GLEASON_PATTERN_4_OR_5","prad_broad_2013"
"Absolute Purity","Absolute purity.","STRING",false,"1","PURITY_ABSOLUTE","prad_broad_2013"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","prad_broad_2013"
"Serum PSA","Serum PSA.","NUMBER",true,"1","SERUM_PSA","prad_broad_2013"
"WGS Based Purity Estimation","WGS based purity estimation","NUMBER",false,"1","WGS_BASED_PURITY_ESTIMATION","prad_broad_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_cpcg_2017"
"Biochemical Recurrence Indicator","Biochemical Recurrence Indicator","STRING",true,"1","BIOCHEMICAL_RECURRENCE_INDICATOR","prad_cpcg_2017"
"Bone Scan Result","Bone scan result.","STRING",true,"1","BONE_SCAN_RESULT","prad_cpcg_2017"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","prad_cpcg_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_cpcg_2017"
"Cellularity","Tumor Content","NUMBER",false,"1","CELLULARITY","prad_cpcg_2017"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","prad_cpcg_2017"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","prad_cpcg_2017"
"Cohort","Cohort.","STRING",true,"1","COHORT","prad_cpcg_2017"
"Ct scan ab pelvis indicator","Diagnostic ct abd pelvis performed","STRING",true,"1","CT_SCAN_AB_PELVIS_INDICATOR","prad_cpcg_2017"
"Ct scan ab pelvis results","Diagnostic ct abd pelvis result","STRING",true,"1","CT_SCAN_AB_PELVIS_RESULTS","prad_cpcg_2017"
"Days to biochemical recurrence first","Days to first biochemical recurrence","NUMBER",true,"1","DAYS_TO_BIOCHEMICAL_RECURRENCE_FIRST","prad_cpcg_2017"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","prad_cpcg_2017"
"Days to bone Scan performed","Days to bone Scan performed","NUMBER",true,"1","DAYS_TO_BONE_SCAN_PERFORMED","prad_cpcg_2017"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","prad_cpcg_2017"
"Days to ct scan ab pelvis","Days to diagnostic computed tomography performed","NUMBER",true,"1","DAYS_TO_CT_SCAN_AB_PELVIS","prad_cpcg_2017"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","prad_cpcg_2017"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","prad_cpcg_2017"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","prad_cpcg_2017"
"Days to mri","Days to diagnostic mri performed","NUMBER",true,"1","DAYS_TO_MRI","prad_cpcg_2017"
"Days to PSA","Days to Prostate-Specific Antigen (PSA) Test","NUMBER",true,"1","DAYS_TO_PSA","prad_cpcg_2017"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","prad_cpcg_2017"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","prad_cpcg_2017"
"Diagonstic MRI Result","Diagonostic MRI result.","STRING",true,"1","DIAGNOSTIC_MRI_RESULT","prad_cpcg_2017"
"ERG FISH Result","ERG Fish result.","STRING",false,"1","ERG_FISH_RESULT","prad_cpcg_2017"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","prad_cpcg_2017"
"ETS","ETS","STRING",false,"1","ETS","prad_cpcg_2017"
"Family History of Prostate Adenocarcinoma","Family History of Prostate Adenocarcinoma","STRING",true,"1","FAMILY_HISTORY_PRAD","prad_cpcg_2017"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","prad_cpcg_2017"
"Gleason pattern primary","Gleason pattern primary","NUMBER",true,"1","GLEASON_PATTERN_PRIMARY","prad_cpcg_2017"
"Gleason pattern secondary","Gleason pattern secondary","NUMBER",true,"1","GLEASON_PATTERN_SECONDARY","prad_cpcg_2017"
"Gleason pattern tertiary","Gleason pattern tertiary","NUMBER",true,"1","GLEASON_PATTERN_TERTIARY","prad_cpcg_2017"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE","prad_cpcg_2017"
"Gleason Score Percent 4 & 5","Gleason score percent 4 & 5.","NUMBER",false,"1","GLEASON_SCORE_PERCENT_4_AND_5","prad_cpcg_2017"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","prad_cpcg_2017"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","prad_cpcg_2017"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","prad_cpcg_2017"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","prad_cpcg_2017"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","prad_cpcg_2017"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","prad_cpcg_2017"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","prad_cpcg_2017"
"Initial pathologic diagnosis method","Initial pathologic diagnosis method","STRING",true,"1","INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD","prad_cpcg_2017"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","prad_cpcg_2017"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","INITIAL_WEIGHT","prad_cpcg_2017"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","prad_cpcg_2017"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","prad_cpcg_2017"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","prad_cpcg_2017"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","prad_cpcg_2017"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","prad_cpcg_2017"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","prad_cpcg_2017"
"Mri results","Diagnostic mri result","STRING",true,"1","MRI_RESULTS","prad_cpcg_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_cpcg_2017"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","prad_cpcg_2017"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","prad_cpcg_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_cpcg_2017"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","prad_cpcg_2017"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","prad_cpcg_2017"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","prad_cpcg_2017"
"Pathology report uuid","Pathology report uuid","STRING",true,"1","PATHOLOGY_REPORT_UUID","prad_cpcg_2017"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","prad_cpcg_2017"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","prad_cpcg_2017"
"Platform","Platform.","STRING",false,"1","PLATFORM","prad_cpcg_2017"
"Ploidy","Ploidy.","NUMBER",false,"1","PLOIDY","prad_cpcg_2017"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","prad_cpcg_2017"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","prad_cpcg_2017"
"Psa most recent results","Psa most recent results","NUMBER",true,"1","PSA_MOST_RECENT_RESULTS","prad_cpcg_2017"
"Absolute Purity","Absolute purity.","NUMBER",false,"1","PURITY_ABSOLUTE","prad_cpcg_2017"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","prad_cpcg_2017"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","prad_cpcg_2017"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","prad_cpcg_2017"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","prad_cpcg_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","prad_cpcg_2017"
"Sample type id","Sample type id","STRING",true,"1","SAMPLE_TYPE_ID","prad_cpcg_2017"
"Sex","Sex","STRING",true,"1","SEX","prad_cpcg_2017"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","prad_cpcg_2017"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","prad_cpcg_2017"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","prad_cpcg_2017"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","prad_cpcg_2017"
"Treatment","Treatment","STRING",true,"1","TREATMENT","prad_cpcg_2017"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","prad_cpcg_2017"
"Tumor Level","Tumor level.","STRING",false,"1","TUMOR_LEVEL","prad_cpcg_2017"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","prad_cpcg_2017"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","prad_cpcg_2017"
"Vial number","Vial number","STRING",true,"1","VIAL_NUMBER","prad_cpcg_2017"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","prad_cpcg_2017"
"WGS Based Purity Estimation","WGS based purity estimation","NUMBER",false,"1","WGS_BASED_PURITY_ESTIMATION","prad_cpcg_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_eururol_2017"
"Bladder Neck Invasion","Bladder neck invasion","STRING",true,"1","BLADDER_NECK_INVASION","prad_eururol_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_eururol_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_eururol_2017"
"Extraprostatic Extension","Extraprostatic extension","STRING",true,"1","EXTRAPROSTATIC_EXTENSION","prad_eururol_2017"
"FPSA/PSA","FPSA/PSA","NUMBER",true,"1","FPSA_PSA","prad_eururol_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_eururol_2017"
"Radical Prostatectomy Gleason Score for Prostate Cancer","""The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.""","STRING",true,"1","GLEASON_SCORE","prad_eururol_2017"
"Lymph Nodes Metastasis","Lymph nodes metastasis.","STRING",true,"1","LYMPH_NODE_METASTASIS","prad_eururol_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_eururol_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_eururol_2017"
"Prostate-specific antigen","Prostate-specific antigen (ng/ml)","NUMBER",true,"1","PSA","prad_eururol_2017"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","prad_eururol_2017"
"Seminal Vesicle Invasion","Seminal vesicle invasion","STRING",true,"1","SEMINAL_VESICLE_INVASION","prad_eururol_2017"
"Sex","Sex","STRING",true,"1","SEX","prad_eururol_2017"
"Stage","Stage","STRING",true,"1","TNMSTAGE","prad_eururol_2017"
"Tumor Purity","Tumor Purity","STRING",false,"1","TUMOR_PURITY","prad_eururol_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_fhcrc"
"Androgen Deprivation Therapy (ADT)","Androgen Deprivation Therapy (ADT)","STRING",true,"1","ANDROGEN_DEPRIVATION_THERAPY","prad_fhcrc"
"BLOCK ID","BLOCK ID","STRING",false,"1","BLOCK_ID","prad_fhcrc"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_fhcrc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_fhcrc"
"CGH","CGH","STRING",false,"1","CGH","prad_fhcrc"
"CGH Sample ID","CGH Sample ID","STRING",false,"1","CGH_SAMPLE_ID","prad_fhcrc"
"Chemotherapy","Chemotherapy.","STRING",true,"1","CHEMOTHERAPY","prad_fhcrc"
"Exome","Exome","STRING",false,"1","EXOME","prad_fhcrc"
"EXOME Sample ID","EXOME Sample ID","STRING",false,"1","EXOME_SAMPLE_ID","prad_fhcrc"
"EXP","EXP","STRING",false,"1","EXP","prad_fhcrc"
"EXP Sample ID","EXP Sample ID","STRING",false,"1","EXP_SAMPLE_ID","prad_fhcrc"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_fhcrc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_fhcrc"
"Number of Tumors","Number of Tumors","NUMBER",true,"1","NUMBER_OF_TUMORS","prad_fhcrc"
"NUM SAMPLES CAPTURE MULTIPLEX","NUM SAMPLES CAPTURE MULTIPLEX","STRING",false,"1","NUM_SAMPLES_CAPTURE_MULTIPLEX","prad_fhcrc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_fhcrc"
"Prostate-specific antigen","Prostate-specific antigen (ng/ml)","NUMBER",true,"1","PSA","prad_fhcrc"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","prad_fhcrc"
"SEQCAP EZ EXOME VERSION","SEQCAP EZ EXOME VERSION","STRING",false,"1","SEQCAP_EZ_EXOME_VERSION","prad_fhcrc"
"Sequenced","Sequenced.","STRING",false,"1","SEQUENCED","prad_fhcrc"
"Source Lab","Source Lab","STRING",false,"1","SOURCE_LAB","prad_fhcrc"
"Tissue Site","Tissue Site","STRING",false,"1","TISSUE_SITE","prad_fhcrc"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_mich"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_mich"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_mich"
"ETS RAF-SPINK1 Status","ETS RAF-SPINK1 status.","STRING",false,"1","ETS_RAF_SPINK1_STATUS","prad_mich"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_mich"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","prad_mich"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE","prad_mich"
"Matched GE ACGH","Matched GE acgh.","STRING",false,"1","MATCHED_GE_ACGH","prad_mich"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_mich"
"Normal location","Tissue where normal was derived.","STRING",false,"1","NORMAL_SITE","prad_mich"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_mich"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","prad_mich"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","prad_mich"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","prad_mich"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","prad_mich"
"Serum PSA","Serum PSA.","NUMBER",true,"1","SERUM_PSA","prad_mich"
"Survival from First Chemotherapy","Survival from first chemotherapy.","NUMBER",true,"1","SURVIVAL_FROM_FIRST_CHEMOTHERAPY","prad_mich"
"Survival from First Hormone Therapy","Survival from first hormone therapy","NUMBER",true,"1","SURVIVAL_FROM_FIRST_HORMONE_THERAPY","prad_mich"
"Chemotherapy","Chemotherapy.","STRING",true,"1","TREATMENT_CHEMOTHERAPY","prad_mich"
"Hormone Therapy","Hormone therapy.","STRING",true,"1","TREATMENT_HORMONE_THERAPY","prad_mich"
"Palliative Radiation","Palliative radiation.","STRING",true,"1","TREATMENT_PALLIATIVE_RADIATION","prad_mich"
"Prostatectomy","Prostatectomy.","STRING",true,"1","TREATMENT_PROSTATECTOMY","prad_mich"
"Radiation","Radiation.","STRING",true,"1","TREATMENT_RADIATION","prad_mich"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","prad_mskcc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_mskcc"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","prad_mskcc"
"CNA Data","CNA data.","STRING",false,"1","CNA_DATA","prad_mskcc"
"Complete Data","Complete data.","STRING",false,"1","COMPLETE_DATA","prad_mskcc"
"Copy Number Cluster","Copy number cluster.","STRING",true,"1","COPY_NUMBER_CLUSTER","prad_mskcc"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","prad_mskcc"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","prad_mskcc"
"ERG Fusion ACGH","ERG fusion acgh.","STRING",false,"1","ERG_FUSION_ACGH","prad_mskcc"
"ERG Fusion GEX","ERG fusion gex.","STRING",false,"1","ERG_FUSION_GEX","prad_mskcc"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_mskcc"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE","prad_mskcc"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE_1","prad_mskcc"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE_2","prad_mskcc"
"MRNA Data","MRNA data.","STRING",false,"1","MRNA_DATA","prad_mskcc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_mskcc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_mskcc"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","prad_mskcc"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","prad_mskcc"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","prad_mskcc"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","prad_mskcc"
"Sequenced","Sequenced.","STRING",false,"1","SEQUENCED","prad_mskcc"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_mskcc_2014"
"BIOPSY GLEASON SCORE","BIOPSY GLEASON SCORE","STRING",false,"1","BIOPSY_GLEASON_SCORE","prad_mskcc_2014"
"BIOPSY GLEASON SCORE 1","BIOPSY GLEASON SCORE 1","STRING",false,"1","BIOPSY_GLEASON_SCORE_1","prad_mskcc_2014"
"BIOPSY GLEASON SCORE 2","BIOPSY GLEASON SCORE 2","STRING",false,"1","BIOPSY_GLEASON_SCORE_2","prad_mskcc_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_mskcc_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_mskcc_2014"
"CHEMO_TREATMENT_ADJUVANT","CHEMO_TREATMENT_ADJUVANT","STRING",true,"1","CHEMO_TREATMENT_ADJUVANT","prad_mskcc_2014"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","prad_mskcc_2014"
"CNA","CNA","NUMBER",true,"1","CNA","prad_mskcc_2014"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","prad_mskcc_2014"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","prad_mskcc_2014"
"ECE","ECE","STRING",false,"1","ECE","prad_mskcc_2014"
"ECE Binary","ECE Binary","STRING",false,"1","ECE_BINARY","prad_mskcc_2014"
"Follow up time months","Follow up time months","NUMBER",true,"1","FOLLOW_UP_TIME_MONTHS","prad_mskcc_2014"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_mskcc_2014"
"HORM_TREATMENT_ADJUVANT","HORM_TREATMENT_ADJUVANT","STRING",true,"1","HORM_TREATMENT_ADJUVANT","prad_mskcc_2014"
"LNI","Lymph Node Invovlement","STRING",false,"1","LNI","prad_mskcc_2014"
"MetsFreeTime_Months","MetsFreeTime_Months","NUMBER",true,"1","METSFREETIME_MONTHS","prad_mskcc_2014"
"METS_STATUS","METS_STATUS","STRING",true,"1","METS_STATUS","prad_mskcc_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_mskcc_2014"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","prad_mskcc_2014"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","prad_mskcc_2014"
"PATH GLEASON SCORE","PATH GLEASON SCORE","STRING",false,"1","PATH_GLEASON_SCORE","prad_mskcc_2014"
"PATH GLEASON SCORE 1","PATH GLEASON SCORE 1","STRING",false,"1","PATH_GLEASON_SCORE_1","prad_mskcc_2014"
"PATH GLEASON SCORE 2","PATH GLEASON SCORE 2","STRING",false,"1","PATH_GLEASON_SCORE_2","prad_mskcc_2014"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","prad_mskcc_2014"
"PRE_TREATMENT_PSA","PRE_TREATMENT_PSA","STRING",true,"1","PRE_TREATMENT_PSA","prad_mskcc_2014"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","prad_mskcc_2014"
"Did patient start neoadjuvant preoperative radiotherapy?","A yes/no indicator that asks whether the patient startedneoadjuvant preoperative radiotherapy?","STRING",true,"1","RADIATION_TREATMENT_NEOADJUVANT","prad_mskcc_2014"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","prad_mskcc_2014"
"sms","sms","STRING",false,"1","SMS","prad_mskcc_2014"
"stephanson 5yr nomogram","stephanson 5yr nomogram","STRING",false,"1","STEPHANSON_5YR_NOMOGRAM","prad_mskcc_2014"
"SURGERY_TYPE","SURGERY_TYPE","STRING",true,"1","SURGERY_TYPE","prad_mskcc_2014"
"svi","svi","STRING",false,"1","SVI","prad_mskcc_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_mskcc_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_mskcc_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_mskcc_2017"
"Clinical Gleason","Clinical Gleason","NUMBER",false,"1","CLINICAL_GLEASON","prad_mskcc_2017"
"Clinical State","Clinical State","STRING",false,"1","CLINICAL_STATE","prad_mskcc_2017"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_mskcc_2017"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","prad_mskcc_2017"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","prad_mskcc_2017"
"Mutations per megabase","Mutations per megabase","NUMBER",false,"1","MUTATIONS_PER_MEGABASE","prad_mskcc_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_mskcc_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_mskcc_2017"
"Purity","Purity","NUMBER",false,"1","PURITY","prad_mskcc_2017"
"Sample coverage","Sample coverage","NUMBER",false,"1","SAMPLE_COVERAGE","prad_mskcc_2017"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","prad_mskcc_2017"
"ALB_(g/dL)","ALB_(g/dL)","NUMBER",true,"1","ALB_(G/DL)","prad_mskcc_cheny1_organoids_2014"
"alp (u/l)","alp (u/l)","STRING",false,"1","ALP_(U/L)","prad_mskcc_cheny1_organoids_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_mskcc_cheny1_organoids_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_mskcc_cheny1_organoids_2014"
"DOUBLING_TIME_DAYS","DOUBLING_TIME_DAYS","NUMBER",true,"1","DOUBLING_TIME_DAYS","prad_mskcc_cheny1_organoids_2014"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_mskcc_cheny1_organoids_2014"
"HGB_(g/dL)","HGB_(g/dL)","NUMBER",true,"1","HGB_(G/DL)","prad_mskcc_cheny1_organoids_2014"
"KPS","KPS","STRING",true,"1","KPS","prad_mskcc_cheny1_organoids_2014"
"ldh (u/l)","ldh (u/l)","STRING",false,"1","LDH_(U/L)","prad_mskcc_cheny1_organoids_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_mskcc_cheny1_organoids_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_mskcc_cheny1_organoids_2014"
"PRIOR_THERAPY","PRIOR_THERAPY","STRING",true,"1","PRIOR_THERAPY","prad_mskcc_cheny1_organoids_2014"
"PSA_(ng/dL)","PSA_(ng/dL)","STRING",true,"1","PSA_(NG/DL)","prad_mskcc_cheny1_organoids_2014"
"STUDIES","STUDIES","STRING",true,"1","STUDIES","prad_mskcc_cheny1_organoids_2014"
"Tissue Site","Tissue Site","STRING",false,"1","TISSUE_SITE","prad_mskcc_cheny1_organoids_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_p1000"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_p1000"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_p1000"
"Copy Number","Copy Number","STRING",false,"1","COPY_NUMBER","prad_p1000"
"Data Source","Data Source","STRING",true,"1","DATA_SOURCE","prad_p1000"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_p1000"
"Fusion","Fusion","STRING",false,"1","FUSION","prad_p1000"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",false,"1","GLEASON_SCORE_1","prad_p1000"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","prad_p1000"
"Mutation Burden","Mutation Burden","STRING",false,"1","MUTATION_BURDEN","prad_p1000"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_p1000"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_p1000"
"Ploidy","Ploidy.","NUMBER",false,"1","PLOIDY","prad_p1000"
"Purity","Purity","NUMBER",false,"1","PURITY","prad_p1000"
"Reviewed Gleason Category","Reviewed Gleason category","STRING",false,"1","REVIEWED_GLEASON_CATEGORY","prad_p1000"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","prad_p1000"
"Abiraterone (ABI) and Enzalutamide (ENZA) Exposure Status","Abiraterone (ABI) and Enzalutamide (ENZA) Exposure Status","STRING",true,"1","ABI_ENZA_EXPOSURE_STATUS","prad_su2c_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_su2c_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_su2c_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_su2c_2015"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","prad_su2c_2015"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_su2c_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_su2c_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_su2c_2015"
"Prior Treatment","Prior treatment.","STRING",true,"1","PRIOR_TREATMENT","prad_su2c_2015"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","prad_su2c_2015"
"Sex","Sex","STRING",true,"1","SEX","prad_su2c_2015"
"Site Sequenced","Site Sequenced","STRING",false,"1","SITE_SEQUENCED","prad_su2c_2015"
"tumor content","tumor content","NUMBER",false,"1","TUMOR_CONTENT","prad_su2c_2015"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","prad_su2c_2015"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","prad_su2c_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","prad_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","prad_tcga"
"Biochemical Recurrence Indicator","Biochemical Recurrence Indicator","STRING",true,"1","BIOCHEMICAL_RECURRENCE_INDICATOR","prad_tcga"
"Bone Scan Result","Bone scan result.","STRING",true,"1","BONE_SCAN_RESULT","prad_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","prad_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_tcga"
"Cause of death source","Source of patient death reason","STRING",true,"1","CAUSE_OF_DEATH_SOURCE","prad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","prad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","prad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","prad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","prad_tcga"
"Ct scan ab pelvis indicator","Diagnostic ct abd pelvis performed","STRING",true,"1","CT_SCAN_AB_PELVIS_INDICATOR","prad_tcga"
"Ct scan ab pelvis results","Diagnostic ct abd pelvis result","STRING",true,"1","CT_SCAN_AB_PELVIS_RESULTS","prad_tcga"
"Days to biochemical recurrence first","Days to first biochemical recurrence","NUMBER",true,"1","DAYS_TO_BIOCHEMICAL_RECURRENCE_FIRST","prad_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","prad_tcga"
"Days to bone Scan performed","Days to bone Scan performed","NUMBER",true,"1","DAYS_TO_BONE_SCAN_PERFORMED","prad_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","prad_tcga"
"Days to ct scan ab pelvis","Days to diagnostic computed tomography performed","NUMBER",true,"1","DAYS_TO_CT_SCAN_AB_PELVIS","prad_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","prad_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","prad_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","prad_tcga"
"Days to mri","Days to diagnostic mri performed","NUMBER",true,"1","DAYS_TO_MRI","prad_tcga"
"Days to PSA","Days to Prostate-Specific Antigen (PSA) Test","STRING",true,"1","DAYS_TO_PSA","prad_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","prad_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","prad_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","prad_tcga"
"Diagonstic MRI Result","Diagonostic MRI result.","STRING",true,"1","DIAGNOSTIC_MRI_RESULT","prad_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","prad_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","prad_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","prad_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","prad_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_tcga"
"Gleason pattern primary","Gleason pattern primary","NUMBER",true,"1","GLEASON_PATTERN_PRIMARY","prad_tcga"
"Gleason pattern secondary","Gleason pattern secondary","NUMBER",true,"1","GLEASON_PATTERN_SECONDARY","prad_tcga"
"Gleason pattern tertiary","Gleason pattern tertiary","NUMBER",true,"1","GLEASON_PATTERN_TERTIARY","prad_tcga"
"Radical Prostatectomy Gleason Score for Prostate Cancer","The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","STRING",true,"1","GLEASON_SCORE","prad_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","prad_tcga"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","prad_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","prad_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","prad_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","prad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","prad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","prad_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","prad_tcga"
"Initial pathologic diagnosis method","Initial pathologic diagnosis method","STRING",true,"1","INITIAL_PATHOLOGIC_DIAGNOSIS_METHOD","prad_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","prad_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","prad_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","prad_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","prad_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","prad_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","prad_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","prad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","prad_tcga"
"Mri results","Diagnostic mri result","STRING",true,"1","MRI_RESULTS","prad_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","prad_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","prad_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","prad_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","prad_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","prad_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","prad_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","prad_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","prad_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","prad_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","prad_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","prad_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","prad_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","prad_tcga"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","prad_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","prad_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","prad_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","prad_tcga"
"Psa most recent results","Psa most recent results","NUMBER",true,"1","PSA_MOST_RECENT_RESULTS","prad_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","prad_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","prad_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","prad_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","prad_tcga"
"Sample Initial Weight","Sample Initial Weight","NUMBER",false,"1","SAMPLE_INITIAL_WEIGHT","prad_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","prad_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","prad_tcga"
"Sex","Sex","STRING",true,"1","SEX","prad_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","prad_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","prad_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","prad_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","prad_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","prad_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","prad_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","prad_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","prad_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","prad_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","prad_tcga"
"Tumor Level","Tumor level.","STRING",true,"1","TUMOR_LEVEL","prad_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","prad_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","prad_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","prad_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","prad_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","prad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","prad_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","prad_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","prad_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","prad_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","prad_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","prad_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","prad_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","prad_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","prad_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","prad_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","prad_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","prad_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","prad_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","prad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","prad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","prad_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","prad_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","prad_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","prad_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","prad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","prad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","prad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","prad_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","prad_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","prad_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","prad_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","prad_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","prad_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","prad_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","prad_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","prad_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","prad_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","prad_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","prad_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","prad_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","prad_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","prad_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","prad_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","prad_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","prad_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","prad_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","prad_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","prad_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","prad_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","prad_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","prad_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","prad_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","prad_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","prad_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","prad_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","prad_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","prad_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","prad_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","prad_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","prad_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","prad_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","prad_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","prad_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","prad_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","prad_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","prad_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","prad_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","prad_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","prad_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","prad_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","prad_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","prad_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","prad_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","prad_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","prad_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","prad_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","prad_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","prad_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","prad_tcga_pan_can_atlas_2018"
"Absolute Extract Ploidy","Absolute extract ploidy.","NUMBER",false,"1","ABSOLUTE_EXTRACT_PLOIDY","prad_tcga_pub"
"Absolute Extract Purity","Absolute extract purity.","NUMBER",false,"1","ABSOLUTE_EXTRACT_PURITY","prad_tcga_pub"
"Absolute Genome Doublings","Absolute Genome Doublings","STRING",false,"1","ABSOLUTE_GENOME_DOUBLINGS","prad_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","prad_tcga_pub"
"AKT1 Mutation","AKT1 Mutation","STRING",false,"1","AKT1_MUTATION","prad_tcga_pub"
"AR mRNA","AR mRNA","NUMBER",false,"1","AR_MRNA","prad_tcga_pub"
"AR Protein","AR Protein","NUMBER",false,"1","AR_PROTEIN","prad_tcga_pub"
"AR Score","AR score","NUMBER",false,"1","AR_SCORE","prad_tcga_pub"
"AR V7 Presence","AR V7 Presence","NUMBER",false,"1","AR_V7_PRESENCE","prad_tcga_pub"
"AR V7 Ratio","AR V7 Ratio","NUMBER",false,"1","AR_V7_RATIO","prad_tcga_pub"
"AR V7 Reads","AR V7 Reads","NUMBER",false,"1","AR_V7_READS","prad_tcga_pub"
"ATM Mutation","ATM Mutation","NUMBER",false,"1","ATM_MUT","prad_tcga_pub"
"Average DNA Purity","Average DNA Purity","NUMBER",false,"1","AVE_DNA_PURITY","prad_tcga_pub"
"Average RNA Purity","Average RNA Purity","NUMBER",false,"1","AVE_RNA_PURITY","prad_tcga_pub"
"Batch Number","Batch number.","STRING",false,"1","BATCH_NUMBER","prad_tcga_pub"
"BRAF mutation","BRAF mutation","STRING",false,"1","BRAF_MUTATION","prad_tcga_pub"
"Brca1 cna","Brca1 cna","STRING",true,"1","BRCA1_CNA","prad_tcga_pub"
"BRCA1 Germline Mutation","BRCA1 Germline Mutation","NUMBER",false,"1","BRCA1_GERMLINE_MUT","prad_tcga_pub"
"BRCA1 Mutation","BRCA1 Mutation is present","STRING",false,"1","BRCA1_MUTATION","prad_tcga_pub"
"BRCA2 CNA","BRCA2 CNA","STRING",false,"1","BRCA2_CNA","prad_tcga_pub"
"BRCA2 Germline Mutation","BRCA2 Germline Mutation","NUMBER",false,"1","BRCA2_GERMLINE_MUT","prad_tcga_pub"
"BRCA2 Mutation","BRCA2 Mutation is present","STRING",false,"1","BRCA2_MUTATION","prad_tcga_pub"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","prad_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","prad_tcga_pub"
"CDK12 CNA","CDK12 CNA","STRING",false,"1","CDK12_CNA","prad_tcga_pub"
"CDK12 Mutation","CDK12 Mutation","NUMBER",false,"1","CDK12_MUT","prad_tcga_pub"
"CDKN1B CNA","CDKN1B CNA","STRING",false,"1","CDKN1B_CNA","prad_tcga_pub"
"Cdkn1b mut","Cdkn1b mut","NUMBER",true,"1","CDKN1B_MUT","prad_tcga_pub"
"CHD1 CNA","CHD1 CNA","STRING",false,"1","CHD1_CNA","prad_tcga_pub"
"CHD1 Mutation","CHD1 Mutation is present","STRING",false,"1","CHD1_MUTATION","prad_tcga_pub"
"Clinical Gleason","Clinical Gleason","STRING",false,"1","CLINICAL_GLEASON","prad_tcga_pub"
"Clinical Gleason category","Clinical Gleason category","STRING",false,"1","CLINICAL_GLEASON_CATEGORY","prad_tcga_pub"
"Clinical Gleason Sum","Clinical Gleason Sum","NUMBER",false,"1","CLINICAL_GLEASON_SUM","prad_tcga_pub"
"CLONET Purity","CLONET Purity","NUMBER",false,"1","CLONET_PURITY","prad_tcga_pub"
"CTNNB1 Mutation","CTNNB1 Mutation is present","STRING",false,"1","CTNNB1_MUTATION","prad_tcga_pub"
"DeMix Purity","DeMix Purity","NUMBER",false,"1","DEMIX_PURITY","prad_tcga_pub"
"Erg status","Erg status","STRING",true,"1","ERG_STATUS","prad_tcga_pub"
"ETV1 Status","ETV1 Status","STRING",false,"1","ETV1_STATUS","prad_tcga_pub"
"ETV4 Status","ETV4 Status","STRING",false,"1","ETV4_STATUS","prad_tcga_pub"
"Exon Imbalance Score","Exon Imbalance Score","NUMBER",false,"1","EXON_IMBALANCE_SCORE","prad_tcga_pub"
"FAM175A CNA","FAM175A CNA","STRING",false,"1","FAM175A_CNA","prad_tcga_pub"
"FANCC CNA","FANCC CNA","STRING",false,"1","FANCC_CNA","prad_tcga_pub"
"FANCC Mutation","FANCC Mutation","NUMBER",false,"1","FANCC_MUT","prad_tcga_pub"
"FANCD2 CNA","FANCD2 CNA","STRING",false,"1","FANCD2_CNA","prad_tcga_pub"
"FANCD2 Mutation","FANCD2 Mutation","NUMBER",false,"1","FANCD2_MUT","prad_tcga_pub"
"FLI1 Status","FLI1 Status","STRING",false,"1","FLI1_STATUS","prad_tcga_pub"
"FOXA1 mutation","FOXA1 mutation is present","STRING",false,"1","FOXA1_MUTATION","prad_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","prad_tcga_pub"
"HRAS mutation","HRAS mutation is present","STRING",false,"1","HRAS_MUTATION","prad_tcga_pub"
"iCluster","ICluster.","STRING",false,"1","ICLUSTER","prad_tcga_pub"
"IDH1 Mutation","IDH1 mutation is present","STRING",false,"1","IDH1_MUTATION","prad_tcga_pub"
"ISOpure Purity","ISOpure Purity","NUMBER",false,"1","ISOPURE_PURITY","prad_tcga_pub"
"KDM6A mutation","KDM6A mutation is present","STRING",false,"1","KDM6A_MUTATION","prad_tcga_pub"
"KMT2A mutation","KMT2A mutation is present","STRING",false,"1","KMT2A_MUTATION","prad_tcga_pub"
"KMT2C Mutation","KMT2C Mutation","NUMBER",false,"1","KMT2C_MUT","prad_tcga_pub"
"KMT2D Mutation","KMT2D Mutation","STRING",false,"1","KMT2D_MUTATION","prad_tcga_pub"
"MED12 Mutation","MED12 Mutation is present","STRING",false,"1","MED12_MUTATION","prad_tcga_pub"
"Methylation Cluster","Methylation cluster.","STRING",false,"1","METHYLATION_CLUSTER","prad_tcga_pub"
"MIRNA Cluster","MICRNA cluster","STRING",false,"1","MIRNA_CLUSTER","prad_tcga_pub"
"MRNA Expression Cluster","MRNA expression cluster.","STRING",false,"1","MRNA_EXPRESSION_CLUSTER","prad_tcga_pub"
"Mutations","Mutations","NUMBER",false,"1","MUTATIONS","prad_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","prad_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","prad_tcga_pub"
"PIK3CA Mutation","PIK3CA mutation is present.","STRING",false,"1","PIK3CA_MUTATION","prad_tcga_pub"
"Preop PSA","Preop PSA","NUMBER",true,"1","PREOPERATIVE_PSA","prad_tcga_pub"
"PTEN CNA","PTEN CNA","STRING",false,"1","PTEN_CNA","prad_tcga_pub"
"PTEN Mutation","PTEN Mutation is present","STRING",false,"1","PTEN_MUTATION","prad_tcga_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","prad_tcga_pub"
"RAD51C CNA","RAD51C CNA","STRING",false,"1","RAD51C_CNA","prad_tcga_pub"
"RB1 CNA","RB1 CNA","STRING",false,"1","RB1_CNA","prad_tcga_pub"
"Rb1 mut","Rb1 mut","NUMBER",true,"1","RB1_MUT","prad_tcga_pub"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","prad_tcga_pub"
"Reviewed gleason","Reviewed gleason","STRING",false,"1","REVIEWED_GLEASON","prad_tcga_pub"
"Reviewed Gleason Category","Reviewed Gleason category","STRING",false,"1","REVIEWED_GLEASON_CATEGORY","prad_tcga_pub"
"Reviewed Gleason Sum","Reviewed Gleason Sum","NUMBER",false,"1","REVIEWED_GLEASON_SUM","prad_tcga_pub"
"RPPA Cluster","RPPA Cluster.","STRING",false,"1","RPPA_CLUSTER","prad_tcga_pub"
"SCNA Cluster","SCNA Cluster","STRING",false,"1","SCNA_CLUSTER","prad_tcga_pub"
"SETD2 Mutation","SETD2 Mutation","STRING",false,"1","SETD2_MUTATION","prad_tcga_pub"
"SPINK1 High","SPINK1 High","STRING",false,"1","SPINK1_HIGH","prad_tcga_pub"
"SPOPL CNA","SPOPL CNA","STRING",false,"1","SPOPL_CNA","prad_tcga_pub"
"SPOP Mutation","SPOP Mutation","STRING",false,"1","SPOP_MUTATION","prad_tcga_pub"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","prad_tcga_pub"
"TP53 CNA","TP53 CNA","STRING",false,"1","TP53_CNA","prad_tcga_pub"
"TP53 Mutation","TP53 mutation is present.","STRING",false,"1","TP53_MUTATION","prad_tcga_pub"
"Tumor cellularity dominant pathology review","Tumor cellularity dominant pathology review","STRING",false,"1","TUMOR_CELLULARITY_PATHOLOGY_REVIEW","prad_tcga_pub"
"Zmym3 mut","Zmym3 mut","NUMBER",true,"1","ZMYM3_MUT","prad_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","rms_nih_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","rms_nih_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","rms_nih_2014"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","rms_nih_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","rms_nih_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","rms_nih_2014"
"PAX Fusion","PAX Fusion","STRING",false,"1","PAX_FUSION","rms_nih_2014"
"Primary Tumor Location","Primary Tumor Location","STRING",false,"1","PRIMARY_TUMOR_LOCATION","rms_nih_2014"
"Risk Group","Risk group.","STRING",true,"1","RISK_GROUP","rms_nih_2014"
"Sex","Sex","STRING",true,"1","SEX","rms_nih_2014"
"Tumor Sample Histology","Tumor Sample Histology","STRING",false,"1","TUMOR_SAMPLE_HISTOLOGY","rms_nih_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","rt_target_2018_pub"
"Diagnosis Age (days)","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE_IN_DAYS","rt_target_2018_pub"
"Analysis Cohort","Analysis Cohort","STRING",false,"1","ANALYSIS_COHORT","rt_target_2018_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","rt_target_2018_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","rt_target_2018_pub"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","rt_target_2018_pub"
"Time To Event (days)","Time To Event (days)","NUMBER",true,"1","DAYS_TO_EVENT","rt_target_2018_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","rt_target_2018_pub"
"First Event","First Event","STRING",true,"1","FIRST_EVENT","rt_target_2018_pub"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","rt_target_2018_pub"
"ICD-0-3-T","ICD-0-3-T","STRING",false,"1","ICD_0_3_T","rt_target_2018_pub"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","rt_target_2018_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","rt_target_2018_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","rt_target_2018_pub"
"Overall Survival Days","Overall patient survival days","NUMBER",true,"1","OS_DAYS","rt_target_2018_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","rt_target_2018_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","rt_target_2018_pub"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","rt_target_2018_pub"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","rt_target_2018_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","rt_target_2018_pub"
"Sex","Sex","STRING",true,"1","SEX","rt_target_2018_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","sarc_mskcc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","sarc_mskcc"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","sarc_mskcc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","sarc_mskcc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","sarc_mskcc"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","sarc_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","sarc_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","sarc_tcga"
"Contiguous organ invaded","Contiguous organ invaded","STRING",true,"1","CONTIGUOUS_ORGAN_INVADED","sarc_tcga"
"Contiguous organ resection","Contiguous organ resection site","STRING",true,"1","CONTIGUOUS_ORGAN_RESECTION","sarc_tcga"
"Contiguous organ resection other","Other contiguous organ resection site","STRING",true,"1","CONTIGUOUS_ORGAN_RESECTION_OTHER","sarc_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","sarc_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","sarc_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","sarc_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","sarc_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","sarc_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","sarc_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","sarc_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","sarc_tcga"
"Discontinuous lesions count","Discontiguous lesion count","NUMBER",true,"1","DISCONTINUOUS_LESIONS_COUNT","sarc_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","sarc_tcga"
"Disease multifocal indicator","Disease multifocal indicator","STRING",true,"1","DISEASE_MULTIFOCAL_INDICATOR","sarc_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","sarc_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","sarc_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","sarc_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","sarc_tcga"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","sarc_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","sarc_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","sarc_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","sarc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","sarc_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","sarc_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","sarc_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","sarc_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","sarc_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","sarc_tcga"
"Leiomyosarcoma uterine involvement","Primary tumor lower uterus segment","STRING",true,"1","LEIOMYOSARCOMA_UTERINE_INVOLVEMENT","sarc_tcga"
"Leiomyo major vessel involvement","Leiomyosarcoma major vessel involvement","STRING",true,"1","LEIOMYO_MAJOR_VESSEL_INVOLVEMENT","sarc_tcga"
"Locoregional recurrence indicator","Local disease recurrence","STRING",true,"1","LOCOREGIONAL_RECURRENCE_INDICATOR","sarc_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","sarc_tcga"
"Metastatic disease confirmed","Metastatic neoplasm confirmed","STRING",true,"1","METASTATIC_DISEASE_CONFIRMED","sarc_tcga"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",true,"1","METASTATIC_SITE","sarc_tcga"
"Metastatic Site Other","Metastatic Site Other","STRING",true,"1","METASTATIC_SITE_OTHER","sarc_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","sarc_tcga"
"Mitotic Count","Mitotic Count","NUMBER",true,"1","MITOTIC_COUNT","sarc_tcga"
"Mpnst nf1 genetic testing indicator","Mpnst nf1 genetic testing","STRING",true,"1","MPNST_NF1_GENETIC_TESTING_INDICATOR","sarc_tcga"
"Mpnst nf1 mutations identified","Mpnst specific mutations","STRING",true,"1","MPNST_NF1_MUTATIONS_IDENTIFIED","sarc_tcga"
"Mpnst nf familial or sporadic","Mpnst neurofibromatosis heredity","STRING",true,"1","MPNST_NF_FAMILIAL_OR_SPORADIC","sarc_tcga"
"Mpnst nf indicator","Mpnst neurofibromatosis","STRING",true,"1","MPNST_NF_INDICATOR","sarc_tcga"
"Mpnst plexiform neurofibroma site","Mpnst exisiting plexiform neurofibroma","STRING",true,"1","MPNST_PLEXIFORM_NEUROFIBROMA_SITE","sarc_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","sarc_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","sarc_tcga"
"Nte lesion pathologic depth","Nte lesion pathologic depth","STRING",true,"1","NTE_LESION_PATHOLOGIC_DEPTH","sarc_tcga"
"Nte lesion pathologic length","Nte lesion pathologic length","STRING",true,"1","NTE_LESION_PATHOLOGIC_LENGTH","sarc_tcga"
"Nte lesion pathologic width","Nte lesion pathologic width","STRING",true,"1","NTE_LESION_PATHOLOGIC_WIDTH","sarc_tcga"
"Nte lesion radiologic depth","Nte lesion radiologic depth","STRING",true,"1","NTE_LESION_RADIOLOGIC_DEPTH","sarc_tcga"
"Nte lesion radiologic length","Nte lesion radiologic length","STRING",true,"1","NTE_LESION_RADIOLOGIC_LENGTH","sarc_tcga"
"Nte lesion radiologic width","Nte lesion radiologic width","STRING",true,"1","NTE_LESION_RADIOLOGIC_WIDTH","sarc_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","sarc_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","sarc_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","sarc_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","sarc_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","sarc_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","sarc_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","sarc_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","sarc_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","sarc_tcga"
"Disease Surgical Margin Status","Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.","STRING",true,"1","PATH_MARGIN","sarc_tcga"
"Percent Necrosis","Percent necrosis.","NUMBER",true,"1","PERCENTAGE_NECROSIS","sarc_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","sarc_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","sarc_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","sarc_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","sarc_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","sarc_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","sarc_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","sarc_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","sarc_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","sarc_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","sarc_tcga"
"Sex","Sex","STRING",true,"1","SEX","sarc_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","sarc_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","sarc_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","sarc_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","sarc_tcga"
"Synovial ss18ssx fusion status","Synovial ss18ssx fusion status","STRING",true,"1","SYNOVIAL_SS18SSX_FUSION_STATUS","sarc_tcga"
"Synovial ss18ssx testing method","Synovial ss18ssx testing method","STRING",true,"1","SYNOVIAL_SS18SSX_TESTING_METHOD","sarc_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","sarc_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","sarc_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","sarc_tcga"
"Tumor burden pathologic","Tumor burden pathologic","STRING",true,"1","TUMOR_BURDEN_PATHOLOGIC","sarc_tcga"
"Tumor burden radiologic","Tumor burden radiologic","STRING",true,"1","TUMOR_BURDEN_RADIOLOGIC","sarc_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","sarc_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","sarc_tcga"
"Tumor total depth","Tumor total depth","STRING",true,"1","TUMOR_TOTAL_DEPTH","sarc_tcga"
"Tumor total necrosis","Tumor total necrosis","STRING",true,"1","TUMOR_TOTAL_NECROSIS","sarc_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","sarc_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","sarc_tcga"
"Well diff liposarc prior dx days to","Days to well differentiated liposarcoma primary dx","NUMBER",true,"1","WELL_DIFF_LIPOSARC_PRIOR_DX_DAYS_TO","sarc_tcga"
"Well diff liposarc prior dx indicator","Well differentiated liposarcoma primary dx","STRING",true,"1","WELL_DIFF_LIPOSARC_PRIOR_DX_INDICATOR","sarc_tcga"
"Well diff liposarc resection days to","Days to well differentiated liposarcoma resection","NUMBER",true,"1","WELL_DIFF_LIPOSARC_RESECTION_DAYS_TO","sarc_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","sarc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","sarc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","sarc_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","sarc_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","sarc_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","sarc_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","sarc_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","sarc_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","sarc_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","sarc_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","sarc_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","sarc_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","sarc_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","sarc_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","sarc_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","sarc_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","sarc_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","sarc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","sarc_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","sarc_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","sarc_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","sarc_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","sarc_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","sarc_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","sarc_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","sarc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","sarc_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","sarc_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","sarc_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","sarc_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","sarc_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","sarc_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","sarc_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","sarc_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","sarc_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","sarc_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","sarc_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","sarc_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","sarc_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","sarc_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","sarc_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","sarc_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","sarc_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","sarc_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","sarc_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","sarc_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","sarc_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","sarc_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","sarc_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","sarc_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","sarc_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","sarc_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","sarc_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","sarc_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","sarc_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","sarc_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","sarc_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","sarc_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","sarc_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","sarc_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","sarc_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","sarc_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","sarc_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","sarc_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","sarc_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","sarc_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","sarc_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","sarc_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","sarc_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","sarc_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","sarc_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","sarc_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","sarc_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","sarc_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","sarc_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","sarc_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","sarc_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","sarc_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","sarc_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","sarc_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","scco_mskcc"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","scco_mskcc"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","scco_mskcc"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","scco_mskcc"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","scco_mskcc"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","scco_mskcc"
"Year of Diagnosis","Year of Diagnosis","NUMBER",true,"1","YEAR_OF_DIAGNOSIS","scco_mskcc"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","sclc_cancercell_gardner_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","sclc_cancercell_gardner_2017"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","sclc_clcgp"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","sclc_clcgp"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","sclc_clcgp"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","sclc_clcgp"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","sclc_clcgp"
"Sex","Sex","STRING",true,"1","SEX","sclc_clcgp"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","sclc_jhu"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","sclc_jhu"
"Diagnosis","Diagnosis.","STRING",true,"1","DIAGNOSIS","sclc_jhu"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","sclc_jhu"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","sclc_jhu"
"Primary tissue","Primary tissue","STRING",true,"1","PRIMARY_TISSUE","sclc_jhu"
"Sample name","Sample name","STRING",true,"1","SAMPLE_NAME","sclc_jhu"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","sclc_jhu"
"SOURCE","SOURCE","STRING",true,"1","SOURCE","sclc_jhu"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","sclc_ucologne_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","sclc_ucologne_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","sclc_ucologne_2015"
"Chemotherapy","Chemotherapy.","STRING",true,"1","CHEMOTHERAPY","sclc_ucologne_2015"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","sclc_ucologne_2015"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","sclc_ucologne_2015"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_SAMPLE_PROCUREMENT","sclc_ucologne_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","sclc_ucologne_2015"
"M Stage","M Stage","STRING",true,"1","M_STAGE","sclc_ucologne_2015"
"Neoadjuvant Chemotherapy","Neoadjuvant Chemotherapy.","STRING",true,"1","NEOADJ_CHEMO","sclc_ucologne_2015"
"N Stage","N Stage","STRING",true,"1","N_STAGE","sclc_ucologne_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","sclc_ucologne_2015"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","sclc_ucologne_2015"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","sclc_ucologne_2015"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","sclc_ucologne_2015"
"Previous Treatment","Previous treatment.","STRING",true,"1","PREVIOUS_TREATMENT","sclc_ucologne_2015"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","sclc_ucologne_2015"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","sclc_ucologne_2015"
"Sex","Sex","STRING",true,"1","SEX","sclc_ucologne_2015"
"Smoker","Indicates if person is a smoker.","STRING",true,"1","SMOKER","sclc_ucologne_2015"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","sclc_ucologne_2015"
"Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING",false,"1","SPECIMEN_PRESERVATION_TYPE","sclc_ucologne_2015"
"T Stage","T Stage","STRING",false,"1","T_STAGE","sclc_ucologne_2015"
"UICC Tumor Stage","UICC Tumor Stage","STRING",true,"1","UICC_TUMOR_STAGE","sclc_ucologne_2015"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","skcm_broad"
"Age At Procurement","Age At Procurement Of The Submitted Specimen","NUMBER",true,"1","AGE_AT_PROCUREMENT","skcm_broad"
"breslow depth","breslow depth","STRING",false,"1","BRESLOW_DEPTH","skcm_broad"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","skcm_broad"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_broad"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_broad"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","skcm_broad"
"Primary Diagosis","Primary Diagnosis","STRING",true,"1","PRIMARY_DIAGNOSIS","skcm_broad"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","skcm_broad"
"Primary Tumor Localization Type","Primary Tumor Localization Type","STRING",true,"1","PRIMARY_TUMOR_LOCALIZATION_TYPE","skcm_broad"
"Sex","Sex","STRING",true,"1","SEX","skcm_broad"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","skcm_broad_brafresist_2012"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","skcm_broad_brafresist_2012"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_broad_brafresist_2012"
"duration of therapy weeks","duration of therapy weeks","STRING",true,"1","DURATION_OF_THERAPY_WEEKS","skcm_broad_brafresist_2012"
"Early Resistance","Early Resistance","STRING",true,"1","EARLY_RESISTANCE","skcm_broad_brafresist_2012"
"Matched Normal Tissue","Matched Normal Tissue","STRING",false,"1","MATCHED_NORMAL_TISSUE","skcm_broad_brafresist_2012"
"mean target coverage normal","mean target coverage normal","STRING",false,"1","MEAN_TARGET_COVERAGE_NORMAL","skcm_broad_brafresist_2012"
"mean target coverage tumor","mean target coverage tumor","STRING",false,"1","MEAN_TARGET_COVERAGE_TUMOR","skcm_broad_brafresist_2012"
"medication","medication","STRING",true,"1","MEDICATION","skcm_broad_brafresist_2012"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_broad_brafresist_2012"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","skcm_broad_brafresist_2012"
"Sex","Sex","STRING",true,"1","SEX","skcm_broad_brafresist_2012"
"Treatment best response","Treatment best response","STRING",true,"1","TREATMENT_BEST_RESPONSE","skcm_broad_brafresist_2012"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","skcm_broad_dfarber"
"Average Ploidy ","Average ploidy ","NUMBER",false,"1","AVE_PLOIDY","skcm_broad_dfarber"
"Braf Status","Braf Status","STRING",false,"1","BRAF_STATUS","skcm_broad_dfarber"
"breslow depth","breslow depth","STRING",false,"1","BRESLOW_DEPTH","skcm_broad_dfarber"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","skcm_broad_dfarber"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_broad_dfarber"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_broad_dfarber"
"nras status","nras status","STRING",false,"1","NRAS_STATUS","skcm_broad_dfarber"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","skcm_broad_dfarber"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","skcm_broad_dfarber"
"pathologic primary tumor stage","pathologic primary tumor stage","STRING",false,"1","PATHOLOGIC_PRIMARY_TUMOR_STAGE","skcm_broad_dfarber"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","skcm_broad_dfarber"
"Sex","Sex","STRING",true,"1","SEX","skcm_broad_dfarber"
"Specimen Type","The broad cancer phenotype and site information values for a sample to be processed.","STRING",false,"1","SPECIMEN_TYPE","skcm_broad_dfarber"
"Exposure to Sun","Exposure to Sun","STRING",true,"1","SUN_EXPOSURE","skcm_broad_dfarber"
"survival after biopsy months","survival after biopsy months","STRING",false,"1","SURVIVAL_AFTER_BIOPSY_MONTHS","skcm_broad_dfarber"
"treatment prior to resection","treatment prior to resection","STRING",false,"1","TREATMENT_PRIOR_TO_RESECTION","skcm_broad_dfarber"
"Tumor Purity","Tumor Purity","STRING",false,"1","TUMOR_PURITY","skcm_broad_dfarber"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","skcm_broad_dfarber"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","skcm_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","skcm_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","skcm_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","skcm_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","skcm_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","skcm_tcga"
"breslow depth","breslow depth","STRING",true,"1","BRESLOW_DEPTH","skcm_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","skcm_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_tcga"
"Clark level at diagnosis","Melanoma clark level value","STRING",true,"1","CLARK_LEVEL_AT_DIAGNOSIS","skcm_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","skcm_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","skcm_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","skcm_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","skcm_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_BIRTH","skcm_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","skcm_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_DEATH","skcm_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","skcm_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","skcm_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","skcm_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","skcm_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","skcm_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","skcm_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","skcm_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","skcm_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","skcm_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","skcm_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","skcm_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","skcm_tcga"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","skcm_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","skcm_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","skcm_tcga"
"History neoadjuvant tx type","Prior systemic therapy type","STRING",true,"1","HISTORY_NEOADJUVANT_TX_TYPE","skcm_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","skcm_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","skcm_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","skcm_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","skcm_tcga"
"Idh level","Idh level","STRING",true,"1","IDH_LEVEL","skcm_tcga"
"Ifn tx 90 days prior to resection","Interferon 90 day prior excision admin indicator","STRING",true,"1","IFN_TX_90_DAYS_PRIOR_TO_RESECTION","skcm_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","skcm_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","skcm_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","skcm_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","skcm_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","skcm_tcga"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",true,"1","METASTATIC_SITE","skcm_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","skcm_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","skcm_tcga"
"New tumor event melanoma count","Primary anatomic site count","STRING",true,"1","NEW_TUMOR_EVENT_MELANOMA_COUNT","skcm_tcga"
"New tumor event prior to bcr tumor","New tumor dx prior submitted specimen dx","STRING",true,"1","NEW_TUMOR_EVENT_PRIOR_TO_BCR_TUMOR","skcm_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","skcm_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","skcm_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","skcm_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","skcm_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","skcm_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","skcm_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","skcm_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","skcm_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","skcm_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","skcm_tcga"
"Primary at dx count","Primary melanoma at diagnosis count","NUMBER",true,"1","PRIMARY_AT_DX_COUNT","skcm_tcga"
"Primary melanoma known dx","Primary neoplasm melanoma dx","STRING",true,"1","PRIMARY_MELANOMA_KNOWN_DX","skcm_tcga"
"Primary melanoma mitotic rate","Malignant neoplasm mitotic count rate","NUMBER",true,"1","PRIMARY_MELANOMA_MITOTIC_RATE","skcm_tcga"
"Primary melanoma skin type","Melanoma origin skin anatomic site","STRING",true,"1","PRIMARY_MELANOMA_SKIN_TYPE","skcm_tcga"
"Primary melanoma tumor ulceration","Melanoma ulceration indicator","STRING",true,"1","PRIMARY_MELANOMA_TUMOR_ULCERATION","skcm_tcga"
"Primary multiple at dx","Primary tumor multiple present ind","STRING",true,"1","PRIMARY_MULTIPLE_AT_DX","skcm_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","skcm_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","skcm_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","skcm_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","skcm_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","skcm_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","skcm_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","skcm_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","skcm_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","skcm_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","skcm_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","skcm_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","skcm_tcga"
"Submitted tumor dx days to","Days to submitted specimen dx","STRING",true,"1","SUBMITTED_TUMOR_DX_DAYS_TO","skcm_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","skcm_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","skcm_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","skcm_tcga"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","skcm_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","skcm_tcga"
"Tumor tissue site other","Tumor tissue site other","STRING",true,"1","TUMOR_TISSUE_SITE_OTHER","skcm_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","skcm_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","skcm_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","skcm_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","skcm_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","skcm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","skcm_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","skcm_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","skcm_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","skcm_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","skcm_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","skcm_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","skcm_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","skcm_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","skcm_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","skcm_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","skcm_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","skcm_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","skcm_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","skcm_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","skcm_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","skcm_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","skcm_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","skcm_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","skcm_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","skcm_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","skcm_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","skcm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","skcm_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","skcm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","skcm_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","skcm_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","skcm_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","skcm_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","skcm_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","skcm_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","skcm_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","skcm_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","skcm_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","skcm_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","skcm_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","skcm_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","skcm_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","skcm_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","skcm_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","skcm_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","skcm_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","skcm_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","skcm_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","skcm_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","skcm_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","skcm_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","skcm_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","skcm_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","skcm_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","skcm_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","skcm_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","skcm_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","skcm_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","skcm_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","skcm_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","skcm_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","skcm_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","skcm_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","skcm_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","skcm_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","skcm_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","skcm_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","skcm_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","skcm_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","skcm_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","skcm_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","skcm_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","skcm_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","skcm_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","skcm_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","skcm_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","skcm_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","skcm_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","skcm_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","skcm_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","skcm_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","skcm_ucla_2016"
"Anatomical Subtype","Anatomical Subtype","STRING",false,"1","ANATOMICAL_SUBTYPE","skcm_ucla_2016"
"Biopsy Time","Biopsy Time","STRING",false,"1","BIOPSY_TIME","skcm_ucla_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","skcm_ucla_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_ucla_2016"
"Disease Status","Disease Status","STRING",true,"1","DISEASE_STATUS","skcm_ucla_2016"
"Location","Location","STRING",true,"1","LOCATION","skcm_ucla_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_ucla_2016"
"Note","Note.","STRING",false,"1","NOTE","skcm_ucla_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","skcm_ucla_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","skcm_ucla_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","skcm_ucla_2016"
"Previous Treatment","Previous treatment.","STRING",true,"1","PREVIOUS_TREATMENT","skcm_ucla_2016"
"RECIST Response","RECIST Response","STRING",true,"1","RECIST_RESPONSE","skcm_ucla_2016"
"Sex","Sex","STRING",true,"1","SEX","skcm_ucla_2016"
"Treatment","Treatment","STRING",true,"1","TREATMENT","skcm_ucla_2016"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","skcm_ucla_2016"
"Whole Exome Sequencing","Whole Exome Sequencing","STRING",false,"1","WHOLE_EXOME_SEQUENCING","skcm_ucla_2016"
"AGENT","AGENT","STRING",true,"1","AGENT","skcm_vanderbilt_mskcc_2015"
"BORR","BORR","STRING",true,"1","BORR","skcm_vanderbilt_mskcc_2015"
"BRAIN METS","Brain Metatstasis","STRING",true,"1","BRAIN_METS","skcm_vanderbilt_mskcc_2015"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","skcm_vanderbilt_mskcc_2015"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_vanderbilt_mskcc_2015"
"Chemotherapy","Chemotherapy.","STRING",true,"1","CHEMOTHERAPY","skcm_vanderbilt_mskcc_2015"
"Comments","Comments.","STRING",true,"1","COMMENTS","skcm_vanderbilt_mskcc_2015"
"ECOG status","ECOG status","STRING",true,"1","ECOG_STATUS","skcm_vanderbilt_mskcc_2015"
"Greater than 3 sites","Greater than 3 sites","STRING",false,"1","GREATER_THAN_3_SITES","skcm_vanderbilt_mskcc_2015"
"Immunotherapy","Immunotherapy","STRING",true,"1","IMMUNE_TREATMENT","skcm_vanderbilt_mskcc_2015"
"Liver Involvement","Liver Involvement","STRING",true,"1","LIVER_INVOLVEMENT","skcm_vanderbilt_mskcc_2015"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_vanderbilt_mskcc_2015"
"M Stage","M Stage","STRING",true,"1","M_STAGE","skcm_vanderbilt_mskcc_2015"
"Number Of Sites","Number Of Sites","NUMBER",false,"1","NUMBER_OF_SITES","skcm_vanderbilt_mskcc_2015"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","skcm_vanderbilt_mskcc_2015"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","skcm_vanderbilt_mskcc_2015"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","skcm_vanderbilt_mskcc_2015"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","skcm_vanderbilt_mskcc_2015"
"RECIST burden of disease (mm)","RECIST burden of disease (mm)","NUMBER",true,"1","RECIST_BURDEN_OF_DISEASE","skcm_vanderbilt_mskcc_2015"
"Response grade","Response grade","STRING",true,"1","RESPONSE_GRADE","skcm_vanderbilt_mskcc_2015"
"Response to Target Therapy","Did the patient respond to Target Therapy","STRING",true,"1","RESPONSE_TO_TARGET_THERAPY","skcm_vanderbilt_mskcc_2015"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","skcm_vanderbilt_mskcc_2015"
"Stage","Stage","STRING",true,"1","STAGE","skcm_vanderbilt_mskcc_2015"
"Age At Procurement","Age At Procurement Of The Submitted Specimen","NUMBER",true,"1","AGE_AT_PROCUREMENT","skcm_yale"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","skcm_yale"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","skcm_yale"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","skcm_yale"
"Mutation Status","Mutation Status","STRING",false,"1","MUTATION_STATUS","skcm_yale"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","skcm_yale"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","skcm_yale"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","skcm_yale"
"Sex","Sex","STRING",true,"1","SEX","skcm_yale"
"Specimen Site","Specimen Site","STRING",false,"1","SPECIMEN_SITE","skcm_yale"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","skcm_yale"
"Type","Type","STRING",false,"1","TYPE","skcm_yale"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","stad_pfizer_uhongkong"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","stad_pfizer_uhongkong"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","stad_pfizer_uhongkong"
"EBV Status","Epstein-Barr Virus (EBV) Status","STRING",true,"1","EBV_STATUS","stad_pfizer_uhongkong"
"H-PYLORI Infection","H-PYLORI infection.","STRING",true,"1","H_PYLORI_INFECTION","stad_pfizer_uhongkong"
"MSI","MSI","STRING",true,"1","MSI","stad_pfizer_uhongkong"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","stad_pfizer_uhongkong"
"M Stage","M Stage","STRING",true,"1","M_STAGE","stad_pfizer_uhongkong"
"Neoadjuvant Chemotherapy","Neoadjuvant Chemotherapy.","STRING",true,"1","NEOADJUVANT_CHEMO","stad_pfizer_uhongkong"
"N Stage","N Stage","STRING",true,"1","N_STAGE","stad_pfizer_uhongkong"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","stad_pfizer_uhongkong"
"Pathology Lauren","Pathology Lauren.","STRING",true,"1","PATHOLOGY_LAUREN","stad_pfizer_uhongkong"
"Sex","Sex","STRING",true,"1","SEX","stad_pfizer_uhongkong"
"tumor content","tumor content","NUMBER",false,"1","TUMOR_CONTENT","stad_pfizer_uhongkong"
"Tumor Differentiation","Tumor Differentiation","STRING",false,"1","TUMOR_DIFFERENTIATION","stad_pfizer_uhongkong"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","stad_pfizer_uhongkong"
"T Stage","T Stage","STRING",false,"1","T_STAGE","stad_pfizer_uhongkong"
"UICC Tumor Stage","UICC Tumor Stage","STRING",true,"1","UICC_TUMOR_STAGE","stad_pfizer_uhongkong"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","stad_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","stad_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","stad_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","stad_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","stad_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","stad_tcga"
"Barretts Esophagus","Barretts esophagus.","STRING",true,"1","BARRETTS_ESOPHAGUS","stad_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","stad_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","stad_tcga"
"City of Procurement","City of procurement.","STRING",true,"1","CITY_OF_PROCUREMENT","stad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","stad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","stad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","stad_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","stad_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","stad_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","stad_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_DEATH","stad_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","stad_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","stad_tcga"
"days_to_patient_progression_free","days_to_patient_progression_free","STRING",true,"1","DAYS_TO_PATIENT_PROGRESSION_FREE","stad_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","stad_tcga"
"days_to_tumor_progression","days_to_tumor_progression","STRING",true,"1","DAYS_TO_TUMOR_PROGRESSION","stad_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","stad_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","stad_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","stad_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","stad_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","stad_tcga"
"Family History of Stomach Cancer","Family history of stomach cancer.","STRING",true,"1","FAMILY_HISTORY_OF_STOMACH_CANCER","stad_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","stad_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","stad_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","stad_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","stad_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","stad_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","stad_tcga"
"H-PYLORI Infection","H-PYLORI infection.","STRING",true,"1","H_PYLORI_INFECTION","stad_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","stad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","stad_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","stad_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","stad_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","stad_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","stad_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","stad_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","stad_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","stad_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","stad_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","stad_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","stad_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","stad_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","stad_tcga"
"Number of lymphnodes positive by ihc","Number of lymphnodes positive by ihc","STRING",true,"1","NUMBER_OF_LYMPHNODES_POSITIVE_BY_IHC","stad_tcga"
"Number of Relatives w/Stomach Cancer","Number of relatives with stomach cancer.","STRING",true,"1","NUMBER_OF_RELATIVES_WITH_STOMACH_CANCER","stad_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","stad_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","stad_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","stad_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","stad_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","stad_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","stad_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","stad_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","stad_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","stad_tcga"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","stad_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","stad_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","stad_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","stad_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","stad_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","stad_tcga"
"Reflux History","History of reflux.","STRING",true,"1","REFLUX_HISTORY","stad_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","stad_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","stad_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","stad_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","stad_tcga"
"Sex","Sex","STRING",true,"1","SEX","stad_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","stad_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","stad_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","stad_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","stad_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","stad_tcga"
"Adjuvant Postoperative Targeted Therapy Administered Indicator","Text term to signify postoperative adjuvant cancer therapies which use drugs to act upon specific molecules, metabolic pathways or processes involved in carcinogenesis, tumor growth, or tumor spread. [Manually-curated]","STRING",true,"1","TARGETED_MOLECULAR_THERAPY","stad_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","stad_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","stad_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","stad_tcga"
"Treatment","Treatment","STRING",true,"1","TREATMENT","stad_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","stad_tcga"
"Treatment Type","Treatment Type","STRING",true,"1","TREATMENT_TYPE","stad_tcga"
"Tumor sample procurement country","Tumor sample procurement country","STRING",true,"1","TUMOR_SAMPLE_PROCUREMENT_COUNTRY","stad_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","stad_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","stad_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","stad_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","stad_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","stad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","stad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","stad_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","stad_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","stad_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","stad_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","stad_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","stad_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","stad_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","stad_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","stad_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","stad_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","stad_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","stad_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","stad_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","stad_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","stad_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","stad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","stad_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","stad_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","stad_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","stad_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","stad_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","stad_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","stad_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","stad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","stad_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","stad_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","stad_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","stad_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","stad_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","stad_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","stad_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","stad_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","stad_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","stad_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","stad_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","stad_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","stad_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","stad_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","stad_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","stad_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","stad_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","stad_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","stad_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","stad_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","stad_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","stad_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","stad_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","stad_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","stad_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","stad_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","stad_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","stad_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","stad_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","stad_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","stad_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","stad_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","stad_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","stad_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","stad_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","stad_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","stad_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","stad_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","stad_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","stad_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","stad_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","stad_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","stad_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","stad_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","stad_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","stad_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","stad_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","stad_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","stad_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","stad_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","stad_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","stad_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","stad_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","stad_tcga_pan_can_atlas_2018"
"Absolute Extract Ploidy","Absolute extract ploidy.","NUMBER",false,"1","ABSOLUTE_EXTRACT_PLOIDY","stad_tcga_pub"
"Absolute Extract Purity","Absolute extract purity.","NUMBER",false,"1","ABSOLUTE_EXTRACT_PURITY","stad_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","stad_tcga_pub"
"Anatomic Region","Anatomic Region.","STRING",true,"1","ANATOMIC_REGION","stad_tcga_pub"
"ARHGAP26-ARHGAP6-CLDN18 Rearrangement","ARHGAP26-ARHGAP6-CLDN18 Rearrangement.","STRING",false,"1","ARHGAP26_ARHGAP6_CLDN18_REARRANGEMENT","stad_tcga_pub"
"ARID1A Mutation","ARID1A mutation is present.","STRING",false,"1","ARID1A_MUTATION","stad_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","stad_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","stad_tcga_pub"
"CDKN2A Silencing","Epigenetic silencing status of CDKN2A.","STRING",false,"1","CDKN2A_SILENCING","stad_tcga_pub"
"CIMP Category","CIMP category.","STRING",false,"1","CIMP_CATEGORY","stad_tcga_pub"
"Copy Number Cluster","Copy number cluster.","STRING",true,"1","COPY_NUMBER_CLUSTER","stad_tcga_pub"
"Country of Procurement","Country of procurement.","STRING",true,"1","COUNTRY_OF_PROCUREMENT","stad_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","stad_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","stad_tcga_pub"
"EBV Present","EBV present.","STRING",true,"1","EBV_PRESENT","stad_tcga_pub"
"Estimated Leukocyte Percentage","Estimated leukocyte percentage.","NUMBER",false,"1","ESTIMATED_LEUKOCYTE_PERCENTAGE","stad_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","stad_tcga_pub"
"Gene Expression Cluster","Gene expression cluster.","STRING",false,"1","GENE_EXPRESSION_CLUSTER","stad_tcga_pub"
"Hyper-mutated","Hyper-mutated.","STRING",false,"1","HYPERMUTATED","stad_tcga_pub"
"Intestinal Type Subclass","Intestinal type subclass.","STRING",true,"1","INTESTINAL_TYPE_SUBCLASS","stad_tcga_pub"
"KRAS Mutation","KRAS mutation is present.","STRING",false,"1","KRAS_MUTATION","stad_tcga_pub"
"Lauren Class","Lauren class.","STRING",true,"1","LAUREN_CLASS","stad_tcga_pub"
"Methylation Cluster","Methylation cluster.","STRING",false,"1","METHYLATION_CLUSTER","stad_tcga_pub"
"MET Skipped Exons 18 & 19","MET skipped exons 18 and 19.","STRING",false,"1","MET_SKIPPED_EXONS_18_AND_19","stad_tcga_pub"
"MET Skipped Exon 2","MET skipped exon 2.","STRING",false,"1","MET_SKIPPED_EXON_2","stad_tcga_pub"
"MicroRNA Expression Cluster","MicroRNA expression cluster.","STRING",false,"1","MICRORNA_EXPRESSION_CLUSTER","stad_tcga_pub"
"MLH1 Silencing","Epigenetic silencing status of MLH1.","STRING",false,"1","MLH1_SILENCING","stad_tcga_pub"
"Molecular Subtype","Molecular subtype.","STRING",false,"1","MOLECULAR_SUBTYPE","stad_tcga_pub"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","stad_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","stad_tcga_pub"
"Mutation Rate","Mutation Rate","NUMBER",false,"1","MUTATION_RATE","stad_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","stad_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","stad_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","stad_tcga_pub"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","stad_tcga_pub"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","stad_tcga_pub"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","stad_tcga_pub"
"Percent Lymphocyte Infiltration","Numeric value to represent the percentage of infiltration by lymphocytes in a tumor sample or specimen.","NUMBER",true,"1","PERCENT_LYMPHOCYTE_INFILTRATION","stad_tcga_pub"
"Percent Tumor Cells","Numeric value to represent the percentage of malignant cell tumor nuclei content in a tumor sample or specimen.","NUMBER",true,"1","PERCENT_TUMOR_CELLS","stad_tcga_pub"
"Percent Tumor Nuclei","Numeric value to represent the percentage of tumor nuclei in a malignant neoplasm sample or specimen.","NUMBER",true,"1","PERCENT_TUMOR_NUCLEI","stad_tcga_pub"
"PIK3CA Mutation","PIK3CA mutation is present.","STRING",false,"1","PIK3CA_MUTATION","stad_tcga_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","stad_tcga_pub"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","stad_tcga_pub"
"RHOA Mutation","RHOA mutation is present.","STRING",false,"1","RHOA_MUTATION","stad_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","stad_tcga_pub"
"Signet Ring","Signet ring.","STRING",true,"1","SIGNET_RING","stad_tcga_pub"
"TNM Stage","TNM Stage.","STRING",false,"1","TNMSTAGE","stad_tcga_pub"
"TP53 Mutation","TP53 mutation is present.","STRING",false,"1","TP53_MUTATION","stad_tcga_pub"
"WHO Class","WHO class.","STRING",true,"1","WHO_CLASS","stad_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","stad_uhongkong"
"CANCER_SPECIFIC_SURVIVAL_MONTH_","CANCER_SPECIFIC_SURVIVAL_MONTH_","NUMBER",true,"1","CANCER_SPECIFIC_SURVIVAL_MONTH_","stad_uhongkong"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","stad_uhongkong"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","stad_uhongkong"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","stad_uhongkong"
"EBV Status","Epstein-Barr Virus (EBV) Status","STRING",true,"1","EBV_STATUS","stad_uhongkong"
"H-PYLORI Infection","H-PYLORI infection.","STRING",true,"1","H_PYLORI_INFECTION","stad_uhongkong"
"MSI","MSI","STRING",true,"1","MSI","stad_uhongkong"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","stad_uhongkong"
"M Stage","M Stage","STRING",true,"1","M_STAGE","stad_uhongkong"
"N Stage","N Stage","STRING",true,"1","N_STAGE","stad_uhongkong"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","stad_uhongkong"
"OPERATION_TYPE","OPERATION_TYPE","STRING",true,"1","OPERATION_TYPE","stad_uhongkong"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","stad_uhongkong"
"Pathology Lauren","Pathology Lauren.","STRING",true,"1","PATHOLOGY_LAUREN","stad_uhongkong"
"RECURRENCE_STATUS","RECURRENCE_STATUS","STRING",true,"1","RECURRENCE_STATUS","stad_uhongkong"
"Sex","Sex","STRING",true,"1","SEX","stad_uhongkong"
"tumor content","tumor content","NUMBER",false,"1","TUMOR_CONTENT","stad_uhongkong"
"Tumor Differentiation","Tumor Differentiation","STRING",false,"1","TUMOR_DIFFERENTIATION","stad_uhongkong"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","stad_uhongkong"
"T Stage","T Stage","STRING",false,"1","T_STAGE","stad_uhongkong"
"UICC_TUMOR","UICC_TUMOR","STRING",true,"1","UICC_TUMOR","stad_uhongkong"
"Age Group at Diagnosis in Years","Age Group at Diagnosis in Years","STRING",true,"1","AGE_GROUP","stad_utokyo"
"Bone Scan Result","Bone scan result.","STRING",true,"1","BONE_SCAN_RESULT","stad_utokyo"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","stad_utokyo"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","stad_utokyo"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","stad_utokyo"
"HER2 ihc score","HER2 immunohistochemistry level result","NUMBER",false,"1","HER2_IHC_SCORE","stad_utokyo"
"Lauren Class","Lauren class.","STRING",true,"1","LAUREN_CLASS","stad_utokyo"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","stad_utokyo"
"M Stage","M Stage","STRING",true,"1","M_STAGE","stad_utokyo"
"N Stage","N Stage","STRING",true,"1","N_STAGE","stad_utokyo"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","stad_utokyo"
"RHOA Mutation","RHOA mutation is present.","STRING",false,"1","RHOA_MUTATION","stad_utokyo"
"Sex","Sex","STRING",true,"1","SEX","stad_utokyo"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","stad_utokyo"
"T Stage","T Stage","STRING",false,"1","T_STAGE","stad_utokyo"
"UICC Tumor Stage","UICC Tumor Stage","STRING",true,"1","UICC_TUMOR_STAGE","stad_utokyo"
"Absolute cancer dna fraction","Absolute cancer dna fraction","NUMBER",false,"1","ABSOLUTE_CANCER_DNA_FRACTION","stes_tcga_pub"
"Absolute Extract Ploidy","Absolute extract ploidy.","NUMBER",false,"1","ABSOLUTE_EXTRACT_PLOIDY","stes_tcga_pub"
"Absolute Extract Purity","Absolute extract purity.","NUMBER",false,"1","ABSOLUTE_EXTRACT_PURITY","stes_tcga_pub"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","stes_tcga_pub"
"ARHGAP26-ARHGAP6-CLDN18 Rearrangement","ARHGAP26-ARHGAP6-CLDN18 Rearrangement.","STRING",false,"1","ARHGAP26_ARHGAP6_CLDN18_REARRANGEMENT","stes_tcga_pub"
"ARID1A Protein Coding","ARID1A Protein Coding","NUMBER",false,"1","ARID1A_PROTEIN_CODING","stes_tcga_pub"
"Barretts Esophagus","Barretts esophagus.","STRING",true,"1","BARRETTS_ESOPHAGUS","stes_tcga_pub"
"Cancer Type","Disease type","STRING",false,"1","CANCER_TYPE","stes_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","stes_tcga_pub"
"CDKN2A Methylation","CDKN2A Methylation","STRING",false,"1","CDKN2A_MET","stes_tcga_pub"
"CDKN2A Silencing","Epigenetic silencing status of CDKN2A.","STRING",false,"1","CDKN2A_SILENCING","stes_tcga_pub"
"Country","Country of procurement.","STRING",true,"1","COUNTRY","stes_tcga_pub"
"Days from surgery to last followup","Days from surgery to last followup","NUMBER",true,"1","DAYS_FROM_SURGERY_TO_LAST_FOLLOWUP","stes_tcga_pub"
"Days from surgery to recurrence","Days from surgery to recurrence","NUMBER",true,"1","DAYS_FROM_SURGERY_TO_RECURRENCE","stes_tcga_pub"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","stes_tcga_pub"
"Distant Metastasis Pathologic Spread","Distant metastasis pathologic spread.","STRING",false,"1","DISTANT_METASTASIS_PATHOLOGIC_SPREAD","stes_tcga_pub"
"DNA Methylation Cluster - EC","DNA Methylation Cluster - EC","STRING",false,"1","DNA_METHYLATION_CLUSTER_EC","stes_tcga_pub"
"DNA Methylation Cluster - GEA","DNA Methylation Cluster - GEA","STRING",false,"1","DNA_METHYLATION_CLUSTER_GEA","stes_tcga_pub"
"DNA Methylation Cluster - GEA-CIN","DNA Methylation Cluster - GEA-CIN","STRING",false,"1","DNA_METHYLATION_CLUSTER_GEA_CIN","stes_tcga_pub"
"DNA Methylation Cluster - SCC","DNA Methylation Cluster - SCC","STRING",false,"1","DNA_METHYLATION_CLUSTER_SCC","stes_tcga_pub"
"EBV Positive","EBV Positive","NUMBER",true,"1","EBV_POSITIVE","stes_tcga_pub"
"EC","EC","STRING",true,"1","EC","stes_tcga_pub"
"EC-SMG","EC-SMG","STRING",true,"1","EC-SMG","stes_tcga_pub"
"Esophageal tumor cental location","Esophageal tumor cental location","STRING",false,"1","ESOPHAGEAL_TUMOR_LOCATION_CENTERED","stes_tcga_pub"
"Estimated Leukocyte Percentage","Estimated leukocyte percentage.","NUMBER",false,"1","ESTIMATED_LEUKOCYTE_PERCENTAGE","stes_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","stes_tcga_pub"
"Gastric Classification","Gastric Classification","STRING",false,"1","GASTRIC_CLASSIFICATION","stes_tcga_pub"
"GEA","GEA","STRING",true,"1","GEA","stes_tcga_pub"
"GEA-CIN","GEA-CIN","STRING",true,"1","GEA-CIN","stes_tcga_pub"
"GEA-CIN-SMG","GEA-CIN-SMG","STRING",true,"1","GEA-CIN-SMG","stes_tcga_pub"
"GEA-GEJ","GEA-GEJ","STRING",true,"1","GEA-GEJ","stes_tcga_pub"
"GEA-SMG","GEA-SMG","STRING",true,"1","GEA-SMG","stes_tcga_pub"
"GEA CIN Integrated Cluster COCA","GEA CIN Integrated Cluster COCA","STRING",false,"1","GEA_CIN_INTEGRATED_CLUSTER_COCA","stes_tcga_pub"
"GEA CIN Integrated Cluster Consensus","GEA CIN Integrated Cluster Consensus","STRING",false,"1","GEA_CIN_INTEGRATED_CLUSTER_CONSENSUS","stes_tcga_pub"
"GEA CIN Integrated Cluster iCluster","GEA CIN Integrated Cluster iCluster","STRING",false,"1","GEA_CIN_INTEGRATED_CLUSTER_ICLUSTER","stes_tcga_pub"
"GEA CIN Integrated Cluster MKL KNN 4","GEA CIN Integrated Cluster MKL KNN 4","STRING",false,"1","GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_4","stes_tcga_pub"
"GEA CIN Integrated Cluster MKL KNN 7","GEA CIN Integrated Cluster MKL KNN 7","STRING",false,"1","GEA_CIN_INTEGRATED_CLUSTER_MKL_KNN_7","stes_tcga_pub"
"GEA CIN Integrated Cluster SuperCluster","GEA CIN Integrated Cluster SuperCluster","STRING",false,"1","GEA_CIN_INTEGRATED_CLUSTER_SUPERCLUSTER","stes_tcga_pub"
"GEA CIN Integrated Cluster Voting","GEA CIN Integrated Cluster Voting","STRING",false,"1","GEA_CIN_INTEGRATED_CLUSTER_VOTING","stes_tcga_pub"
"GEJ Category","GEJ Category","STRING",true,"1","GEJ_CATEGORY","stes_tcga_pub"
"Gene Expression Cluster - GEA-CIN","Gene Expression Cluster - GEA-CIN","STRING",false,"1","GENE_EXPRESSION_CLUSTER_GEA_CIN","stes_tcga_pub"
"Genome Doublings","Genome Doublings","STRING",false,"1","GENOME_DOUBLINGS","stes_tcga_pub"
"Neoplasm Histologic Grade","""Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.""","STRING",false,"1","GRADE","stes_tcga_pub"
"HER2 Amplification Status","HER2 Amplification Status","STRING",false,"1","HER2_AMPLIFICATION_STATUS","stes_tcga_pub"
"Intestinal Type Subclass","Intestinal type subclass.","STRING",true,"1","INTESTINAL_TYPE_SUBCLASS","stes_tcga_pub"
"KRAS Protein Coding","KRAS Protein Coding","NUMBER",false,"1","KRAS_PROTEIN_CODING","stes_tcga_pub"
"Lauren Class","Lauren class.","STRING",true,"1","LAUREN_CLASS","stes_tcga_pub"
"Major Anatomic Site","Major Anatomic Site","STRING",false,"1","MAJOR_ANATOMIC_SITE","stes_tcga_pub"
"MET Skipped Exons 18 & 19","MET skipped exons 18 and 19.","STRING",false,"1","MET_SKIPPED_EXONS_18_AND_19","stes_tcga_pub"
"MET Skipped Exon 2","MET skipped exon 2.","STRING",false,"1","MET_SKIPPED_EXON_2","stes_tcga_pub"
"miRNA Expression Cluster - EC","miRNA Expression Cluster - EC","STRING",false,"1","MIRNA_EXPRESSION_CLUSTER_EC","stes_tcga_pub"
"miRNA Expression Cluster - GEA","miRNA Expression Cluster - GEA","STRING",false,"1","MIRNA_EXPRESSION_CLUSTER_GEA","stes_tcga_pub"
"miRNA Expression Cluster - GEA-CIN","miRNA Expression Cluster - GEA-CIN","STRING",false,"1","MIRNA_EXPRESSION_CLUSTER_GEA_CIN","stes_tcga_pub"
"miRNA Expression Cluster - SCC","miRNA Expression Cluster - SCC","STRING",false,"1","MIRNA_EXPRESSION_CLUSTER_SCC","stes_tcga_pub"
"MLH1 Methylation","MLH1 methylation.","STRING",false,"1","MLH1_METHYLATION","stes_tcga_pub"
"MLH1 Silencing","Epigenetic silencing status of MLH1.","STRING",false,"1","MLH1_SILENCING","stes_tcga_pub"
"MRNA Expression Cluster EC","MRNA Expression Cluster EC","STRING",false,"1","MRNA_EXPRESSION_CLUSTER_EC","stes_tcga_pub"
"MRNA Expression Cluster GEA","MRNA Expression Cluster GEA","STRING",false,"1","MRNA_EXPRESSION_CLUSTER_GEA","stes_tcga_pub"
"MRNA Expression Cluster SCC","MRNA Expression Cluster SCC","STRING",false,"1","MRNA_EXPRESSION_CLUSTER_SCC","stes_tcga_pub"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","stes_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","stes_tcga_pub"
"Mutation Rate","Mutation Rate","NUMBER",false,"1","MUTATION_RATE","stes_tcga_pub"
"Mutation Rate Cluster","Mutation rate cluster","STRING",false,"1","MUTATION_RATE_CLUSTER","stes_tcga_pub"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","stes_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","stes_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","stes_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","stes_tcga_pub"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","stes_tcga_pub"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","stes_tcga_pub"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","stes_tcga_pub"
"Percent Lymphocyte Infiltration","Numeric value to represent the percentage of infiltration by lymphocytes in a tumor sample or specimen.","NUMBER",true,"1","PERCENT_LYMPHOCYTE_INFILTRATION","stes_tcga_pub"
"Percent Tumor Cells","Numeric value to represent the percentage of malignant cell tumor nuclei content in a tumor sample or specimen.","NUMBER",true,"1","PERCENT_TUMOR_CELLS","stes_tcga_pub"
"Percent Tumor Nuclei","Numeric value to represent the percentage of tumor nuclei in a malignant neoplasm sample or specimen.","NUMBER",true,"1","PERCENT_TUMOR_NUCLEI","stes_tcga_pub"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","stes_tcga_pub"
"PIK3CA Protein Coding","PIK3CA Protein Coding","NUMBER",false,"1","PIK3CA_PROTEIN_CODING","stes_tcga_pub"
"RHOA Protein Coding","RHOA Protein Coding","NUMBER",false,"1","PROTEIN_CODING_RHOA","stes_tcga_pub"
"Recurrence","Recurrence","STRING",true,"1","RECURRENCE","stes_tcga_pub"
"Reflux History","History of reflux.","STRING",true,"1","REFLUX_HISTORY","stes_tcga_pub"
"Regional Lymph Node","Regional Lymph Node","STRING",false,"1","REGIONAL_LYMPH_NODE","stes_tcga_pub"
"Regional Lymph Nodes","Regional Lymph Nodes","STRING",true,"1","REGIONAL_LYMPH_NODES","stes_tcga_pub"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","stes_tcga_pub"
"RPPA Cluster - GEA","RPPA Cluster - GEA","STRING",false,"1","RPPA_CLUSTER _GEA","stes_tcga_pub"
"RPPA Cluster - GEA-CIN","RPPA Cluster - GEA-CIN","STRING",false,"1","RPPA_CLUSTER _GEA_CIN","stes_tcga_pub"
"RPPA Cluster - EC","RPPA Cluster - EC","STRING",false,"1","RPPA_CLUSTER_EC","stes_tcga_pub"
"RPPA Cluster - SCC","RPPA Cluster - SCC","STRING",false,"1","RPPA_CLUSTER_SCC","stes_tcga_pub"
"SCC","SCC","STRING",true,"1","SCC","stes_tcga_pub"
"SCC-SMG","SCC-SMG","STRING",true,"1","SCC-SMG","stes_tcga_pub"
"SCC Cluster iCluster and SMARCA4","SCC Cluster iCluster and SMARCA4","STRING",false,"1","SCC_CLUSTER_ICLUSTER_AND_SMARCA4","stes_tcga_pub"
"SCNA Cluster EC","SCNA Cluster EC","STRING",false,"1","SCNA_CLUSTER_EC","stes_tcga_pub"
"SCNA Cluster GEA","SCNA Cluster GEA","STRING",false,"1","SCNA_CLUSTER_GEA","stes_tcga_pub"
"SCNA Cluster GEA CIN","SCNA Cluster GEA CIN","STRING",false,"1","SCNA_CLUSTER_GEA_CIN","stes_tcga_pub"
"SCNA Cluster SCC","SCNA Cluster SCC","STRING",false,"1","SCNA_CLUSTER_SCC","stes_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","stes_tcga_pub"
"Signet Ring","Signet ring.","STRING",true,"1","SIGNET_RING","stes_tcga_pub"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","stes_tcga_pub"
"TNM Stage","TNM stage.","STRING",false,"1","TNMSTAGE","stes_tcga_pub"
"Patient Smoking History Category","Category describing current smoking status and smoking history as self-reported by a patient.","STRING",true,"1","TOBACCO_SMOKING_HISTORY_INDICATOR","stes_tcga_pub"
"TP53 Protein Coding","TP53 Protein Coding","NUMBER",false,"1","TP53_PROTEIN_CODING","stes_tcga_pub"
"Tumor extent","Tumor extent","STRING",true,"1","TUMOR_EXTENT","stes_tcga_pub"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","stes_tcga_pub"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","stes_tcga_pub"
"WHO Class","WHO class.","STRING",true,"1","WHO_CLASS","stes_tcga_pub"
"Amplification Status","Amplification Status","STRING",false,"1","AMPLIFICATION_STATUS","summit_2018"
"Best objective response rate","Best objective response rate","STRING",true,"1","BEST_ORR","summit_2018"
"Bubble Group","Bubble Group","STRING",false,"1","BUBBLE_GROUP","summit_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","summit_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","summit_2018"
"Central","Central","STRING",false,"1","CENTRAL","summit_2018"
"Clonality","Clonality","STRING",false,"1","CLONALITY","summit_2018"
"Cohort","Cohort.","STRING",true,"1","COHORT","summit_2018"
"Coverage","Coverage","STRING",false,"1","COVERAGE","summit_2018"
"Criteria","Criteria","STRING",false,"1","CRITERIA","summit_2018"
"Data","Data","STRING",false,"1","DATA","summit_2018"
"Domain","Domain","STRING",false,"1","DOMAIN","summit_2018"
"duration of therapy days","duration of therapy days","STRING",true,"1","DURATION_OF_THERAPY_DAYS","summit_2018"
"ER_PR","ER_PR","STRING",false,"1","ER_PR_STATUS","summit_2018"
"Gene","Gene","STRING",false,"1","GENE","summit_2018"
"Matched Normal","Has matched normal.","STRING",false,"1","HAS_MATCHED_NORMAL","summit_2018"
"IMPACT","IMPACT","STRING",false,"1","IMPACT","summit_2018"
"Local Test","Local Test","STRING",false,"1","LOCAL_TEST","summit_2018"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","summit_2018"
"Multi ERBB2","Multi ERBB2","STRING",false,"1","MULTI_ERBB2","summit_2018"
"Mutation Burden","Mutation Burden","STRING",false,"1","MUTATION_BURDEN","summit_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","summit_2018"
"Oncoprint","Oncoprint","STRING",false,"1","ONCOPRINT","summit_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","summit_2018"
"Ongoing Treatment","Ongoing Treatment","STRING",true,"1","ONGOING_TREATMENT","summit_2018"
"Progress Free Survival (Months)","Progress Free Survival (Months)","NUMBER",true,"1","PFS_MONTHS","summit_2018"
"Purity","Purity","NUMBER",false,"1","PURITY","summit_2018"
"Qualifying Mutation","Qualifying Mutation","STRING",false,"1","QUALIFYING_MUT","summit_2018"
"TumorChange","TumorChange","STRING",false,"1","TUMOR_CHANGE","summit_2018"
"Waterfall Group","Waterfall Group","STRING",false,"1","WATERFALL_GROUP","summit_2018"
"ACGH Data","ACGH Data.","STRING",false,"1","ACGH_DATA","tet_nci_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","tet_nci_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","tet_nci_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","tet_nci_2014"
"Diagnosis","Diagnosis.","STRING",true,"1","DIAGNOSIS","tet_nci_2014"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","tet_nci_2014"
"GTF2I Mutation Status","GTF2I Mutation Status","STRING",false,"1","GTF2I_MUTATION_STATUS","tet_nci_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","tet_nci_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","tet_nci_2014"
"Sex","Sex","STRING",true,"1","SEX","tet_nci_2014"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","tet_nci_2014"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","tet_nci_2014"
"WHO Class","WHO class.","STRING",true,"1","WHO_CLASS","tet_nci_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","tgct_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_CLINICAL_TUMOR_STAGE","tgct_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","tgct_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","tgct_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CN","tgct_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CT","tgct_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","tgct_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","tgct_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","tgct_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","tgct_tcga"
"Bilateral Diagnosis Timing Type","Bilateral Diagnosis Timing Type","STRING",true,"1","BILATERAL_DIAGNOSIS_TIMING_TYPE","tgct_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","tgct_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","tgct_tcga"
"Cause of death source","Source of patient death reason","STRING",true,"1","CAUSE_OF_DEATH_SOURCE","tgct_tcga"
"Days to bilateral tumor dx","Days to bilateral tumor dx","NUMBER",true,"1","DAYS_TO_BILATERAL_TUMOR_DX","tgct_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","tgct_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","tgct_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","tgct_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","tgct_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_LAST_FOLLOWUP","tgct_tcga"
"Days to post orchi serum test","Days to post orchi serum test","NUMBER",true,"1","DAYS_TO_POST_ORCHI_SERUM_TEST","tgct_tcga"
"Days to pre orchi serum test","Days to pre orchi serum test","NUMBER",true,"1","DAYS_TO_PRE_ORCHI_SERUM_TEST","tgct_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","tgct_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","tgct_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","tgct_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","tgct_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","tgct_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","tgct_tcga"
"Family History Cancer Relationship","Text indicator to represent a report or record of a cancer diagnosis in any relative with whom one half of an individuals genes is shared (i.e., parent, sibling, offspring).","STRING",true,"1","FAMILY_HISTORY_CANCER_RELATIONSHIP","tgct_tcga"
"Family history other cancer","Family history other cancer","STRING",true,"1","FAMILY_HISTORY_OTHER_CANCER","tgct_tcga"
"Family history testicular cancer","Family history testicular cancer","STRING",true,"1","FAMILY_HISTORY_TESTICULAR_CANCER","tgct_tcga"
"First treatment success","First treatment success","STRING",true,"1","FIRST_TREATMENT_SUCCESS","tgct_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","tgct_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","tgct_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","tgct_tcga"
"Histologic diagnosis percent","Histological percentage","STRING",true,"1","HISTOLOGIC_DIAGNOSIS_PERCENT","tgct_tcga"
"History fertility","History fertility","STRING",true,"1","HISTORY_FERTILITY","tgct_tcga"
"History hypospadias","History hypospadias","STRING",true,"1","HISTORY_HYPOSPADIAS","tgct_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","tgct_tcga"
"History of undescended testis","History of undescended testis","STRING",true,"1","HISTORY_OF_UNDESCENDED_TESTIS","tgct_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","tgct_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","tgct_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","tgct_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","tgct_tcga"
"Igcccg stage","Igcccg stage","STRING",true,"1","IGCCCG_STAGE","tgct_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","tgct_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","tgct_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","tgct_tcga"
"Intratubular germ cell neoplasm","Intratubular germ cell neoplasm","STRING",true,"1","INTRATUBULAR_GERM_CELL_NEOPLASM","tgct_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","tgct_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","tgct_tcga"
"Level of non descent","Level of non descent","STRING",true,"1","LEVEL_OF_NON_DESCENT","tgct_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","tgct_tcga"
"Lymphovascular invasion present","Lymphovascular invasion present","STRING",true,"1","LYMPHOVASCULAR_INVASION_PRESENT","tgct_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","tgct_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","tgct_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","tgct_tcga"
"Molecular test result","Molecular test result","STRING",true,"1","MOLECULAR_TEST_RESULT","tgct_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","tgct_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","tgct_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","tgct_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","tgct_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","tgct_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","tgct_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","tgct_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","tgct_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","tgct_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","tgct_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","tgct_tcga"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","tgct_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","tgct_tcga"
"Postoperative tx","Postoperative tx","STRING",true,"1","POSTOPERATIVE_TX","tgct_tcga"
"Post orchi afp","Post orchi afp","NUMBER",true,"1","POST_ORCHI_AFP","tgct_tcga"
"Post orchi hcg","Post orchi hcg","NUMBER",true,"1","POST_ORCHI_HCG","tgct_tcga"
"Post orchi ldh","Post orchi ldh","NUMBER",true,"1","POST_ORCHI_LDH","tgct_tcga"
"Post orchi lh","Post orchi lh","NUMBER",true,"1","POST_ORCHI_LH","tgct_tcga"
"Post orchi lymph node dissection","Post orchi lymph node dissection","STRING",true,"1","POST_ORCHI_LYMPH_NODE_DISSECTION","tgct_tcga"
"Post orchi testosterone","Post orchi testosterone","STRING",true,"1","POST_ORCHI_TESTOSTERONE","tgct_tcga"
"Pre orchi afp","Pre orchi afp","NUMBER",true,"1","PRE_ORCHI_AFP","tgct_tcga"
"Pre orchi hcg","Pre orchi hcg","NUMBER",true,"1","PRE_ORCHI_HCG","tgct_tcga"
"Pre orchi ldh","Pre orchi ldh","NUMBER",true,"1","PRE_ORCHI_LDH","tgct_tcga"
"Pre orchi lh","Pre orchi lh","NUMBER",true,"1","PRE_ORCHI_LH","tgct_tcga"
"Pre orchi testosterone","Pre orchi testosterone","STRING",true,"1","PRE_ORCHI_TESTOSTERONE","tgct_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","tgct_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","tgct_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","tgct_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","tgct_tcga"
"Relation testicular cancer","Relation testicular cancer","STRING",true,"1","RELATION_TESTICULAR_CANCER","tgct_tcga"
"Relative family cancer hx text","Relative family cancer hx text","STRING",true,"1","RELATIVE_FAMILY_CANCER_HX_TEXT","tgct_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","tgct_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","tgct_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","tgct_tcga"
"Serum markers","Serum markers","STRING",true,"1","SERUM_MARKERS","tgct_tcga"
"Sex","Sex","STRING",true,"1","SEX","tgct_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","tgct_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","tgct_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","tgct_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","tgct_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","tgct_tcga"
"Synchronous tumor histology pct","Synchronous tumor histology pct","STRING",true,"1","SYNCHRONOUS_TUMOR_HISTOLOGY_PCT","tgct_tcga"
"Testis tumor macroextent","Testis tumor macroextent","STRING",true,"1","TESTIS_TUMOR_MACROEXTENT","tgct_tcga"
"Testis tumor macroextent other","Testis tumor macroextent other","STRING",true,"1","TESTIS_TUMOR_MACROEXTENT_OTHER","tgct_tcga"
"Testis tumor microextent","Testis tumor microextent","STRING",true,"1","TESTIS_TUMOR_MICROEXTENT","tgct_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","tgct_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","tgct_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","tgct_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","tgct_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","tgct_tcga"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","tgct_tcga"
"Undescended testis corrected","Undescended testis corrected","STRING",true,"1","UNDESCENDED_TESTIS_CORRECTED","tgct_tcga"
"Undescended testis corrected age","Undescended testis corrected age","STRING",true,"1","UNDESCENDED_TESTIS_CORRECTED_AGE","tgct_tcga"
"Undescended testis method left","Undescended testis method left","STRING",true,"1","UNDESCENDED_TESTIS_METHOD_LEFT","tgct_tcga"
"Undescended testis method right","Undescended testis method right","STRING",true,"1","UNDESCENDED_TESTIS_METHOD_RIGHT","tgct_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","tgct_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","tgct_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","tgct_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","tgct_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","tgct_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","tgct_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","tgct_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","tgct_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","tgct_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","tgct_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","tgct_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","tgct_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","tgct_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","tgct_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","tgct_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","tgct_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","tgct_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","tgct_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","tgct_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","tgct_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","tgct_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","tgct_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","tgct_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","tgct_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","tgct_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","tgct_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","tgct_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","tgct_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","tgct_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","tgct_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","tgct_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","tgct_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","tgct_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","tgct_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","tgct_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","tgct_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","tgct_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","tgct_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","tgct_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","tgct_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","tgct_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","tgct_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","tgct_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","tgct_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","tgct_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","tgct_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","tgct_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","tgct_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","tgct_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","tgct_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","tgct_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","tgct_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","tgct_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","tgct_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","tgct_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","tgct_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","tgct_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","tgct_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","tgct_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","tgct_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","tgct_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","tgct_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","tgct_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","tgct_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","tgct_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","tgct_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","tgct_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","tgct_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","tgct_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","tgct_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","tgct_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","tgct_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","tgct_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","tgct_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","tgct_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","tgct_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","tgct_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","tgct_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","tgct_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","tgct_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","tgct_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","tgct_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","thca_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","thca_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","thca_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","thca_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","thca_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","thca_tcga"
"BRAF mutation","BRAF mutation","STRING",true,"1","BRAF_MUTATION","thca_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","thca_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","thca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","thca_tcga"
"Clinical Status Within 3 Mths Surgery","Clinical Status Within 3 Mths Surgery","STRING",true,"1","CLINICAL_STATUS_WITHIN_3_MTHS_SURGERY","thca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","thca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","thca_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","thca_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","thca_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","thca_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","thca_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","thca_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","thca_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","thca_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","thca_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","thca_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","thca_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","thca_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","thca_tcga"
"Extrathyroidal Extension","Extrathyroidal Extension","STRING",true,"1","EXTRATHYROIDAL_EXTENSION","thca_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","thca_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","thca_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","thca_tcga"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","thca_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","thca_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","thca_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","thca_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","thca_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","thca_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","thca_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","thca_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","thca_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","thca_tcga"
"Primary Tumor Laterality","For tumors in paired organs, designates the side on which the cancer originates.","STRING",true,"1","LATERALITY","thca_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","thca_tcga"
"Primary Lymph Node Presentation Assessment Ind-3","the yes/no/unknown indicator whether a lymph node assessment was performed at the primary presentation of disease.","STRING",true,"1","LYMPH_NODES_EXAMINED","thca_tcga"
"Positive Finding Lymph Node Hematoxylin and Eosin Staining Microscopy Count","Numeric value to signify the count of positive lymph nodes identified through hematoxylin and eosin (H&E) staining light microscopy.","NUMBER",true,"1","LYMPH_NODES_EXAMINED_HE_COUNT","thca_tcga"
"Lymph Node(s) Examined Number","The total number of lymph nodes removed and pathologically assessed for disease.","NUMBER",true,"1","LYMPH_NODE_EXAMINED_COUNT","thca_tcga"
"Metastatic Neoplasm Confirmed Diagnosis Method Name","Metastatic Neoplasm Confirmed Diagnosis Method Name","STRING",true,"1","METASTATIC_DX_CONFIRMED_BY","thca_tcga"
"Metastatic Neoplasm Confirmed Diagnosis Method Text","Metastatic Neoplasm Confirmed Diagnosis Method Text","STRING",true,"1","METASTATIC_DX_CONFIRMED_BY_OTHER","thca_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","thca_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","thca_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","thca_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","thca_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","thca_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","thca_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","thca_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","thca_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","thca_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","thca_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","thca_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","thca_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","thca_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","thca_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","thca_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","thca_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","thca_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","thca_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","thca_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","thca_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","thca_tcga"
"Sex","Sex","STRING",true,"1","SEX","thca_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","thca_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","thca_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","thca_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","thca_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","thca_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","thca_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","thca_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","thca_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","thca_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","thca_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","thca_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","thca_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","thca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","thca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","thca_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","thca_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","thca_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","thca_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","thca_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","thca_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","thca_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","thca_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","thca_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","thca_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","thca_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","thca_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","thca_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","thca_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","thca_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","thca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","thca_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","thca_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","thca_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","thca_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","thca_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","thca_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","thca_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","thca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","thca_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","thca_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","thca_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","thca_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","thca_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","thca_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","thca_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","thca_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","thca_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","thca_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","thca_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","thca_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","thca_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","thca_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","thca_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","thca_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","thca_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","thca_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","thca_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","thca_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","thca_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","thca_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","thca_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","thca_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","thca_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","thca_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","thca_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","thca_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","thca_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","thca_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","thca_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","thca_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","thca_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","thca_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","thca_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","thca_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","thca_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","thca_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","thca_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","thca_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","thca_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","thca_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","thca_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","thca_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","thca_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","thca_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","thca_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","thca_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","thca_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","thca_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","thca_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","thca_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","thca_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","thca_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","thca_tcga_pub"
"ArmDriver CN","ArmDriver CN","STRING",false,"1","ARMDRIVER_CN","thca_tcga_pub"
"Arm-level SCNA cluster assignment","Arm-level SCNA cluster assignment","STRING",false,"1","ARM_SCNA_CLUSTER","thca_tcga_pub"
"BRAFV600E RAF Score","BRAFV600E RAF Score","NUMBER",false,"1","BRAFV600E_RAF_SCORE","thca_tcga_pub"
"BRAF600E mutation vs. RAS mutation sample","BRAF600E mutation vs. RAS mutation sample","STRING",false,"1","BRAFV600E_RAS","thca_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","thca_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","thca_tcga_pub"
"Primary exome sample with no driver found","Primary exome sample with no driver found","STRING",true,"1","DARK","thca_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","thca_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","thca_tcga_pub"
"Differentiation Score","Differentiation Score","NUMBER",false,"1","DIFFERENTIATION_SCORE","thca_tcga_pub"
"Disease Stage","Disease Stage","STRING",false,"1","DISEASE_STAGE","thca_tcga_pub"
"ERK Score","ERK Score ","NUMBER",false,"1","ERK_SCORE","thca_tcga_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","thca_tcga_pub"
"Exome","Exome","STRING",false,"1","EXOME","thca_tcga_pub"
"Extrathyroidal Extension","Extrathyroidal Extension","STRING",false,"1","EXTRATHYROIDAL_EXTENSION","thca_tcga_pub"
"Gene with focal SCNA, CN level","Gene with focal SCNA, CN level","STRING",false,"1","FOCAL_DRIVER_CN","thca_tcga_pub"
"Percentage of follicular component","Percentage of follicular component","STRING",false,"1","FOLLICULAR_COMPONENT_PERCENT","thca_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","thca_tcga_pub"
"Other Gene Fusion","Description of other gene fusions identified by RT-PCR/qPCR/WGS (non-MYB/MYBL1/NFIB).","STRING",true,"1","FUSION_OTHER","thca_tcga_pub"
"Genome Doublings","Genome Doublings","STRING",false,"1","GENOME_DOUBLINGS","thca_tcga_pub"
"Germline nonsense or indels within a set of genes: variant type","Germline nonsense or indels within a set of genes: variant type","STRING",false,"1","GERMLINE_MUT_GENES_VARIANT","thca_tcga_pub"
"Histological Type","Histological Type","STRING",true,"1","HISTOLOGICAL_TYPE","thca_tcga_pub"
"Histological Type Details","Text field to describe the tumor histological type (cancer type).","STRING",false,"1","HISTOLOGICAL_TYPE_OTHER","thca_tcga_pub"
"History radiation exposure","Person lifetime risk radiation exposure indicator","STRING",true,"1","HISTORY_RADIATION_EXPOSURE","thca_tcga_pub"
"Lowpass WGS Sequenced Sample","Lowpass WGS sequenced sample","STRING",false,"1","LOWPASS","thca_tcga_pub"
"MACIS Score","MACIS Score","NUMBER",true,"1","MACIS_SCORE","thca_tcga_pub"
"MB Cov","MB Cov","NUMBER",true,"1","MB_COV","thca_tcga_pub"
"Method for purity (ABSOLUTE SNP AC, or AF for mutation allele fraction only)","Method for purity (ABSOLUTE SNP AC, or AF for mutation allele fraction only)","STRING",false,"1","METHOD_PURITY","thca_tcga_pub"
"Methylation Cluster","Methylation cluster.","STRING",false,"1","METHYLATION_CLUSTER","thca_tcga_pub"
"MIRNA Cluster","MICRNA cluster","STRING",false,"1","MIRNA_CLUSTER","thca_tcga_pub"
"MRNA Cluster","MRNA Cluster","NUMBER",false,"1","MRNA_CLUSTER","thca_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","thca_tcga_pub"
"Mutation Cancer Gene Census Protein Change","Mutation Cancer Gene Census Protein Change","STRING",false,"1","MUT_CANCER_GENE_CENSUS_PROTEIN_CHANGE","thca_tcga_pub"
"Clinicaly relevant gene non-silent mutations; protein-change, alt allele counts","Clinicaly relevant gene non-silent mutations; protein-change, alt allele counts","STRING",false,"1","MUT_CLINDX_TX_GENE_PROTEIN_CHANGE","thca_tcga_pub"
"DNA repair gene non-silent mutations ; protein-change, alt allele counts","DNA repair gene non-silent mutations ; protein-change, alt allele counts","STRING",false,"1","MUT_DNAREPAIR_GENE_PROTEIN_CHANGE","thca_tcga_pub"
"Non-silent mutation protein change BRAF, HRAS, NRAS, KRAS, EIF1AX: number of alternate allele counts","Non-silent mutation protein change BRAF, HRAS, NRAS, KRAS, EIF1AX: number of alternate allele counts","STRING",false,"1","MUT_DRIVER_PROTEIN_CHANGE","thca_tcga_pub"
"Epigenetic modifier gene with protein change and alt allel counts","Epigenetic modifier gene with protein change and alt allel counts","STRING",false,"1","MUT_EPIGENETIC_PROTEIN_CHANGE","thca_tcga_pub"
"Interesting gene with protein change and alt allel counts","Interesting gene with protein change and alt allel counts","STRING",false,"1","MUT_OTHER_PROTEIN_CHANGE","thca_tcga_pub"
"Non-silent mutation protein change PP1MD, CHEK2, TSHR : number of alternate allele counts","Non-silent mutation protein change PP1MD, CHEK2, TSHR : number of alternate allele counts","STRING",false,"1","MUT_RARE_DRIVER_PROTEIN_CHANGE","thca_tcga_pub"
"TumorPortal Gene Lawrence et. al. (2014) cancer genes non-silent mutations; protein-change, alt allele counts","TumorPortal Gene Lawrence et. al. (2014) cancer genes non-silent mutations; protein-change, alt allele counts","STRING",false,"1","MUT_TUMORPORTAL_GENE_PROTEIN_CHANGE","thca_tcga_pub"
"Nonsilent Mutation Density Residual with Age Fit","Nonsilent Mutation Density Residual with Age Fit","NUMBER",false,"1","NONSILENT_DENSITY_AGE_FIT","thca_tcga_pub"
"Nonsilent Mutation Density","Nonsilent Mutation Density","NUMBER",false,"1","NONSILENT_MUTATION_DENSITY","thca_tcga_pub"
"Normal Exome Depth","Normal Exome Depth","NUMBER",false,"1","NORMAL_EXOME_DEPTH","thca_tcga_pub"
"APOBEC Mutation Number","APOBEC Mutation Number","NUMBER",false,"1","NUM_MUT_APOBEC","thca_tcga_pub"
"CpGT Mutation Number","CpGT Mutation Number","NUMBER",false,"1","NUM_MUT_CPGT","thca_tcga_pub"
"Number of mutations in dbSNP","Number of mutations in dbSNP","NUMBER",false,"1","NUM_MUT_DBSNP","thca_tcga_pub"
"Total Number of Nonsilent Mutation","Total Number of Nonsilent Mutation","NUMBER",false,"1","NUM_NONSILENT_MUTATION","thca_tcga_pub"
"Total Number of Silent Mutation","Total Number of Silent Mutation","NUMBER",false,"1","NUM_SILENT_MUTATION","thca_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","thca_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","thca_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","thca_tcga_pub"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","thca_tcga_pub"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","thca_tcga_pub"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","thca_tcga_pub"
"Ploidy","Ploidy.","NUMBER",false,"1","PLOIDY","thca_tcga_pub"
"Sample Has Exome Passing QC","Sample has exome passing QC","STRING",false,"1","PRIMARY_EXOME","thca_tcga_pub"
"Purity","Purity","NUMBER",false,"1","PURITY","thca_tcga_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","thca_tcga_pub"
"Risk Group","Risk group.","STRING",true,"1","RISK_GROUP","thca_tcga_pub"
"RNA-SEQ Data","RNA-SEQ data.","STRING",false,"1","RNASEQ_DATA","thca_tcga_pub"
"RPPA Cluster","RPPA Cluster.","STRING",false,"1","RPPA_CLUSTER","thca_tcga_pub"
"Sex","Sex","STRING",true,"1","SEX","thca_tcga_pub"
"Tumor Exome Depth","Tumor Exome Depth","NUMBER",false,"1","TUMOR_EXOME_DEPTH","thca_tcga_pub"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","thca_tcga_pub"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","thca_tcga_pub"
"WGS Status","Yes/No indicator for WGS data","STRING",false,"1","WGS_STATUS","thca_tcga_pub"
"Ablation embolization tx adjuvant","Ablation embolization tx adjuvant","STRING",true,"1","ABLATION_EMBOLIZATION_TX_ADJUVANT","thym_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","thym_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","thym_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","thym_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","thym_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","thym_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","thym_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","thym_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","thym_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","thym_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_BIRTH","thym_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","thym_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","thym_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","thym_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","thym_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","thym_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","thym_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","thym_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","thym_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","thym_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","thym_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","thym_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","thym_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","thym_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","thym_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","thym_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","thym_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","thym_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","thym_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","thym_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","thym_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","thym_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","thym_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","thym_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","thym_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","thym_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","thym_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","thym_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","thym_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","thym_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","thym_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","thym_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","thym_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","thym_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","thym_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","thym_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","thym_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","thym_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","thym_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","thym_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","thym_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","thym_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","thym_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","thym_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","thym_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","thym_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","thym_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","thym_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","thym_tcga"
"Sex","Sex","STRING",true,"1","SEX","thym_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","thym_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","thym_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","thym_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","thym_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","thym_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","thym_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","thym_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","thym_tcga"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","thym_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","thym_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","thym_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","thym_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","thym_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","thym_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","thym_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","thym_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","thym_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","thym_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","thym_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","thym_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","thym_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","thym_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","thym_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","thym_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","thym_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","thym_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","thym_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","thym_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","thym_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","thym_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","thym_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","thym_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","thym_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","thym_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","thym_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","thym_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","thym_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","thym_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","thym_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","thym_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","thym_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","thym_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","thym_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","thym_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","thym_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","thym_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","thym_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","thym_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","thym_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","thym_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","thym_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","thym_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","thym_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","thym_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","thym_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","thym_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","thym_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","thym_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","thym_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","thym_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","thym_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","thym_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","thym_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","thym_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","thym_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","thym_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","thym_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","thym_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","thym_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","thym_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","thym_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","thym_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","thym_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","thym_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","thym_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","thym_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","thym_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","thym_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","thym_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","thym_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","thym_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","thym_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","thym_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","thym_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","thym_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","thym_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","thym_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","thym_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","thym_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","thym_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","thym_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","thym_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","thym_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","thyroid_mskcc_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","thyroid_mskcc_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","thyroid_mskcc_2016"
"Cytological Phenotype","Cytological Phenotype","STRING",false,"1","CYTOLOGICAL_PHENOTYPE","thyroid_mskcc_2016"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","thyroid_mskcc_2016"
"Growth Pattern","Growth Pattern","STRING",false,"1","GROWTH_PATTERN","thyroid_mskcc_2016"
"Matched Normal","Has matched normal.","STRING",false,"1","HAS_MATCHED_NORMAL","thyroid_mskcc_2016"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",false,"1","METASTATIC_SITE","thyroid_mskcc_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","thyroid_mskcc_2016"
"M Stage","M Stage","STRING",true,"1","M_STAGE","thyroid_mskcc_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","thyroid_mskcc_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","thyroid_mskcc_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","thyroid_mskcc_2016"
"Other Sample ID","Other sample identifier","STRING",false,"1","OTHER_SAMPLE_ID","thyroid_mskcc_2016"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","thyroid_mskcc_2016"
"American Joint Committee on Cancer Tumor Stage Code"," Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC). ","STRING",true,"1","PATH_T_STAGE","thyroid_mskcc_2016"
"PDTC Definition","PDTC Definition","STRING",true,"1","PDTC_DEFINITION","thyroid_mskcc_2016"
"Sample Class","The sample classification (i.e., tumor, cellline, xenograph).","STRING",false,"1","SAMPLE_CLASS","thyroid_mskcc_2016"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"9","SAMPLE_TYPE","thyroid_mskcc_2016"
"Sex","Sex","STRING",true,"1","SEX","thyroid_mskcc_2016"
"Specimen Preservation Type","The method used for preparing the tissue for examination and study.","STRING",false,"1","SPECIMEN_PRESERVATION_TYPE","thyroid_mskcc_2016"
"Tumor Purity","Tumor Purity","NUMBER",false,"1","TUMOR_PURITY","thyroid_mskcc_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","uccc_nih_2017"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","uccc_nih_2017"
"Cohort","Cohort.","STRING",true,"1","COHORT","uccc_nih_2017"
"Normal Sample Coverage(fold)","Normal Sample Coverage(fold)","NUMBER",false,"1","COVERAGE_NORMAL","uccc_nih_2017"
"Estimated Tumor Cellularity","Estimated tumor cellularity.","STRING",false,"1","EST_TUMOR_CELLULARITY","uccc_nih_2017"
"Matched Normal","Has matched normal.","STRING",false,"1","HAS_MATCHED_NORMAL","uccc_nih_2017"
"Mean Coverage (x)","Mean Coverage (x)","NUMBER",false,"1","MEAN_COVERAGE","uccc_nih_2017"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","uccc_nih_2017"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","uccc_nih_2017"
"Secondary Pathological Review","Tumor subject to Secondary Pathological review?","STRING",false,"1","SECONDARY_PATHOLOGICAL_REVIEW","uccc_nih_2017"
"Source","Source","STRING",false,"1","SOURCE","uccc_nih_2017"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ucec_msk_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ucec_msk_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ucec_msk_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ucec_msk_2018"
"IHC Detail","IHC Detail","STRING",true,"1","IHC_DETAIL","ucec_msk_2018"
"MMR-D by IHC","MMR-D by IHC","STRING",false,"1","MMRD_IHC","ucec_msk_2018"
"MSI Status","MSI status.","STRING",false,"1","MSI_STATUS","ucec_msk_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ucec_msk_2018"
"Oncotree Code","Oncotree Code","STRING",false,"0","ONCOTREE_CODE","ucec_msk_2018"
"First-Line Therapy PFS","First-Line Therapy PFS (months)","NUMBER",true,"1","PFS_MONTHS_FIRST_LINE_TX","ucec_msk_2018"
"POLE ultra-mutated","POLE ultra-mutated by IMPACT","STRING",true,"1","POLE_IMPACT","ucec_msk_2018"
"Progression Status","Progression Status","STRING",true,"1","PROGRESSION_STATUS","ucec_msk_2018"
"SCNA Cluster","SCNA Cluster","STRING",false,"1","SCNA_CLUSTER","ucec_msk_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ucec_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","ucec_tcga"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","ucec_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","ucec_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ucec_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","ucec_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","ucec_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","ucec_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","ucec_tcga"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","ucec_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","ucec_tcga"
"Death from Initial Pathologic Diagnosis Date","Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_DEATH","ucec_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","ucec_tcga"
"Days to Last Followup","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.","STRING",true,"1","DAYS_TO_LAST_FOLLOWUP","ucec_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","ucec_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","ucec_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","ucec_tcga"
"Participant Personal Medical History Diabetes Mellitus Ind-3","Participant medical history -diabetes mellitus: a metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization._A term that is used to indicate a question with permissible values of yes/no/unknown.","STRING",true,"1","DIABETES_DIAGNOSIS_INDICATOR","ucec_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","ucec_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","ucec_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","ucec_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","ucec_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ucec_tcga"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",true,"1","GRADE","ucec_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","ucec_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","ucec_tcga"
"History colorectal cancer","History colorectal cancer","STRING",true,"1","HISTORY_COLORECTAL_CANCER","ucec_tcga"
"History hormonal contraceptives use","History hormonal contraceptives use","STRING",true,"1","HISTORY_HORMONAL_CONTRACEPTIVES_USE","ucec_tcga"
"History menopausal hormone therapy","History menopausal hormone therapy","STRING",true,"1","HISTORY_MENOPAUSAL_HORMONE_THERAPY","ucec_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","ucec_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","ucec_tcga"
"History tamoxifen use","History tamoxifen use","STRING",true,"1","HISTORY_TAMOXIFEN_USE","ucec_tcga"
"Hypertension diagnosis","Hypertension diagnosis","STRING",true,"1","HYPERTENSION_DIAGNOSIS","ucec_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","ucec_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","ucec_tcga"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","ucec_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","ucec_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","ucec_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","ucec_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","ucec_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","ucec_tcga"
"Lymph nodes aortic examined count","Lymph nodes aortic examined count","NUMBER",true,"1","LYMPH_NODES_AORTIC_EXAMINED_COUNT","ucec_tcga"
"Lymph nodes aortic pos by he","Lymph nodes aortic pos by he","NUMBER",true,"1","LYMPH_NODES_AORTIC_POS_BY_HE","ucec_tcga"
"Lymph nodes aortic pos by ihc","Lymph nodes aortic pos by ihc","NUMBER",true,"1","LYMPH_NODES_AORTIC_POS_BY_IHC","ucec_tcga"
"Lymph nodes aortic pos total","Lymph nodes aortic pos total","NUMBER",true,"1","LYMPH_NODES_AORTIC_POS_TOTAL","ucec_tcga"
"Lymph nodes pelvic examined count","Lymph nodes pelvic examined count","NUMBER",true,"1","LYMPH_NODES_PELVIC_EXAMINED_COUNT","ucec_tcga"
"Lymph nodes pelvic pos by he","Lymph nodes pelvic pos by he","NUMBER",true,"1","LYMPH_NODES_PELVIC_POS_BY_HE","ucec_tcga"
"Lymph nodes pelvic pos by ihc","Lymph nodes pelvic pos by ihc","NUMBER",true,"1","LYMPH_NODES_PELVIC_POS_BY_IHC","ucec_tcga"
"Lymph nodes pelvic pos total","Lymph nodes pelvic pos total","NUMBER",true,"1","LYMPH_NODES_PELVIC_POS_TOTAL","ucec_tcga"
"Menopause Status","Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea.","STRING",true,"1","MENOPAUSE_STATUS","ucec_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","ucec_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","ucec_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","ucec_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ucec_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ucec_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","ucec_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","ucec_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","ucec_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","ucec_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","ucec_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","ucec_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","ucec_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","ucec_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","ucec_tcga"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","ucec_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","ucec_tcga"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","ucec_tcga"
"Peritoneal washing","Peritoneal washing","STRING",true,"1","PERITONEAL_WASHING","ucec_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","ucec_tcga"
"Pregnancies full term count","Pregnancies full term count","STRING",true,"1","PREGNANCIES_FULL_TERM_COUNT","ucec_tcga"
"Primary Other Site of Disease Name","A text description of an 'other' originating or primary anatomic site of the disease/condition under investigation or review.","STRING",true,"1","PRIMARY_SITE_OTHER","ucec_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","ucec_tcga"
"Tissue Prospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project.","STRING",true,"1","PROSPECTIVE_COLLECTION","ucec_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","ucec_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","ucec_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","ucec_tcga"
"Tissue Retrospective Collection Indicator","Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project.","STRING",true,"1","RETROSPECTIVE_COLLECTION","ucec_tcga"
"Sample Type","The type of sample (i.e., normal, primary, met, recurrence).","STRING",false,"1","SAMPLE_TYPE","ucec_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","ucec_tcga"
"Sex","Sex","STRING",true,"1","SEX","ucec_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","ucec_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","ucec_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","ucec_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","ucec_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","ucec_tcga"
"Surgical approach at diagnosis","Surgical approach at diagnosis","STRING",true,"1","SURGICAL_APPROACH_AT_DIAGNOSIS","ucec_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","ucec_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","ucec_tcga"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",true,"1","TISSUE_SOURCE_SITE","ucec_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","ucec_tcga"
"Tumor invasion percent","Tumor invasion percent","NUMBER",true,"1","TUMOR_INVASION_PERCENT","ucec_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","ucec_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","ucec_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","ucec_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","ucec_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","ucec_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ucec_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","ucec_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","ucec_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","ucec_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ucec_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","ucec_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ucec_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","ucec_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","ucec_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","ucec_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","ucec_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","ucec_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","ucec_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ucec_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","ucec_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ucec_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","ucec_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","ucec_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","ucec_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","ucec_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","ucec_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","ucec_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ucec_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ucec_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ucec_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","ucec_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","ucec_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","ucec_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","ucec_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","ucec_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","ucec_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","ucec_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","ucec_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","ucec_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","ucec_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","ucec_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","ucec_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","ucec_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","ucec_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","ucec_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","ucec_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","ucec_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","ucec_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","ucec_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","ucec_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","ucec_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","ucec_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","ucec_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","ucec_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","ucec_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","ucec_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","ucec_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","ucec_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","ucec_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","ucec_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","ucec_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","ucec_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","ucec_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","ucec_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","ucec_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","ucec_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","ucec_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","ucec_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","ucec_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","ucec_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","ucec_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","ucec_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","ucec_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","ucec_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","ucec_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","ucec_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","ucec_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","ucec_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","ucec_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","ucec_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","ucec_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","ucec_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","ucec_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","ucec_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","ucec_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ucec_tcga_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ucec_tcga_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ucec_tcga_pub"
"CNA Cluster K4","CNA cluster K4.","STRING",false,"1","CNA_CLUSTER_K4","ucec_tcga_pub"
"CNA Data","CNA data.","STRING",false,"1","CNA_DATA","ucec_tcga_pub"
"Data Core Sample","Data core sample.","STRING",false,"1","DATA_CORE_SAMPLE","ucec_tcga_pub"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","ucec_tcga_pub"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","ucec_tcga_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ucec_tcga_pub"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ucec_tcga_pub"
"Tumor Other Histologic Subtype","Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.","STRING",true,"1","HISTOLOGICAL_SUBTYPE","ucec_tcga_pub"
"MAF Data","MAF Data.","STRING",false,"1","MAF_DATA","ucec_tcga_pub"
"Methylation Cluster","Methylation cluster.","STRING",false,"1","METHYLATION_CLUSTER","ucec_tcga_pub"
"MicroRNA Cluster","MicroRNA cluster.","STRING",false,"1","MICRO_RNA_CLUSTER","ucec_tcga_pub"
"MicroRNA Score","MicroRNA score.","NUMBER",false,"1","MICRO_RNA_SCORE","ucec_tcga_pub"
"MLH1 Silencing","Epigenetic silencing status of MLH1.","STRING",false,"1","MLH1_SILENCING","ucec_tcga_pub"
"MRNA Expression Cluster","MRNA expression cluster.","STRING",false,"1","MRNA_EXPRESSION_CLUSTER","ucec_tcga_pub"
"MSI Status 5 Marker Call","MSI status 5 marker call.","STRING",false,"1","MSI_STATUS_5_MARKER_CALL","ucec_tcga_pub"
"MSI Status 7 Marker Call","MSI status 7 marker call.","STRING",false,"1","MSI_STATUS_7_MARKER_CALL","ucec_tcga_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ucec_tcga_pub"
"Mutation Rate Cluster","Mutation rate cluster","STRING",false,"1","MUTATION_RATE_CLUSTER","ucec_tcga_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ucec_tcga_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","ucec_tcga_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","ucec_tcga_pub"
"RNA-SEQ Data","RNA-SEQ data.","STRING",false,"1","RNASEQ_DATA","ucec_tcga_pub"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","ucec_tcga_pub"
"Tumor Stage 2009","Tumor stage 2009.","STRING",false,"1","TUMOR_STAGE_2009","ucec_tcga_pub"
"Adjuvant Treatment","Adjuvant treatment.","STRING",true,"1","ADJUVANT_TX","ucs_jhu_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ucs_jhu_2014"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ucs_jhu_2014"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ucs_jhu_2014"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ucs_jhu_2014"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ucs_jhu_2014"
"Percent Tumor Purity","Percent tumor purity.","NUMBER",false,"1","PERCENTAGE_TUMOR_PURITY","ucs_jhu_2014"
"Site","Site","STRING",true,"1","SITE","ucs_jhu_2014"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","ucs_jhu_2014"
"Tumor Stage","Tumor stage.","STRING",false,"1","TUMOR_STAGE","ucs_jhu_2014"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ucs_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code"," The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria. ","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","ucs_tcga"
"American Joint Committee on Cancer Publication Version Type"," The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications. ","STRING",true,"1","AJCC_STAGING_EDITION","ucs_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","ucs_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ucs_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage"," Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer. ","STRING",true,"1","CLINICAL_STAGE","ucs_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_M_STAGE","ucs_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Regional Lymph Node N Stage","Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_N_STAGE","ucs_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Primary Tumor T Stage","Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","CLIN_T_STAGE","ucs_tcga"
"Last Communication Contact from Initial Pathologic Diagnosis Date"," Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.. ","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","ucs_tcga"
"Birth from Initial Pathologic Diagnosis Date"," Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days. ","NUMBER",true,"1","DAYS_TO_BIRTH","ucs_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","ucs_tcga"
"Death from Initial Pathologic Diagnosis Date"," Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days. ","NUMBER",true,"1","DAYS_TO_DEATH","ucs_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value"," Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days. ","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","ucs_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","ucs_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","ucs_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","ucs_tcga"
"Participant Personal Medical History Diabetes Mellitus Ind-3","Participant medical history -diabetes mellitus: a metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization._A term that is used to indicate a question with permissible values of yes/no/unknown.","STRING",true,"1","DIABETES_DIAGNOSIS_INDICATOR","ucs_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","ucs_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","ucs_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","ucs_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","ucs_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ucs_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","ucs_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","ucs_tcga"
"History colorectal cancer","History colorectal cancer","STRING",true,"1","HISTORY_COLORECTAL_CANCER","ucs_tcga"
"History hormonal contraceptives use","History hormonal contraceptives use","STRING",true,"1","HISTORY_HORMONAL_CONTRACEPTIVES_USE","ucs_tcga"
"History menopausal hormone therapy","History menopausal hormone therapy","STRING",true,"1","HISTORY_MENOPAUSAL_HORMONE_THERAPY","ucs_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","ucs_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","ucs_tcga"
"History tamoxifen use","History tamoxifen use","STRING",true,"1","HISTORY_TAMOXIFEN_USE","ucs_tcga"
"Hypertension diagnosis","Hypertension diagnosis","STRING",true,"1","HYPERTENSION_DIAGNOSIS","ucs_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","ucs_tcga"
" International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code "," The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data. ","STRING",true,"1","ICD_O_3_HISTOLOGY","ucs_tcga"
" International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code "," The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data. ","STRING",true,"1","ICD_O_3_SITE","ucs_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","ucs_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","ucs_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","ucs_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","ucs_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","ucs_tcga"
"Lymph nodes aortic examined count","Lymph nodes aortic examined count","NUMBER",true,"1","LYMPH_NODES_AORTIC_EXAMINED_COUNT","ucs_tcga"
"Lymph nodes aortic pos by he","Lymph nodes aortic pos by he","NUMBER",true,"1","LYMPH_NODES_AORTIC_POS_BY_HE","ucs_tcga"
"Lymph nodes aortic pos by ihc","Lymph nodes aortic pos by ihc","NUMBER",true,"1","LYMPH_NODES_AORTIC_POS_BY_IHC","ucs_tcga"
"Lymph nodes aortic pos total","Lymph nodes aortic pos total","NUMBER",true,"1","LYMPH_NODES_AORTIC_POS_TOTAL","ucs_tcga"
"Lymph nodes pelvic examined count","Lymph nodes pelvic examined count","NUMBER",true,"1","LYMPH_NODES_PELVIC_EXAMINED_COUNT","ucs_tcga"
"Lymph nodes pelvic pos by he","Lymph nodes pelvic pos by he","NUMBER",true,"1","LYMPH_NODES_PELVIC_POS_BY_HE","ucs_tcga"
"Lymph nodes pelvic pos by ihc","Lymph nodes pelvic pos by ihc","NUMBER",true,"1","LYMPH_NODES_PELVIC_POS_BY_IHC","ucs_tcga"
"Lymph nodes pelvic pos total","Lymph nodes pelvic pos total","NUMBER",true,"1","LYMPH_NODES_PELVIC_POS_TOTAL","ucs_tcga"
"Menopause Status"," Text term to signify the status of a woman's menopause, the permanent cessation of menses, usually defined by 6 to 12 months of amenorrhea. ","STRING",true,"1","MENOPAUSE_STATUS","ucs_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","ucs_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","ucs_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","ucs_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ucs_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ucs_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","ucs_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","ucs_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","ucs_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","ucs_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","ucs_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","ucs_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","ucs_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","ucs_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","ucs_tcga"
"American Joint Committee on Cancer Metastasis Stage Code"," Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC). ","STRING",true,"1","PATH_M_STAGE","ucs_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","ucs_tcga"
"American Joint Committee on Cancer Tumor Stage Code"," Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC). ","STRING",true,"1","PATH_T_STAGE","ucs_tcga"
"Peritoneal washing","Peritoneal washing","STRING",true,"1","PERITONEAL_WASHING","ucs_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","ucs_tcga"
"Pregnancies full term count","Pregnancies full term count","STRING",true,"1","PREGNANCIES_FULL_TERM_COUNT","ucs_tcga"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",true,"1","PRIMARY_SITE","ucs_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","ucs_tcga"
"Tissue Prospective Collection Indicator"," Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project. ","STRING",true,"1","PROSPECTIVE_COLLECTION","ucs_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","ucs_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","ucs_tcga"
"Surgical Margin Resection Status","Text terms to describe the status of a tissue margin following surgical resection.","STRING",true,"1","RESIDUAL_TUMOR","ucs_tcga"
"Tissue Retrospective Collection Indicator"," Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project. ","STRING",true,"1","RETROSPECTIVE_COLLECTION","ucs_tcga"
"Sample Type"," The type of sample (i.e., normal, primary, met, recurrence). ","STRING",false,"1","SAMPLE_TYPE","ucs_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","ucs_tcga"
"Sex","Sex","STRING",true,"1","SEX","ucs_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","ucs_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","ucs_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","ucs_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","ucs_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","ucs_tcga"
"Surgical approach at diagnosis","Surgical approach at diagnosis","STRING",true,"1","SURGICAL_APPROACH_AT_DIAGNOSIS","ucs_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","ucs_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","ucs_tcga"
"Tissue Source Site"," A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource. ","STRING",true,"1","TISSUE_SOURCE_SITE","ucs_tcga"
"Primary Therapy Outcome Success Type","Text term for the measure of success of outcome after primary treatment (surgery and adjuvant therapies).","STRING",true,"1","TREATMENT_OUTCOME_FIRST_COURSE","ucs_tcga"
"Tumor invasion percent","Tumor invasion percent","NUMBER",true,"1","TUMOR_INVASION_PERCENT","ucs_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","ucs_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","ucs_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","ucs_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","ucs_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","ucs_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","ucs_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","ucs_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","ucs_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","ucs_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","ucs_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","ucs_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","ucs_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","ucs_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","ucs_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","ucs_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","ucs_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","ucs_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","ucs_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","ucs_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","ucs_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","ucs_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","ucs_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","ucs_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","ucs_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","ucs_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","ucs_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","ucs_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","ucs_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","ucs_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","ucs_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","ucs_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","ucs_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","ucs_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","ucs_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","ucs_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","ucs_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","ucs_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","ucs_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","ucs_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","ucs_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","ucs_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","ucs_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","ucs_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","ucs_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","ucs_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","ucs_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","ucs_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","ucs_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","ucs_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","ucs_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","ucs_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","ucs_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","ucs_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","ucs_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","ucs_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","ucs_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","ucs_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","ucs_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","ucs_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","ucs_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","ucs_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","ucs_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","ucs_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","ucs_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","ucs_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","ucs_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","ucs_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","ucs_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","ucs_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","ucs_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","ucs_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","ucs_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","ucs_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","ucs_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","ucs_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","ucs_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","ucs_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","ucs_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","ucs_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","ucs_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","ucs_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","ucs_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","ucs_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","ucs_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","ucs_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","urcc_mskcc_2016"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","urcc_mskcc_2016"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","urcc_mskcc_2016"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","urcc_mskcc_2016"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","urcc_mskcc_2016"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","urcc_mskcc_2016"
"Gene Panel","Gene panel.","STRING",false,"1","GENE_PANEL","urcc_mskcc_2016"
"Matched Normal","Has matched normal.","STRING",false,"1","HAS_MATCHED_NORMAL","urcc_mskcc_2016"
"Other Cancer","Has other cancer.","STRING",true,"1","HAS_OTHER_CANCER","urcc_mskcc_2016"
"Other Kidney Condition","Has other kidney condition.","STRING",true,"1","HAS_OTHER_KIDNEY_CONDITION","urcc_mskcc_2016"
"Last Status","Last Status.","STRING",true,"1","LAST_STATUS","urcc_mskcc_2016"
"Local Recurrence","Local recurrence.","STRING",true,"1","LOCAL_RECURRENCE","urcc_mskcc_2016"
"Local Recurrence (months)","Local recurrence (months).","NUMBER",true,"1","LOCAL_RECURRENCE_MONTHS","urcc_mskcc_2016"
"Metastasis","Metastasis.","STRING",true,"1","METASTASIS","urcc_mskcc_2016"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","urcc_mskcc_2016"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","urcc_mskcc_2016"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","urcc_mskcc_2016"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","urcc_mskcc_2016"
"Pathology Cancer Maximum Dimension (cm)","Pathology cancer maximum dimension (cm).","NUMBER",true,"1","PATH_CANCER_MAX_DIM_CM","urcc_mskcc_2016"
"Disease Surgical Margin Status","Text descriptor of the conclusive results following examination of tissue margin(s) for the presence of disease.","STRING",true,"1","PATH_MARGIN","urcc_mskcc_2016"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","urcc_mskcc_2016"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","urcc_mskcc_2016"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","urcc_mskcc_2016"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","urcc_mskcc_2016"
"Primary Tumor Site","Text term to describe the organ sub-division in an individual with cancer.","STRING",false,"1","PRIMARY_SITE","urcc_mskcc_2016"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","urcc_mskcc_2016"
"Sex","Sex","STRING",true,"1","SEX","urcc_mskcc_2016"
"Time to Last Followup","Time to last followup.","NUMBER",true,"1","TIME_TO_LAST_FOLLOWUP","urcc_mskcc_2016"
"Time to Metastasis (months)","Time to metastasis (months).","NUMBER",true,"1","TIME_TO_MET_MONTHS","urcc_mskcc_2016"
"Adjuvant Chemotherapy","Adjuvant Chemotherapy","STRING",true,"1","ADJUVANT_CHEMO","utuc_mskcc_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","utuc_mskcc_2013"
"CIS","CIS.","STRING",true,"1","CIS","utuc_mskcc_2013"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","utuc_mskcc_2013"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","utuc_mskcc_2013"
"Distant Recurrence","Distant recurrence.","STRING",true,"1","DISTANT_RECURRENCE","utuc_mskcc_2013"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","utuc_mskcc_2013"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","utuc_mskcc_2013"
"Local Recurrence","Local recurrence.","STRING",true,"1","LOCAL_RECURRENCE","utuc_mskcc_2013"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","utuc_mskcc_2013"
"Neoadjuvant Chemotherapy","Neoadjuvant Chemotherapy.","STRING",true,"1","NEOADJ_CHEMO","utuc_mskcc_2013"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","utuc_mskcc_2013"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","utuc_mskcc_2013"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","utuc_mskcc_2013"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","utuc_mskcc_2013"
"Primary histology","Primary Histology","STRING",true,"1","PRIMARY_HISTOLOGY","utuc_mskcc_2013"
"Sex","Sex","STRING",true,"1","SEX","utuc_mskcc_2013"
"Smoking History","Smoking History","STRING",true,"1","SMOKING_HISTORY","utuc_mskcc_2013"
"Person Cigarette Smoking History Pack Year Value","Numeric computed value to represent lifetime tobacco exposure defined as number of cigarettes smoked per day x number of years smoked divided by 20.","NUMBER",true,"1","SMOKING_PACK_YEARS","utuc_mskcc_2013"
"Status","Status.","STRING",true,"1","STATUS","utuc_mskcc_2013"
"Surgery","Surgery.","STRING",true,"1","SURGERY","utuc_mskcc_2013"
"Time to distant recurrence","Time to distant recurrence","NUMBER",true,"1","TIME_TO_DISTANT_RECURRENCE","utuc_mskcc_2013"
"TIME_TO_LAST_FOLLOW_UP","TIME_TO_LAST_FOLLOW_UP","NUMBER",true,"1","TIME_TO_LAST_FOLLOW_UP","utuc_mskcc_2013"
"Time to local recurrence status","Time to local recurrence status","STRING",true,"1","TIME_TO_LOCAL_RECURRENCE_STATUS","utuc_mskcc_2013"
"Tumor Site","Tumor Site","STRING",true,"1","TUMOR_SITE","utuc_mskcc_2013"
"Urothelial Primary","Urothelial primary.","STRING",true,"1","UROTHELIAL_PRIMARY","utuc_mskcc_2013"
"Variant Histology","Variant Histology","STRING",true,"1","VARIANT_HISTOLOGY","utuc_mskcc_2013"
"Year of Surgery","Year of surgery.","NUMBER",false,"1","YEAR_OF_SURGERY","utuc_mskcc_2013"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","uvm_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code"," The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria. ","STRING",true,"1","AJCC_CLINICAL_TUMOR_STAGE","uvm_tcga"
"Neoplasm American Joint Committee on Cancer Clinical Distant Metastasis M Stage","Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.","STRING",true,"1","AJCC_METASTASIS_CLINICAL_CM","uvm_tcga"
"American Joint Committee on Cancer Metastasis Stage Code"," Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC). ","STRING",true,"1","AJCC_METASTASIS_PATHOLOGIC_PM","uvm_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CN","uvm_tcga"
"American Joint Committee on Cancer Lymph Node Stage Code","The codes that represent the stage of cancer based on the nodes present (T stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_CLINICAL_CT","uvm_tcga"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","AJCC_NODES_PATHOLOGIC_PN","uvm_tcga"
"Neoplasm Disease Stage American Joint Committee on Cancer Code"," The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria. ","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","uvm_tcga"
"American Joint Committee on Cancer Publication Version Type"," The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications. ","STRING",true,"1","AJCC_STAGING_EDITION","uvm_tcga"
"American Joint Committee on Cancer Tumor Stage Code"," Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC). ","STRING",true,"1","AJCC_TUMOR_PATHOLOGIC_PT","uvm_tcga"
"Cancer Type","Cancer type","STRING",false,"1","CANCER_TYPE","uvm_tcga"
"Cancer Type Detailed","Cancer type detailed","STRING",false,"1","CANCER_TYPE_DETAILED","uvm_tcga"
"Cause of death other","Death cause text","STRING",true,"1","CAUSE_OF_DEATH_OTHER","uvm_tcga"
"Cytogenetic abnormality type","Cytogenetic abnormality type","STRING",true,"1","CYTOGENETIC_ABNORMALITY_TYPE","uvm_tcga"
"Last Communication Contact from Initial Pathologic Diagnosis Date"," Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days.. ","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","uvm_tcga"
"Birth from Initial Pathologic Diagnosis Date"," Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days. ","NUMBER",true,"1","DAYS_TO_BIRTH","uvm_tcga"
"Days to Sample Collection.","Days to sample collection.","NUMBER",false,"1","DAYS_TO_COLLECTION","uvm_tcga"
"Death from Initial Pathologic Diagnosis Date"," Time interval from a person's date of death to the date of initial pathologic diagnosis, represented as a calculated number of days. ","NUMBER",true,"1","DAYS_TO_DEATH","uvm_tcga"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value"," Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days. ","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","uvm_tcga"
"Days to Sample Procurement","Days to sample procurement.","STRING",false,"1","DAYS_TO_SPECIMEN_COLLECTION","uvm_tcga"
"Disease Free (Months)","Disease free (months) since initial treatment.","NUMBER",true,"1","DFS_MONTHS","uvm_tcga"
"Disease Free Status","Disease free status since initial treatment.","STRING",true,"1","DFS_STATUS","uvm_tcga"
"Disease code","Disease code","STRING",true,"1","DISEASE_CODE","uvm_tcga"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","uvm_tcga"
"Extranocular Nodule Size","Extranocular Nodule Size","STRING",true,"1","EXTRANOCULAR_NODULE_SIZE","uvm_tcga"
"Lymphomatous Extranodal Site Involvement Indicator","Indicator that identifies whether a patient with malignant lymphoma has lymphomatous involvement of an extranodal site.","STRING",true,"1","EXTRANODAL_INVOLVEMENT","uvm_tcga"
"Extrascleral Extension","Extrascleral Extension","STRING",true,"1","EXTRASCLERAL_EXTENSION","uvm_tcga"
"Extravascular Matrix Patterns","Extravascular Matrix Patterns","STRING",true,"1","EXTRAVASCULAR_MATRIX_PATTERNS","uvm_tcga"
"Eye Color","Eye Color","STRING",true,"1","EYE_COLOR","uvm_tcga"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","uvm_tcga"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","uvm_tcga"
"Gene Expression Profile","Gene Expression Profile","STRING",true,"1","GENE_EXPRESSION_PROFILE","uvm_tcga"
"Patient Height","Height in centimeters.","NUMBER",true,"1","HEIGHT","uvm_tcga"
"Neoplasm Histologic Type Name","Text term for the structural pattern of cancer cells used to define a microscopic diagnosis.","STRING",true,"1","HISTOLOGICAL_DIAGNOSIS","uvm_tcga"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treament given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","uvm_tcga"
"Prior Cancer Diagnosis Occurence","Text term to describe the patient's history of prior cancer diagnosis and the spatial location of any previous cancer occurrence.","STRING",true,"1","HISTORY_OTHER_MALIGNANCY","uvm_tcga"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","uvm_tcga"
" International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code "," The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data. ","STRING",true,"1","ICD_O_3_HISTOLOGY","uvm_tcga"
" International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code "," The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data. ","STRING",true,"1","ICD_O_3_SITE","uvm_tcga"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","uvm_tcga"
"Year Cancer Initial Diagnosis","Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer.","NUMBER",true,"1","INITIAL_PATHOLOGIC_DX_YEAR","uvm_tcga"
"Initial Patient Weight","Weight measured in kilograms.","NUMBER",false,"1","INITIAL_WEIGHT","uvm_tcga"
"Is FFPE","If the sample is from FFPE","STRING",false,"1","IS_FFPE","uvm_tcga"
"Longest Dimension","Longest Dimension","NUMBER",false,"1","LONGEST_DIMENSION","uvm_tcga"
"Metastatic Site","The anatomic location to which the cancer has spread.","STRING",true,"1","METASTATIC_SITE","uvm_tcga"
"Metastatic Site Other","Metastatic Site Other","STRING",true,"1","METASTATIC_SITE_OTHER","uvm_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT","uvm_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Other Method Type","Text to describe a method used to secure tissue for an original pathologic diagnosis that is different from other identified methods.","STRING",true,"1","METHOD_OF_INITIAL_SAMPLE_PROCUREMENT_OTHER","uvm_tcga"
"First Pathologic Diagnosis Biospecimen Acquisition Method Type","Text name of the procedure to secure the tissue used for the original pathologic diagnosis.","STRING",false,"1","METHOD_OF_SAMPLE_PROCUREMENT","uvm_tcga"
"Microvascular Density Mvd","Microvascular Density Mvd","STRING",true,"1","MICROVASCULAR_DENSITY_MVD","uvm_tcga"
"Mitotic Count","Mitotic Count","NUMBER",true,"1","MITOTIC_COUNT","uvm_tcga"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","uvm_tcga"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","uvm_tcga"
"Oct embedded","Oct embedded","STRING",false,"1","OCT_EMBEDDED","uvm_tcga"
"Oncotree Code","Oncotree code","STRING",false,"1","ONCOTREE_CODE","uvm_tcga"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","uvm_tcga"
"Overall Survival Status","Overall patient survival status.","STRING",true,"1","OS_STATUS","uvm_tcga"
"Specimen Collection Method","The type of procedure or method used to collect the specimen.","STRING",false,"1","OTHER_METHOD_OF_SAMPLE_PROCUREMENT","uvm_tcga"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","uvm_tcga"
"Other Sample ID","Legacy DMP sample identifier (DMPnnnn)","STRING",false,"1","OTHER_SAMPLE_ID","uvm_tcga"
"Pathology Report File Name","Pathology Report File Name","STRING",false,"1","PATHOLOGY_REPORT_FILE_NAME","uvm_tcga"
"Pathology report uuid","Pathology report uuid","STRING",false,"1","PATHOLOGY_REPORT_UUID","uvm_tcga"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","uvm_tcga"
"Pet Ct Standardized Values","Pet Ct Standardized Values","STRING",true,"1","PET_CT_STANDARDIZED_VALUES","uvm_tcga"
"Adjuvant Postoperative Pharmaceutical Therapy Administered Indicator","Indicator to signify whether or not whether the patient had adjuvant/post-operative pharmaceutical therapy.","STRING",true,"1","PHARMACEUTICAL_TX_ADJUVANT","uvm_tcga"
"Project code","Project code","STRING",true,"1","PROJECT_CODE","uvm_tcga"
"Tissue Prospective Collection Indicator"," Text indicator for the time frame of tissue procurement, indicating that the tissue was procured in parallel to the project. ","STRING",true,"1","PROSPECTIVE_COLLECTION","uvm_tcga"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","uvm_tcga"
"Did patient start adjuvant postoperative radiotherapy?","A yes/no indicator that asks whether the patient started adjuvant postoperative radiotherapy.","STRING",true,"1","RADIATION_TREATMENT_ADJUVANT","uvm_tcga"
"Tissue Retrospective Collection Indicator"," Text indicator for the time frame of tissue procurement, indicating that the tissue was obtained and stored prior to the initiation of the project. ","STRING",true,"1","RETROSPECTIVE_COLLECTION","uvm_tcga"
"Sample Type"," The type of sample (i.e., normal, primary, met, recurrence). ","STRING",false,"1","SAMPLE_TYPE","uvm_tcga"
"Sample type id","Sample type id","STRING",false,"1","SAMPLE_TYPE_ID","uvm_tcga"
"Sex","Sex","STRING",true,"1","SEX","uvm_tcga"
"Shortest Dimension","Shortest Dimension","NUMBER",false,"1","SHORTEST_DIMENSION","uvm_tcga"
"Specimen Current Weight","The weight of the specimen.","STRING",false,"1","SPECIMEN_CURRENT_WEIGHT","uvm_tcga"
"Specimen Freezing Means","The method used to freeze the tissue after removal from the patient.","STRING",false,"1","SPECIMEN_FREEZING_METHOD","uvm_tcga"
"Specimen Second Longest Dimension","The second longest dimension of the specimen.","NUMBER",false,"1","SPECIMEN_SECOND_LONGEST_DIMENSION","uvm_tcga"
"Stage Other","Stage Other","STRING",true,"1","STAGE_OTHER","uvm_tcga"
"Time between clamping and freezing","Time between clamping and freezing","STRING",false,"1","TIME_BETWEEN_CLAMPING_AND_FREEZING","uvm_tcga"
"Time between excision and freezing","Time between excision and freezing","STRING",false,"1","TIME_BETWEEN_EXCISION_AND_FREEZING","uvm_tcga"
"Tissue Source Site"," A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource. ","STRING",true,"1","TISSUE_SOURCE_SITE","uvm_tcga"
"Tumor Basal Diameter","Tumor Basal Diameter","NUMBER",true,"1","TUMOR_BASAL_DIAMETER","uvm_tcga"
"Tumor Basal Diameter Mx","Tumor Basal Diameter Mx","STRING",true,"1","TUMOR_BASAL_DIAMETER_MX","uvm_tcga"
"Tumor Infiltrating Lymphocytes"," Tumor infiltrating lymphocytes (TILs) are a type of white blood cell found in tumors. TILs are implicated in killing tumor cells, and the presence of lymphocytes in tumors is often associated with better clinical outcomes. ","STRING",true,"1","TUMOR_INFILTRATING_LYMPHOCYTES","uvm_tcga"
"Tumor Infiltrating Macrophages","Tumor Infiltrating Macrophages","STRING",true,"1","TUMOR_INFILTRATING_MACROPHAGES","uvm_tcga"
"Tumor Morphology Percentage","Tumor Morphology Percentage","STRING",true,"1","TUMOR_MORPHOLOGY_PERCENTAGE","uvm_tcga"
"Tumor Shape Pathologic Clinical","Tumor Shape Pathologic Clinical","STRING",true,"1","TUMOR_SHAPE_PATHOLOGIC_CLINICAL","uvm_tcga"
"Person Neoplasm Status","The state or condition of an individual's neoplasm at a particular point in time.","STRING",true,"1","TUMOR_STATUS","uvm_tcga"
"Tumor Thickness","Tumor Thickness","NUMBER",true,"1","TUMOR_THICKNESS","uvm_tcga"
"Tumor Thickness Measurement","Tumor Thickness Measurement","STRING",true,"1","TUMOR_THICKNESS_MEASUREMENT","uvm_tcga"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",true,"1","TUMOR_TISSUE_SITE","uvm_tcga"
"Vial number","Vial number","STRING",false,"1","VIAL_NUMBER","uvm_tcga"
"Patient's Vital Status","The survival state of the person.","STRING",true,"1","VITAL_STATUS","uvm_tcga"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","uvm_tcga"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","uvm_tcga_pan_can_atlas_2018"
"Neoplasm Disease Stage American Joint Committee on Cancer Code","The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.","STRING",true,"1","AJCC_PATHOLOGIC_TUMOR_STAGE","uvm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Publication Version Type","The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","STRING",true,"1","AJCC_STAGING_EDITION","uvm_tcga_pan_can_atlas_2018"
"Aneuploidy Score","Aneuploidy Score","NUMBER",false,"1","ANEUPLOIDY_SCORE","uvm_tcga_pan_can_atlas_2018"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","uvm_tcga_pan_can_atlas_2018"
"TCGA PanCanAtlas Cancer Type Acronym","Text field to hold cancer type acronym used by TCGA PanCanAtlas.","STRING",true,"1","CANCER_TYPE_ACRONYM","uvm_tcga_pan_can_atlas_2018"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","uvm_tcga_pan_can_atlas_2018"
"Center of sequencing","Center of sequencing","STRING",true,"1","CENTER","uvm_tcga_pan_can_atlas_2018"
"Last Communication Contact from Initial Pathologic Diagnosis Date","Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..","NUMBER",true,"1","DAYS_LAST_FOLLOWUP","uvm_tcga_pan_can_atlas_2018"
"Birth from Initial Pathologic Diagnosis Date","Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_BIRTH","uvm_tcga_pan_can_atlas_2018"
"Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value","Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.","NUMBER",true,"1","DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS","uvm_tcga_pan_can_atlas_2018"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","uvm_tcga_pan_can_atlas_2018"
"Form completion date","Form completion date","STRING",true,"1","FORM_COMPLETION_DATE","uvm_tcga_pan_can_atlas_2018"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","uvm_tcga_pan_can_atlas_2018"
"Person Gender","Patient gender.","STRING",true,"1","GENDER","uvm_tcga_pan_can_atlas_2018"
"Neoplasm Histologic Grade","Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","STRING",false,"1","GRADE","uvm_tcga_pan_can_atlas_2018"
"Neoadjuvant Therapy Type Administered Prior To Resection Text","Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.","STRING",true,"1","HISTORY_NEOADJUVANT_TRTYN","uvm_tcga_pan_can_atlas_2018"
"ICD-10 Classification","10th revision of the International Statistical Classification of Diseases and Related Health Problems.","STRING",true,"1","ICD_10","uvm_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_HISTOLOGY","uvm_tcga_pan_can_atlas_2018"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","uvm_tcga_pan_can_atlas_2018"
"Informed consent verified","Informed consent verified","STRING",true,"1","INFORMED_CONSENT_VERIFIED","uvm_tcga_pan_can_atlas_2018"
"In PanCan Pathway Analysis","Patient Part of PanCan Pathway Analysis","STRING",true,"1","IN_PANCANPATHWAYS_FREEZE","uvm_tcga_pan_can_atlas_2018"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","uvm_tcga_pan_can_atlas_2018"
"New Neoplasm Event Post Initial Therapy Indicator","Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.","STRING",true,"1","NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT","uvm_tcga_pan_can_atlas_2018"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","uvm_tcga_pan_can_atlas_2018"
"Other Patient ID","Legacy DMP patient identifier (DMPnnnn)","STRING",true,"1","OTHER_PATIENT_ID","uvm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Metastasis Stage Code","Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_M_STAGE","uvm_tcga_pan_can_atlas_2018"
"Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code","The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.","STRING",true,"1","PATH_N_STAGE","uvm_tcga_pan_can_atlas_2018"
"American Joint Committee on Cancer Tumor Stage Code","Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).","STRING",true,"1","PATH_T_STAGE","uvm_tcga_pan_can_atlas_2018"
"Person Neoplasm Cancer Status","Person neoplasm cancer status.","STRING",true,"1","PERSON_NEOPLASM_CANCER_STATUS","uvm_tcga_pan_can_atlas_2018"
"Primary Lymph Node Presentation Assessment","Primary lymph node presentation assessment.","STRING",true,"1","PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT","uvm_tcga_pan_can_atlas_2018"
"Prior Diagnosis","Prior diagnosis.","STRING",true,"1","PRIOR_DX","uvm_tcga_pan_can_atlas_2018"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","uvm_tcga_pan_can_atlas_2018"
"Radiation Therapy","Radiation Therapy.","STRING",true,"1","RADIATION_THERAPY","uvm_tcga_pan_can_atlas_2018"
"10p Status","Chromosome Arm-Calls: 10p","STRING",false,"1","STATUS_10P","uvm_tcga_pan_can_atlas_2018"
"10q Status","Chromosome Arm-Calls: 10q","STRING",false,"1","STATUS_10Q","uvm_tcga_pan_can_atlas_2018"
"11p Status","Chromosome Arm-Calls: 11p","STRING",false,"1","STATUS_11P","uvm_tcga_pan_can_atlas_2018"
"11q Status","Chromosome Arm-Calls: 11q","STRING",false,"1","STATUS_11Q","uvm_tcga_pan_can_atlas_2018"
"12p Status","Chromosome Arm-Calls: 12p","STRING",false,"1","STATUS_12P","uvm_tcga_pan_can_atlas_2018"
"12q Status","Chromosome Arm-Calls: 12q","STRING",false,"1","STATUS_12Q","uvm_tcga_pan_can_atlas_2018"
"13 (13q) Status","Chromosome Arm-Calls: 13 (13q)","STRING",false,"1","STATUS_13_13Q","uvm_tcga_pan_can_atlas_2018"
"14 (14q) Status","Chromosome Arm-Calls: 14 (14q)","STRING",false,"1","STATUS_14_14Q","uvm_tcga_pan_can_atlas_2018"
"15 (15q) Status","Chromosome Arm-Calls: 15 (15q)","STRING",false,"1","STATUS_15_15Q","uvm_tcga_pan_can_atlas_2018"
"16p Status","Chromosome Arm-Calls: 16p","STRING",false,"1","STATUS_16P","uvm_tcga_pan_can_atlas_2018"
"16q Status","Chromosome Arm-Calls: 16q","STRING",false,"1","STATUS_16Q","uvm_tcga_pan_can_atlas_2018"
"17p Status","Chromosome Arm-Calls: 17p","STRING",false,"1","STATUS_17P","uvm_tcga_pan_can_atlas_2018"
"17q Status","Chromosome Arm-Calls: 17q","STRING",false,"1","STATUS_17Q","uvm_tcga_pan_can_atlas_2018"
"18p Status","Chromosome Arm-Calls: 18p","STRING",false,"1","STATUS_18P","uvm_tcga_pan_can_atlas_2018"
"18q Status","Chromosome Arm-Calls: 18q","STRING",false,"1","STATUS_18Q","uvm_tcga_pan_can_atlas_2018"
"19p Status","Chromosome Arm-Calls: 19p","STRING",false,"1","STATUS_19P","uvm_tcga_pan_can_atlas_2018"
"19q Status","Chromosome Arm-Calls: 19q","STRING",false,"1","STATUS_19Q","uvm_tcga_pan_can_atlas_2018"
"1p Status","Chromosome Arm-Calls: 1p","STRING",false,"1","STATUS_1P","uvm_tcga_pan_can_atlas_2018"
"1q Status","Chromosome Arm-Calls: 1q","STRING",false,"1","STATUS_1Q","uvm_tcga_pan_can_atlas_2018"
"20p Status","Chromosome Arm-Calls: 20p","STRING",false,"1","STATUS_20P","uvm_tcga_pan_can_atlas_2018"
"20q Status","Chromosome Arm-Calls: 20q","STRING",false,"1","STATUS_20Q","uvm_tcga_pan_can_atlas_2018"
"21 (21q) Status","Chromosome Arm-Calls: 21 (21q)","STRING",false,"1","STATUS_21_21Q","uvm_tcga_pan_can_atlas_2018"
"22 (22q) Status","Chromosome Arm-Calls: 22 (22q)","STRING",false,"1","STATUS_22_22Q","uvm_tcga_pan_can_atlas_2018"
"2p Status","Chromosome Arm-Calls: 2p","STRING",false,"1","STATUS_2P","uvm_tcga_pan_can_atlas_2018"
"2q Status","Chromosome Arm-Calls: 2q","STRING",false,"1","STATUS_2Q","uvm_tcga_pan_can_atlas_2018"
"3p Status","Chromosome Arm-Calls: 3p","STRING",false,"1","STATUS_3P","uvm_tcga_pan_can_atlas_2018"
"3q Status","Chromosome Arm-Calls: 3q","STRING",false,"1","STATUS_3Q","uvm_tcga_pan_can_atlas_2018"
"4p Status","Chromosome Arm-Calls: 4p","STRING",false,"1","STATUS_4P","uvm_tcga_pan_can_atlas_2018"
"4q Status","Chromosome Arm-Calls: 4q","STRING",false,"1","STATUS_4Q","uvm_tcga_pan_can_atlas_2018"
"5p Status","Chromosome Arm-Calls: 5p","STRING",false,"1","STATUS_5P","uvm_tcga_pan_can_atlas_2018"
"5q Status","Chromosome Arm-Calls: 5q","STRING",false,"1","STATUS_5Q","uvm_tcga_pan_can_atlas_2018"
"6p Status","Chromosome Arm-Calls: 6p","STRING",false,"1","STATUS_6P","uvm_tcga_pan_can_atlas_2018"
"6q Status","Chromosome Arm-Calls: 6q","STRING",false,"1","STATUS_6Q","uvm_tcga_pan_can_atlas_2018"
"7p Status","Chromosome Arm-Calls: 7p","STRING",false,"1","STATUS_7P","uvm_tcga_pan_can_atlas_2018"
"7q Status","Chromosome Arm-Calls: 7q","STRING",false,"1","STATUS_7Q","uvm_tcga_pan_can_atlas_2018"
"8p Status","Chromosome Arm-Calls: 8p","STRING",false,"1","STATUS_8P","uvm_tcga_pan_can_atlas_2018"
"8q Status","Chromosome Arm-Calls: 8q","STRING",false,"1","STATUS_8Q","uvm_tcga_pan_can_atlas_2018"
"9p Status","Chromosome Arm-Calls: 9p","STRING",false,"1","STATUS_9P","uvm_tcga_pan_can_atlas_2018"
"9q Status","Chromosome Arm-Calls: 9q","STRING",false,"1","STATUS_9Q","uvm_tcga_pan_can_atlas_2018"
"Subtype","Subtype","STRING",true,"1","SUBTYPE","uvm_tcga_pan_can_atlas_2018"
"Tissue Prospective Collection Indicator","Tissue prospective collection indicator.","STRING",false,"1","TISSUE_PROSPECTIVE_COLLECTION_INDICATOR","uvm_tcga_pan_can_atlas_2018"
"Tissue Retrospective Collection Indicator","Tissue retrospective collection indicator.","STRING",false,"1","TISSUE_RETROSPECTIVE_COLLECTION_INDICATOR","uvm_tcga_pan_can_atlas_2018"
"Tissue Source Site","A Tissue Source Site collects samples (tissue, cell, or blood) and cliincal metadata which are then sent to tha Biospecimen Core Resource.","STRING",false,"1","TISSUE_SOURCE_SITE","uvm_tcga_pan_can_atlas_2018"
"Tumor Disease Anatomic Site","Text term that describes the anatomic site of the tumor or disease.","STRING",false,"1","TUMOR_TISSUE_SITE","uvm_tcga_pan_can_atlas_2018"
"Tumor Type","Tumor Type","STRING",false,"1","TUMOR_TYPE","uvm_tcga_pan_can_atlas_2018"
"Patient Weight","Weight measured in kilograms.","NUMBER",true,"1","WEIGHT","uvm_tcga_pan_can_atlas_2018"
"Diagnosis Age","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE","wt_target_2018_pub"
"Diagnosis Age (days)","Age at which a condition or disease was first diagnosed.","NUMBER",true,"1","AGE_IN_DAYS","wt_target_2018_pub"
"Analysis Cohort","Analysis Cohort","STRING",false,"1","ANALYSIS_COHORT","wt_target_2018_pub"
"Cancer Type","Cancer Type","STRING",false,"1","CANCER_TYPE","wt_target_2018_pub"
"Cancer Type Detailed","Cancer Type Detailed","STRING",false,"1","CANCER_TYPE_DETAILED","wt_target_2018_pub"
"Neoplasm American Joint Committee on Cancer Clinical Group Stage","Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","STRING",true,"1","CLINICAL_STAGE","wt_target_2018_pub"
"Time To Event (days)","Time To Event (days)","NUMBER",true,"1","DAYS_TO_EVENT","wt_target_2018_pub"
"Ethnicity Category","The text for reporting information about ethnicity.","STRING",true,"1","ETHNICITY","wt_target_2018_pub"
"Event Type","Event Type","STRING",true,"1","EVENT_TYPE","wt_target_2018_pub"
"Fraction Genome Altered","Fraction Genome Altered","NUMBER",false,"20","FRACTION_GENOME_ALTERED","wt_target_2018_pub"
"Histology Classification in Primary Tumor","Histology classification in primary tumor","STRING",false,"1","HISTOLOGY_CLASSIFICATION_IN_PRIMARY_TUMOR","wt_target_2018_pub"
"ICD-0-3-T","ICD-0-3-T","STRING",false,"1","ICD_0_3_T","wt_target_2018_pub"
"International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code","The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.","STRING",true,"1","ICD_O_3_SITE","wt_target_2018_pub"
"Mutation Count","Mutation Count","NUMBER",false,"30","MUTATION_COUNT","wt_target_2018_pub"
"Oncotree Code","Oncotree Code","STRING",false,"1","ONCOTREE_CODE","wt_target_2018_pub"
"Overall Survival Days","Overall patient survival days","NUMBER",true,"1","OS_DAYS","wt_target_2018_pub"
"Overall Survival (Months)","Overall survival in months since initial diagonosis.","NUMBER",true,"1","OS_MONTHS","wt_target_2018_pub"
"Overall Survival Status","Overall patient survival status.","STRING",true,"9","OS_STATUS","wt_target_2018_pub"
"Patient Death Reason","Text term to identify the cause of death for a patient.","STRING",true,"1","PATIENT_DEATH_REASON","wt_target_2018_pub"
"Protocol","Protocol.","STRING",true,"1","PROTOCOL","wt_target_2018_pub"
"Race Category","The text for reporting information about race.","STRING",true,"1","RACE","wt_target_2018_pub"
"Sex","Sex","STRING",true,"1","SEX","wt_target_2018_pub"